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Abstract 
The dorsal vagal nucleus (DMNX) and nucleus ambiguus (NA) are two anatomically 
distinct regions of the medulla oblongata of the brainstem involved with the control of 
the heart on a beat to beat basis.  The vagus nerve has parasympathetic cell bodies 
located in the DMNX and NA.  The presence of the disease associated prion (PrPD) in 
the DMNX and NA is used in the post mortem diagnosis of transmissible spongiform 
encephalopathies (TSEs) in animals.  It has been shown that  PrPD alters the 
neuronal discharge properties of infected tissue (Barrow, Holmgren et al. 
1999;Collinge, Whittington et al. 1994).  I wished to investigate whether a change in 
heart rate variability (HRV) influenced by the presence of PrPD deposits in brainstem 
areas of animals and people incubating TSEs would be detectable. 
Recordings from control and infected sheep, cattle and humans, consisting of three-
hundred-second samples of electrocardiogram (ECG) were collected from species 
specific healthy controls and subjects incubating TSE disease.  Data were digitised at 
a sampling frequency of 1kHz and were translated and analysed using standard 
software (CED Spike2 ; IBM SPSS). Artefacts and missed beats were corrected 
based upon screening by eye.  ECG R-wave timings were obtained in order to 
determine variability in the R-R intervals. An instantaneous tachogram was 
constructed from which power spectra were calculated.  
Power spectral analysis along with simpler time domain estimates of HRV, such as 
RMSSD, were employed to investigate differences between control and infected 
animals.  In addition R wave variability within each breath was utilized to examine the 
vagal control of the heart in relation to breathing and thus investigate a change in 
function of the specific neurological areas of the brainstem used as diagnostic criteria 
for such diseases. 
It was found there were significant differences (p<0.05) in the HRV of infected sheep, 
cattle and humans incubating TSE disease compared to control samples.  Repeated 
non-invasive longitudinal tests may provide a means to screen animals and humans 
for the presence of disease associated prions and may give applications in the 
objective assessments of putative therapeutics in addition to identifying TSE disease 
at a preclinical stage. 
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Chapter 1 Introduction: Prions, heart and brain. 
Transmissible Spongiform Encephalopathies (TSEs) which are also referred to as 
prion diseases, include kuru, variant Creutzfeldt–Jakob disease (vCJD), sporadic 
Creutzfeldt–Jakob disease (sCJD), iatrogenic Creutzfeldt–Jakob disease (iCJD) and 
Gerstmann– Sträussler–Scheinker disease (GSS) of humans as well as animal 
diseases such as scrapie in sheep, chronic wasting disease of deer (CWD) and 
bovine spongiform encephalopathy (BSE) in cattle.  The diseases are almost always 
fatal, although one vCJD patient has survived over eight years post diagnosis (as of 
December 2010).  A comprehensive understanding of prion diseases and their 
proposed infectious agents is useful in determining the risk of infection from various 
strains of TSEs to human and animal populations.  In addition, an increased 
understanding and assessment of the problem of TSEs may help in the design of a 
treatment or cure for diseases of this type.  This is highlighted by the threat of BSE to 
the human population and exemplifies the ability of TSEs to overcome the species 
barrier, where a disease of cattle, BSE, is thought to cause pathogenic disease in 
humans, vCJD (Asante, Linehan et al. 2002;Collinge 2001;Hill, Desbruslais et al. 
1997). 
More recent analysis of the epidemiology and risks involved in the transmission of BSE 
to the human population has been done (Ironside, Bishop et al. 2006).  That work 
highlighted the possibility that vCJD may affect not only the methionine recessive 
genotype but also the heterozygous and valine homozygous genotypes.  The 
proposed long incubation period of up to 40 years (Hilton 2006) in some individuals for 
this type of prion disease, coupled with the fact that there has now been 3 iatrogenic 
infections from blood transfusions (Wroe, Pal et al. 2006), raised concern about 
subclinical carriers of the disease donating blood to more susceptible genotypes.  One 
of these iatrogenic infections was identified in a patient heterozygous at the PRNP 
codon 129, indicating that human to human transmission of prion diseases is not 
isolated to the methionine recessive genotype and suggests a lower barrier to 
transmission within species than between species (Peden, Head et al. 2004). This 
emphasizes the need to not only know those individuals who express the clinical signs 
of TSEs but also those that carry it. 
13 
Doubt about the infectious agent is being mooted in current research.  Recent work 
has suggested there may be factors other than prions that cause the infection (Jeffrey, 
Gonzalez et al. 2006) or that prions need crucial cofactors (Caughey & Baron 
2006;Fasano, Campana, & Zurzolo 2006).  Even the prospect of silent prions lying 
dormant has been suggested; lying dormant in normal human brains that may seed 
the conversion cascade of normal cellular prion into the disease associated 
conformation (Yuan, Xiao et al. 2006).  Around 30 years ago vCJD and BSE were 
unknown. The area of TSE diseases and prion research is still very active and will 
contribute to the knowledge of those diseases currently being studied and importantly 
may help in identification of diseases we do not yet know.  
Characterization of the disease associated marker 
The Prion Theory 
In 1982, Stanley Prusiner used the term “Proteinacious Infectious Particle” or PRION 
to describe the biochemically purified scrapie agent which he equated to the prion 
protein PrP, which constituted the major component of the infectious preparation 
(Prusiner 1982). 
Prion protein was thought to differ from all other infectious pathogens since it did not 
contain nucleic acid molecules that coded for the constituent protein.  The principal 
component of the isolated scrapie agent was termed PrP.  From this isolation the 
complementary DNA and gene were cloned and it was found to be encoded by the 
human gene, PRNP.  In turn this lead to the identification of two types of PrP, the 
cellular isoform, PrPc and the pathogenic protease resistant conformation, PrPSc 
(Prusiner.1982).  It is thought that the normal cellular prion protein, PrPc, is converted 
into an abnormal, protease-resistant isoform, PrPSc, by a post-translational process 
which involves a conformational change in the protein structure. 
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Various forms of this pathological isoform have been identified and may be denoted 
by different labels such as PrPcwd , PrPvCJD , PrPbse depending on the disease under 
investigation.  The nomenclature to designate the wild-type and mutant prion protein 
associated with the infectious disease, different prion isolates, and the normal and 
artificial prion proteins expressed in transgenic mice, are currently evolving.  To 
denote the distinction between the naturally occurring shape and disease associated 
isoform of the prion, the term PrPD will be used in this thesis to distinguish the disease 
associated pathological isoform from the naturally occurring conformer, PrPc.  
Therefore, PrPc designates the normal cellular isoform of prion found in humans and 
animals and PrPD designates the pathogenic prion synthesized in any animal or 
human whether its synthesis is initiated by inoculation or infection with human or 
animal prions.  
The presence of infectious prion (PrPD) in regions of the medulla oblongata of the 
brainstem, specifically the dorsal vagal nucleus (DMNX) and nucleus ambiguus (NA), 
is used in post mortem diagnosis of Bovine Spongiform Encephalopathy (BSE).  In 
addition, a range of human transmissible spongiform encephalopathies have a 
pathological hallmark of the accumulation of PrPD in the central nervous system 
which included strongly stained regions of the DMNX in relation to variant Creutzfeldt 
Jakob Disease (vCJD) (Armstrong, Cairns et al. 2002;Armstrong, Lantos et al. 
2003;Ironside 2000). 
Alternative historical theories for TSE infection 
Evidence for the existence and infectivity of TSEs was postulated as early as 1922 by 
McGowan.  The term scrapie was applied to this disease due to the infected sheep 
scraping on fences.  This disease had been evident since 1732, and became such a 
problem that there was a memorial to the House of Commons regarding its 
destructiveness from sheep breeders in 1755.  It was considered “a disease of 
muscle caused by the parasite Sarcosporidia” (McGowan J 1922).  In 1939, Cullié 
and Chelle demonstrated that scrapie was transmissible to sheep and goats by 
intraocular inoculation and later by intracerebral, oral, subcutaneous, intramuscular 
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and intravenous injection of brain extracts from scrapie incubating sheep (Cuillé & 
Chelle 1939).   Gordon, in 1946, presented his observations when trying to develop a 
vaccination for louping-ill virus (an acute viral tick-transmitted disease primarily of 
sheep characterized by ataxia, muscular incoordination, tremors, posterior paralysis, 
coma, and death).  After vaccinating with formalin (a solution of formaldehyde in 
water used to disinfect or preserve biological specimens) treated ovine lymphoid 
extracts, he found around 1500 sheep developed scrapie two years after vaccination.  
This highlighted that the infectious agent was resistant to formalin and also illustrated 
the lengthy incubation time for the disease (Gordon 1946).   Alper, Haig and Clarke
demonstrated that scrapie infectivity resisted inactivation by ultra violet (UV) and 
ionizing radiation and other evidence that was incompatible with the involvement of 
nucleic acid, lead them to postulate that the infectious agent may be a protein (Alper, 
Haig, & Clarke 1966).  In addition, theories that suggested the infection for scrapie 
was related to a replicable change in the structure of commonly occurring unit 
membranes were being developed (Gibbons & Hunter 1967).  Griffith then outlined 
the “protein only” hypothesis that suggested the infectious agent consisted of a 
modified form of a normal cellular protein and exhibited self-replication (Griffith 1967).    
The development in the concept of prion infection evolved from the infectious agent 
first being thought of as a parasite (McGowan J.1922) and progressed to ideas of a 
“slow virus”(Leader & Hurvitz 1972;Sigurdsson 1954).  The next postulates were then 
advanced since the “slow virus” postulated by Sigurdsson was able to withstand salt 
concentrations and UV radiation which destroys nucleic acid structure.   
Various hypotheses on the structure of the prion are currently held.  The most popular 
is the “Protein Only” hypothesis which suggests that the disease associated 
conformation of TSEs is able to reproduce itself independent of nucleic acid and 
initially the infectious agent is derived from a natural protein (prion , PrPc) by a 
conformational change to form the disease associated isoform ( PrPD).  (Cohen & 
Prusiner 1998).  To accommodate both the protein only nature of this theory and to 
account for different strains of prion formed as a result of transfer in different hosts, 
the uniform theory of propagation was postulated (Weissmann 1999).  This model 
assumed the disease causing isoform, designated the aproprion, was associated with 
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a small nucleic acid, the co-prion.  This co-prion could confer the strain specific 
variations to the combined infectious agent, termed the holoprion (apoprion + co-prion 
= holoprion).  The protein only component, the apoprion, is still able to mediate 
disease pathogenesis on its own.   Coupling of these newly generated apoprions with 
a new nucleic acid co-prion from the host, could code for a different strain.  The 
nucleic acid component not being essential for disease transmission, but would 
account for the strain varieties observed upon transfer to different hosts. 
A number of other hypotheses have been presented and some are still under 
consideration as alternatives to the protein only model.  The virus theory, suggested 
the disease pathogenesis may be described as a virus induced amyloidosis.  The 
virus was suggested to replicate in the lymphoid tissue and then enter the brain 
where replication led to higher concentrations of the infectious agent which caused 
aggregation of nerve cell proteins into amyloid fibrils which caused cell death and loss 
of neuronal function (Diringer 1991). 
The virino theory suggested a small amount of nucleic acid is involved with the 
infectious agent and this non translated nucleic acid is protected by a host derived 
protective coat.  This is distinct from a virus, where the protective shield for the 
nucleic material is coded by the virus.  This virino theory addressed the absence of an 
immune response in TSE diseases (Diener 1973).  Another idea was based on the 
infectious agent, this time termed a viroid,  that contained a nucleic acid of such a 
simple sequence that small sections of the polynucleotide retained the full 
informational sequence of the agent (Diener.1973). 
The virus, viroid and virino hypotheses all fit into the concept of slow infections 
designated by Sigurdsson.  They contrast to the protein only theory proposed by 
Prusiner which nominated the prion as the infectious agent devoid of nucleic material.  
Regardless of the exact mode of infection, TSE diseases are still causing death and 
contamination issues to humans and animals.  As such, the protein only theory and 
the term prion can be used as an operational model whilst the history of TSEs is 
being written as the result of on-going research.  
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Further issues that relate to the protein only hypothesis of TSE transmission relate to 
the idea that PrPD , the proposed infectious agent, is replicated by imparting its 
aberrant shape onto PrPc .  A prediction of the protein only hypothesis suggests that it 
should be possible to create infectivity of modified prion protein in vitro.  Kurt  
Wüthrich has commented that continued failure to do this, calls the theory into 
question.    
Although work by Castilla (Castilla, Saβ et al. 2005) and subsequent researchers 
(Deleault, Harris et al. 2007;Wang, Wang et al. 2010) goes a long way to 
accomplishing this goal by producing prion disease from a prion entirely generated in 
vitro and has inferred that a misfolded protein is an active component of the infectious 
agent it remains unclear whether another molecule besides the misfolded prion 
protein might be an essential element of the infectious agent (Soto 2010) . Also from 
the protein only postulate, it should be possible to abolish the structure of a prion by 
in vitro chemical treatment and then attempt to restore the original structure and 
function of the disease initiating prion.  Experiments to achieve this have also failed to 
demonstrate the expected outcome.   
Wüthrich has commented that accumulation of PrPD may be considered as a build-up 
of garbage in cells and suggested that a better understanding of the normal prion 
protein and its function is needed to more fully understand prion diseases (reported in  
(Aguzzi & Heikenwalder 2003)commenting on (Wuthrich 2003).  The accumulation of 
PrPD , the garbage referred to above, in the cytosol of neurons is thought to bring 
about nerve cell death (Ma & Lindquist 2002;Ma, Wollmann, & Lindquist 2002).   
It is suggested that PrPc resides in the cell membrane and is transported there by the 
network of internal membranes, the endoplasmic reticulum(ER).  However, a certain 
amount of PrPc does not reach the cell membrane and re-enters the cytosol by 
“retrotranslocation” from the ER (the mechanism where a protein that has entered the 
ER gets back to the cytoplasm) in a similar manner that other mis-folded proteins are 
directed towards proteasomes for disposal.  This PrPc in the cytosol forming the basis 
for PrPD expression. 
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Lindquist’s group demonstrated that a prion protein specifically targeted to the cytosol 
caused rapid neural cell death in their experiments with mice.  It was suggested that 
this prion protein did not acquire protease resistance as PrPD but proteasome 
inhibition lead to the accumulation of slightly protease resistant prion protein in 
cultured cells.  Lindquist postulated that mutations in prion protein associated with 
TSE diseases may lead to enhanced retrotranslocation which in conjunction with 
impaired proteasome function, may lead to the expression of a particular disease.  In 
this case, the site of PrP mediated neuronal death begins in the cytosol, supporting 
the idea of a build-up of garbage.   
This idea is contested by Harris’ group who reported that cytosolic prion protein 
retains its “single peptide” which is normally removed after a protein enters the ER 
and cytosolic prion protein does not have the “ glycosyl phosphatidyl-inositol (GPI)  
anchor” required to attach to membranes (Drisaldi, Stewart et al. 2003).  
Consequently it is suggested by Drisaldi et al that these proteins have never entered 
the ER and consequently could not have undergone retrotranslocation.  The authors 
also state that proteasome inhibitors have strong effects on the levels of mRNA which 
may have contributed to differing results in previous work in this area.
Questions about the Prion Hypothesis 
Currently there are increasing questions being raised that challenge the Prion Theory 
for TSE infectivity.  Among the more recent evidence is the work where infectious 
prions inoculated into sheep, did not appear as expected in the Peyers patches, but 
were either digested by endogenous digestive chemicals or transported into the 
lymph nodes.  It was also found that abnormal disease associated prions began 
accumulating in the Peyers patches 30 days after the initial inoculation (Jeffrey, 
Gonzalez et al.2006).  This may suggest that some different infectious agent invaded 
the cells of the animal to provoke de novo accumulation of the diseases associated 
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PrP in the Peyers patches 30 days after the initial inoculation.  The question may 
then be proposed as to where this infectious agent went during this 30 day period? 
Further evidence of the existence of an infectious agent differing from PrP is given by 
the identification of damaged areas of brain where there were no prions (Jeffrey, 
Goodsir et al. 2004).  An in depth critique of the prion hypothesis is given in the recent 
work that postulates that a 25 nm “virion” is the likely cause of TSEs (Manuelidis 
2006).  Here, it is suggested that the particle size may accommodate a viral genome 
of sufficient size to encode for an enzyme required for its replication and host PrP 
may act as a facilitator for infectious particles eventually acquiring pathological 
features.   Here, PrP is thought to act as a viral receptor rather than infectious agent.  
Disassociation of prion protein and infectivity has also been demonstrated by 
treatment with hydrochloric acid where infectivity is always inactivated faster than PrP 
at differing concentrations and temperatures (Appel, Lucassen et al. 2006).  It is also 
suggested that host responses similar to those found to other viral infections are also 
displayed in TSE disease incubation and are observed before PrPD is evident (Lu, 
Baker, & Manuelidis 2004).  
Furthermore, it is pointed out that the Prion Hypothesis does not accommodate any of 
Koch’s postulates for an infectious agent.  These may be summarized as: The agent 
must be present in every case of the disease; the agent must be isolated from the 
host with the disease and grown in pure culture; the specific disease must be 
reproduced when a pure culture of the agent is inoculated into a healthy susceptible 
host; the agent must be recoverable from the experimentally infected host 
(Manuelidis.2006). 
Recent publications in relation to this topic review the work of Nazor, Castilla and 
Deleault and conclude that none of these reports provide conclusive evidence that the 
infectious agent for TSEs is composed of just protein and “robust” infection failed to 
be created in vitro from constituent building blocks.  This work suggest that other 
molecules derived from the host, such as sulphated glycosaminoglycans and nucleic 
acids may be involved (Caughey & Baron.2006).  In addition to prions, various co-
factors are also being suggested due to in vitro experiments failing to generate robust 
infection (Fasano, Campana et al.2006).  The possibility of disease associated prions 
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that may be “silent” in some host species awaiting the trigger from an infectious agent 
for disease expression to occur is also suggested (Yuan, Xiao et al.2006) 
We must bear in mind that there is a possibility that prions may not be the primary 
causal agent of the disease and may be a secondary pathological marker for the 
family of diseases; correlation is not proof of causation.   
Prion Strains 
A surrogate marker for prion diseases is the presence of a proteinase resistant 
isoform (PrPD) of the host prion protein (PrPc).   The proteinase resistant form may 
appear in a number of different subtypes, categorised by its glycosylation patterns.  
Both PrPc and PrPD may appear in unglycosylated, monoglycosylated or 
diglycosylated forms.   These subtypes of prion are used to classify types of disease 
and the distinct glycosylation patterns of PrPD correlate with a specific disease 
phenotype incubated in a particular host genotype.  Hence, glycosylation of PrPD may 
be considered a surrogate marker for strains of prion diseases.  However, recent 
work has identified that some forms of CJD had both Type 1 and Type 2 glycosylation 
patterns, based from the banding patterns observed from western blot analysis of a 
range of neural tissues (Polymenidou, Stoeck et al. 2005).  This leads to the 
possibility that more than one prion strain can be present in one disease phenotype 
and suggests a continuum of diseases may be expressed due to the diversity of 
strains and variable interactions with the genotype of the host.  In the identification of 
CJD for example, the occurrence of new variant CJD may have been more akin to the 
discovery of yet another variety of the continuum of disease expression rather than a 
new disease, an idea that is supported by the increasing number of “atypical” cases 
of TSE diseases in a range of mammals.  This in turn must then illustrate the potential 
for a future occurrence of another “new” variation of TSE disease.  This emphasises 
the need for a better understanding of TSE diseases and their pathogenesis.    
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There is also diversity in strains of TSEs, some of which may be apparent as sporadic 
(as yet of undetermined origin) neurodegenerative diseases. In addition some strains 
may affect more than one species.  For example the recent reoccurrence of scrapie 
has been suggested to be ovine BSE due to the difficulty in distinguishing scrapie and 
BSE in sheep (Aguzzi, Heikenwalder, & Polymenidou 2007).  Indeed it may be 
noteworthy to recall that the florid plaques associated with the pathology of vCJD in 
humans were initially compared to those seen in mice with Icelandic scrapie 
(Ironside.2000).  Here, the TSE from cows appeared in humans with similar traits to 
those of scrapie in mice.  These facts illustrate that there may be a significant 
interaction of a strain of TSE disease with a particular host, consequently, different 
disease phenotypes may present as a result of the species and strain interaction. 
It is suggested that if two strains co-infect a host, there is a possibility that one strain 
impedes the second strain in exercising its disease phenotype (Dickinson, Fraser et 
al. 1972;Manuelidis 1998).  If this is the case, an infected animal may harbour two 
strains only one of which is pathogenic in that individual.  If a host genotype, 
susceptible to the second strain, was then subjected to the same joint infection 
regime, the susceptible genotype may express a different disease phenotype than the 
original animal.  Here a subclinical carrier for the previously silent infection may pass 
this on to a susceptible genotype in which it subsequently is expressed. The 
expression of infection may thus be interpreted as contracting only one strain, from a 
continuum, that is pathological for the particular host genotype. This theory would 
emphasise the diversity of strains of TSEs and their potential differing effect on a 
range of genotypes and highlight the prospect of subclinical carriers infecting 
susceptible genotypes. 
The origins of certain TSEs are still unknown.  Considerable debate surrounds the 
origin of sporadic CJD.  Among the hypotheses proffered to address the aetiology of 
this disease are the random formation of PrPD molecules from a somatic cell mutation 
or a change in the protein kinetics stabilizing PrPC (Cohen 1999), the possible 
somatic mutation of PrPc in neural tissue (Prusiner 1991)  and a reduction in the 
ability to remove PrPD with respect to increasing length of incubation time (Safar, 
Dearmond et al. 2005).  Work by Deleault et al investigating the formation of native 
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prions from lipid molecules and a polyanion cofactor has suggested that native PrPC 
may interact ,infrequently, with polyanions to create PrPD (Deleault, Harris et al.2007).   
This method is suggested to be associated with the generation of the disease 
associated prions in sporadic forms of CJD (Lee & Caughey 2007).  The origins of 
BSE may be via a similar polyanion interaction with native PrPC molecules.  
Subsequent strains of TSEs, including the newly-arising atypical forms of BSE may 
be initiated by similar polyanion interactions with native PrPC, which could also give 
rise to other unfamiliar prion diseases in the future.  Suggestions that the H-type 
variant of BSE had a spontaneous origin support this theory (Gavier-Widen, 
Noremark et al. 2008).
Function of PrP 
Evidence from transgenic mice studies and the GPI anchor 
Prion protein is expressed in high levels in the brain and in many body tissues.  
However, work with PrPc knockout mice (mice lacking PrPc) has demonstrated that a 
natural role for PrPc is somewhat of an enigma.  These mice demonstrated changed 
sleeping patterns with little change in physiology and otherwise they functioned 
normally (Bueler, Fischer et al. 1992).  The proposed functions of prion protein range 
from a universally vital role in cell survival to a more specific role as a metal ion binding 
protein which regulates the copper concentration in neuronal synaptic regions. 
 PrPD was found to be harmless in its self by experiments where brain tissue devoid of 
PrPD but having PrP is grafted onto brains of mice lacking normal prion protein and 
then subsequently exposed to infectious prions.  The results of such experiments show 
that considerable amounts of PrPD are formed but the mouse does not succumb to 
TSE disease.  Therefore, this suggests that PrP deficient neurons are not affected by 
the infectious agent (Brandner, Isenmann et al. 1996)   
Transgenic mice have been used in further studies to investigate the role of PrPD in 
the pathogenesis of TSEs.  During the construction of PrPc, the molecule is involved in 
the cellular secretory pathway of the lumen of the endoplasmic reticulum. Following 
this a glycosylphosphatidylinositol (GPI) lipid anchor is added to the C terminus of the 





















Not attached to cell membrane Attached to cell membrane, inducing neurotoxic signal
Transgenic mice were engineered to exhibit the lack of the single peptide responsible 
for GPI anchoring (GPI-negative mice) and so produced a non-anchoring soluble 
secreted form of PrPc (Chesebro, Trifilo et al. 2005)   Chesebro et al then infected 
these transgenic mice with three strains of scrapie and it was found that GPI negative 
transgenic mice never developed clinical signs of prion disease although their brains 
contained significant amounts of PrPD deposits.   
The inference from this study is that removing the GPI anchor abolishes the 
susceptibility to clinical disease but still allows the PrPc molecule to support prion 
replication and hence the generation and accumulation of PrPD in the brain (see 
figure1.1).  Aguzzi  (Aguzzi 2005), suggests that this idea concurs with accruing 
evidence that normal prion protein may function as a signalling molecule, with the 
abnormal PrPD variant causing altered cell signalling that causes cell death.   
Figure 1. 1  All sail and no anchor. 
Diagram modified, From Aguzzi, A. 2005, "Cell biology. Prion toxicity: all sail and no anchor", Science, 
vol. 308, no. 5727, pp. 1420-1421.   Reprinted with permission from AAAS.To illustrate the requirement 
for the PrP
D
 molecules to be attached to the cell membrane to induce a neurotoxic signal. 
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Some of the accruing evidence includes the work of Solforosi who indicated that cross 
linking of PrPc on the surface of hippocampal neurons with antibodies causes these 
neurons to die (Solforosi, Criado et al. 2004).  Mice lacking normal prion protein do not 
exhibit signs of prion disease and so loss or change in function of clustered PrPc is not 
a cause of brain damage in TSEs.  However clustering of PrPc is a crucial step in the 
formation of PrPD. The work of Chesebro et al gives evidence for a link between the 
cell surface topology of PrPD and pathogenesis of TSEs. When PrPc is disengaged 
from the membrane surface, PrPD replication, accumulation and formation of brain 
plaques occurs but clinical disease is not evident.  Consequently one interpretation of 
this evidence is that prion replication avails itself of membrane bound signal 
transducers to elicit brain damage and therefore membrane bound PrPc would be 
required for the manifestation of clinical signs.  Meier’s work with transgenic mice that 
express a dimeric form of PrPc do not accumulate PrPD and do not develop or transmit 
TSEs.  It is thought that this dimeric form competes and wins with endogenous PrPc
and delays prion pathogenesis (Meier, Genoud et al. 2003).  In combination with the 
work of Chesebro , this indicates that the detachment of PrPc from the membrane does 
not abolish its prion replication abilities.  It may be that a soluble dimeric form 
requisitions PrPD making it unavailable and thus inhibiting the disease.  Infectious 
prions, therefore, may damage the brain by distorting signalling events at the 
membrane that PrPc normally controls.
In non-neuronal cells, PrPc is often found at the cell membranes allied to rafts of 
cholesterol (a combination of a lipid, steroid and alcohol and is an important 
constituent of cell membranes) rich molecules (Vey, Pilkuhn et al. 1996).  One 
exception to this is in the stomach where PrPc was observed in the secretion granules 
of epithelial cells (Fournier, Escaig-Haye et al. 1998).  It is also found in the secretory 
mammary gland tissue where its expression is related to physiological state 
(Lasmezas 2003).  This latter statement may have implications for the maternal 
transmission of TSEs as recently identified by Castilla and Bellworthy in mice and 
sheep respectively (Bellworthy, Dexter et al. 2005;Castilla, Brun et al. 2005).  
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Interactions of PrPc with other proteins  
PrPc interacting proteins, such as synapsin I, are abundant not only in neural tissue but 
also in other tissues involved in exocytosis, such as tissues of the endocrine system.  
Another PrPc interacting molecule is glial fibrillary acidic protein (GFAP), which is an 
astrocytic marker that is shown to accumulate at the same time with disease 
associated PrPD during TSEs (Dormont, Delpech et al. 1981).  Another interesting 
property of PrPc is that it binds laminin, a molecule that promotes cell adhesion, neurite 
outgrowth and maintenance in primary neurons of rodents.  As such the effects of 
laminin are mediated by PrPc (Graner, Mercadante et al. 2000).  
A further PrPc ligand was identified as stress inducible protein 1 (STI-1) which is a heat 
shock protein (a protein which increases its expression when the cells which contain 
them are exposed to elevated temperatures) that resides in the cell membrane and 
cytoplasm.  Both proteins are thought to interact in a specific and high affinity manner 
and PrPc binds to cellular STI-1 in vivo.  Furthermore, it was found that this binding of 
PrPc and STI-1 induce neuroprotective signals that can rescue cells from apoptosis. 
(Zanata, Lopes et al. 2002)  From this evidence it is clear that a disassociation 
between the diseased PrPD and STI-1 molecule could abolish the protective effects of 
the conventional PrPc and STI-1 binding and thus contribute to neuronal cell death.   
It has been shown that the binding site of the laminin receptor precursor (37kDa, LRP) 
and its mature form, termed high affinity laminin receptor (67 kDa, LR), maps to amino 
acid 161-179 of the PrPc molecule (Gauczynski, Peyrin et al. 2001).  It is distinct from 
that of the STI-1 binding domain of amino acids 113-128 (Zanata, Lopes et al.2002). It 
is suggested by Zanata et al, that there may be the prospect of binding of both laminin 
and STI-1 to PrPc.  The binding of both ligands may have a contributory effect to the 
survival of neuronal cells.  From this example, it is evident that the complexity of the 
potential cascade of a PrPc macromolecular complex formed between the cell surface 
and extracellular proteins, may mediate signals that promote cell survival and 
differentiation.  Again, this is another area that could be the target for the dysfunction 
of neuronal cells caused by the involvement of the mis folded PrPD in diseased states. 
26 
Consequently the disruption in binding of STI-1 and laminin to the mis-shaped PrPD, 
will have a direct effect on neuronal survival and have a direct consequence to the 
neurophysiological function of distinct brain regions infected with PrPD.  Reports show 
that heparan sulphates play a role in the life cycle of PrPc molecules and in the 
pathogenesis of the disease state.  Cell surface glycosaminoglycan molecules are 
components of heparan sulphates and play a role in the internalization of PrPc.  It is 
also possible that binding of laminin receptors and PrPc is influenced by copper ions 
since the heparan sulphate proteoglycans binds to a PrPc copper binding domain 
(Brown, Qin et al. 1997).  Conversely PrPc and STI-1 binding is not influenced by 
copper (Zanata, Lopes et al.2002) and the internalization of PrPc may be involved in 
switching off signals triggered by the PrPc -STI interaction.  Sulphated glycans 
stimulate cell free conversion of PrPc and are associated with amyloid plaque 
formation in PrPD accumulation in TSE pathogenesis.  Clearly, there are numerous 
areas for disruption in binding other molecules to prion proteins, caused by the 
replacement of PrPc with PrPD, that will have functional consequences for neurons.  
This in turn will disrupt the integrated, coordinated electrical communication properties 
of particular infected regions of the brain. 
Synaptic function in relation to prions 
The role of copper in the various associations and functions of PrPc is still unclear.  It 
may be of structural importance for the N terminus of PrPc and may influence the 
binding of other proteins, such as those mentioned above.  Further investigations on 
the role of copper have revealed that PrPc shows cooperative copper binding 
(Kretzschmar, Tings et al. 2000).  PrPc found in brain homogenates reveals the highest 
concentration in synaptosomal fractions and mice devoid of PrPc (Prnp 0/0) show a 
50% reduction in synaptosomal copper concentrations.  PrPc was found in the 
presynaptic nerve terminal by several groups including Fournier (Fournier, Escaig-
Haye et al. 1995), Sales (Sales, Rodolfo et al. 1998) and Herms (Herms, Tings et al. 
1999).  PrPc has also been associated with synaptic vesicles (Pauly & Harris 
1998;Shyng, Moulder et al. 1995).  It is likely that PrPc cycles between these two 
compartments as summarized by figure 1.2, postulated by Kretzschmar (Kretzschmar, 
Tings et al.2000).  
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Figure 1. 2  Role for prion in regulation of copper. 
Figure adapted with kind permission of Springer Science and Business Media. 
from Prion Diseases; Diagnosis and Pathogenesis Groschup, Martin H.; Kretzschmar, Hans (Eds.)  Special 
edition of Archives of Virology, Suppl. 16 2000, IX, 290 p. 89 illus., Hardcover ISBN: 978-3-211-83530-2.  










































Figure adapted from Kretzschmar illustrating function of prion in binding copper.
(1) Prion protein attached to presynaptic plasma membrane.
(2) N terminal of prion binds free copper.
(3) Endocytic uptake of prion into presynapse.
(4) Prion bound copper isreleased possibly by changes in endosomal pH.
(5) Copper isreleased into synaptic cleft with synaptic vesicle release.
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In this hypothetical model it is suggested that prion protein is attached to the 
presynaptic membrane where its N terminal domain may bind free copper in the 
synaptic cleft, due to synaptic vesicle release (Hartter & Barnea 1988;Kardos, Kovacs 
et al. 1989).  An endocytic uptake of PrPc into the presynapse (Pauly & 
Harris.1998;Shyng, Moulder et al.1995) is then postulated, where PrPc bound copper 
is released.  Hence PrPc acts to keep the copper concentration in the presynaptic 
cytosol and the synaptic cleft constant despite losses due to synaptic vesicle release. 
Research into the affinity of copper binding to PrP suggests that PrP may scavenge 
excess copper during neuronal activity and so protect the function of the synapse 
(Walter, Chattopadhyay, & Millhauser 2006b).  Due to negative cooperativity, that is 
the PrP protein responds to copper over a wide concentration range, the “spikes” in 
copper concentration in the synapse may be matched during the synaptic process to 
the affinity of PrP.  This “sponge like” behaviour of PrP for copper allows an antioxidant 
function that may be the key to long term preservation of neuronal function.  In the 
diseased state, PrPD may fail to “mop up” this excess copper and a perturbation in 
neural function could result. 
Specific work on PrPc and binding copper was done by Brown. (Brown, Qin et al.1997)    
It was reported here that the amino terminus of PrPc contains an octapeptide (8 amino 
acids linked in a polypeptide chain, PHGGGWGQ) that is repeated four times and it is 
the best preserved region of mammalian PrPc.  It was shown that this amino terminal 
exhibits five or six sites that bind copper.  This work also involved the use of two lines 
of Prnp 0/0 mice to evaluate the effects of copper in these lines versus wild type mice.  
The Prnp 0/0 mice demonstrated severe reduction in copper content of membrane 
enriched brain extracts and in synaptosomal and endosomal enriched cellular 
fractions.  These mice also demonstrated altered electrophysiological properties in the 
presence of copper compared to wild type mice.  Total X-ray fluorescence was used to 
test copper binding in vitro and it was found that wild type mice had 20.1 g of copper 
per gram of membrane from brain homogenate compared to 1.3 g of copper per 
gram for Prnp 0/0 mice. Little difference was found in other tissues from areas such as 
liver, kidney and muscle.  It was concluded from this research that PrPc is either a 
29 
principal copper binding protein in brain membrane fractions or that it controls activity 
of other membrane binding proteins. Brown (Brown, Qin et al.1997), stated that these 
copper binding proteins regulated via PrPc either possess GPI anchors or are tethered 
to membranes through an interaction with PrPc.  Thus PrPc may act as a buffer for 
excess copper and so regulate the copper content of the intracellular compartment.   
Conformational changes to PrPc when copper binds have been reported by Hornshaw. 
(Hornshaw, McDermott, & Candy 1995).   As Hornshaw alludes to, cooperative binding 
may amplify the conformational shift in prion protein structure and consequently the 
misfolded PrPD would not mimic the same transformation in shape following copper 
binding as the wild type PrPc in diseased states.  Copper binding to proteins may thus 
exert a deleterious effect on the normal function of such proteins.  The work by Brown 
showed that prion protein is a cuproprotein like those implicated in the pathogenesis of 
Parkinson’s disease and Alzheimer’s disease.  The common denominator of 
cuproproteins indicates that neurons are sensitive to changes in copper and 
physiological mechanisms may exist to regulate the distribution of this ion, such as that 
proposed by Walter(Walter, Chattopadhyay, & Millhauser 2006a).   
Potential for a change in synaptic function in the diseased state 
A role for prions in the recycling of the synaptic vesicles or a more direct role in 
synaptic activity is suggested by Herms (Herms, Tings et al.1999)  This more direct 
role in synaptic activity is supported by electrophysiological work involving Prnp 0/0 
mice, devoid of PrPc.  Collinge et al (Collinge, Whittington et al.1994) described a 
change in synaptic transmission (a change in long term potentiation, LTP) following 
repetitive stimulation in one particular Prnp 0/0 line generated by Bueler. (Bueler, 
Fischer et al.1992)  These findings were replicated in the Prnp 0/0 mouse line 
generated by Manson (Manson, Clarke et al. 1994).  Collinge also identified a change 
in the inhibitory postsynaptic currents (IPSCs) in hippocampal neurons of Prnp 0/0 
mice.  This prolonged rise time of GABAA receptor mediated IPSCs may have been 
due to changes in the GABAA receptor on the postsynaptic membrane.  However other 
workers did not find this (Lledo, Tremblay et al. 1996).  To clarify the question of 
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whether the increase in rise time seen in Prnp 0/0 mice was due to the loss of PrPc
expression in the presynapse or postsynapse, an additional transgenic line of mice 
was developed (tg20) which only expresses PrPc at the presynapse (Fischer, Rulicke 
et al. 1996).  In this line, rise times similar to the wild type were found and hence it was 
postulated that the loss of the presynaptic PrPc expression at the inhibitory synapse is 
responsible for the prolongation of IPSCs in Prnp 0/0 mice. 
Barrow also described another electrophysiological observation in scrapie infected 
hamsters (Barrow, Holmgren et al.1999).  A disturbance of the late after 
hyperpolarisation current (I AHP) was observed.  This current is involved in action 
potential repolarisation and hence affects the frequency of action potentials.  The 
cause of the alterations in electrophysiological properties in PrPc deficient mice are not 
yet fully understood but it is thought it relates to the decreased copper concentrations 
in synaptic membrane fractions of Prnp 0/0 mice.  This decrease may be caused by 
deregulation of copper in the brains of Prnp 0/0 mice caused by the loss of PrPc
(Kretzschmar, Tings et al.2000).  So, to associate these findings from Prnp 0/0 mice to 
the pathogenesis of TSEs it is useful to remember that the disease may result from a 
dominant negative effect of PrPD leading to a progressive loss of function of PrPc.  To 
this extent, Prnp 0/0 mice may emulate this loss of function of PrPc in a diseased state.  
Consequently there is putative evidence that neurodegeneration caused by prion 
diseases may be pre-empted by a perturbation in neurophysiological function.  One of 
the aims of this study is to investigate the change in electrophysiological function of 
specific areas of the brainstem, the histopathologically important NA and DMNX, to 
see if a change in their function could form the basis of a non-invasive live test for 
prion disease. 
Synaptic transmission and short term plasticity were used to assess the differences in 
the expression of neurophysiological properties of two strains of PrPc deficient mice 
and mice carrying a wild type transgene.  It was found that the range of synaptic 
responses studied in sections of the hippocampus, in vitro, increased with the level of 
PrPc expression.  It was thought that the probability of transmitter release was 
unchanged in these situations (Carleton, Tremblay et al. 2001).  In addition this group 
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found that with age, the absence of PrPc is accompanied by an increased synaptic 
strength, assessed by comparing the slope of normalized input-output curves of 
excitatory postsynaptic potentials (EPSP). Increased strength was thought to happen 
by an increased recruitment of fibres before interactions at the synapse as opposed to 
increased probability of transmitter release at the synapse. 
This latter observation would presume the existence of some mechanism by which 
older hippocampal fibres, depleted of PrPc, may compensate for a smaller range in 
synaptic response to restore or maintain functionality of compromised neural networks 
(Turrigiano 1999).  This study confirmed the synaptic location of PrP and its role in 
regulating synaptic transmission as found by other workers (Herms, Tings et al.1999).  
The data also support the idea of PrPc being linked to the presynaptic vesicle protein 
synaptophysin (Fournier, Escaig-Haye et al.1995).  Thus, there is strong evidence for 
a functional role of PrPc in modulating synaptic transmission. 
Additional evidence of the presynaptic location and function of prion protein is given in 
the work of Herms (Herms, Tings et al.1999). It was found that synaptic activity in 
response to hydrogen peroxide (H2O2) correlated with the amount of PrP
c expression 
in presynaptic neurons of the mouse cerebellum.  H2O2 is known to decompose to 
hydroxyl radicals in the presence of iron or copper and alter synaptic activity.  
Consequently, evidence for the synaptic location and involvement in regulation of the 
presynaptic copper concentration for PrPc was elucidated.  Further investigations by 
these workers suggested that PrPc is involved with the re-uptake of copper from the 
synaptic cleft since observations in Prnp 0/0 mice suggest copper is not taken up from 
the extracellular space and is not taken up into the presynaptic cytosol for reuse.  
Furthermore they postulated that the increase in concentration in the extracellular fluid 
in such mice may explain the change in GABAA receptors and change in long term 
potentiation reported by other workers such as Collinge.  In addressing this functional 
role for PrPc, Herms considered the conflicting results of Collinge, Lledo and others 
including their own previous work published in 1995 and concluded that slight 
differences in the extracellular copper concentration, temperature, brain sample 
thickness and location of cell recording within that sample may have contributed to the 
reported differences.   
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Other evidence for differences in observations by different groups on the location of 
PrPc was given by Sales (Sales, Rodolfo et al.1998).  It was suggested that PrPc
staining of cell bodies was not seen, which contrasts with the work of DeArmond 
(Dearmond, Mobley et al. 1987).  Sales suggested the reason for this difference may 
be that the reagents used for the latter study were insensitive to PrP from hamster 
brains and that a more recent study by Taraboulos (Taraboulos, Jendroska et al. 
1992), using the “histoblot” technique, supported the findings of their work.  However 
one area that gave different observed PrPc immunoreactivity between the study of 
Sales and Taraboulus was the basal ganglia.  Sales noted a marked presence of PrPc
in the caudate, putamen and ventral pallidum.  These reported differences in 
methodology represent caveats to a variety of histochemical analysis techniques and 
highlight the complexity and need for careful control in the identification of PrPc at the 
cellular level.  Possibly a complementary functional investigation of the changed 
neurophysiological function of normal versus abnormal prion may help comment on 
the overall effect of the pathogenesis of TSEs. 
Signalling Functions of PrPC 
Further information on the role of PrPc in the body comes from experiments on the 
signalling function of PrPc.  A cellular pathway through which PrPc may influence 
synaptic function may be achieved by activation of the non-receptor, tyrosine kinase 
Fyn (Mouillet-Richard, Ermonval et al. 2000).    This work involved the neuronal 
differentiation model 1C11.   The 1C11 clone is a neuroectodermal progenitor with 
epithelial morphology that lacks neuron associated functions.  Upon induction, the cells 
develop a neural like morphology and convert into serotonergic or noradrenergic cells.   
From this work it was observed that in order to trigger the PrPc dependent tyrosine 
kinase Fyn activation in differentiating 1C11 cells, it depended upon the cells being 
fully differentiate serotonergic or noradrenergic progenies.  Fyn is an intracellular 
protein and PrPc is anchored to the outer membrane.  Consequently, intermediate 
factors are likely to be involved in the PrPc dependent signalling mechanism causing 
Fyn activation.    It is also suggested that since the 37kDa laminin receptor binds PrPc
and that a GPI anchor relates PrPc to the membrane, then a role as a cell surface 
signalling or cell adhesion molecule is possible for PrPc.  With the identification of PrPc
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as a signalling molecule there is an implication that extracellular signals may exist to 
trigger this membrane bound protein. 
A signalling role during axonal growth has been suggested, with PrPc localization at 
the surface of elongating retinal axons being reported by Sales (Sales, Hassig et al. 
2002).  This work highlights the importance of the interaction of PrPc with the laminin 
receptor which binds laminin expressed on the surface of other cells.  Laminin is 
regulated during development and contributes to axon growth and fibre tract formation 
by altering cell adhesion and presenting guidance cues dependent on structure and 
neuronal type (Dou & Levine 1995).  Importantly, TSE infection is thought to spread 
along such fibre tracts (Beekes, McBride, & Baldauf 1998;Kimberlin, Hall, & Walker 
1983).  It is suggested that the transfer of these guidance cues may be achieved by 
PrPc activation of Fyn (as alluded to by Mouillet-Richard, above).   It was also noted 
that the relative abundance of PrPc during neuronal development varied.  If the results 
from this hamster study could be extrapolated to other mammalian species, it may 
suggest an abundance of PrPc during brain development in childhood and 
adolescence which may have a bearing not only on the incidence of vCJD, but also on 
infection of BSE in young cows.  In addition, this work identified regions such as the 
olfactory bulb and hippocampus as regions of high plasticity that were associated with 
high levels of PrPc that remained high during adulthood. Consequently, the threat of 
prion infection could remain during adulthood.  In contrast, the brainstem was seen to 
have little capacity for plasticity in adulthood and contained a lower level of PrPc with 
little modulation of PrPc during postnatal life.   
The relationship of neuronal plasticity to PrPc is also highlighted by the work of 
(Collinge, Whittington et al.1994).  Here it was found that poor long term potentiation 
(LTP), which is associated with synaptic plasticity of memory and learning, is 
weakened in Prnp 0/0 mice.  It was thought that the lack of PrPc enhanced the N-
methyl-D-aspartate (NMDA) receptor component of the excitatory post synaptic 
potentials (EPSPs) and this abnormal activation impaired LTP induction.   
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Prion Pathogenesis 
Different pathogenesis based upon different disease strains 
The dynamic process of prion pathogenesis may depend upon the strain of TSE 
infection.  Aguzzi (Aguzzi, Heikenwalder, & Miele 2004) reported that prions are found 
in the lymph tissues in sheep scrapie and vCJD and less so in sCJD and BSE. He 
also states that it is well established that replication of the prion agent occurs in 
lymphoid tissues well before neuroinervation and subsequent detection in the CNS 
(Aguzzi, Heikenwalder et al.2004).  This latter statement is supported by Glatzel, 
(Glatzel, Klein et al. 2000) who gave evidence for the role of the lymphoreticular 
system (LRS) in the spread of prions to the central nervous system.   
The characteristic long incubation time for such diseases may be due to the 
multiplication of prions in reservoirs and it is suggested that parts of the peripheral 
nervous system or the LRS may be the location for such reservoirs (Glatzel, Klein et 
al.2000).  Of particular interest are the intestinal Peyer’s patches of the LRS which 
have been shown, in mice, to be the site of prion replication immediately after oral 
administration of infective agent (Kimberlin & Walker 1989).  It is then postulated that 
certain components of the immune system such as follicular dendritic cells (FDC) are 
required for the spread of infection.   
The transfer of infection from areas of the LRS to areas of the peripheral nervous 
system (PNS) may occur in unmyelinated nerve terminals associated with the mantle 
zone of the lymph follicles.  This region may have processes belonging to FDC in 
close contact with nerve fibres of the PNS (Brown, Stewart et al. 2000).  Axonal and 
non-axonal modes of transport may conceivably transport prions from the PNS to the 
central nervous system (CNS).  Studies show that the rate of transport of PrPD in the 
PNS was 1 to 2 mm per day (Kimberlin, Hall et al.1983) which does not correspond to 
fast axonal transport and so non axonal, retrograde transport via the glia or Schwan 
cells may be favoured.   
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A range of neural routes to transfer infectivity to the CNS is suggested from 
observations from the fact that direct intraneural injection of prions infects the CNS 
via the injected nerve.  After intraperitoneal or oral infection, prions accumulate in 
lymphatic organs which are innervated mainly by fibres from the sympathetic nervous 
system (SNS).  This would suggest a lymph-SNS-spinal cord-CNS pathway of 
infection.  However, in more recent studies identification of a more direct route 
involving nerves of the parasympathetic nervous system (PNS), namely the vagus 
(cranial nerve X), have been shown (Beekes, McBride et al.1998).  Glatzel reports 
that this more direct route seems to be highly significant when animals are challenged 
via the oral route (Glatzel, Klein et al.2000).   
The pathogenesis of TSE diseases may depend on the particular strain of infection.  
Different strains may take a different route of infection.  It may be possible that the 
target sites for this infection also play a part in the determination of the phenotype of 
the disease.  For example, in the animal models involving intraperitoneal or 
intracerebral inoculation, the infection pathways may be different to those studies that 
mimic the “real world” postulate of infectivity by presenting oral challenge of infectious 
titre. Indeed, infectivity of one scrapie strain failed to produce pathology following 
intraperitoneal or intravenous inoculation but did demonstrate pathological signs 
following intracerebral inoculation (Blattler, Brandner et al. 1997). 
Transfer of infectivity from the spleen to the central nervous system has been 
reported to be crucially dependent upon the expression of PrP in a “tissue 
compartment” interposed between the LRS and CNS (Blattler, Brandner et al.1997).  
Blattler further suggested that this compartment may comprise parts of the peripheral 
nervous system.  Therefore, prion infectivity may well accumulate in areas of the 
LRS, specifically the Peyer’s patches of intestinal system, and then be directly 
transported via a PrP expressing tissue compartment, which may be the vagus, 
directly to the CNS, specifically the dorsal motor nucleus of the vagus nerve (DMNX).   
From the work of Blattler, in mice it was observed that the only tissue outside the 
CNS in which scrapie prions had been detected was the LRS.  It was not clear 
whether this may have been “spill-over”, infectivity generated in the CNS.  One 
36 
postulate may be that there is a direct and relatively quick route of infection via the 
vagus to the CNS and due to centrifugal (down from brain) transport via peripheral 
nerves, secondary infectivity is promoted and replicated in areas of the LRS.  Hence, 
there is a prospect of these reservoirs of infectivity facilitating the spread of PrPD to 
many areas of the body.  It may also be possible that the relatively small amounts of 
infectivity, initially seen in areas of the brainstem, may not be sufficient to be identified 
by current histochemical tests but may affect the neurophysiology, i.e. the functional 
activity of the brainstem neurons, in such a way as to be detectable. 
New methods used to identify PrPD have been recently developed which are many 
more times sensitive than previous tests.  Such tests have been able to relate 
histological findings to biochemical investigations enabling the investigation of 
discrete areas of tissue (Krebs, Kohlmannsperger et al. 2006).  In addition, continued 
refinement of the techniques used to identify the disease associated prion have been 
able to identify PrPD in the muscle of scrapie infected hamsters (Thomzig, Schulz-
Schaeffer et al. 2004) and autopsied muscles of humans with vCJD, CJD and 
iatrogenic CJD (Peden, Ritchie et al. 2006). 
Vagal route of entry for Prion to the CNS 
Evidence for the idea of multiple routes of infection comes from the work of Baldauf 
(Baldauf, Beekes, & Diringer 1997).   The data from this study, using intraperitoneal 
infection in hamsters, suggested three points of entry into the spinal cord for scrapie 
infectivity.  In addition, strong evidence for a direct route, by-passing the spinal cord, 
for infectivity to access the brain was seen.  This alternative pathway to the brain was 
confirmed by data from hamsters which received an oral challenge.  By assaying 
various tissue samples for scrapie infectivity for each animal, it was shown in many 
animals that accumulation of infective prion protein was seen in the lower spinal cord 
and in some brain areas with no pathological protein in the cervical spinal cord.  
Similar observations were seen in experiments with sheep (van Keulen, Schreuder et 
al. 2000) see figure 1.3.   
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Recent reports stated that the vagus of cows infected with BSE were found to be 
positive for the disease conformation of the prion protein (Yoshifumi Iwamaru, Yuka 
Okubo et al. 2005).  Further observations from the work of Baldauf (Baldauf, Beekes 
et al.1997) were the lack of pathological prion in the spleens of some animals, 
leading to the conclusion that the spleen may play a role in the pathogenesis in some 
animals, but it may not be essential. 
Further work on this proposed “alternative” direct route of infection was performed by 
Beekes, again with oral challenge of scrapie to hamsters (Beekes, McBride et 
al.1998).  Results for this study presented evidence that in this animal model, initial 
infection of the brain occurred via the vagus nerve rather than by spread along the 
spinal cord.  The first area of the brain to show prion deposition was the DMNX 
followed by the Nucleus Tractus Solitarii (NTS).  Consequently, it is suggested that 
the spread of infectious prion to the brain may be facilitated by parasympathetic 
efferents and associated afferent fibres of the vagus.   
Vagal efferents have nerve cell bodies in the DMNX and vagal afferents have nerve 
cell bodies in the ganglion nodosum (GN).  However, afferent fibres terminate in the 
NTS where they synapse with interneurons which directly project to motor neurons in 
the DMNX.  It is important to note that efferents and afferents of the vagal circuit 
innervate the heart and visceral organs of the digestive tract such as the stomach.  
Consequently a “fast vagal” route of infection from the stomach to DMNX may be 
provided by the vagus which may be the required “compartment” referred to by 
Blattler mentioned above.  In addition if figures 1.3 and 1.4 are considered in 
conjunction with further evidence from van Keulen, it is suggested that the DMNX is 
stained positive for prion at around 10 months post inoculation.  At this time in the 
same animal the GN was negative.  This suggested an initial infection facilitated by 
the efferent vagal fibres and a later spread from the DMNX  to cell bodies of the 
afferent branch of the vagus situated in the GN.  Consequently there was putative 
evidence for a stomach-vagus-DMNX-NTS-GN chain of infectivity. 
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Examination of the DMNX of 10 scrapie infected sheep showed typical vacuolation 
and variable gliosis.  In addition, herniation of membranes and organelles from 
seemingly healthy processes into neighbouring vacuoles and dendrites were seen 
(Ersdal, Simmons et al. 2003).  Similar observations were identified by 
Jeffery(Jeffrey, Goodsir et al. 2009) and Dorban (Dorban, Defaweux et al. 2007)  
Consequently it may be possible that the abnormal PrPD may cause herniation in the 
myelination of vagal fibres which would limit the transmission of neural control to and 
from target organs such as the heart, due to a breakdown in saltatory conduction as 
a result in this disruption of the myelination. 
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Figure 1. 3  Pathology of natural scrapie.  
Figure adapted with kind permission of Springer Science and Business Media. 
from Prion Diseases; Diagnosis and Pathogenesis Groschup, Martin H.; Kretzschmar, Hans (Eds.)  
Special edition of Archives of Virology, Suppl. 16 2000, IX, 290 p. 89 illus.,  
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Pseudorabies virus in relation to proposed prion infection 
Both Bauldauf and Beekes mentioned that the neuroanatomical sequence of target 
areas for TSE prions were reminiscent of the pathology of pseudorabies virus (PRV, a 
virus of the genus Varicellovirus that is the etiologic agent of pseudorabies and also 
called suid herpesvirus 1) as studied by Card and Standish (Card, Rinaman et al. 
1993;Standish, Enquist, & Schwaber 1994).  Although prions are not considered as 
viruses, the viral route of infection may also be a mode for brainstem infection for 
prions as recently illustrated by the spongiform neurodegeneration similar to that 
caused by prions induced by a retrovirus (Li, Cardona et al. 2010).  Work using PRV 
to trace the innervation of the heart showed it was possible to trace the targets of the 
vagal motor neurons, which are interrupted by postganglionic neurons at the heart.  
The pseudorabies virus was used as a transynaptic tracer.  PRV can be injected 
directly into the myocardium and traced from there to postganglionic neurons that 
innervate this area.  Here, PRV is seen to replicate and then retrogradely crosses 
synapses to be transported to specific vagal preganglionic neurons. If prion was to 
follow a similar modality then this would highlight the importance of postganglionic 
complexes and also suggest a site for “reservoirs” of infectivity mentioned previously 
(Glatzel, Klein et al.2000). 
The PRV work also suggests a potential difference in neuronal target sites 
dependent upon different strains. Experiments with PRV demonstrated that different 
distributions of vagal motor neurons were labelled by different viral strains.  The more 
virulent strain labelled the DMNX and NA in contrast to two less virulent strains which 
targeted neurons of the NA and rarely those of the DMNX.  This difference in 
labelling due to strain differences of the virus may also indicate a different functional 
consequence if TSE strains infect and damage different populations of neurons. 
Again, if this model may be applied to the passage of infective prion to similar areas 
of the brainstem then it may be possible that a less virulent strain of TSE may cause 
a different evolution with respect to time, neurophysiological and clinical signs. 
Consequently, one postulate may be the current incidence of vCJD may be due to 
one (virulent) strain of infectious TSE and other individuals may succumb to a lesser 
strain, later in time.  
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Work with PRV by Card illustrated a potential route of infection for TSEs (Card, 
Rinaman et al.1993).  Card stated “the peripheral projections of the DMV (DMNX) 
neurons and the ability to infect them by injecting virus into the wall of the stomach 
provide an ideal system for evaluating the CNS response to infection.”  This 
statement highlights a potential route for prion infectivity, illustrated here with PRV, 
that suggests that the spread to the CNS following inoculation in the stomach may be 
accomplished by retrograde transport to the DMNX.  This is supportive of the vagal 
route of infection postulated by Beekes as an alternative route of prion infection (see 
figure 1.3). 
Possible polypeptides associated with prion pathogenesis 
In support of the route of infection illustrated by the work with PRV, Mishra (Mishra, 
Basu et al. 2004) cited many workers, including Bons et al, Beekes and McBride, 
Foster et al, Nicotera, Haik et al, Aguzzi and Polymenidou, who reported 
accumulation of PrPD in the Peyer’s patches, lymphoid tissue of the gastro intestinal 
(GI) tract and peripheral and enteric nervous systems (an interdependent section of 
the autonomic nervous system pertaining to the small intestine) .  PrPD from the 
lumen of the intestine was believed to be involved with, among other cell types, 
dendritic cells of the intestine and M cells lining the mucosa as it was taken up into 
the lymphoid tissues of the gut and replicated.  Mishra et al unexpectedly found, from 
in vitro studies, that ferritin was co transported with PrPD.  Ferritin is a prominent 
component of the PrPD-protein complex formed when infected brain homogenate is 
treated with digestive enzymes.  A receptor or transporter mediated pathway is 
thought to be used in the transport of the PrPD – ferritin complex.  Since ferritin has a 
similar homology across a wide range of species, there is thus potential that PrPD
associated proteins, such as ferritin, may facilitate PrPD uptake in intestines of distant 
related species and therefore “lower the species barrier”.  This may allow the infected 
animal to become a carrier or confer increased susceptibility to a wider variety of 
prion strains.   
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Links between the vagus nerve and the intestines are expressed in research on 
ghrelin.  Ghrelin is a 28 amino acid gastric peptide hormone that has been reported to 
coordinate multiple functions in the gastro intestinal (GI) system (Zhang, Lin et al. 
2004).  This coordination and regulation of the GI system is mediated by a vagus 
nerve (activity in cranial nerve X) dependent mechanism.  Zhang et al also reported 
that ghrelin receptors were present in the DMNX of rats and that ghrelin promoted 
neurogenesis in vitro and in vivo.  The dorsal vagal complex was found to respond to 
perturbation in the level of ghrelin, induced by vagotomy, by an increase in cell 
proliferation.  This may, therefore, suggest a degree of neuronal plasticity in the 
DMNX.   Thus, the DMNX could alter its neurogenesis and hence change its 
neurophysiological function dependent upon deficient vagal input.  It is interesting to 
think that an intestinal protein such as ghrelin would have a neural link to the DMNX 
(via the vagus) with specific receptors situated in this brain region.  The activation of 
these ghrelin receptors would promote neurogenesis to generate more neural activity 
so as to attempt to maintain functional loss caused by vagal mediated neuronal 
damage to areas of the DMNX.  This work highlighted a vagal pathway for peptides 
from the gut to the brain and also raised the possibility of a degree of plasticity and 
recovery of function for regions in the DMNX.  This deficient vagal input created in 
this experiment could also be achieved by the presence of PrPD in the cell bodies of 
vagal fibres originating in the DMNX.  Consequently a recovery of function in the 
output of vagal efferents, to the heart for example, may be seen in incubating subjects 
with TSE diseases, presenting a “see-saw” pattern in their output with respect to time. 
Further research involving ghrelin illustrates a potential link to feeding in sheep.  It 
was suggested that ghrelin secretion is modulated by cholinergic neurons of the 
vagus (Sugino, Yamaura et al. 2003). A similar relationship of ghrelin to 
parasympathetic preganglionic neurons of the rat and mouse has been observed 
(Zigman, Jones et al. 2006).  This relationship between the stomach and neurons of 
the brainstem emphasises a neural pathway that may provide a route of infection for 
disease associated prion. 
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Additional evidence to support this “alternative” route of infection from stomach to 
brainstem via the vagus nerve fibres as intimated by Beekes, is presented in the work 
of van Keulen (van Keulen, Schreuder et al.2000).  The pathogenesis of scrapie in 
sheep raised on land where scrapie had occurred at a high incidence for a number of 
years was investigated.  It was found that at 5 months old, PrPD was present in all 
lymphoid tissues, including Peyer’s patches and it was evident in the enteric nervous 
system (ENS) at the level of duodenum and ileum (see figure 1.4).  At 10 months, 
PrPD deposition was evident in the DMNX and by 17 months the entire nucleus of the 
DMNX stained positive in some animals and low grade vacuolation was also present 
in DMNX.  In addition at 17 months old the NTS and NA were also stained indicating 
the presence of PrPD. After 21 months PrPD was widely distributed in the brain from 
the obex to the thalamic area and also infected the trigeminal ganglion and spinal 
ganglion of segments T7-T12.  PrPD was also seen in the grey matter of the spinal 
cord of segments T1-L3.  In the late stages of the disease, around 26 months old, 
PrPD was widely distributed in the brain and spinal cord encompassing all cervical, 
thoracic and lumbar segments and in the majority of spinal ganglia.   
From such longitudinal studies of scrapie infection it is concluded that the ENS may 
act as a portal for entry of infectivity to neural tissues.  Infectivity then spreads in a 
centripetal and retrograde manner through the parasympathetic efferent fibres to the 
DMNX at the same time as spread via sympathetic fibres to the spinal cord.  PrPD
accumulation in sensory ganglia after infection of the CNS may be due to centrifugal 
and anterograde spread from the CNS through afferent fibres.  This idea may equate 
to the “spill-over” of infectivity suggested by Blattler, mentioned above. 
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Figure 1. 4  Pathogenesis of  PrPD in scrapie. 
Figure adapted with kind permission of Springer Science and Business Media. 
from Prion Diseases; Diagnosis and Pathogenesis Groschup, Martin H.; Kretzschmar, Hans (Eds.)  
Special edition of Archives of Virology, Suppl. 16 2000, IX, 290 p. 89 illus.,  
Hardcover ISBN: 978-3-211-83530-2. 






















Schematic representation, adapted from van Keulen, indicating PrP
D
 accumulation (Grey 
shading) in the ENS, efferent nerve fibres and CNS. Note DMNX is stained independently 
from spinal cord presumably via the vagus nerve at 17 and 21 months 
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Interaction of brain and heart 
A wandering path from brainstem to heart 
The Dorsal Motor Nucleus (DMNX) and Nucleus Tractus Solatarii (NTS) of the 
brainstem are used as diagnostic regions in the diagnosis of TSEs.  These regions of 
the brainstem are the locations of the cell bodies for the efferent and afferent 
parasympathetic nerve fibres that control the heart on a beat to beat basis and 
connect to the heart via the vagus nerve. 
The vagus nerve (cranial nerve X) contains both afferent and efferent fibres forming 
an extensive “wandering” (vagus derived from the Latin vagus meaning wandering) 
network of neural communication.  Among other alternative names for the vagus 
nerve is the pneumogastric nerve which emphasises the fact that the 10th cranial 
nerve targets the lungs and stomach, especially relevant to the physiologically-
coordinated function of the lungs and the postulated ingress of infectious agent in 
prion disease discussed here.  In mammals, around 80% of the nerve fibres are 
afferent transmitting sensory information to the brainstem and the remaining 20% are 
efferent conveying information to target organs.   Both myelinated and unmyelinated 
efferent cardiac nerve fibres have their nuclei in the medulla oblongata of the 
brainstem.  The majority of myelinated, fast-conducting nerve fibres have their cell 
bodies in the nucleus ambiguus (NA) and cardiac motor efferents with slower, 
unmyelinated nerve fibres have their origin in the dorsal motor nucleus of cranial 
nerve X (DMNX).  The nucleus tractus solitarii (NTS) provides a sensory centre for 
afferent information from a variety of target organs including coordinating the afferent 
information from the lungs, heart and stomach. 
The efferent vagal control of the heart on a beat to beat basis is similarly complex.  In 
addition to vagal innervation of the atria via the SA node, the ventricles have also 
been shown to have vagal innervation (Standish, Enquist et al.1994).  As part of 
providing histological evidence for these neural connections, a new type of retrograde 
tracing technique using pseudorabies virus, instead of cholera toxin-conjugated 
horseradish peroxidase (CT-HRP), was required to overcome the barrier provided by 
intrinsic cardiac ganglion on the heart.  Three strains that differed in their virulence 
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were used in the retrograde tracing studies and it was observed the most virulent 
strain labelled neurons of the DMNX and NA at the level of the obex, while the less 
virulent strains identified neurons of the NA and infrequently neurons of the DMNX.  
Secondly, it was noted that given a longer time following injection of the pseudorabies 
virus in the heart wall, the NTS was also identified by retrograde labelling.  This 
latency in labelling suggests a possible interneuron connection between the 
NA/DMNX and NTS in cardiac vagal regulation of the heart (Standish, Enquist et 
al.1994).   Prion infection could echo the pathway illustrated by the pseudorabies 
virus and affect those sites listed above. 
Similar pseudorabies virus tracing has been performed on the vagal connection to the 
gut.  It was found that injection of the stomach with the retrograde tracer, labelled 
neurons in the DMNX.  This observation also highlights the path and a putative 
mechanism for the entry of disease associated causative agents whether or not they 
are prions or virus like particles as some workers point out (Manuelidis 
2004;Manuelidis.2006;Manuelidis, Liu, & Mullins 2009;Manuelidis, Yu et al. 
2007;Walker, Levine, & Jucker 2006). 
The vagus nerve also communicates with the lungs and provides a means of 
matching the beat to beat change in the heart rate with the breathing frequency.  The 
slight increase in heart rate during inspiration and decrease during expiration is 
termed respiratory sinus arrhythmia (RSA) and is mediated by cardioinhibitory 
parasympathetic neurons communicating from the brainstem to the heart by means of 
the vagus nerve.  During the inspiratory phase of respiration, GABAergic and 
glycinergic spontaneous firing rates are reported to increase.  Application of a 
nicotinic antagonist abolished the respiratory increase in GABAergic neurons and did 
not alter the increased rate seen in glycinergic neurons, consequently a functional 
role for acetylcholine is apparent in the coordination of RSA along with GABA and 
glycine (Neff, Wang et al. 2003).   
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Further work into the spontaneous GABAergic inhibitory post synaptic potentials in 
the control of cardiac vagal neurons has elicited that the presynaptic GABAergic input 
to these vagal neurons in the NA occurred at a lower frequency than those cardiac 
vagal neurons in the DMNX.  When the NTS was electrically stimulated, neurons in 
both the NA and DMNX were evoked (Wang, Irnaten, & Mendelowitz 2001), 
emphasising the inter-relationship between the NTS, NA and DMNX.  Also, this 
evoked activity was abolished by application of the GABA(A) antagonist bicuculline, 
therefore implicating a GABA(A) mediated pathway linking the NTS to both NA and 
DMNX. 
The vagus nerve has been identified as being positive for disease associated prion 
protein (PrpD) in cows incubating BSE (Masujin, Matthews et al. 2007).  The DMNX is 
reported to be one of the first areas to be infected with PrpD  in similar transmissible 
spongiform encephalopathies (TSEs) (Ersdal, Simmons et al. 2004;Sigurdson, 
Spraker et al. 2001;Spraker, Zink et al. 2002;van Keulen, Bossers, & van Zijderveld 
2008;van Keulen, Schreuder et al.2000).  The NTS and NA are also reported to show 
the presence of disease associated prion in TSE disease (Ersdal, Ulvund et al. 
2003;Nentwig, Oevermann et al. 2007). Prion has also been reported in heart muscle 
following prion disease infection (Jewell, Brown et al. 2006). 
The complex dynamic neural interactions between the heart and brain were first 
noted by Bernard and Darwin in the nineteenth century.  Claude Bernard in 1865  
described the heart as a “...centre influenced by all sensory influences.  They may be 
transmitted from the periphery through the spinal cord, from the organs through the 
sympathetic nervous system, or from the central nervous system itself” (Cournand 
1979).  
Charles Darwin emphasizes the findings of Bernard by stating that “especial notice” 
should be paid to a two way communication between the heart and brain, which 
Darwin refers to as “the two most important organs of the body”.  Darwin states on 
page 69 of  “Expressions of the Emotions in Man and Animals”; ”when the heart is 
affected it reacts on the brain; and the state of the brain again reacts through the 
pneumo-gastric [ vagus] on the heart” (Darwin 1872).  This quote, by referring to the 
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vagus as the pneumo-gastric nerve, also serves to remind us of the relationship of the 
vagus to the gut and lungs.   The intimate association of the vagus with the gut may 
have a role to play in the infection for transmissible spongiform encephalopathies.  It 
also suggests a neural feedback system between the heart and brain and in addition 
suggests why changing activity in the “pneumo-gastric nerve” [vagus] may relate to 
neural involvement of both the heart and lungs via this common pathway.   
Although these observations and statements were made by adopting a 
psychophysiological approach, their effect on current neurophysiological and 
anatomical studies is clear. The dynamic interactive bi-directional relationship 
between the heart, lungs and brain was established and provided the topic for further 
investigation. 
The Orienting Response
Further evidence for the neural regulation of the heart by the autonomic nervous 
system may be taken from research into the psychophysiological study of the 
bidirectional interactions between the brain and peripheral sensory processes that 
constitute psychological and physiological state (Sokolov 1963). 
Contemporary studies of this orienting reflex, suggests there is a bradycardia which 
functionally influences the sensitivity of perception by allowing the processing of 
information about the external environment to occur. The time course of the 
responses and studies of clinical cases suggested that mediation of the cardiac 
orienting component is neural and specifically involves the brainstem and the 
thalamic portion of the reticular formation. (Graham & Clifton 1966;Lacey 
1967;Sokolov.1963).  In their review of the Sokolov and Lacey theories, Graham and 
Clifton state that the orientating reflex is not observed in human infants until after the 
first few months of life.  From this evidence I note that this may also indicate that 
functional neuronal maturity is developed in the new-born infant during the first 
months of life and the lack of functional maturity in neural circuits may have relevance 
in Sudden Infant Death Syndrome (SIDS) during these first months of life.   
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Research utilizing atropine blockade demonstrated that the short duration slowing of 
the heart involved in this orienting response are mediated by cholinergic pathways of 
the vagus (Berntson, Cacioppo, & Quigley 1994).  Various clinical populations with 
peripheral neuropathies report abnormal vagal function.  Changes in heart rate, as a 
result of changing autonomic function, were observed with respect to changes in 
blood pressure and age (De Meersman 1993;Gribbin, Pickering et al. 1971;Weise & 
Heydenreich 1991;Wieling, van Brederode et al. 1982).   Wieling and Weise used 
techniques based on the beat to beat variability of heart rate (RR interval analysis) to 
assess vagal tone in a diseased state (diabetes) and suggested that a change in such 
indices may be evident when the diabetic patient was first diagnosed as opposed to 
the more common observations of vagal dysfunction in patients who have endured 
diabetes for a length of time. 
Further studies of individuals with unilateral brain damage indicate that heart rate 
responses are affected most in individuals with right side damage (Yokoyama, 
Jennings et al. 1987).    This evidence relates to the neurophysiological and 
neuroanatomical investigations in animals and man, suggesting that  the regulation of 
heart rate is mainly related to the right vagus affecting the sinoatrial node (SA node) 
(Mace & Levy 1983) with  higher ipsilateral brain centres controlling heart rate 
(Williams & Warwick 1980).  From these lines of evidence it may be concluded that 
the vagus, particularly the right hand branch, is able to convey neural signals which 
can have a direct and quickly acting beat to beat effect on the heart beat cycle. 
The Vagal Paradox 
Respiratory Sinus Arrhythmia (RSA) is the change in the beat to beat variability that is 
synchronized to the breathing cycle.  Porges in his seminal work on the “Polyvagal 
Theory” (Porges 1995)  indicated cases where heart rate increases and RSA 
decrease in relation to each other , such as in exercise (Billman & Dujardin 1990) and 
studies using atropine, as a  neural  blockade, to covary (negatively) both heart rate 
and RSA (Cacioppo, Berntson et al. 1994;Dellinger, Taylor, & Porges 1987;Porges 
1986).   
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Physiological and anatomical evidence would suggest both chronotropic control of the 
heart (i.e. heart rate) and the degree of RSA are both controlled by vagal 
mechanisms (Jordan, Khalid et al. 1982;Katona & Jih 1975).  Here, a direct linear 
relationship between change in the beat to beat interval, and parasympathetic activity 
is demonstrated.   
So although there are occasions where certain measures of cardiac control, RSA and 
heart rate vary in conjunction with each other, there are occasions where the changes 
suggest independent sources for neural control of heart rate and RSA.  This 
divergence in functional outcome for the control of the heart has been postulated as 
the result of the average heart rate representing tonic vagal influences (from neurons 
generating an extended sequence of activity or entering a state where action 
potentials are generated continuously) and the changing RSA as representing phasic 
vagal influences (from neurons generating one or more action potentials in a short 
time)  (Berntson, Cacioppo, & Quigley 1993;Jennings & McKnight 1994;Malik & 
Camm 1993).  Other explanations include the variations being due to changes in 
respiratory parameters and the methods used to quantify the changes in heart rate 
and RSA.  Further explanations have taken a more holistic interpretation and 
suggested that the average heart rate is a product of complex and dynamic 
interactions of the sympathetic and parasympathetic systems in conjunctions with 
mechanical and biochemical constraints (Berntson, Cacioppo et al.1993), whereas
RSA is considered to be a more purely vagal phenomenon.  Similarly divergences 
have also been observed in anaesthesia where RSA may form a more useful 
indicator of depth of anaesthesia than heart rate (Donchin, Feld, & Porges 
1985;Pomfrett 1995;Pomfrett, Sneyd et al. 1994).  
Porges goes on to summarize that there may be a contradiction in the duality of the 
relationship of heart rate and RSA based on the assumption that there is one central 
source for cardiac vagal tone.  He summarizes it as a Vagal Paradox in the table 
below: 
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Table 1-1  The Vagal Paradox 
1 Increased vagal tone produces neurogenic bradycardia 
2 Decreased vagal tone produces suppression of RSA 
3 Bradycardia occurs during periods of suppressed RSA 
                                                      (from Porges, A Polyvagal Theory, 1995) 
On occasions RSA and heart rate seem to reflect the same physiological change but 
in other instances they seem to reflect separate processes.  This line of reasoning led 
Porges to suggest that, in mammals, there are two anatomically based vagal 
response systems.   
Porges suggests the proposed Polyvagal Theory is better understood if the 
neuroanatomy and neurophysiology related to the vagus are explored.  The vagus 
nerve contains a variety of neural pathways, 80% of the experimentally evaluated 
30,000 fibres were afferent fibres (Agostoni, De Daly et al. 1957;Chase & Ranson 
1914).  Cell bodies of the vagus are located in the left and right sides of the brainstem 
and these perform different functions in regulation, with the right side vagus being the 
dominant factor in chronogenic regulation of the heart.  In addition to this, different 
vagi have different roles in the regulation of their target organs and may have 
opposing effects on the same target organ (Williams & Warwick.1980).  Vagal tone 
then, may not be applied to either the vagus as a whole or indeed to the control of a 
specific organ but may be applied to a particular branch of a specific part of the vagus 
and caution on the assessment of vagal tone on the heart from interpretation of RSA 
alone is intimated (Grossman & Kollai 1993;Malik & Camm.1993).   
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Anatomical and functional evidence to support the Polyvagal Theory 
Within the medulla of the brainstem, three neural structures are involved with the 
primary central regulation of the vagus.  The dorsal motor nucleus (DMNX)  and the 
nucleus ambiguus (NA) are areas of the medulla from which the vagal motor fibres 
originate, with DMNX located in the dorsomedial medulla and NA being more ventral 
(Kandell, Schwartz, & Jessell 2000;Williams & Warwick.1980). A third nucleus in the 
medulla, the nucleus tractus solitarius (NTS) is the site where many afferent 
pathways from peripheral organs terminate.  Both the DMNX and NA have neural 
input from NTS along with input from central nucleus of the amygdala and 
hypothalamus (Hopkins 1987;Leslie, Reynolds, & Lawes 1992).  
In mammals the main inhibitory motorneurons for the heart are located in the NA and 
motorneurons from the DMNX contribute non-myelinated axons to the cardiac vagal 
branch (Bennett, Ford et al. 1984;Bennett, Kidd et al. 1981).   Myelinated vagal axons 
from neurons in the NA have a cardioinhibitory and bronchoconstrictor role and 
conduct in the B fibre range (McAllen & Spyer 1976;McAllen & Spyer 1978b).  In 
contrast, the nonmyelinated fibres from neurons in the DMNX conduct in the slower C 
fibre range(Ford, Bennett et al. 1990).  (There are also reports of cardioinhibitory 
neurons located in both the DMNX and NA of the rabbit and cat, with efferent axons 
conducting in the B fibre range (Ciriello & Calaresu 1980;Ciriello & Calaresu 
1982;Jordan, Khalid et al.1982)).   
The role of these nonmyelinated vagal fibres from neurons in the DMNX is not well 
understood at present, with conflicting responses to their stimulation seen in different 
animals.  Heart rates of cats (Ford, Bennett et al.1990) and dogs (Donald, Samueloff, 
& Ferguson 1967) did not alter when these nonmyelinated fibres were stimulated.  In 
contrast, the heart rate of rabbits slowed when these fibres were stimulated (Ford & 
McWilliam 1986;Woolley, McWilliam et al. 1987b).  So their effect on HRV in different 
mammalian species is also not defined and raises the question of the organizational 
diversity of theses vagal nuclei in relation to function for different mammalian species.   
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Porges postulates that the function of these nonmyelinated fibres may be dependent 
on the outflow of the myelinated NA fibres.  The contribution of these nonmyelinated 
fibres may change as the effect of the NA fibres on the SA node of the heart is 
changed.  For example, when the “vagal brake” on the heart is released by decreased 
efferent activity from the NA fibres, the slower unmyelinated fibres from the DMNX 
may act as a lower frequency (longer time period) mediator of heart rate and HRV.  
Studies involving the rabbit have found that recruitment of nonmyelinated fibres of the 
vagus in conjunction to myelinated fibres increase the magnitude and duration of the 
evoked bradycardia in response to electrical stimulation (Ford & McWilliam.1986). 
This type of synergistic effect of myelinated and nonmyelinated vagal fibres may also 
play a role in the control of the heart. The complementary action of the DMNX to the 
NA is also suggested by domoic acid lesion studies in rats (Cheng, Zhang et al. 
2004b). 
I propose this idea may have direct relevance to malfunctioning vagal nuclei, as a 
result of incubating prion disease, leading to a change in beat to beat variability in the 
control of heart rate.  In addition, if the gating of intrinsic cardiac ganglia (see Intrinsic 
and Thoracic Ganglia section, on page 60 of this thesis) is factored into the analysis 
then there is further atypical coordination that could result from damaged cardiac 
vagal efferent and afferent nerve fibres. 
More evidence that relates to prion diseases possibly causing a change in the beat to 
beat variability in the control of heart rate (HRV) is the observation that degenerating 
fibres are present in the cardiac branch of the vagus following lesions to the DMNX 
(Calaresu & Cottle 1965).  In the incubation of prion diseases, the build-up of prion 
protein may cause lesions in the DMNX, which is a diagnostic criterion, that could 
then cause cardiac vagal fibres to degenerate and hence malfunction.  The resultant 
abnormal vagal output may be detected by HRV analysis.  This advancing 
deterioration in vagal efferent and afferent traffic may give rise to a “See-Saw” 
response in the heart rate variability as the dynamic and integrated system of neural 
activity attempts to restore physiological homeostasis to the heart rate.  This idea is 
supported by the recovery of function of areas of the brainstem in adult rats following 
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domoic acid lesions, with HRV returning to normal values 90 days after lesions 
(Cheng, Guo et al. 2002). 
This neurophysiological and anatomical evidence suggests a clear structural 
difference between the two vagi which would support the functional dichotomy on 
which the “Polyvagal Theory” is based.  Under certain circumstances, the control of 
the heart and degree of RSA (hence HRV) acts as if it is controlled by one “centre” 
and in other circumstances, behaves as at least two separate controllers are involved.  
Any model of functionality must account for this duality of control and changes in 
heart rate variability.   
In addition to the central neurological control of the heart, Porges also states the 
“Polyvagal Theory” requires an expansive conceptualization of the ANS to include 
target organ afferent and efferent pathways.  Furthermore his theory is derived from a 
series of neurological investigations that decompose and partition the beat to beat  
heart rate signal into constituent periodic components representing 
neurophysiological feedback loops that represent the sub second, beat to beat 
variability in the heart rate as the sum of several superimposed oscillations and slow 
trends that vary with metabolic demands.  The two most reliably described oscillations 
occur at "fast" frequencies associated with breathing and a slower or "low" frequency 
change associated with the endogenous rhythm of blood pressure regulation via 
baroreceptors and vasomotor activity.(Porges 2006b).  Consequently peripheral 
systemic factors are included in the evolution of the theory but only those that have a 
periodicity that would affect the "fast" and "slow bands" of oscillations on which the 
theory was developed. 
From neuroanatomical and neurophysiological evidence, Porges’ Polyvagal Theory 
constructs various premises, the first of which is that the bradycardia associated with 
the orienting response is mediated by the DMNX and that suppression of the 
amplitude of RSA is mediated by NA.  Porges states that suppression of heart rate 
variability is the same as reducing the amplitude of RSA.  The degree of RSA may not 
be a total indicator of HRV since it may be possible to have very little RSA but have 
lower frequency changes in HRV.  HRV being the sum of all spectral components not 
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just the high frequency band (>0.15 Hz) that represents RSA.  The distinction of RSA 
as a subset of total HRV may be useful in interpreting subtle and dynamic variation in 
HRV and may give a better insight into the relationship of NA and DMNX on heart 
rate in diseased states where “normal” function is mitigated.  For example if the 
normal NA efferent action is compromised, the slower acting DMNX efferents may 
alter the beat to beat fluctuations in heart rate as discussed above.  
Further evidence is presented for the involvement for the DMNX in non-baroreceptor 
mediated bradycardia in rabbits.  These animals exhibited different bradycardic 
conditioned responses following sinoaortic denervation.  Here the afferent branch of 
the baroreceptor reflex was destroyed which did not stop bradycardia from occurring. 
It is argued that the induced conditioned bradycardia was mediated along DMNX 
pathways (Jarrell, Gentile et al. 1986). 
The aortic depressor nerve communicates with both the DMNX and NA and when this 
was electrically stimulated in the rabbit, there was a bradycardia and increased RSA.  
Stimulation of the DMNX in isolation only gave bradycardia, with a 50% reduction in 
the extent of bradycardia elicited (McCabe, Yongue et al. 1984).  
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Figure 1. 5  Stimulation of DMNX and Aortic Depressor Nerve. 
Reproduced by kind permission of John Wiley and Sons licence number 2450160944459,June 15, 
2010 from; 
Porges, S. W. 1995, "Orienting in a defensive world: mammalian modifications of our evolutionary 
heritage. A Polyvagal Theory", Psychophysiology, vol. 32, no. 4, pp. 301-318. Figure 3 and figure 4 
Figure 1.5, from Porges’ Presidential Address to the Psychophysiology Society in 
1994 (Porges.1995), representing the work of McCabe, illustrates the difference 
between electrical stimulation of the DMNX and the aortic depressor nerve stimulation 
to elicit bradycardia.  There is a very obvious difference, not only in the magnitude of 
bradycardia, but also the manner in which that bradycardia was delivered.  In the first 
of the figures (stimulation of the DMNX directly) there appears to be a more smoothly 
mediated increase in heart period hence slowing of the heart), with a relative smooth 
maintenance of the elicited bradycardia.  
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This contrasts markedly with the over shoot seen when both DMNX and NA were 
stimulated via aortic depressor nerve along with the large scale changes in heart 
period seen throughout the stimulation period.  I postulate this could demonstrate a 
greater degree of deviation in the heart rate period when the NA and DMNX were 
stimulated together. There may be evidence here for an increased amount of HRV 
associated with the heart rate when both NA and DMNX are activated when 
compared with DMNX activation alone.  Conversely there is a smaller deviation in 
heart period without the activation of neurons from the NA.  Possibly a change in HRV 
would be evident if any abnormal or forced firing of these brainstem nuclei occurred.  
This may be the case in prion diseases where damage to one or both of the neural 
pathways could result in abnormal HRV. 
So the NA plays a major role in baroreflex mediated changes in heart rate with 
contradicting evidence for the role of the DMNX in baroreflex mediated changes to 
heart rate.  The weight of evidence from scientific investigation in many species, 
however, suggests that both the NA and DMNX are involved with the control and 
coordination of the heartbeat.  This inconsistency in structure and function of the 
DMNX may be due to several reasons.  Firstly, the method of stimulation or lesion 
generation may not be able to solely stimulate or lesion purely the DMNX due to its 
close proximity to NA.  Secondly there may be species differences in the functions of 
these two areas of the medulla and some mammals may have neurons near or 
integrated with the DMNX that are part of a common cardiopulmonary oscillator 
(Richter & Spyer 1987).  It is important to note that a change in activity in either or 
both vagal nuclei may give differing results depending upon the species being 
studied. 
From Reptiles to Mammals 
Porges gives more evidence to support his Polyvagal Theory by identifying evidence 
from the evolution of reptiles and mammals.  He stated that in mammals, the DMNX 
maintains its reptilian functions of controlling digestion and slowing the heart and is 
regulated by hypothalamic communication (Hopkins.1987;Leslie, Reynolds et 
al.1992).  He specifically uses the example of the vagal control of the heart to 
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highlight an apparent contradiction.  In most reptiles there is no boundary between 
DMNX and NA and cardiac vagal efferent pathways appear only in the DMNX.   
In mammals there is a distinction in the anatomy of the DMNX and NA and the 
cardiac vagal efferent pathways occur mainly in the NA.  In mammals there are also 
direct neural connections between the amygdala and the NA, with the NA capable of 
regulating vocalization, facial expressions and coordinating breathing with sucking 
and swallowing.  This evolutionary change in the structure and function of brainstem 
areas and corresponding change in the role of the vagus has led to the DMNX vagal 
general visceral efferents becoming part of the passive reflexive motor system and 
retaining the “vegetative” function of reptilian ancestors.  The special vagal efferents 
from the NA are part of an active voluntary motor system involved with conscious 
functions such as communication and emotion, motion and attention.  Thus, Porges 
has termed them as the DMNX being the “vegetative” vagus and the NA as the 
“smart” vagus. 
Studies on rats has revealed the NA is made of a series of interconnected 
subdivisions (Bieger & Hopkins 1987).  A respiratory rhythm was demonstrated in 
vagal fibres originating in one of these subdivisions, the external formation (NAex ),  
that terminated in the bronchi (Haselton, Solomon et al. 1992) and the sinoatrial (SA) 
node of the heart (Spyer & Jordan 1987).  Consequently, Porges suggests the 
resultant RSA may be thought of as having its origins, at least in part, in the NA.  The 
results of cross correlation studies of the firing patterns of single units lead to the 
hypothesis that respiratory rhythm is dependent on the interaction between groups of 
neurons in both the NA and NTS (Richter & Spyer.1987).  These areas are also the 
sites of motor neuronal activity that control cardiac, respiratory and laryngeal 
functions.  This lead to the model of a cardio-respiratory control centre formed from 
the interaction of the NTS and NA, being distinct from the DMNX whose neurons 
were found to have no respiratory rhythm associated with them.   
Further work has established that other brain structures are involved in the regulation 
of, if not the generation of, this cardio-pulmonary centre.  Respiratory rhythms have 
been found in nuclei of the brainstem, midbrain and forebrain.  Cross correlation 
59 
techniques were again used to identify these regions of the brain that demonstrated 
firing in time with the breath by breath rate.  Regions that demonstrated this 
correlation with breathing were: periaqueductal grey where 62% of discharge from 
sampled neurons correlated with respiration, (Ni, Zhang, & Harper 1990); central 
nucleus of the amygdala contributed to inspiratory cycle (Frysinger & Harper 1986); 
hippocampus in humans, cells from which also demonstrated correlations with heart 
rate  as well as breathing (Frysinger & Harper 1989); and anterior cingulate cortex 
which also demonstrated discharge properties of single neurons that were correlated 
with timing aspects of the respiratory and cardiac cycle (Frysinger & Harper.1986).  In 
the light of this information, monitoring RSA as one component of HRV, may reflect 
the function and control of this complex integrated neuronal cardio-pulmonary 
oscillator.  In relation to diseased states and malfunction of brainstem nuclei, RSA 
measures may yield a non-invasive measure of changing abnormal function. 
The NA, DMNX and heart rate variability
There are other vagal and non-vagal effects that contribute to the rhythm and heart 
rate.  The combined and synchronised effect on the SA node of the heart comprises 
influences from DMNX, NA, sympathetic nervous system and intrinsic rhythm 
generators of the heart.  In considering aspects from Porges’ Polyvagal Theory, “RSA 
is therefore, not a global measure of vagal tone nor is it a measure of total vagal 
control of the heart” (Porges.1995).  RSA represents one aspect of HRV which 
indicates the complex and integrated functional consequences of a neuronal system 
consisting of vagal fibres originating in the NA and terminating on the SA node of the 
heart via intrinsic ganglionated complexes.   To quantify the degree of RSA 
independent of slower oscillations and trends is therefore most important and will 
represent one spectral component of the total HRV.   
Equally important in establishing neuronal interaction and function between areas of 
the brainstem and the heart, is the consideration of other spectral components of 
HRV, representing the effect of the DMNX, and these effects coupled with RSA.  
Possibly the dynamic interaction between RSA and other components of HRV could 
give greater information on the malfunction of the vagal control on the heart.   
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To support this theory, work on depth of anaesthesia demonstrated that inhalant 
anaesthetics dramatically reduce RSA but leave the overall heart rate little changed 
(Donchin, Feld et al.1985).  This emphasises that the control of heart rate is not solely 
influenced by the NA since the drive from this centre is reduced, as indicated by the 
decrease in RSA during anaesthesia, but the heart rate is unaffected with both DMNX 
and NA being capable of influencing heart rate. Further work in analysing HRV with 
respect to anaesthesia demonstrated a shift in the power spectral analyses from 
respiratory frequencies to lower frequencies as anaesthesia increased (Blues & 
Pomfrett 1998;Pomfrett.1995).  This may suggest a shift from a dominant NA 
influence on heart rate to more prominent role for the DMNX as the NA drive is 
reduced.  The nonmyelinated fibres of the DMNX conduct with a slower velocity and 
so would exhibit a lower frequency control over the heart rate. 
A further example of the utility of considering other aspects of HRV in conjunction with 
RSA is the evidence from research into high risk preterm babies (Porges 1992).  
Many of these infants show a depressed degree of RSA and bradycardia, which is 
often associated with apnea.  This drop in available oxygen may be assumed to 
reflect the vestigial reptilian adaptive regulation of the heart by DMNX  (Porges.1995).  
Perhaps the degree of the involvement of DMNX along with NA could be calculated 
by the relative shifts in the balance of low and high frequency indices of HRV, with 
this measure giving a better predictor of emerging dynamic physiological state.   
There is a weight of evidence to support the interactive competition of the 
parasympathetic and sympathetic neuronal systems on individual organs (Berntson, 
Cacioppo, & Quigley 1991;Levy 1984;Vanhoutte & Levy 1979).  There may also be 
competition between two branches of the vagus on the same target organ.  For 
example, the two branches of the vagus on the heart are capable of affecting the 
cardiac cycle (Geis & Wurster 1980) and there may be competition at the SA node of 
the heart.   
The continued drive from the NA to the SA of the heart (vagal brake) may be a 
protective mechanism to functionally limit the effects of the suppressed bradycardia 
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resultant from DMNX activity.  This protection being functional achieved by the rate of 
acetylcholine (ACh) degradation on the SA nodal tissue which is thought to have a 
half-life of 2.7 s (Dexter, Levy, & Rudy 1989;Dexter, Saidel et al. 1989).   In cases 
where this protective activity of neurogenic NA activity are removed, indicated by a 
decreased RSA measure, there may be a massive and acute pathological 
bradycardia which could be an explanation for the physiological stress induced in 
Sudden Infant Death Syndrome and may also be involved in sudden death following 
exercise in adult populations (Porges.1995). 
The example above illustrates the functional interaction of the NA and the DMNX and 
suggests that measurement of RSA alone does not impart all the information 
available from HRV analysis and would not estimate the neural control of the heart 
from these two brainstem centres.  Dual innervation of many organs, such as the 
heart, lungs, pancreas, liver, and stomach has been documented (Brown 1990).  By 
investigating the control of bronchial asthma, the interaction of NA and DMNX may be 
researched further.  In relation to asthma, NA efferents cause the bronchi to exhibit a 
cyclical change in relation to breathing (Porges.1995).  It is proposed that the 
continuous stimulation of the bronchi by NA efferents may allow functional protection 
of the bronchi from a detrimental effect from the DMNX (In a similar fashion to the 
vagal brake on the heart, above).  Without this protection, the bronchi would become 
vulnerable to the vagal surges from DMNX.   
In an asthma attack, a monosynaptic reflex may be illustrated, with motor fibres 
originating from and afferent fibres terminating in the DMNX.  There is also evidence 
that dendritic process from DMNX project into the NTS.  This highlights an example of 
vagal afferent fibres that may communicate directly with DMNX neurons, forming an 
integrated reflex pathway (Neuhuber & Sandoz 1986).
Evidence from the investigation of both preterm babies and asthma attacks has 
suggested anatomical and functional relationships between DMNX and NA, which 
has led to notable changes in RSA.  This leads to the idea that study of diseased and 
malfunctioning physiology, by means of investigating changes in HRV, may give an 
insight into the changing physiological state in the disease. 
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Characterizing the anatomy and function of distinct brainstem areas
Anatomy of the DMNX and NA 
The DMNX and NA are two anatomically distinct regions of the brainstem and there is 
evidence to suggest that there are at least two populations of neurons which project 
to the cardiac vagal branches of many species such as rat, cat and dog (Bennett, 
Kidd et al.1981;Ciriello & Calaresu.1980;Ciriello & Calaresu.1982;Geis & 
Wurster.1980;Kalia & Mesulam 1980;Nosaka, Yasunaga, & Kawano 1979;Nosaka, 
Yasunaga, & Tamai 1982). Neurones with small myelinated axons conduct in the B 
fibre range, originating in the NA and have a respiratory related component to their 
on-going activity (Gilbey, Jordan et al. 1984;McAllen & Spyer.1978b).  The other 
population of neurones have axons which conduct in the slower C fibre range and are 
located in the DMNX and do not have any respiratory related rhythm (Ford, Bennett et 
al.1990;Jones, Wang, & Jordan 1998).  Efferent signals from the neurons in the NA 
are thought to convey a chronotropic action on the heart (McAllen & Spyer.1978b) 
and implicated heavily in respiratory sinus arrhythmia and the respiratory evoked 
reflex bradycardia (Richter & Spyer.1987;Spyer & Jordan.1987).  
In addition, there is debate about the functional significance of the C fibres originating 
in the DMNX.  It has been suggested that they may be involved in controlling blood 
flow to the heart (Feigl 1969) or have an inotropic action (Geis & Wurster.1980).  
Further work has been carried out where selective stimulation of vagal efferent C 
fibres can evoke bradycardia in rats, rabbits and cats. (Jones, Wang, & Jordan 
1995;Nosaka, Yasunaga et al.1979;Woolley, McWilliam et al. 1987a).  
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Function of DMNX and NA
The baroreceptor reflex constitutes a major control mechanism for circulation and 
involves coordination between the sympathetic nervous system, somatic 
baroreceptors as well as the parasympathetic system (Julien, Chapuis et al. 2003;Ma, 
Abboud, & Chapleau 2002;Stauss 2002;Thrasher 2002).  A focus on the 
parasympathetic involvement of the baroreceptor reflex demonstrates a pivotal role 
for the NA and DMNX in the reflex regulation of the heart to this reflex.   
An association between the DMNX and neurogenic bradycardia has been 
demonstrated in studies involving chronic bilateral lesion of the NA in rats; it was 
shown that there was a reduction in, but not totally removal of, the baroreceptor 
reflex-mediated bradycardia while conscious (Machado & Brody 1988a;Machado & 
Brody 1988b). This supports two ideas.  The first is that the DMNX is capable of 
mediating bradycardia with a latency associated with baroreceptor reflex.  The 
second idea is that similar neuronal control is exerted by the NA since lesions of the 
cell bodies reduces the bradycardia suggesting that in an intact system it contributed 
to the control of heart rate.   
Activation of baroreceptors in arteries evokes excitation in the vagal cardioinhibitory 
neurons of the external formation of the nucleus ambiguous NA(e) (Ciriello & de 
Oliveira 2003).  Likewise, activation of neurons of the NA using hypocretin 1 (hcrt-1), 
a neuropeptide recently identified exclusively in the lateral and perifornical 
hypothalamic neurons, significantly potentiates the reflex decrease in heart rate 
elicited by activation of the arterial baroreflex.  This work by Ciriello and de Oliveira 
presents data to suggest that hcrt-1 is changing the activity of vagal neurons of the 
NA to incoming baroreceptor inputs and that hrct-1 neurons of the hypothalamus and 
the NTS form part of a neuronal circuit involved in the control of the baroreceptor 
reflex at the level of the vagal efferent neuron (de Oliveira, Rosas-Arellano et al. 
2003).    
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Suggestions of how hcrt-1 exerts its effects include direct action on the vagal 
cardiomotor neurons, or it may act by changing the release of neurotransmitters in the 
afferents of the NTS that pass on the baroreflex signals to the NA.  Glutamate is used 
as a putative neurotransmitter in afferents of the NTS (Kodama & Kimura 2002;Siegel 
2004;van den Pol 1999). Therefore, there is a possibility that hcrt-1 may act by 
increasing the release of glutamate from NTS axonal terminals within the NA and so 
potentiate the reflex vagal bradycardia (Ciriello & de Oliveira.2003).  These lines of 
evidence underline the importance of the interaction of brainstem nuclei in the control 
of heart rate and give an insight on how damage to such areas caused by prion 
diseases could consequently affect HRV and cardiac reflexes in a complex and 
interlaced manner. 
Extracellular recordings were made from cardiac vagal motorneurons conducting in 
the B fibre range of the NA of the rat.  In response to brief arterial pressure changes, 
these neurons demonstrated that there was an increase in activity due to active cells 
firing faster and by recruitment of previously silent neurons (Rentero, Cividjian et al. 
2002).  This suggested that these neurons of the NA were barosensitive and that 
there may be a degree of functional redundancy associated with the integrated neural 
response to changes in arterial pressure.  Patterns of spontaneous activity of these 
cardio vagal motorneurons were also investigated and it was found, from the small 
population investigated, that the fastest firing neurons showed a symmetrical 
distribution about its modal interval and the majority of the others showed a skewed, 
Poisson-like distribution indicating irregular firing.  Superimposed on these firing rates 
were influences from the cardiac and respiratory cycles.   
Bradycardias evoked by activation of arterial baroreceptors were partially or wholly 
blocked if they were stimulated during the inspiration phase of respiration (Davidson, 
Goldner, & McCloskey 1976;Gandevia, McCloskey, & Potter 1978).  The study of 
such phenomenon suggests evidence for the neural coupling between brainstem 
nuclei and respiratory and cardiac control.   In cats this attenuation of the bradycardia 
has been shown to be related to inspiration related inhibitory gating of the synaptic 
input to cardiac vagal preganglionic neurones (Gilbey, Jordan et al.1984).  It has been 
shown that the bradycardia evoked by stimulating pulmonary C fibre afferents was not 
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influenced by the phase of respiratory cycle or degree of lung inflation (Daly & 
Kirkman 1989;Daly 1991).  Daly suggested there may be two types of cardiac vagal 
preganglions, both with chronotropic actions on the heart.   One that can be inhibited 
by pulmonary stretch afferents and the other population of neurons cannot.  The 
degree of modulation of a cardioinhibitory reflex will depend on the proportion of the 
two populations of cardiac vagal motoneurons that are excited by lung inflation. 
There is a possibility that non myelinated axons from the DMNX may mediate the 
bradycardia evoked by pulmonary C fibre stimulation and these neurones do not 
possess a central respiratory relationship (Daly.1991;Jones, Wang et al.1998).  Jones 
suggested that the identification of such fibres in the cat did not completely account 
for the hypothesis proposed by Daly since the evoked changes on the heart from the 
pulmonary chemoreflex have a longer time course than the brief bursts of activity 
elicited in neurons of the DMNX.  In conjunction with this observation, it has been 
observed that cardiac C fibre efferents alone are not potent enough to evoke dramatic 
changes in cardiac function, such as cardiac arrest (Jones, Wang et al.1995).  These 
observations have led to an altered hypothesis being postulate by Jones.  He 
suggests that cardiac projections from the NA and DMNX preganglionic neurons may 
converge on target neurons in the cardiac ganglia with the final integrated activity 
being translated into the homeostatic level of sinus arrhythmia and heart rate 
variability. 
A small group of peripheral C fibre axons was found to have respiratory related 
modulation and some additionally had a cardiac related discharge and so giving an 
activity profile similar to preganglionic neurons with B fibre axons (Jones, Wang et 
al.1998).  Research has revealed there was a small group of vagal preganglionic 
neurones located in the area between NA and DMNX which had slowly conducting 
axons (Nosaka, Yasunaga et al.1982).  The possibility thus existed that Jones was 
recording from such neurons.  An alternate idea may be taken from the research into 
vagal afferent (Duclaux, Mei, & Ranieri 1976) and efferent fibres (Chase & 
Ranson.1914) that suggests some fibres may be myelinated centrally and may lose 
their myelination peripherally, hence would present slower conduction velocities when 
recorded peripherally.   
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It was also observed that the respiratory association of the neurons of the rat NA 
were different to that seen in cats and dogs.  In rats maximum activity always 
occurred during the central inspiratory phase rather than the expiratory phase.  This 
was demonstrated by use of respiratory cycle triggered activity histograms and 
correlation with phrenic nerve activity.  With this exception, the properties of the 
cardio vagal motorneurons of the rat NA agree well with findings from cat neuronal 
activity (McAllen & Spyer.1976;McAllen & Spyer 1978a;McAllen & Spyer.1978b) and 
fibre recordings in cats and dogs (Gilbey, Jordan et al.1984;Katona, Lipson, & 
Dauchot 1977;Katona, Poitras et al. 1970;Kunze 1972;Potter 1981).  Evidence from 
the work of Mendelowitz and colleagues (Irnaten, Neff et al. 2001;Mendelowitz 
1999;Mendelowitz 2000), using Bartha pseudorabies virus, found that the rat cardio 
vagal motorneurons are innervated by collateral axons from branches of Superior 
laryngeal neurons.  Superior laryngeal neurons are most active during inspiration and 
Renetero suggested this may be the reason for this phasic change of firing during the 
respiration cycle in the rat that is distinct from other animals. 
Research to investigate whether stimulation of pulmonary C fibres also activated 
respiratory modulated B fibre cardiac preganglionic neurons of the NA was 
undertaken (Wang, Jones et al. 2000).  This work did demonstrate that stimulation of 
pulmonary C fibre afferents activated respiratory modulated B fibre axons and also 
suggested that part of this excitation was independent of inhibition of central 
respiratory drive from these C fibre afferents.  Wang et al postulated that respiratory 
modulation may be inhibited by the activity of the stimulated pulmonary C fibre 
afferents on the inspiratory input synapses of these neurons.   
Another idea presented was that an interaction between activity in non-respiratory 
modulated C fibres axons (as studied by (Jones, Wang et al.1998)) and respiratory 
modulated B fibre axons (as studied by (Wang, Jones et al.2000)) occur at the 
cardiac ganglion and, or, postganglionic nerve endings in the sinoatrial node (Cheng, 
Zhang et al. 2004a).  This may serve to abolish the respiratory rhythm previously 
associated with vagal preganglionic neurons of the NA by the inhibitory action of the 
C fibre activity from the DMNX as the result of pulmonary afferent stimulation. 
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Work by Cheng utilizing domoic acid, an excitatory neurotoxin,  to specifically disrupt 
neurons of the NA (Cheng, Zhang et al.2004b) has demonstrated that in the rat both 
DMNX and NA motor neurons are barosensitive with vagal cardioinhibitory neurons 
from the nucleus ambiguus (NA) demonstrating a powerful excitation to baroreflex 
stimulation. A 68% reduction in the numbers of neurons in the NA gave rise to an 
attenuation in barosensitivity of around 83%.  Their results indicated that neurons in 
the NA and DMNX send axons that converge to the same cardiac ganglia but 
innervate distinct principal neurons within these cardiac ganglia.  This suggests that 
both NA and DMNX could synergistically moderate heart rate activity, A-V conduction 
and myocardial contractility.  The major control of the baroreflex bradycardia is from 
the NA but it is postulated that the DMNX may mediate the heart through some other 
cardiac reflex.  It has been suggested that the DMNX may intervene in the pulmonary 
C fibre-evoked bradycardia. 
One of the functional deductions from the work of Cheng is the fact that preganglionic 
motorneurons from the NA and DMNX may exercise control over distinct populations 
of cardiac ganglions.  In addition, axons from these vagal efferents are routed via 
different nerves to innervate different populations of intrinsic cardiac cholinergic 
postganglionic neurons (Cheng, Zhang et al.2004a). 
This would also mean the possibility exists for a degree of integrated complementary 
control for the vagal efferent activity from anatomically distinct parasympathetic nuclei 
at the cardiac ganglions.  This idea, coupled with evidence of brainstem nuclei 
(specifically DMNX and NTS neurons) recovering function following brainstem 
lesions, would suggest a changing and integrated control of heart rate variability over 
a period of around 30 days as observed in a rat following domoic acid lesion to the 
brainstem nuclei (Cheng, Guo et al.2002). 
Prion protein builds up in the DMNX and NA which causes lesion and subsequent 
loss of function in those nuclei in a similar manner to domoic acid lesions induced by 
the experiments of Cheng and colleagues.  Following on from these lines of evidence, 
suggesting recovery of function of mammalian brainstem nuclei, it is worth 
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considering whether the incubation of prion diseases may cause a transient change in 
beat to beat control of the heart resultant from a change in the normal balance of 
DMNX and NA efferent output as brainstem nuclei regain their function.  
Intrinsic and thoracic cardiac ganglia 
The cardiac ganglia alluded to by Cheng above, include extracardiac intrathoracic 
neurons and intrinsic intracardiac neurons located on the heart itself.  Their affects in 
conjunction with brainstem nuclei and the action of parasympathetic axonal efferent 
fibres need to be considered.  These neurons are arranged in hierarchical control 
structures, with the neurons at the heart exerting beat by beat control over myocardial 
function (Armour 1994).  Their interaction with higher brain structures is illustrated in 
figure 1.6.  
Afferent and efferent intracardiac neurons form local circuits and extend throughout 
the atria and ventricles, displaying on-going activity in the beating heart.  This activity 
may be modulated by inputs from intrathoracic ganglia and the central nervous 
system.  Of particular interest is the interaction of the descending vagal drive from the 
medulla and the interaction with the intrinsic cardiac ganglia and resultant 
chronotropic regulation of the heart (Randall, Brown et al. 2003).   The descending 
vagal efferent pathways are highlighted by red dots in figure 1.6.  It can be seen that 
the activity from the DMNX and NA may be integrated and possibly gated at either or 
both of the intrinsic ganglionated plexus (RAGP and PAGP) 
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Figure 1. 6  Schematic of Neural connections from CNS to SA node via 
ganglionated complexes. 
Used with permission, from Armour, J. A., Collier, K., Kember, G., & Ardell, J. L. 1998, "Differential 
selectivity of cardiac neurons in separate intrathoracic autonomic ganglia", Am J Physiol, vol. 274, no. 
4 Pt 2, p. R939-R949. Figure 7.  Comprising elements from Armour and Randall (Armour, Collier et al. 
1998;Randall, Brown et al. 1998a;Randall, Brown et al.2003). 
The “triumvirate” of brainstem nuclei (NTS, NA and DMNX) and their relationship to intrinsic ganglionated complexes (RAGP and 
PAGP) and subsequent action on the SA node is illustrated here.  Parasympathetic efferent communication is indicated in red, 
sympathetic activity is indicated in blue. Black lines indicate efferent communication of the ANS with higher brain centres. 






























Work by Thompson has given evidence for the potential involvement of local 
intracardiac control of the heart by investigating the functioning of the spinal cord and 
brainstem in conjunction with the nested feedback loops of intrathoracic and 
intracardiac neurones of the canine ganglionated plexus. (Thompson, Collier et al. 
2000)   The canine intrinsic cardiac ganglia cluster within fatty pads at discrete 
locations on the heart.   This study involved taking simultaneous recordings from 
neurons in two separate locations of one fat pad during a control state and a state 
where substances (veratridine) known to activate sensory neuronal activity were 
applied to the epicardium of the heart.  Their work illustrated that the activity of two 
populations of neurons at different regions within a single intrinsic cardiac plexus 
displayed intervals, of around ten seconds, of coupled behaviour every fifteen to thirty 
seconds.   
These episodes of synchronicity described above, occurred during both the control 
periods and during the periods of topical application of substrate.  These observations 
may be explained if these two population of neurons received common inputs or 
these two groups of neurons communicated with each other.  To assess the mode of 
interaction, the activity of these two populations of neurons were cross correlated 
over five minutes and 15 from the 16 recorded neurons displayed synchronised 
bursting of activity.  This coupled behaviour was not seen when intracardiac neuronal 
activity was compared with that of extracardiac intrathoracic neurons (Armour, Collier 
et al.1998).  The interaction of intracardiac neurons and extracardiac intrathoracic 
neurons often generate low frequency rhythms that are out of phase and the 
suggested function of such activity is to stabilize overall coordination of cardiac 
function.  Thus, there are indications that regional cardiac control of the heart is a 
result of integrative neuronal competition in the intrinsic ganglionated complexes 
located on the heart mediated by afferent neuronal feedback and extracardiac 
sensory input from intrathoracic neurons.  
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Intrathoracic Ganglia 
Evidence for the contribution of intrathoracic ganglia to the control of the heart may be 
taken from the work of Armour (Armour, Collier et al.1998)  The activity of neurons of 
the middle cervical or stellate ganglia were compared and contrasted to neurons of 
intrinsic cardiac ganglia in consequence to various cardiovascular changes.   It was 
found that the spontaneous activity of 19% of intrathoracic neurons and 32% of 
intrinsic cardiac neurons were related to specific phases of cardiovascular 
perturbation.  14% of the identified extracardiac and 8% of the identified intrinsic 
cardiac neurons generated respiratory related activity.  Other intrathoracic neurons 
generated sporadic activity.  In addition, approximately 60% of extrinsic cardiac 
neurons and around 80% of intrinsic cardiac neurons displayed increased activity to 
epicardial mechanical stimulation. Activity generated by neurons in intrinsic cardiac 
ganglia did not show any short term relationship to activity in extracardiac ganglia.   
Following experiments which involved decentralization (disconnection of intrathoracic 
nervous system from spinal cord and brainstem) it was suggested that intrinsic 
cardiac neurons received afferent inputs mainly from cardiac chemosensitive 
neuronal networks and the neurons of the middle cervical ganglia received afferent 
inputs mainly from cardiac mechanosensory neural networks.  
Importantly, cardiac and respiratory related activity continued to be generated by sub 
populations of intrathoracic neurons after acute decentralization.  Armour also 
summarized intrathoracic ganglia as containing afferent neurons, local circuit 
neurons, sympathetic efferent postganglionic neurons and parasympathetic efferent 
postganglionic neurons.  It was concluded that different reflex controls of cardiac 
function may be established due to the activity of populations of neurons within 
different intrathoracic ganglia.  Their redundancy of function and independent 
behaviour reduced the dependency on a single population of neurons and a single 
neuronal pathway in regulating the heart on a beat to beat basis.   
Populations of neurons located in separate intrathoracic ganglia show little short term, 
in the order of milliseconds, interactions.  Although sympathetic efferent preganglionic 
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neurons may input directly to both extrinsic and intrinsic subpopulations of neurons, 
these do not appear to be the main source of coordinated neuronal activity within 
intrathoracic ganglia.  Armour et al suggested that most intrathoracic neurons function 
relatively independently when controlling cardiac function.  They postulated that they 
act as a part of a subsystem of overlapping nested neural feedback loops.  It was 
suggested that there exists various feedback loops characterised by the time of 
neural activation of the induced cardiac changes.  
Short term feedback facilitated by intrinsic cardiac nervous system, medium term 
feedback by middle cervical and stellate ganglia and long term feedback occurs as 
the result of spinal cord and brain neural communication pathways. Functional 
redundancy of intrathoracic neurons is also suggested by the observation of 
functional selectivity of the behaviour of neurons when modulating cardiodynamics.  
Coordination of autonomic output from intrathoracic neurons is achieved to some 
degree by a sharing of inputs from higher centres in conjunction with neural 
communication between neurons in and between various peripheral ganglia.  The 
independence of function of intrathoracic ganglia is endorsed by the 10-20 second 
bursting of neuronal activity of intrathoracic neurons when disconnected from central 
nervous system.  This evidence supports the concept of a diversity of afferent 
feedback in the cardiac control cycle which creates a potential for the maintenance of 
coordinated efferent neuronal outflow while providing the flexibility required for the 
beat to beat regulation of efferent outflow to the heart.    
Intracardiac Ganglia 
The work of Armour et al above, by utilizing the decentralization technique, 
demonstrated the importance of input from the central nervous system.  Some 
neurons of the intrinsic cardiac ganglia receive direct inputs from parasympathetic 
efferent preganglionic neurons (Armour & Hopkins 1984;Armour, Huang et al. 
1994;Armour & Janes 1988).  The subsequent loss of these direct connections with 
the change in function of the long feedback loops would be observed by a change in 
the coordinated regulation of the heart on a beat to beat basis. This surgical 
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decentralization may also be used as an analogy to the possible malfunction in neural 
function seen in affected brainstem neurons and the vagus nerve in TSE diseases.   
Thus the work of Armour provided anatomical and neurophysiological evidence for a 
change in the beat to beat effects on heart rate caused by dysfunction in the nested 
neural feedback loops, altered by the breakdown of the normally coordinated neural 
communication to the heart, via the vagus, from the medullary areas of the brainstem.   
The interaction of the sympathetic and parasympathetic nervous system also has a 
role to play in the regulation of the beat to beat variation of heart rate.  It is thought 
that one site of interaction of these two branches of the autonomic nervous system is 
the autonomic neuroeffector junctions at the myocardium.  The intracardiac ganglia 
have also been postulated to be a site for parasympathetic-sympathetic interaction.  
Reports have indicated that sympathetic terminals exist in intracardiac ganglia, so 
giving the prospect of both sympathetic and parasympathetic inputs converging on 
single intracardiac ganglia (Ellison & Hibbs 1976;Moravec, Moravec, & Forsgren 
1990).   
Research investigated the intracellular response of single intracardiac neurons to 
stimulation of both efferent limbs of the autonomic nervous system.  The response of 
single intracardiac neurons, in vitro, to various patterns of stimulation delivered to the 
excised stumps of the vagus (parasympathetic) and cardiopulmonary nerve 
(sympathetic) were investigated in the pig (Smith 1999).  In this study, none of the 
sampled neurons received inputs solely from cardiopulmonary nerves.  Instead, 
extrinsic sympathetic inputs (to sampled neurons) converged on a subset (17%) of 
neurons that were vagally innervated.   
Three types of intracardiac neurons were identified by Smith, based on their firing 
patterns to 60ms depolarizing test currents.  40% of those tested were found to be 
phasic, discharging one action potential at the start of the stimulus.  35% were 
accommodating, discharging multiple action potentials at a decreasing frequency as 
the stimulus continued and 27% were tonic, discharging multiple action potentials 
during the stimulus period with little change in the frequency of discharge throughout 
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the stimulus period.  Of the 66% of neurons that responded to vagal stimulation, 
some did not depolarize sufficiently to reach the threshold to generate an action 
potential.  Of these neurons incapable of generating an action potential to vagal 
stimulation, it was observed that multiple excitatory post synaptic potentials (EPSPs) 
were summed to generate an action potential.  Therefore intracardiac neurons 
generating EPSPs must integrate synaptic inputs from multiple preganglionic axons.   
Those neurons that gave an action potential in response to vagal stimulation may be 
the classical efferent parasympathetic neurons innervating the myocardium.  Smith et 
al noted that these neurons did not represent the majority of intracardiac neurons 
sampled.  If this sample was representative of the whole this would imply that vagal 
stimulation of intracardiac neurons involves integration of synaptic inputs from a 
range of postganglionic axons.  The potential of intracardiac neuronal range and 
complexity of function is thus evident. 
The postsynaptic effects of vagal stimulation are eliminated by using a nicotinic 
channel blocker (hexamethonium) or perfusion with a “Tyrode” solution containing 
reduced calcium and increased magnesium levels which block the release of 
neurotransmitter at nerve terminals.  Utilizing these techniques, Smith’s work stated 
that the effects of nerve stimulation were mediated synaptically and the induced 
depolarisations were produced by acetylcholine (ACh) released from vagal 
preganglionic terminals acting at nicotinic postsynaptic receptors (Smith.1999). 
The interaction of the sympathetic and parasympathetic systems at the level of these 
intracardiac ganglia was postulated by evidence obtained by observing the effects of 
stimulating the vagus and cardiopulmonary nerves in those neurons that are dually 
innervated.  The duration of the action potential and afterhyperpolarization lengthened 
when the vagus and cardiopulmonary nerves were stimulated together, compared to 
stimulation of the vagus alone.  This response was characterised as a type one 
response by Smith.  Since there was no direct postsynaptic effect from stimulating the 
cardiopulmonary nerve, it is thought that the increase in duration of action potential 
and afterhyperpolarization is caused by a substance (another neurotransmitter or 
neuropeptide,) released from intraganglionic sympathetic terminals that may act 
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presynaptically on vagal terminals to increase the release of acetylcholine (ACh).  
The prolonged channel opening causing the increased action potential and 
afterhyperpolarization times, would result from higher ACh concentrations within the 
synaptic cleft (Smith.1999).  
The majority of neurons that demonstrated an influence from cardiopulmonary nerve 
stimulation gave a type 2 response to concurrent stimulation of the vagus and 
cardiopulmonary nerve.  Action potentials were generated as a result of costimulation 
and during vagal stimulation alone, evoked depolarisations could be blocked  by 
hexamethonium and demonstrated similar amplitude and duration of mean EPSPs to 
those neurons only innervated by the vagus.   
EPSPs produced by cardiopulmonary nerve stimulation with these type 2 responses 
were smaller in amplitude and duration than those produced in the same neurons by 
vagal stimulation.  Nicotinic receptors were not involved in responses to 
cardiopulmonary nerve stimulation, as demonstrated by no change in the response to 
cardiopulmonary nerve stimulation of these neurons during exposure to 
hexamethonium.  However, Timolol, a beta antagonist, blocked postsynaptic 
responses to cardiopulmonary nerve stimulation. When both hexamethonium and 
timolol were given together, no postsynaptic activity was seen when stimulation of the 
vagus and cardiopulmonary nerve were costimulated.  This suggested that different 
synaptic inputs are activated by stimulation of these branches of the autonomic 
nervous system.   
It was suggested by Smith that Ach released from vagal preganglionic terminals 
acting at nicotinic postsynaptic receptors, mediates the effects produced by vagal 
nerve stimulation.  Smith also suggested it was likely that norepinephrine released 
from postganglionic sympathetic nerve terminals, acting at beta adrenergic receptors 
was involved in the effects of cardiopulmonary nerve stimulation.   
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It is thus possible that integration and mediation of function of the heart by both the 
sympathetic and parasympathetic branches of the autonomic nervous system can be 
established at the location of the intrinsic cardiac ganglia which may exert beat to 
beat changes on the cardiac cycle.   
Other work has shown that application of nicotinic, muscarinic and -adrenergic 
agonists to intracardiac ganglia of a dog heart in vivo produced an increase in the 
firing of intracardiac neurons and changed cardiac regulation (Huang, Smith, & 
Armour 1993b).  Data from this work also confirms that in situ mammalian 
intracardiac neurons possess nicotinic, muscarinic and -adrenergic receptors and 
are involved in cardiac regulation. 
Smith also suggested that due to the lower membrane conductance of phasic 
neurons as deduced from his work, smaller currents would be required to depolarize 
the voltage gated channels responsible to generate an AP.  This characteristic of 
phasic neurons may mean they are more excitable than the other accommodating or 
tonic neurons of intracardiac ganglia.   
Smith reported that from his observations, extrinsic vagal inputs appeared to be 
directed to phasic and some accommodating neurons whereas extrinsic sympathetic 
input is directed to target phasic neurons of the intracardiac ganglia.  Most tonic 
neurons received no extrinsic input.  The firing properties of phasic and 
accommodating neurons were less able to respond to on-going high frequency 
synaptic input sufficient to depolarize the membrane to firing threshold.  
Consequently, phasic and accommodating neurons would act as a low pass filter to 
sustained high frequency synaptic input.  It is also stated that the identification of sites 
of vagosympathetic convergence within the intrinsic ganglia allow the possibility of 
activity in one branch of the ANS to gate the activity in the other.  For example, 
parasympathetic inputs may alter the activity of subsequent sympathetic inputs by 
“priming” the neuronal sensitivity to such vagal activity or vice versa.   This interaction 
between the parasympathetic and sympathetic branches of the ANS are revealed in 
the paced breathing study where cardiac sympathetic outflow was found to mediate 
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RSA demonstrating that RSA is not mediated solely by vagal cardiac nerve activity 
(Taylor, Myers et al. 2001). 
Research involving the ablation of specific atrial populations of intrinsic cardiac 
ganglia, the posterior atrial ganglionated plexus (PAGP), suggested that a major role 
for the constituent parasympathetic neurons was to inhibit sympathetic 
neurotransmitter release.  PAGP ablation augments the HR increase by potentiating 
the action of sympathetic nervous system at the SA node (Randall, Brown et al. 
1998b).   
Leading on from this idea that there is potential for the parasympathetic activity to 
selectively modify sympathetic activity in addition to independent direct action, I 
suggest activities in certain brainstem nuclei may have the ability to “gate” the 
sympathetic action on the heart.  This may also mean that damaged functional output 
of DMNX and NA, caused by prion invasion, may cause an abnormal disruption in 
descending neuronal vagal input to these complexes. Thus, a change in the gating of 
activity at the intrinsic ganglionated complexes that communicate to the SA node may 
consequently alter the cardiodynamics of the heart and affect HRV. 
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Chapter 2 Common Methods used in this thesis. 
Introduction 
Heart Rate Variability (HRV) is used as a non-invasive tool to investigate changing 
autonomic function.  Certain analyses are reported to highlight cardiac 
parasympathetic activity in the study of diabetes; work by Ewing indicated a 
difference in HRV of diabetic patients suffering from neuropathy compared to healthy 
control subjects and also illustrated a difference in HRV of heart transplant patients 
having medically denervated hearts (Ewing, Neilson, & Travis 1984).  In Parkinson's 
Disease (PD) and Lewey body dementia patients, where Lewey bodies appear in 
peripheral autonomic and enteric ganglia, autonomic dysfunction is reported in 
peripheral autonomic ganglia as a precursor to the neurodegeneration seen in the 
central nervous system (CNS) (Iwanaga, Wakabayashi et al. 1999;Kaufmann, Nahm 
et al. 2004).  Specifically, HRV analysis was used to assess an early parasympathetic 
dysfunction in Parkinson’s disease (Buob, Winter et al. 2010) that may occur before 
or at the same time as a sympathetic dysfunction of the autonomic nervous system 
(Shibata, Morita et al. 2009).  Consequently the parasympathetic control of the heart 
on a beat to beat basis has been shown to be altered in early stages of Parkinson’s 
Disease. 
Questions about Parkinson’s disease being a prion disorder have been mooted 
(Olanow & Prusiner 2009) consequently the comparisons to prion disease and how a 
disease can change cardiac function, specifically the parasympathetic mediated 
control of the heart, are apparent.  Of particular interest to prion diseases is the vagus 
nerve and its parasympathetic control on the heart since branches of the vagus 
nerve, along with the enteric nervous system, have been postulated as a possible 
conduit for the infectious agent in prion diseases (Beekes, McBride et al.1998;Beekes 
& McBride 2007;Pomfrett, Glover, & Pollard 2007;van Keulen, Bossers et al.2008;van 
Keulen, Schreuder et al.2000). 
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In light of the above information I wished to investigate whether incubating TSEs 
changed heart rate variability (HRV) influenced by the presence of PrPD deposits in 
brainstem areas as discussed in chapter 1, in a similar fashion to the changes 
reported in Parkinson's disease.
Electrodes 
In order to accurately record a good quality ECG from sheep and cattle, specialized 
electrode pads were constructed.  These were individually manufactured from 
polythene document wallets approximately 0.001 m thick that were cut into 0.1m 
diameter circles each with a hole approximately 0.02 m diameter cut in the middle of 
this circle.  Standard 3M Silver/Silver Chloride monitoring electrodes with foam tape 
(3M ID: DH-9999-3816-9) were placed in these inner circles.  Various colours were 
used to allow individual use for each animal and isolate each batch of electrodes to 
one of the testing pens (see figures 2.1 and 2.2).  This was done to exclude cross 
contamination between control groups along with wiping the testing rig and equipment 
with “Chloros” solution (Sodium Hypochlorite solution from Martin Manufacturing Co. 
Ltd, Belfast) used to limit prion infection when moving between sheep of different 
groups.  In addition protective clothing was changed between such groups. 
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Figure 2. 1  Standard electrode and adapted electrode. 
Figure 2. 2  Range of colours for constructed electrode to reduce cross contamination. 
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The contact surface of the constructed electrode was covered with a liberal amount of 
“Magnafloc” gel  (Magnafloc LT20 Gel in 0.1 M sodium chloride solution. Magnafloc 
LT20 is a polyacrylamide gel approved under regulation 25(1)(a) of the Committee on 
Chemicals and materials for use in public water supplies and swimming pools for use 
as a flocculent, supplied by Ciba Specialty Chemicals, UK,Bradford,West Yorkshire).  
A simple three connection bipolar ECG recording, giving a similar trace to a lead II 
configuration, was used since no interpretation of various ECG complexes would be 
required and it provided a quick, stable and accurate trace from which to detect the R-
wave (the largest deviation in the ECG montage).  Electrode position was adjusted to 
obtain the greatest difference between R-wave and baseline.  No filtering was applied 
to the raw ECG since the accurate recording of the R-wave times was of paramount 
importance. 
To record approximately 300 seconds of ECG data 3 devices were used in this thesis.  
Two “Depth of Anaesthesia” monitors were used along with a modified Variacardio 
TF4. 
One of the “Depth of Anaesthesia” monitors was developed by Otter Controls Ltd, 
(Buxton, Derbyshire; (Blues & Pomfrett.1998;Pomfrett, Glover et al. 2004).  This 
consisted of a programmable physiological amplifier (CED 1902) acquiring the ECG 
which was then digitized by a computer using a DAP800 12 bit card sampling at 
1kHz.  This was enclosed in a box which conformed to IP65 (IEC 60529 (ed2.1), 
clause 4.1) that facilitated the cleaning of the equipment with Chloros solution (Aguzzi 
& Collinge 1997;Defra 2007) which allowed the transfer of the equipment between 
pens and so prevented cross contamination between the experimental herds. 
A second “Depth of Anaesthesia Monitor” was also used.  This was called “Fathom”, 
which is a commercially available depth of anaesthesia monitor based upon analysis 
of HRV during anaesthesia.  This was available from Amtec Medical Ltd (County 
Antrim, BT41 1QS Antrim, 6 Technology Park, Belfast Road, Belfast, Northern 
Ireland.) 
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The TS1 recording device was adapted from a Variacardio TF4 (MIE Medical 
Research Ltd, 6 Wortley Moor Road, Leeds).  The modifications to the TF4 were 
carried out by MIE to my specifications and a software program to export from the 
device and import into Spike 2 was written by MIE with advice and direction from 
myself.  The modifications consisted of alterations to the transmission of the 
telemetric data to the computer for archiving.  The ECG and R-R intervals were 
sampled at 1 kHz in this modified version compared to sampling rates of 500 Hz for 
ECG signals and 1 kHz for R-R intervals in the TF4 model.  This was designed to give 
precise correlation between the raw ECG waveform and the R-wave times.  This 
enabled accurate screening of missed or ectopic beats by comparing the two 
synchronous data streams.  Further modifications to this device included the addition 
of a breath sensor based upon registering a change in current as the subjects 
exhaled breath changed the resistance of a thermistor positioned in proximity to the 
nose or mouth.  This sensor was not used in this study, however. 
The basic function of these devices was to accurately record the R wave times and 
archive these data to be later imported into Spike2.  All devices used to collect ECG 
data recorded equivalent ECG data tested by common input to the systems and 




For both types of “Depth of Anaesthesia” monitors, data were collected and archived 
in a common format (CED SON data Library provided by Cambridge Electronic 
Design) on the device and later transferred to a computer for analysis.  This common 
pathway is illustrated in figure 2.5. 
300 seconds of data without artefact were used to obtain spectral and time domain 
estimates of HRV.  On occasions this required data collection to be in the range of 5 
to 10 minutes for each animal.  Each file was checked by eye to ensure there were no 
missed or ectopic beats since such errors were reported to affect the resultant 
estimate of HRV (Berntson & Stowell 1998).  Spike 2 version 4.22 and version 6.02 
software (CED, Cambridge Electronic Design) and an automated analysis program 
(BSEnsor v8, script file) was used to analyse the data files in batches. 
To test the hypothesis that prion infection alters HRV, ECG data sampled at 1kHz 
was archived in a proprietary format to be imported to Spike 2 (Cambridge Electronic 
Design) for the analysis performed in this thesis.  Following data capture R-waves 
were detected from the ECG waveform by an automated process based on a 
purpose-written script which performed peak detection based upon a signal change 
that was 3.5 times the standard deviation of the baseline between two cursors equally 
spaced in the data sample.  The R-wave times were then put into an array and the R-
wave events displayed on a new channel.  These R-wave event markers were then 
screened by eye to look for missed R-waves and ectopic beats.  Such abnormalities 
were corrected using automated and manual addition and removal of R-wave events 
from the event channel.  However, analysing HRV data with the ectopic beats 
included has indicated that information about the dynamic cerebral autoregulatory 
response gained from observations from impulse like disturbances of blood pressure, 
associated with these ectopic beats, can be gained (Eames, Potter, & Panerai 2005).  
The use of the methods used to analyse HRV per breath used here may have utility in 
such analysis by analysing pulse pressures within the physiological epoch (breath) 
before the ectopic and contrasted with similar samples from the physiological epoch 
(breath) containing the ectopic beat.  Ectopic beats may consequently have an effect 
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on HRV since they are reported to affect blood pressure which could alter the “set” 
point of regulation of the heart over a time scale of a few seconds correlating to very 
low frequency changes in HRV spectrum. 
To facilitate this screening by eye, a separate channel illustrated the areas of the 300 
second data file that contained abnormalities by showing a break in a continuous line.  
A channel of instantaneous heart rate was derived from the R-wave events by using 
the Spike2 command DrawMode.  This error check channel was created by 
assessing “good” data as events that fell within the maximum and minimum 
acceptable instantaneous heart rates.  The minimum rate was chosen to be 20 and 
the maximum was chosen to be 165.  Figure 2.6 shows an example of how the 
instantaneous rate channel was created.   
The instantaneous rate (IR) is related to the R-wave interval (t) by the following 
formula: 
The values chosen by the acceptable maximum and minimum rates equated to 
intervals of 3 seconds and 0.3636 seconds respectively.  In reality these limits 
checked for a break in the ECG recording and noise being picked up as R-waves.   
Deviations from these limits were represented by large peaks or troughs in the 
instantaneous rate display and a break in the derived signal quality line. 
For the TS1 device, data were digitised at a sampling frequency of 1 kHz and 
wireless transmission allowed the raw ECG to be imported into the TS1 software 
running on a conventional laptop computer (Dell Latitude P4 computer model PP01L). 
Using this software and hardware automated QRS wave detection was applied.  The 
software was able to correct for missed beats and artefacts by the manual use of an 
in built proprietary routine.  In addition to the filtered R-wave event times, the 
unfiltered R-wave event times and raw ECG were archived together for each 







times were exported to a common file format (CED SON data Library) and then 
imported into and analysed using standard software (CED Spike2 ; SPSS ). Artefacts 
and missed beats correction were again checked by eye by comparing the raw ECG 
with the filtered output from the TS1.  Any corrections for missed or extra R-wave 
events were performed in Spike2. 
An event series of ECG R-wave timings were obtained in order to determine 
variability in the R-R intervals and an instantaneous tachogram constructed from this 
event series.  Using Spike 2 Software from Cambridge Electronic Design (CED), the 
tachogram was constructed by replacing each R-wave event marker by a raised 
cosine wave fragment of unit area (see figures 2.3, 2.4). This was done to investigate 
the frequency changes in the sequence of R-wave events.  This technique used to 
construct a tachogram has been peer reviewed in publications investigating BSE in 
cows, scrapie in sheep and vCJD in humans and is reported to be equivalent  to 
tachograms constructed from the interval of the time series (DeBoer, Karemaker, & 
Strackee 1984).  An FFT was performed on filtered versions of this tachogram to 
indicate HF and LF components of HRV (see figure 2.4).   The methods used here 
were adapted from previous work by our group to investigate BSE in cows (Pomfrett, 
Glover et al.2004) and vCJD in humans (L.A.M.Woolfson, D.G.Glover et al. 2003). 
Figure 2. 3  Theoretical construction of Tachogram.  
(Reproduced with permission from CED The Spike2 Script Language booklet) 
Construction of a Tachogram from R-wave event markers.  An event at time t is spread over a range 
from t-smooth to t+smooth.  This is performed to assess the slow frequency changes in the sequence 
of events.   
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Figure 2. 5  Summary of Methods used in this study. 
   
Off line analysis using “BSEnsor” v 8, automated software written by CED with 
contributions and specifications from myself, allowed batches of data to be analysed 
with resultant HF powers, LF powers, heart rate, and instantaneous heart rate along 
with other combination variables to be archived for each batch.  The program was 
easily adapted to enable different frequency bands to be set to represent the HF and 
LF bands of interest.  This program was modified to output the R-wave event time 
series for export into statistical packages such as SPSS v 11 and a routine was 
incorporated that calculated the RMSSD of the R-wave events (see appendix 1.1 for 
worked example).  In addition time domain metrics of HRV were explored using 
CMETX software (John Allen 2002) on the exported R-wave event time series that 
explores the variation in the inter beat intervals (IBI) (Allen 2002;Allen, Chambers, & 
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From this basic series of R-wave events, various types of HRV analysis were 
performed.  Data from sheep was analysed using power spectral analysis as 
described in Chapter 3.  Data from cows, in addition, was analysed using a time 
domain metric (CMETX) which gave measures of CVI and CSI as described in 
chapter 4. 
The development of a program to estimate breathing events from various 
parameters of the ECG trace was accomplished in chapter 5 and the algorithm 
tested against breathing events recorded with a Magtrak turbine (Ferraris Medical 
Ltd) used in conjunction with a face mask and filter (Intersurgical Mask 1515 and 
Intersurgical filter 1944: Intersurgical, Berkshire).  Once this breath estimation was 
verified, some of chapter 5 and chapter 6 implemented it to investigate the 
relationship between the R-wave distributions within each breath.  Circular 
statistics was employed in assessing the relationship to the beat to beat variability 
per breath since such statistics are suited to investigate physiological relationships 
where one event is related to another event in a cyclical manner.  For example the 
heart beats within each breath are linked to the breath event and also to each beat 
within the breath.  A heart beat is influenced by the preceding beat and influences 
the subsequent beat. 
Limitations to data collection and Technical Caveats 
Fourier analysis encompasses a range of mathematical techniques by which 
signals may be decomposed into a series of sine waves.  This type of analysis is 
named after Jean Baptistie Joseph Fourier (1768-1830).  He published a paper in 
1807 that suggested any continuous periodic signal could be represented as the 
sum of properly chosen sinusoids (Brigham 1988).
The Fast Fourier transform (FFT) is an example of how to calculate the Discrete 
Fourier Transform (DFT) which is itself one example of this mathematical 
technique used with digitized signals to decompose a signal into sine waves.   The 
DFT requires an input function that is discrete and the values have a finite duration 
that is greater than zero. These inputs are created by sampling a continuous 
function such as the constructed tachogram.  Using the DFT implies that the finite 
segment that is analysed is one epoch or segment of an infinitely extended 
periodic signal.  Multiple segments of data are used in the calculation of the FFT to 
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improve confidence in spectral estimates by reducing the variance of the DFT 
spectral estimate. 
Various people have been involved with the concept of FFT including the German 
mathematician Karl Friedrich Gauss (1777-1855) who was using the technique 
around the 1840s.  However, Cooley and Tukey were credited with bringing the 
FFT to the attention of the world in an effective algorithm that could be used on a 
computer (Cooley & Tukey 1965). 
The continued development of the FFT and the advancement of computational 
power means that it is now a widely used signal processing tool.  The FFT is now 
a practical and readily available procedure that may be applied effectively without 
detailed theoretical knowledge of the “complex” mathematics involved.  The 
analysis package used here is based on the FFT algorithm incorporated in Spike 2 
version 4.22 (CED software) and used with a personal desktop computer (Mesh 
Matrix A3500). The result of the analysis is scaled to RMS power so it may be 
converted to energy by multiplying by the time over which the transform was done.  
Consequently the bespoke program that was written to analyse the data, in one 
procedure, can provide a power spectrum from any selected waveform channel. 
The tachogram constructed from the ECG waveform, on which the FFT is 
performed, is a very much simpler waveform than the raw ECG trace and more 
closely represents a sine wave, or at least a series of sine waves with similar 
amplitudes. The mathematics behind the FFT assumes the waveform the analysis 
is performed on repeats cyclically (see above in relation to the input function for 
the DFT).  
 In most cases there is a step or discontinuity in the data epoch if it is segmented 
in to “blocks” and each block spliced end to end.  These steps may cause 
additional frequency components in the result.  To limit the influence of these edge 
effects to the resultant power spectrum a solution is to taper the start and end of 
the blocks so they start and end smoothly.  This is known as windowing and will 
cause smearing of the data and loss of power in the result. 
Each “window” function has advantages and disadvantages with windows 
designed to have the smallest side lobes spreading the frequency peaks out more.  
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In an attempt the change the data by the least amount and give a more accurate 
representation of the spectral peaks the initial analysis was performed with no 
windowing function.  (In appendix 1.3  HF and LF values obtained with different 
windowing functions are compared graphically).  
Another critical area for data integrity is the consideration of missed and extra R-
wave identification gained from the raw ECG trace.  It has been suggested that 
even one missed or extra beat in a sample of 128 seconds may significantly alter 
the resultant computed spectral power(Berntson & Stowell.1998).   The authors of 
this work found that the effect of the artefacts increased power in all frequency 
bands ( 0.15-0.4 Hz, 0.05-0.15 Hz, 0.008-0.05Hz, corresponding to high, mid and 
low frequency bands respectively) with missed beats causing a greater effect than 
additional erroneous R-wave detections.  The resulting change in spectral powers 
obtained from FFT analysis on data sets with experimental artefacts are illustrated 
by figure 2.7, reproduced below.   
Figure 2. 7  The effect of artefacts on power spectrums. 
Reproduced with permission from Cambridge University Press; Figure 1 Berntson, G. G. & Stowell, 
J. R. 1998, "ECG artifacts and heart period variability: don't miss a beat!", Psychophysiology, vol. 
35, no. 1, pp. 127-132. 
Here it can be seen that the introduction of the artefacts leads to a broadening and 
increase of spectral power.   A slight lateral shift in the power spectra may have 
caused a reduction in power in one frequency band and a corresponding increase 
in another as a result of the introduction of an additional artefact.  In addition 
Berntson and Stowell found that some patterns of artefacts may invalidate the 
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assumption of stationarity as discussed below although moderate deviations from 
the assumption of stationarity may not compromise analyses as suggested by 
Grossman et al.  Berntson and Stowell also performed assessments for the effects 
of missed and extra beats on the time domain methods of analysis such as those 
used by Porges and Bohrer (1990) and found the artefacts caused similar effects 
in this assessment too. 
Consequently the effects of such missed or additional R-wave detections are 
critical to the analyses performed on the data here.  In an attempt to minimize the 
errors each 300 - 400 second data set was checked by eye to screen for such 
missed or extra beats following the automated R-wave pick off that was coded in 
the bespoke software program BSEnsor v8.  Errors were corrected manually using 
purpose written routines to add or delete erroneous R-waves.  For an animal with 
a heart rate of around 100 beats per minute, there may be around 500 R-wave 
events in 300 seconds of data.  To screen and correct one such data set may take 
from a period of a few minutes up to an hour.  This is a laborious but essential 
element to ensure accurate representation of the frequency variation in the beat to 
beat time series obtained from this analysis.        
It is also prudent to consider the effect of such missed or erroneous R-waves may 
be much greater than the lack of a suitable windowing function or indeed violations 
of the principle of stationarity as discussed below. 
Further considerations about data integrity and caveats for analysis concern the 
stationarity of those data on which spectral analysis is to be performed.  For 
example if the heart rate transiently exhibited a step change during the period of 
analysis this may induce artificial frequency components in the resultant spectrum 
that were the result of this transient  change in heart rate and not due to the 
autonomic change in HRV.  In the written debate of Weber and Grossman on the 
subject of stationarity (Berntson, Bigger, Jr. et al. 1997;Grossman 
1992;Grossman, van, & Wientjes 1990;Weber, Molenaar, & van der Molen 1992) 
Grossman argued that the lack of stationarity is very unlikely to compromise the 
calculation of RSA or the 0.1 Hz cardiac component to any great extent.  Weber 
maintained that the time series on which an FFT is performed should be no more 
than “weakly stationary” and provides a relatively complicated algorithm based on 
a double window analysis technique performed on the time and frequency 
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domains leading to a two way analysis of variance which in turn yields a test for 
the stationarity of the data.   
Both workers agreed that “very interesting things are likely to be happening during 
a non-steady state phase of a measurement period”.  The question of the lack of 
stationarity in each frequency band also exists and we must bear in mind that it 
may be a change in the exhibited stationarity that is a sign of abnormal neuronal 
control as a result of incubating TSE diseases.  It may be that in the diseased 
state there is a greater degree of stationarity, of the time series events, than in 
“healthy” controls.  With the approach of testing data for stationarity and only 
analysing stationary data sets raises the issue that the results would be from 
highly selected segments of data and may not be a representative sample.  Non-
stationarity may be an inherent dynamic feature of the R-wave event time series 
and should not be removed since it may yield significant differences in the normal 
and TSE infected animal. 
To limit erroneous effects of gross stationarity violations, the automated analysis 
program, BSEnsor, had a “screen” based upon maximal and minimal 
instantaneous heart rate values (see pages 80-82 of this thesis).  Areas of data 
that were outside these limits were identified as bad data on channel 12 of the 
data file.  This also had the benefit of focusing attention to missed or additional R-
wave detection to make the correction of these errors easier.  Only files without 
bad data were analysed and step changes in heart rate within the 300 second data 
file resulted in the file being excluded from the analysis.  In addition, the epochs for 
data analysis were 300 seconds to minimize the possibility of non stationarity and 
the FFT was performed on the tachogram of R-wave events which was further 
filtered by band pass filters to remove slow trends and concentrate the FFT on low 
frequency and high frequency spectral components of HRV. 
The epoch of 300 seconds was chosen to provide a standardized analysis 
duration that would allow comparisons between studies and comparisons between 
recordings within each study.  HRV increases with the length of the analysed data 
epoch (Berntson, Bigger, Jr. et al.1997) but also will increase the chance that the 
assumptions of stationarity will be violated.  It was found that the time period of 
300 seconds and a sampling frequency of 1 KHz allowed an FFT of 512 bins and 
a frequency resolution of 0.004Hz over the range of 0-2 Hz which was considered 
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accurate enough to investigate the proposed frequency ranges involved in the 
analysis of HRV.  The 300 second or 5 minute recording period is also 
recommended for clinical studies to investigate HF and LF components of HRV 
(Electrophysiology 1996). 
In an attempt to quantify errors in my data capture and analysis routines, a heart 
rate simulator (HeartSim200 di) was used to create an ECG with very little natural 
HRV.  Since this was an electronic simulation of an ECG rhythm designed to have 
little arrhythmia we would not expect much beat to beat variation in this trace since 
it was not programmed to output any.  When the data capture and analysis 
routines were performed on this file the maximum powers reported in the power 
spectral estimates were at least 1000 x lower than the lowest real estimates of 
HRV from sheep.  In some cases the powers were “0” (see appendix 1.2). What 
little powers that were calculated would represent the inherent “noise” in the 
system representing errors in mathematical calculations such as rounding errors.  
This gave confidence in the measurement system and that it was recording and 
analysing HRV that was little distorted by either errors in the mathematical 
calculations or by signal artefact from extraneous signals at higher frequencies 
that were reflected back into the power spectrum of interest.
The data collection and analysis were further verified following the analysis of one 
of our data sets by another laboratory using a moving polynomial approach  (v hat) 
as described  by McCabe (McCabe, Yongue et al.1984).  Each group of workers 
compared the analysed results from the same sets of event time series and 
concluded the trends of various indices of HRV were similar for both groups with 
the test data lying outside the 95% confidence intervals for normal controls on 
most occasions from this longitudinal data set (Porges, S.W. personal 
communication). This exercise helps give validity to the methods used here by 
comparison with those used by Porges based on 30 years experience in HRV 
analysis. 
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Chapter 3 Investigation of heart rate variability in 
scrapie infected sheep 
Introduction 
I was invited to record HRV from scrapie-infected sheep and controls at the VLA 
International Research Centre, Lasswade.  The animals were part of an on-going 
study investigating rectal biopsy as a means to identify the presence of scrapie in 
these sheep.   
Studies of a large number of sheep with and without scrapie,  show that PrPD
aggregates are consistently present in the recto-anal mucosa associated lymphoid 
tissue (RAMALT)  of pre-clinically and clinically infected sheep (Gonzalez, 
Dagleish et al. 2006;Gonzalez, Jeffrey et al. 2005).   
Following all local animal handling and welfare legislation and under the 
supervision of a government vet, I was given permission to record the 
electrocardiogram (ECG), non-invasively, from controls, naturally-infected field 
cases and orally-challenged infected sheep.  Epochs of at least three-hundred-
seconds from control and scrapie-infected sheep were collected and archived for 
off line analysis. 
96
Methods 
As previously stated, the electrode modifications and cleaning of the recording 
equipment before moving between groups was carried out.  In addition protective 
clothing was also changed before moving to the next group of sheep. 
Data were collected using a modified Variacardio TF4 which is called a TS1, as 
previously described in chapter 2. 
The sheep were placed on their backs in a commercially available treatment 
cradle previously used to inspect and maintain hoof health (See figure 3.1).  The 
electrode gel complex was attached to the recording leads from the data recording 
telemetric headstage (labelled Transmitter in figure 3.1) via “press studs” on the 
leads, typical of conventional ECG recording devices.  
 The sheep were shaved around their thorax to remove body hair and the contact 
surface of the constructed electrode was covered with a liberal amount of 
“Magnafloc” gel.     
The closely shaved skin of the animal was dampened down with normal saline and 
the electrodes were placed either side of the animal’s heart to obtain a useable 
trace (See figure 3.2).  The gel allowed repeated repositioning of the electrode 
around the thorax to obtain the best trace for this purpose.  This took around 30 -
90 seconds for each animal and allowed time for the animal to settle in the cradle.  
It was noted that some animals tolerated the inverted position better than others 
with the majority becoming still after a 10-30 seconds in the cradle. 
The resultant power spectral analysis on the filtered tachograms (described in 
chapter 2) was easily recalculated to produce different spectral bands.  The ones 
that were used here were : LF 0.0-0.15 Hz; HF 0.15-1.0 Hz; HLF 0.032-0.138 Hz 
and HHF 0.15-0.5 Hz.  The heart rate along with other derivatives of these data 
were calculated and archived for each data file from each animal. 
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In addition the R-wave event series was analysed using time domain measures to 
gain the root mean square of successive differences (RMSSD) which was 
calculated by finding the square root, of the mean of the squared differences 
between adjacent RR intervals (Bloomfield, Zweibel et al. 
1998;Electrophysiology.1996) (see Appendix 1.1 for worked example).  
Boxplots were used to graphically illustrate groups of data from sheep.  Boxplots 
display differences between groups of data without making any assumption about 
the constituent distribution and may be considered to be nonparametric.  The 
spacings between the different parts of the box help indicate the degree of 
dispersion and skewness in the data.  The box is defined by the first and third 
quartile and the "whiskers" illustrate the range.  The median is illustrated as the 
line between these two bounds.  Outliers  are show as values that are between 1.5 
and 3 times the interquartile range (see figure 3.4 for an example). 
To address the problem of multiple significant testing for nonparametric data, a 
Kruskal-Wallis test followed by Mann-Whitney tests using Bonferroni correction 
(Bland & Altman 1995) was used.  The Kruskal-Wallis test identifies if there is a 
statistically  significant difference between the groups based upon their ranked 
means.  To investigate the difference, if one exists, between the groups a Mann-
Whitney test with Bonferroni correction was used. 
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Figure 3. 1  Sheep in Cradle. 




Data were collected from 26 animals, one of which showed clinical signs at the 
time of measurement and so was excluded from this analysis (group 4 below).  
The remaining 25 animals were from the following groups. 
Group 1   Control Animals, orally challenged with scrapie free brain homogenate   3 Sheep 
Group 2   Orally challenged with scrapie agent, no clinical signs, rectal biopsy negative. 4 Sheep 
Group 3   Orally challenged with scrapie agent, no clinical signs, rectal biopsy positive. 6 Sheep 
Group 4   Orally challenged with scrapie agent showing clinical signs.   1 Sheep 
Group 5   Naturally exposed, resistant genotype, biopsy negative.         9 Sheep 
Group 6   Naturally exposed, no clinical signs mixed genotype, biopsy negative.  3 Sheep 
Negative Biopsy Positive Biopsy 
Unexposed 
2 ARQ/ARQ (grp 1)
1 VRQ/VRQ (grp 1)
- 
Oral exposure 4 ARQ/ARQ (grp 2)
3 ARQ/ARQ (grp 3)
3 VRQ/VRQ( grp 3)
Natural exposure
9 ARR/ARR (grp 5)
2 ARQ/ARR (grp 6)
1 ARQ/ARQ (grp 6)
- 
Table 3- 1  The number of  sheep in each group and their genotype and RAMALT biopsy result. 
From table 3-1, groups 1, 2 and 3 constituted “Experimental animals” that were 
kept in isolation pens under strict regulations to minimise potential cross 
contamination of the groups with scrapie agent.  Groups 5 and 6 represent “field 
animals” that were not orally challenged but allowed to feed and inhabit fields 
where naturally scrapie infected sheep had previously been farmed.  The box plots 
in figures 3.4 and 3.5 represent these groups of animals that form the 
“Experimental” and “Field” animals. 
A typical example of a control animal from group 5 (top panel figure 3.3) shown 
against a scrapie infected animal from group 3 (lower trace figure 3.3) is shown.  
The R-wave events are shown on the bottom of each panel along with the 










































waveform.   A difference in these two files may be seen by eye, with the control 
animal demonstrating more power in both the HF and LF bands in the power 
spectrum.  This is illustrated here by the greater undulations in the representations 
of the power spectrums, with the infected animal showing “flat lines” by 
comparison. 
Figure 3. 3  Comparison of tachograms from control and infected sheep.
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A box plot showing median and upper and lower quartiles for each sheep group 
against each variable were plotted in SPSS v11.5.  It was found that the variable 
that seemed to show the greatest differences between the groups was HLF (see 
figure 3.4).   This distribution of the HLF values was tested for normality by using a 
Kolmogorov-Smirnov test with Lilliefors Significance Correction.  
It was found that the data did not fit a normal distribution and so nonparametric 
tests were used to investigate the differences in HLF values between the groups.  
These statistical tests were performed to compare the values of the animals that 
had a positive biopsy result (group 3) against all the other groups.  Group 4 was 
excluded from the analysis since it was a group of one and showed clinical signs 
unlike all the other animals. 
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          Experimental           |           Field
                               
Figure 3. 4  HLF and HHF values for Experimental and Field animals. 
Box plots (median, upper and lower quartiles and range) to show significance of HLF  and HHF for 
5 groups. Significant differences, as assessed by Mann-Whitney test with Bonferroni correction 
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Figure 3. 5 Heart rates and RMSSD for Experimental and Field animals.  
Boxplots to show significance of heart rate and RMSSD for 5 groups. 
By comparison with fig 3.4, HLF is distinct from heart rate and RMSSD, between field and 
experimentally infected animals since no significant difference in RMSSD or heart rate is seen 
between group 3 and any other group. (note: the lack of a top range bar for group 1 heart rate 
illustrates that 2 of the measures were at the level indicated by the median line and the group only 




















































From figure  3.4 it can be seen that there is a significant difference (p<0.05, using 
the Mann-Whitney test with Bonferroni correction) in HLF values between the field 
animals that were of a resistant genotype (group 5, scrapie free) and  animals that 
were orally challenged with scrapie, showing no clinical signs but rectal biopsy 
positive (groups 3).   This would indicate that this index of HRV was able to detect 
scrapie infection between experimentally infected sheep and non-infected field 
cases. 
It may also be noted, from figure 3.5, that the heart rate and RMSSD do not show 
this significant difference and so emphasise the fact that the HLF variable is 
distinct from heart rate and RMSSD.  The HHF band of HRV also did not show any 
significant differences between the groups.   
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Figure 3. 6 Boxplots to show significance of HLF and HHF grouped by biopsy result.
HLF signifies a difference (p<0.005) in animals that were negative and positive for rectal biopsy.  
This difference is not seen in HHF band of HRV. Significant differences, as assessed by Mann-
























































Figure 3. 7 Boxplots to show the lack of significance differences in heart rate and RMSSD grouped 
by biopsy.   
Again HLF is distinct from RMSSD and heart rate values, in animals that were negative and 










































Following this investigation of the data, comparisons with the rectal biopsy results 
were explored with a positive result showing the presence of PrPD (Gonzalez, 
Dagleish et al.2006;Wadsworth, Joiner et al. 2006).  In figures 3.6 and 3,7, it may 
be seen that HLF is able to distinguish a significant difference (p<0.004, using the 
Mann-Whitney test) between the animals that showed a negative rectal biopsy, 
which include groups 1,2, 5 and 6 from those with a positive biopsy in group 3.  
These groups now contain 19 animals for the negative biopsy group and 6 for the 
positive biopsy group.   
Figure 3.8 shows a Receiver Operating Characteristic (ROC) curve that illustrates 
how HLF performs against the biopsy result for these sheep.  Sensitivity on the Y-
axis indicates the probability that a positive is correctly classified and on the X-
axis, 1-specificity equals the probability of a false positive.  The associated table in 
the figure displays the area under the curve which represents the probability that 
the value of HLF for a randomly chosen positive will exceed the result for a 
randomly chosen negative case.  The indicated significance value suggests that 
this is not a chance observation. 
This graph suggest that for 100% sensitivity, based on HLF indicating the 
presence of scrapie, there may be 25% false positives.  This test would be a live 
repeatable test and would be easily repeated at a later stage in the disease 
pathology and this may help in the utility of such a methodology in distinguishing 
diseased animals from controls.  In addition, we must remember that rectal biopsy 
may not be the “gold standard” in identifying diseased animals from healthy ones.  
Since it is based on the presence of PrPD and doubts are being raised about the 
association of prions as the causative agent, doubts about the rectal biopsy results 
may be postulated.  Could it be that the HRV index of HLF is a better predictor of 
Scrapie than rectal biopsy?  Could the time course of the disease affect either of 
these results? 
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Figure 3. 8  ROC curve to illustrate the performance of HLF index of HRV against rectal 
biopsy. 
Area Under the Curve
Test Result Variable(s): HLF
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Limitations and further work to investigate  HRV changes in TSE 
diseases 
Caution should be exercised in interpretation of statistics from such small numbers 
of animals, but it may indicate that the HLF band as opposed to the HHF band, 
would be a better discriminator for the groups at this stage of the disease 
pathogenesis.   
Due to the small size of group 6 this difference may have been due to individual 
differences in HRV of each animal.  One of the animals was of susceptible 
genotype and, although negative in Ramalt at the time of testing, may have been 
incubating scrapie and so may have consequently distorted the HLF values of the 
group.   
The lack of difference in the values of HLF between animals in group 1 (scrapie 
free controls) and group 3 (orally challenged and rectal biopsy positive) may be, 
again, due to the small number of animals in the “experimental” control group.  
However it may be observed from the box plot in figure 3.4, all of the animals in 
group 3 had HLF values below the median of those animals in group 1 and 
displayed a very much more condensed range.  
 If an individual animal’s general physiology is considered in relation to this 
observation, it may be the case that individuals would express a range of values in 
this index of HRV during normal non infected state.  These data represent one 
measurement on one day.  A better method to deduce differences in this measure 
of HRV may be to do longitudinal repeated measures on each animal and look for 
significant changes in its baseline measures over time.  This may give a more 
sensitive insight into changes of HRV with respect to TSE disease incubation in 
individual animals.  The intra-variability of measures of HRV are reported to be 
less than inter-variability measures (Gavin Sandercock 2008;Jira, Zavodna et al. 
2010;Sandercock, Bromley, & Brodie 2005).  Future work would be required to 
investigate these facts in animals incubating TSE diseases.  It may be that there 
are greater magnitudes in the change in HRV for individual animals incubating 
disease  and so, in the diseased state, could give greater intra-variability than 
inter-variability between control populations and in the diseased physiology of 
animals incubating TSE diseases. 
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Other limitations in relation to this study will include the possibility that the 
Bonferroni correction method, used to address the problem of multiple testing, 
may be too conservative and miss significant differences when they are there. 
A number of other methods to estimate HRV are currently used, including FFT 
analysis, autoregressive modelling and a moving polynomial technique.  All 
methods have caveats and the potential to generate aberrant results due to 
violations of data integrity.  No consensus has emerged on an optimal approach 
and since the methods used here attain significant differences it may be prudent to 
continue using these standardised and practiced methods in future studies.  The 
possibility of refinement in the technique and the complementary addition of other 
techniques should also be investigated.  Of particular importance would be the 
characterization of breathing frequency of the subjects and investigation of 
techniques that may be used to estimate a respiration event from the change in 
amplitude of the ECG recording (shown below).   
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Figure 3. 9  Diagram to show putative inspiration events, indicated by change in amplitude of 
ECG. 
An automated program running within Spike2 could identify the maximum and 
minimum ECG amplitudes that would correspond to the change in recorded 
amplitude of the ECG signal as the thorax expands and contracts.  This method 
has been used by Moody (Moody, Mark et al. 1985), Noh (Noh, Park et al. 2007) 
and Cysarz (Cysarz, Zerm et al. 2008).  These events would then indicate 
inspiration and expiration for each breath cycle.  This data could then be used to 
give a precise indicator of RSA using circular statistical techniques (Batschelet 
1981;Pomfrett.1995;Wang, Pomfrett, & Healy 1993) that would relate HRV to each 
breath cycle. A number of such cycles could be studied to compare the degree of 
coupling of RSA to the heart beat cycle in control and infected populations.  It has 
been stated that RSA may contaminate the conventional LF range of 0.05-0.15 Hz 
if the breathing frequency is below about 10 breaths per minute (Berntson, Bigger, 
Jr. et al.1997).  It is apparent that the frequency band discussed here, HLF 0.032-
0.138 Hz, may equally be subject to such contamination and consequently it would 
be useful to dissect the precise component of RSA from this range and it may yield 











The breathing events may be more conveniently measured from human 
populations than animals “in the field” since the positioning of any breath sensors 
is less prone to damage and the cooperation of the human populace is, generally, 
greater than that of animals.  Once the process of obtaining the breath events from 
the change in ECG amplitude has been programmed it could be validated using 
data from human controls where the calculated breath events from the software 
could be correlated to the actual breath events obtained by a suitable transducer.  
The ability to accurately represent the true RSA of each subject would give the 
opportunity to better estimate the degree of decoupling of RSA from the heart beat 
cycle than spectral estimates based on FFT analysis due to some of the caveats 
mentioned above.  RSA calculated in this way would provide another index of HRV 
and may mean an earlier divergence from normality is observed in the diseased 
population and may aid both the diagnosis and also increase the efficacy of any 
putative treatments being developed for TSE diseases. 
It would also be interesting to study other TSE diseases in different animal and 
human populations to see if there is a characteristic signature change in HRV that 
could estimate the specific disease or estimate the rate of disease pathogenesis.  
For example, do the HRV indices exhibit a similar transition with respect to time in 
Scrapie, BSE and vCJD?  Would there be differences that may determine the 
stage of the disease that the individual is at?  Could this longitudinal change be 
monitored by these and other HRV indexes? 
If the analysis of HRV was useful in distinguishing TSE infected subjects from 
controls, the utility of its application, in isolation and in conjunction with other tests, 
to screen for humans and animals incubating such diseases may be explored.   
From the initial study described here on scrapie infected sheep, it is evident that 
indices of HRV are able to significantly distinguish sheep with the disease 
associated marker from those free of the marker before any of the animals showed 
clinical signs of the disease.  This highlights the potential for such methods in 
helping identify diseased animals and their consequential elimination from the food 
chain.  It may also give rise to the possibility to screen human populations and 
reduce human susceptibility to iatrogenic TSE diseases resultant from blood 
transfusions and surgical procedures.   
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Discussion 
The dorsal vagal nucleus (DMNX) and nucleus ambiguus (NA) are two 
anatomically distinct regions of the medulla oblongata of the brainstem involved 
with the control of the heart on a beat to beat basis.  The vagus nerve has 
parasympathetic cell bodies located in the DMNX and NA.  The presence of 
disease associated prion (PrPD) in DMNX and NA are used in the post mortem 
diagnosis of transmissible spongiform encephalopathies (TSEs) in animals.  
It has been shown that  PrPD alters the neuronal discharge properties of infected 
tissue (Barrow, Holmgren et al.1999;Collinge, Whittington et al.1994).  Collinge 
from his work with PrP null mice, that is mice that are genetically modified to have 
no prion, reported a pair of intracellular action potentials recorded as the result of a 
train of stimuli on hippocampal slices from such mice.  Similarly, Barrow recorded 
similar action potential doublets following a series of stimulations in hippocampal 
slices of scrapie-infected hamster.  Taken together, this suggests that the 
presence of PrPD is functionally equivalent to having no PRP, consequently 
abnormal synaptic function would result in the diseased state.  The reduced 
amplitudes of medium and late afterhyperpolarizations observed in scrapie 
infected hamster are suggested to be involved in the production of these double 
action potentials,  It is also reported that these changes in afterhyperpolarization 
appeared before the onset of overt neurological symptoms and histopathological 
change. 
These lines of evidence, coupled with the work of Carleton and Jeffery who 
suggests strong evidence for a functional role for PrPC in modulating synaptic 
transmission, suggest that abnormal prion will disrupt the normal synaptic flow of 
neural information used to regulate target organs, such as the heart. before clinical 
signs of the disease (Carleton, Tremblay et al.2001;Jeffrey, Halliday et al. 2000). 
The presence of PrPD in rectal mucosa has been demonstrated to be a marker of 
TSE disease in animals and humans (Gonzalez, Dagleish et al.2006;Jeffrey, 
McGovern et al. 2000;Spraker, Gidlewski et al. 2006;Wadsworth, Joiner et 
al.2006).  From the results of this initial investigation described above (see figure 
3.6) it can be seen that animals with PrPD positive biopsy, demonstrate a different 
beat to beat control in their autonomic control of the heart compared to the control 
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non-infected animals.  To my knowledge this is the first time that heart rate 
variability has been used on sheep to distinguish preclinical infected animals from 
controls. 
From the results obtained from this study it is apparent that some of the orally 
infected sheep (group2) were negative for PrPD by rectal biopsy testing.  When the 
results for the HLF between the groups are examined it may be seen that this 
group only contained four animals and this group displays a wide range in values 
of HLF, indicated by the quartile bars in the boxplots.  Individual differences in the 
amount of infectivity in the oral challenge these animals received along with 
individual genotype and strain interactions may explain why these animals were 
not positive for PrPD.  In addition individual differences in disease pathology may 
have meant that these animals were at a different stage of infection compared to 
those animals in group 3, for example.  This highlights the possibility of a dynamic 
change in autonomic neural regulation of the heart in a diseased state.  From work 
with transplant patients and animal ablation studies the time course for such 
changes in autonomic control of the heart on a beat to beat basis may be over 
months (Bernardi, Bianchini et al. 1995;Fallen, Kamath et al. 1988;Koskinen, 
Virolainen et al. 1996;Pozza, Kleinmann et al. 2006;Smith, Ellenbogen et al. 
1990).  This may give rise to a see-saw response in various indices of HRV seen 
in incubating subjects over a similar time frame.  It is also reported that a similar 
see-saw in clinical signs of cattle incubating BSE is observed (Wells, Konold et al. 
2007), emphasising the dynamic nature of TSE disease. 
Consequently, a more robust testing regime based on HRV analysis should 
include repeated longitudinal analysis of HRV, using each individual as their own 
control and emphasis put on significant changes in autonomic beat to beat 
regulation of the heart as controlled by the diagnostic brainstem regions of the 
DMNX, NA and NTS.  The data was initially analysed by separating the 
experimentally-infected and naturally-infected field animals into groups as shown 
in figures 3.4 and 3.5.  This was done to investigate any effects due to different 
disease pathogenesis due to different routes of infection as discussed in the 
introduction and figures 1.3 and 1.4.  The naturally-exposed sheep may have had 
a different method of infection than the orally challenged, experimental group. 
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The enteric nervous system (ENS) as shown in figure 1.3 connects the gut to the 
NTS and DMNX via efferent and afferent vagal fibres.  Card suggests a neural 
connection from stomach to the DMNX (Card, Rinaman et al.1993).  In addition 
the ENS connects with the rectal mucosa via efferent and afferent vagal fibres.  
This provides a neural conduit to and from the DMNX and NTS respectively.  
Consequently, prion translocation may occur from the rectal mucosa to the DMNX 
or indeed from the DMNX to the rectal mucosa.  This provides two possibilities for 
the origin of PrPD in the rectal mucosa.  The first is that it originated from passage 
from the gut to the rectum and then infects mucosal tissue.  Secondly, PrPD
deposits originating in the brainstem areas may travel via a neural route to the 
rectal mucosa, having previously been deposited in the brainstem by a vagal route 
from gut to brain. 
If the second of these methods for PrPD deposition in the rectal mucosa is viable 
then it may be that a perturbation in HRV indices, HLF possibly, may be observed 
before the rectal mucosa biopsy was positive.  For those animals orally infected, 
there was a significant difference (p<0.05, using Mann-Whitney test with 
Bonferroni correction) between those having a positive rectal biopsy result (group 
3) and those with a negative result (group 5) although the small number of 
experimental controls (group 1) did not differ significantly from either of these 
groups.  The difference between these groups (group 3 and group 5) indicate that 
HLF may give a similar indication as rectal biopsy, for the presence of scrapie in 
pre-clinical animals. 
In addition, the first variable to change may not be HLF.  It may be that dysfunction 
in different neural pathways earlier in the disease gives a different signature of 
disruption in the neural control of the heart and different indices of HRV would 
better show this change in function due to TSE incubation.  Some of the neural 
tissue that would be putative sites to cause a disruption to normal HRV are 
indicated by the red dots on figure 1.6.  These sites include the intrinsic cardiac 
ganglia.  The range of sites for potential disruption in the integrated and normal 
control of beat to beat variability of the heart cycle illustrate the potential for 
differences in HRV that may be evident in individual animals within an infected 
group.  This underlines the importance for longitudinal monitoring of HRV in the 
early diagnosis of TSE diseases for individuals.   
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For this study, with relatively small numbers, it is surprising that such a clear 
difference between the groups is observed when segregated based upon their 
rectal biopsy results (see figure 3.6).  All of the experimental animals had a mix of 
breeds (Suffolk and Cheviot) and genotypes (ARQ/ARQ, VRQ/VRQ and 
ARQ/VRQ) within them but no significant differences based upon these criteria 
were seen in the calculated HRV indices.  The naturally exposed field animals 
were the same breed but different genotypes.  The resistant genotype was 
designated ARR/ARR and the others were ARQ/ARQ.  The differences reported 
here in infected animals not showing clinical signs, suggest they are independent 
of breed and genotype and relate directly to the presence or not of PrPD in the 
rectal biopsy. 
The HLF component of the analysis can distinguish between sheep with scrapie 
from those scrapie free sheep that do not have PrPD.  All sheep tested and 
analysed did not show any clinical signs for scrapie, consequently assessment of 
HRV indices in incubating animals is able to identify the disease before clinical 
signs are evident.  For the biopsy groups HHF was not able to distinguish positive 
from negative animals, although HLF was.   
Non myelinated vagal fibres from the DMNX and faster myelinated vagal fibres 
from the nucleus ambiguus (NA) are involved in the control of heart rate variability 
(HRV).  Cardiac vagal tone may be considered to be the sum of low frequency 
(HLF) variation in HRV from influences from vagal efferents from the DMNX, plus 
high frequency (HHF) variations, influenced by the respiratory frequency, from the 
efferent output from the NA  (Porges 2006a).   
These facts coupled with the neuroanatomical finding of van Keulen may give 
further support to the use of HRV in early diagnosis of HRV.  van Keulen 
suggested that the initial site of infection for the disease agent in scrapie was via 
the vagus nerve, with an initial build-up of PrPD in the DMNX, followed by the NTS 
and then the NA (van Keulen, Schreuder et al.2000). Correspondingly a functional 
change in the brainstem areas of the DMNX and later the NA may be seen in a 
perturbation in the HLF and HHF bands of HRV respectively. 
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RMSSD has been suggested to reflect the high frequency changes in HRV in the 
respiratory frequency range.  It has also been reported that levels of RMSSD 
between subjects correlate with HHF spectral estimates of HRV (Berntson, 
Lozano, & Chen 2005).  Consequently both HHF and RMSSD may be considered 
to represent estimates of the activity of the NA.  From these observations in sheep 
with scrapie it may be suggested that the difference in low frequency values in 
HRV, and not in higher frequency values, may implicate a malfunctioning DMNX 
but normal functioning NA.  
I present here, empirical evidence for such a theory, with those animals positive in 
rectal biopsy being distinguished from animals of mixed provenance that are 
negative in RAMALT biopsy by the HLF component of HRV.  The HHF band is not 
able, at this preclinical stage of disease, to differentiate between the groups.  This 
may suggest that a neurophysiological malfunction has occurred in the DMNX but 
the function of the NA is intact.  This would agree with the neuroanatomical 
observations of van Keulen.  Whilst there is a need to record data from many more 
animals to attain more reliable indicators of this theory, the proof of principle is 
demonstrated.   
The relatively simple and non-invasive assessment has a role in public health 
issues at many levels and may have utility in other current neurological diseases 
and in addition it may help to characterise any new diseases we have not yet 
discovered. 
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Chapter 4 Investigation of BSE infected Cattle using 
heart rate variability assessments 
Introduction 
Prion diseases affect a wide range of mammals and are classed as transmissible 
spongiform encephalopathies (TSEs) due to their infectious nature and the 
spongiform or sponge like appearance observed in neural tissues of infected 
organisms.  Bovine Spongiform Encephalopathy (BSE) is a transmissible 
spongiform encephalopathy of cattle that has etiological links to vCJD in humans 
(Hill, Desbruslais et al.1997;Scott, Will et al. 1999). 
Two atypical forms of BSE have so far been reported: L-Type or BASE (bovine 
amyloidotic spongiform encephalopathy), with a lower molecular size of the 
unclycosylated isoform of PrPD (without any sugar side chains compared to PrPD
from “classic” BSE; H-Type BSE which demonstrates higher molecular sizes of the 
unclycosylated isoform of PrPD compared to “classical” BSE.  Investigations into 
the transmission of L-Type BSE into different mouse lines demonstrated atypical 
disease phenotypes in human and bovine PrP transgenic mice but gave a “classic” 
BSE phenotype in mice expressing ovine PrP (Beringue, Andreoletti et al. 2007).  
This highlights the interaction of both the strain of TSE and host genotype in the 
final expression of the disease phenotype. 
Further implications from this work demonstrated that the transfer of L-Type BSE 
agent to certain mouse populations (tga20 mouse lines with 6–7 times the normal 
PrPC level) did not produce any overt clinical symptoms; this disease was 
subclinical and therefore masked in this genotype. Yet when this agent was 
transferred to a different mouse line (tgHu transgenic mouse line with human PrP) 
it did result in early accumulation of PrPD in brain regions compared to classical 
BSE and other phenotype traits similar to atypical BSE (Beringue, Andreoletti et 
al.2007).  Thus, it may be possible that a different strain of BSE, here BSE-L, may 
be more virulent to certain genotypes of the human population than “classic” BSE.  
Secondly, it again highlights the possibility of subclinical carriers, in a different host 
genotype, being able to infect susceptible genotypes. 
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Past work investigating the species barrier, involving the transfer of hamster TSEs 
to mice, found that the recipient species did not display overt signs of disease.  
However, upon histopathological investigation there were neuronal signs of the 
disease and high levels of infectious agent.  These subclinical mice were also 
found to be able to infect other mice despite not showing any clinical signs of the 
disease (Hill, Joiner et al. 2000).  Here, the initial hamster prions had caused 
mouse prion to become infectious to mice following passage via a mouse line.  
This raises concerns about an asymptomatic carrier state that, if extrapolated to 
the human population, may raise awareness to the risk of future iatrogenic 
infection.  Consequently, current and future novel strains of such TSE diseases 
may pose further risk to human populations.  Hence, research is vital to not only 
identify more accurately the disease pathogenesis and causative agents of the 
present prion diseases but also to prepare for those diseases we, as yet, do not 
know.
TSEs in farm animals have historically been reported using tests designed and 
developed to be used for surveillance, to assess changes in the level of TSE 
diseases within a population over time.    These tests predated the identification of 
atypical BSE strains and so may have failed to identify these and other strains of 
BSE.  They were designed to be an epidemiological tool and not a test for 
preclinical or clinical infection in animals.   Initially the diagnosis was based on the 
visualization of vacuolation of a precise histological section of the medulla 
oblongata region of the brainstem (Wells, Hancock et al. 1989).  Subsequently the 
identification of the disease associated confirmation of the prion was achieved by 
immunohistochemical (IHC) analysis of fixed brain tissue (Wells, Spencer, & 
Haritani 1994).  The “Rapid tests” (ELISA or Western blot based) approved by the 
European Union (EUROPEAN COMMISSION 1999;EUROPEAN COMMISSION 
2002) use antibodies to detect the disease associated conformation of the native 
prion protein.  This raises two questions on the efficacy of the tests.  
The first is the specificity of the antibody for the disease associated conformation 
of the prion.  Potentially, a different antibody may not recognise and identify a 
different strain of BSE that may have a different disease associated conformation 
of the protein.   Arsac suggests the sensitivity of such tests depends on the 
selection of antibody used and they found that one antibody was able to identify 
both typical and “unusual” BSE types with differing sensitivities (Arsac, Biacabe et 
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al. 2007).  This reasoning has been further supported by Swedish workers 
investigating a H-type variant of BSE using Western Blot techniques (Gavier-
Widen, Noremark et al.2008) who found that the choice of antibody also affected 
the ratios of PrPD glyco-types.  This coupled with the statement that differences in 
the reagents used, such as water (USDA 2005), during the performance of the 
tests highlight the potential for erroneous results.   Recent work has also 
confirmed the existence of more than one strain of BSE with differing affinities for 
the antibody used in the tests and different sensitivities to PK digestion at different 
pH values (Jacobs, Langeveld et al. 2007).  This work concludes the use of 2 
different pH values and three antibodies during the testing procedures would 
provide the ability to identify and discriminate the BSE strains currently identified 
and may help in the identification of other variants.  It must be remembered the 
testing regimes previously used did not benefit from these additional refinements 
and consequently there is a probability that some cases of BSE have been omitted 
from the historic epidemiological analysis for the disease. 
Secondly, PrPD may not be the infectious agent hence the test may be directly 
assessing a surrogate marker for the disease, as supported by recent and on-
going research and theories (Aguzzi, Heikenwalder et al.2007;Barron, Campbell et 
al. 2007;Baskakov 2007;Bastian, Sanders et al. 2007;Collinge & Clarke 
2007;Jeffrey, Gonzalez et al.2006;Liberski & Brown 
2007;Manuelidis.2004;Manuelidis.2006;Manuelidis, Yu et al.2007).   In addition 
there is also the possibility that PK sensitive particles may be able to cause TSE 
disease and would have been nullified by the PK digestion phase of the testing 
regime (Nazor, Kuhn et al. 2005;Safar, Wille et al. 1998) 
Debate in relation to the infectious agent of TSEs and the sensitivity and specificity 
of historic tests indicates that improvements in the testing regime are needed.  To 
assist in the current assessment and the early identification of infection of TSEs, 
HRV analysis may form a suitable adjunct.  Analysis of repeated longitudinal 
measure of HRV data from cattle has demonstrated significant differences 
between infected cattle and controls.  In addition the utility of using HRV analysis 
in the identification of subclinical scrapie infection in sheep has also been 
established.  HRV analysis is an antemortem test and readily allows repeated 
measures to be recorded and analysed as the disease progresses.  Repeated 
measures and subsequent analysis has the advantage of reinforcing the diagnosis 
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and provides data to assess changing HRV in relation to disease pathogenesis. 
This will allow us to build on the knowledge of neural dysfunction as TSE diseases 
progress and will lead to an early preclinical indication of the disease.  This early 
identification would increase the opportunity for the application of putative 
therapies in relation to human disease or allow the removal of infected animals 
from herds and reduce the chance of horizontal transmission of TSEs in farmed 
animals and, as recently reported, in humans (Riverol, Palma et al. ). 
The cattle studied in the independent work of Masujin (Masujin, Matthews et 
al.2007) and Pomfrett (Pomfrett, Glover et al.2004) were part of a government 
established research project termed SE1736 (Defra.2007).  Some of these 
animals were also the same animals that had repeated longitudinal measures of 
their ECG recorded before they demonstrated clinical signs and were culled for 
histopathological examination (personal communication with Dr D. Mathews VLA).  
The sub group of animals that were subjected to detailed pathological examination 
by Masujin and others form the subject group for this detailed analysis using 
metrics of HRV. Different metrics of HRV, based on time domain analysis as 
compared to the frequency domain metrics used previously, are reported here.   
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Methods
In order to investigate perturbations in HRV in cattle incubating BSE, data was 
obtained from cattle purposefully infected with 1 gram or 100 grams of infectious 
material.  These animals were part of a Veterinary Laboratories Agency (VLA) 
directed governmental study based at the ADAS Drayton site (Defra.2007).  Data 
was also collected contemporaneously from control animals held at the same 
facility. The initial numbers of animals in each group and related methods were as 
described previously (Pomfrett, Glover et al.2004) and summarized here.   
The control group consisted of 48 animals, the 1 gram group contained 43 animals 
and the 100 gram group had 42 animals in it.  The animals were orally challenged 
once with either 1g or 100g of infectious brainstem homogenate made from a pool 
of positive and symptomatic field cattle brainstems, or in the case of the controls, 
received no brainstem homogenate.  The homogenate was not assessed for strain 
diversity (reported communication Pomfrett and VLA staff) and so there is a 
possibility that more than one strain was inoculated in some of the animals.  The 
animals were kept in isolated herds with stringent controls in place to eliminate 
cross contamination between the three groups.   
The recording of data from these animals commenced in January 2001.  This was 
29 months after the oral challenge of infectious material.  We were invited to 
record the ECG from these animals after the experiment and associated protocol 
was initiated.  Our investigations had to follow the protocol already running for the 
SE1736 experiment.  This involved a sequential kill to provide a range of infected 
tissues at different stages in the disease pathogenesis which was to be the subject 
for subsequent analysis after euthanasia.  We had no control over the selection of 
the animals that were sequentially killed which contributed to our partial data set.  
Data was also not collected during the 2001 foot and mouth crisis due to limited 
movement of the equipment to and within the facility at DVLA.  We endeavoured to 
collect data once a month from each animal.   
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In an analogous method to the data collection used to study sheep (Chapter 2 and 
Chapter 3) data was obtained using similar electrode and gel combinations but 
captured using a “Depth of Anaesthesia” monitor developed by Otter Controls Ltd, 
as described previously in chapter 2.  
Data were collected by VLA staff due to access restrictions to the governmental 
institution.  Once collected data were sent to Manchester University to be 
archived, checked for quality and analysed.  I analysed all the data presented in 
this chapter in relation to these cattle and liaised with staff at VLA in relation to 
data collection and use and repair of the data collection equipment. 
Figure 4. 1  Cow in a crush with electrodes attached.
Typical cow in a crush with electrodes attached via gel pad arrangement as described in chapter 2. 
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BSEnsor v8, a script running in Spike2 software was modified by myself to output 
raw inter beat intervals (IBI) that were derived from the same section of the data 
file from which the frequency domain measures of HRV were calculated.  This 
ensured the same data series was used in the calculation of time and frequency 
domain metrics by using this IBI series as the input file for the CMETX program. 
CMETX (written by John Allen) is a command-line based utility that will calculate 
several metrics of cardiac chronotropy given a simple inter beat interval (IBI) 
series as an input.   The inter beat interval input is in the form of an ASCII file that 
contains one IBI per row.  CMETX runs in a DOS environment under any version 
of Windows  (Details of its development and use are in (Allen.2002;Allen, 
Chambers et al.2007).  The software has recently been used in peer reviewed 
publications in the area of psychological research and human development 
(Gustafson, Allen et al. 2011;Lutz, Greischar et al. 2009;Weinberg, Klonsky, & 
Hajcak 2009).  This software provided metrics of cardiac vagal  index (CVI) and 
cardiac sympathetic index (CSI) amongst others that were based on work of Toichi 
(Toichi, Sugiura et al. 1997). 
CVI and CSI are constructed from Lorenz plots which analyse the R-R fluctuations 
of the data sampled as indicated in figure 4.2.  In order to obtain the values of L 
and T, the axes were rotated clockwise by 45 0 so the line L was parallel to the x-
axis (Allen.2002).  The values of L and T were estimated as four times the 
standard deviation of the points along the respective axes.   
CVI is designated as log10 (LxT) where L is derived from the length of the 
longitudinal axis parallel to the line  I n= I n+1 where I n represents the nth item in the 
RR sequence and I n+1 represents the next item in the RR sequence.  CSI is given 
by L/T (Toichi, Sugiura et al.1997).  It was found that the measures of T were 
sensitive to both parasympathetic and sympathetic blockade to some extent, in 
contrast to the CVI metric which was not affected during administration of 
propranolol (sympathetic blockade) but diminished by atropine (parasympathetic 
blockade).  CSI was found to be attenuated during sympathetic blockade.  These 
responses were found to be posture sensitive with CSI not reflecting sympathetic 

























































































































































































































































































































































































































































































The aims of this study were to investigate if a difference between the HRV of cattle 
incubating BSE and control cattle could be seen.   
Using the CVI and CSI (Toichi, Sugiura et al.1997) metrics of HRV, calculated 
using CMETX (Allen.2002) the 3 groups of cattle were longitudinally analysed over 
a 12 month period corresponding to 29-41 months post inoculation (PI).   
In addition the utility of this method was applied to investigate the idea that field 
animals (animals that were suspected of having BSE based upon clinical signs 
and due for euthanasia) could be distinguished from controls and to explore 
differences between the experimental animals of this chapter, if they existed. 
Data were investigated by inspection of box plots derived from SPSS v 11.5.  
These display groups of data graphically and illustrate the group’s lower quartile, 
median, upper quartile along with the lowest and largest observation for that 
group.  The data was tested for normality and not all of the groups’ data were 
normally distributed.  Consequently, the nonparametric data sets were compared 
using the Kruskal-Wallis test for differences between groups followed by a Mann-




For this analysis, animals were chosen from those listed in tables 3 and 4 in the 
work of Masujin.  Animals were selected based upon their “BSE status” which 
were derived from IHC examination and identification of disease associated prion 
in midbrain, rostral medulla and medulla obex. In addition the animals analysed 
here were also designated as either positive or negative in either  C1-2, C2-3 or 
T9-10 regions of the spinal cord.  ECG data collection from these animals was 
initiated at 29 months following the oral challenge, consequently we did not have 
data for those killed at 27 months after challenge and not all of the animals 
sacrificed at 30 months appeared in our data archive.  Animal no 161 was 
excluded since the data obtained was incomplete and animals 140 and 174 were 
excluded from this analysis since despite having a positive BSE status, this was 
not confirmed by the standard brainstem investigation for the presence of PrPD.  It 
was noted that for all the animals included in this analysis, a positive result for 
PrPD in the spinal cord indicated that both regions of the spinal cord were 
identified as positive.  This gave reassurance for the classification of a negative 
result in either spinal region as being negative overall.  The animals used in this 
analysis to investigate changing autonomic performance during TSE incubation 
are summarized in table 4-1.  These infected animals were compared to a sample 
of contemporaneous controls that were also part of the SE1736 study. 
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TAG BSE Status Spine (either) Group 
115 + + 100 
120 + + 100 
143 + + 100 
146 + + 100 
173 + + 100 
313 + + 1 
257 + + 1 
194 - - 100 
132 - - 100 
165 - - 100 
178 - - 100 
180 - - 100 
193 - - 100 
196 - - 100 
203 - - 100 
224 - - 1 
247 - - 1
248 - - 1
259 - - 1
271 - - 1
312 - - 1
214 - - 1
234 - - 1
236 - - 1
263 - - 1
266 - - 1
300 - - 1
   
Table 4- 1 A table to display the tag numbers of the experimental animals analysed, their BSE status 
and PrPD in the spine.
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CVI was able to distinguish (p<0.05) the 1g and 100g dosed animals from 
contemporaneous controls in cattle over a twelve month period when the repeated 
measures for each animal were pooled into the three groups (figure 4.3).  
Significant differences (p<0.05) in these groups were also identified by spectral 
assessment of HRV in both the HLF (0.032-0.138 Hz) and HHF (0.15-0.5 Hz) 
bands (figure 4.4).  Interestingly, over this period of investigation, for cattle of the 
challenged groups, the HLF values were significantly higher than controls.  This 
contrasts with the relationship in scrapie-infected sheep where infected animals 
showed significantly lower values than controls (see figures 4.4 and appendix 
1.10) (Glover, Pollard et al. 2007).   
  
For the cows forming the experimental study groups for this research there was a 
significant difference in CVI between controls and 1g and controls and 100g 
groups of the infected animals when looked at over the entire year.  The 
challenged animals demonstrated higher median values in this metric compared to 
controls.  The CSI values only indicated a difference, compared to controls over 
the year, for the 1g group. The CSI values for the 100g group were not 























































































































































































































































































































































































































































































































































































































































































































































































        
Figure 4.5 shows the variation of CVI, CSI and Figure 4.6 shows the variation of 
two spectral estimates of HRV, shown per quarter (3 month epoch) of the year of 
interest.  It can be seen that the HLF values for cattle incubating BSE, either 
challenged with 1g or 100g of infectious material, for any of the 4 epochs are 
always significantly higher than controls (Figure 4.6).   These cattle were 
measured much earlier in the incubation of TSE disease than the stage of 
incubation the sheep were measured at.  The differences in the HRV metrics 
observed here between the cattle and sheep may be due to a difference in 
disease pathogenesis with respect to time.  Some of the sheep displayed clinical 
signs 1-2 months after the measures were taken in contrast to some of the cattle 
not showing clinical signs of BSE for a further 12 months after the initial 
measurements.  
CVI for the 1 gram group was different than controls during measures taken in the 
first 6 months of the year but not in the last 6 months.  Similarly CVI for the 100g 
animals showed an increase, compared to controls, for the first 6 months of the 
year.  CVI between the 1g group and the 100g group were not different (See figure 
4.5). 
CSI values for the 1g group demonstrated a significant difference compared to 
control values in the first 3 months of the year.  There was then no significant 
difference in this metric over the three remaining quarters between controls and 
the 1g challenged animals.  CSI values for the 100 g group showed a significant 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.7 illustrates the changes in CVI and CSI metrics for the challenged 
groups over 4 epochs, each of 3 months, of the year of study.  By comparing the 
changes in CVI and CSI in figure 4.7, it may be seen that the 1g and 100 g groups 
of animals show a different profile.  The 1 g group showed a step wise change in  
CVI that was not seen in the 100g animals.  Following the first three months, there 
was a stepped decrease in CVI in the 1g group.  These changes remained 
significantly different from the values in the first quarter of the year for the 
subsequent quarters of the year (see figure 4.7).     
When the 100 gram group are examined in a similar fashion, the “step” change 
deviation in CVI seen in the 1g group is not apparent (see figure 4.7).  There is no 
significant change in the CSI values of the 100g animals during the 4 quarters of 
the year (CSI values for the 1 gram animals did show significant change during the 
year).  The 100g animals only show a significant decrease in the CVI values 

































































































































































































































































































































































































































Changes in HRV may also demonstrate a relationship to the peripheral 
identification of PrPD in tissues.  When the metrics of HRV are analysed based 
upon the results of tissue screening done by Masujin (Masujin, Matthews et 
al.2007) and separated into those animals from the 100g group that were positive 
in the spine for PrPD and compared to those tested that were negative, a 
distinction may be seen. 
Over the 12 month period it may be seen that the CSI of the 1 gram animals that 
were not identified as having PrPD in the spine (group 1) was the only group that 
did have a significantly different CSI value compared to controls, although CVI was 
significantly higher than the control group (See fig 4.8).   
It may also be observed that CVI values for all the challenged animals, apart from 
the small number in group 2,  were significantly higher than controls despite some 
of the 100 g animals (group 3) and some of the 1g animals (group 1)  being 
classed as BSE negative in the Masujin paper based on IHC examination of 
midbrain, rostral medulla and medulla-obex sections (Masujin, Matthews et 
al.2007). 
If the trends in CVI and CSI are explored over a 12 month period between the 
spine positive and negative groups (see figure 4.9) it may be seen that a change  
in the CVI values are observed in the spine negative 100g group (group 3).  This 
group demonstrated a “step” decrease in CVI from the first to second quarter of 
the year.  This step drop remains significantly different to the first quarter in the 
third and last quarter. Interestingly this trend is not observed in the CVI values of 
the spine positive animals.   
If the animals are grouped together based upon their spine result (i.e. 
amalgamating groups 1 and 3 to form a spine negative group and groups 2 and 4 
to form a spine positive group) the step decrease in the negative animal’s CVI 
values are accompanied by a step increase in their CSI values for the 2nd and 4th 
quarters of the year (see figure 4.10).  By contrast there is no significant change in 
the CVI or CSI of the spine positive group during the 12 months of study (Figure 
4.10).   
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Figure 4. 8  Change in time domain metrics for groups separated by spine result.
Significant differences, as assessed by Mann-Whitney test with Bonferroni correction following a  




































1 = 1g, spine – ve
2 = 1g, spine     + ve
3 = 100g, spine – ve
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Indicating a step change in CVI and CSI  seen in spine negative but not spine positive 
animals. (HRV is suggested to be able to distinguish disease pathogenesis)  Significant 
differences, as assessed by Mann-Whitney test with Bonferroni correction following a 
Kruskal-Wallis test, are indicated by  * with p<0.05  
141
When the same metrics of HRV are used to investigate the differences between 
the experimental animals used in this chapter and "field" animals that acquired 
BSE "naturally" from infection in the "field" (opposed to purposeful oral challenge 
of the experimental cattle) it was found that CVI and CSI were able to distinguish 
experimental and field cases from controls.  CVI was also able to differentiate 
experimental cattle from field animals (see figure 4.11). 
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Indication that HRV metrics are able to distinguish field cases from controls and experimentally 
challenged animals. Significant differences, as assessed by Mann-Whitney test with Bonferroni 
correction following a Kruskal-Wallis test, are indicated by  * with p<0.05  
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Limitations of this study 
This study was an opportunistic study based upon the re-analysis of archived data 
previously collected as part of a Department of Environment, Food and Rural 
Affairs experiment.  The cattle selected for re-analysis were dictated by those 
subjects that were included in the work of Masujin (Masujin, Matthews et al.2007) 
which presented histopathological data for these animals.  As a consequence 
detailed measures of individuals animals blood pressure, respiration and 
temperature were not made.  However all the animals were frequently and 
routinely monitored by trained observers for gross changes in the vital signs and 
assessed for common diseases of cattle, before, during and after data collection.  
These observers were those individuals who obtained the data from the cattle and 
reported changes in behaviour or physiological signs along with any extraneous 
environmental variables, e.g. noise or gross changes in temperature during 
recording HRV data.  For all the animal's data include here, no reports of 
deviations from the norm were reported.  For cows the average heart rate is 
between 60-80 beats per minute and respiratory frequency is 15-25 breaths per 
minute.   
Work on the intra and intervariability of the heart rate of cows has been reported 
and little change was observed over many thousands of measures.  Similar 
methods to obtain HRV data were used to collect data for this chapter as those 
employed by Janzekovic (Janzekovic, Vindis et al. 2011).  To address these 
limitations of individual variability the control group of cattle endured the same 
posture,  temperature and environmental constraints as the animals in the 100g 
and 1g groups.  It was assumed that differences in measures of HRV between the 
dosed groups and controls was related to the oral challenge and prion infection in 
areas of the brainstem.   
The use of  the control group from which comparisons to the orally challenged 
groups were made, was an attempt to limit these confounding variations in 
individual parameters.  In addition, in animals incubating TSE disease individual 
variability in HRV measures may be more or less than individual variability of 
healthy animals.  It may be that a certain times in the incubation of the disease, 
specific measures of HRV show a similar trend in all the animals of a certain group 






























Tag 202 Tag 189 Tag 173 Tag 160 Tag 143 Tag 125 Tag 118
al.2004)).  At other times in the disease incubation, individual animals may show 
particular episodes of abnormal change.  This is illustrated in figure 4.12.  Analysis 
of HRV changes in cattle, orally challenged with 100 grams of infectious material 
on the same day, demonstrate two broad patterns.  Figure 4.12 illustrates these 
two groups of cattle.  Cattle may be split, by eye, into those cattle that exhibit a 
wide range of change in HRV metrics with repeated measures (Tag 202, 160,143) 
and a second group consists of cattle that do not demonstrate these large 
deviations in HRV (Tag 189, 173, 125, 118).  These patterns in HRV perturbation 
may be due to different disease pathogenesis with prion protein causing differing 
functional change in neurological areas concerned with the regulation of the heart 
on a beat to beat basis.   
Figure 4. 12  Trends in HRV change over time in BSE infected cattle.
Illustration of 2 trends in HRV change over time. Tag denotes the unique animal identifier via ear 
tag numbering. 
Figure 4.12 illustrates that changes in HRV are a property of individuals, shown 
here for animals in the 100 gram group but equal diversity in individuals in the 1 
gram group and controls may be seen.  It is unknown if prion infection is causing 
these differences in intra-variability shown here.  Consequently investigations into 
the intra and inter variability of diseased animals in comparison to controls would 
present a suitable extension to this study.   
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Figure 4. 13 Longitudinal changes in HRV in cattle incubating BSE. 
Two infected animal’s longitudinal values of HRV changes (CSI/CVI) with respect to time compared 
to control animals over the same four quarters of a year.  No significant differences were seen in 
the values of CSI/CVI for the control animals (shown in lower panel) over the four quarters. 






























Upper quartile of Controls
















































































































































































































































































































































































































































































Further evidence to illustrate the prospect of transient changes in measures of 
HRV in animals incubating TSE disease are illustrated in figures 4.13 and 4.14.  
These figures show common patterns in the change in HRV measures for the 1 
gram animals (fig 4.13) and different common patterns for the 100 gram animals 
(fig 4.14).   
Caution in the interpretation of the results from this chapter is warranted since 
repeated measures are used in the analysis and not all animals were represented 
in all epochs due to the “random cull” that was part of the protocol. 
While not all the animals in all the groups may echo these patterns of change of 
HRV, it is likely that the significant differences between groups of animals reported 
in the results of this chapter are representative of the different patterns of change 
illustrated in fig 4.14.  While the prospect of not all the animals in one particular 
group demonstrating the same change in HRV at the same time (unlikely due to 
individual physiological differences) may be considered a limitation to this study, it 
also represents a novel finding in relation to the pathogenesis of BSE in cattle.  It 
identifies the fact that patterns of HRV change in infected animals may be different 
depending on the amount of infectious agent they receive.  It also illustrates that 
HRV may change with respect to time during preclinical disease incubation and 
does not follow a simple  two stage process representing before and after 
infection.  Rather the change in HRV illustrates sequences of normal HRV 
parameters mixed with periods of abnormal HRV measures. 
In light of these limiting factors it has been suggested in this thesis that an ideal 
method to investigate changes in HRV in animals would be to use repeated 
longitudinal measures of specific metrics of HRV gathered from individual animals.  
The longitudinal measures should include a series of measures before purposeful 
infection with TSE disease.  In this way an individual's "baseline" measure of HRV 
change could be gathered,  to which future changes could be compared.  This 
would help create a profile of changes in HRV with respect to time as a result of 
prion infection in individual animals.  Limitation of cost and access to large 
numbers of bovine or ovine animals prevented this stage of the investigation. 
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Discussion  
CVI and CSI are increasingly being used to investigate HRV changes and their  
effectiveness is reported (Allen, Chambers et al.2007).  The other metrics used to 
assess HRV in the frequency domain are subject to problems concerning 
stationarity and the application of complicated mathematical algorithms.  In the 
analysis of this data it was noted that the frequency domain measures displayed 
many more outliers than the equivalent time domain metrics.  These outliers may 
have been the result of an error in mathematical computation due to a violation of 
the stationarity recommendations.   In addition measures of the parasympathetic 
component of HRV rely on investigating RSA which must have an associated 
respiratory component.  In a malfunctioning diseased system this coupling of 
breathing with arrhythmia may be the very relationship that breaks down during 
TSE disease pathogenesis.  Consequently the paradigms used to measure RSA 
may be, in some stages of the disease, invalid in these particular circumstances. 
For example the frequency range often used for humans to monitor RSA, and 
hence estimate parasympathetic effect, is 0.15-0.5 Hz.  This would rely on a 
breathing frequency in the range of 9-30 breaths per minute to allow the derived 
components of FFT analysis to represent the arrhythmia due to respiration.  This is 
based upon human adults and may not correlate with healthy cattle, sheep or any 
species incubating TSEs with compromised neurological function.  The frequency 
band correlating with RSA in these cases may vary over such a wider range and 
some measures of RSA, such as HF band (0.15-0.5Hz) may not account for this 
changing respiration range for all individuals and populations.  In addition, in a 
diseased state the average breathing rate, on which estimates of RSA are based, 
may vary significantly within the sampling period due to compromised neural 
control for this autonomic reflex.  Measures of RSA may average out this deviation 
from the normal respiratory pattern and not give a true representation of the breath 
to breath variations of RSA. 
Although these metrics may not be widely accepted, investigations using blockade 
studies suggest that CVI and CSI metrics may give a better representation of 
changing regulatory activity of the autonomic nervous system than spectral 
analysis (Toichi, Sugiura et al.1997).  From this work it is also suggested that the 
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stability of these metrics may be due to a lack of affect from “physiological noise” 
(signal artefacts caused from other physiological processes that alter the results of 
the spectral assessment of HF and LF values from spectral methods of analysis).   
Slight changes, rather than the degree of activity, in the autonomic system are 
reported to be described by CVI and CSI and pictorially represented by Lorenz 
plots (Toichi, Sugiura et al.1997) like those in figure 4.2.  Various ways to calculate 
RSA may be employed but many rely on a mean breathing frequency for their 
derivation.  This coupled with the average magnitude of RSA over a sample period 
representing vagal tone may give rise to the metric of RSA not being able to detect 
changes in the breath to breath variations in HRV.  Possible CVI and CSI metrics 
may be more sensitive to perturbations in activity in either branch of the ANS.  By 
using a longitudinal observation of theses indices of autonomic function a change 
in an individual’s performance may be more easily seen.  It has also been 
established that CVI differs from measures of RSA, from various methods, and this 
may be due to it not being marred by respiratory band constraints (Allen, 
Chambers et al.2007). 
A recent publication examining peripheral nervous tissue in BSE infected cattle 
has identified PrPD in the peripheral nervous system, which is reported to appear 
after or at the same time as PrPD deposition in the central nervous system.  
Furthermore, the vagus nerves of similar animals was found to not only contain 
PrPD but also was proven to be infectious (Masujin, Matthews et al.2007).   This 
supports the idea of a vagal route of entry to the central nervous system for TSE 
infection, an idea first proposed in sheep with scrapie (van Keulen, Schreuder et 
al.2000) then suggested in  cattle with BSE (Arnold, Ryan et al. 2007;Pomfrett, 
Glover et al.2004) and recently hypothesised to other TSE diseases where the 
utility of using HRV analysis to investigate infection was mooted (Pomfrett, Glover 
et al.2007). 
A perturbation in certain frequency domain indices of HRV has been reported in 
cattle with BSE and a dose response relationship was suggested by comparison 
with control animals (Pomfrett, Glover et al.2004).  The use of HRV analysis in the 
frequency domain was used to identify subclinical sheep incubating scrapie, the 
identification of the infected animals was provided by a positive rectal biopsy result 
(Glover, Pollard et al.2007).  In the work investigating preclinical scrapie in sheep 
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spectral analysis in the 0.038-0.15 HZ band was found to distinguish those 
animals that were negative in rectal biopsy from those positive animals.   
Analysis of data in the time domain in addition to the frequency domain is reported 
here.  The time domain metrics were calculated using the inter beat interval (IBI) 
from the ECG R-wave intervals and processed using CMETX (Allen.2002).  
Certain metrics calculated with his program were interpreted with caution since the 
variables used to calculate them were designed and optimized for use on human 
subjects and not diseases animals.  Consequently RSA estimates were not used 
since breathing frequency used in the calculation may not be appropriate for cattle 
or sheep incubating TSE diseases.  The neuroanatomical functional link that is 
responsible for RSA, may be the site of malfunction of neurons caused by 
incubating TSE diseases.   
CVI and CSI for the control animals did not alter significantly between the 4 
epochs making up the 12 month period.  The step changes in CVI and in CSI 
reported here for the 1 gram and 100 gram dosed animals are deviations towards 
control values (see figure 4.7).    This questions the previous values of these 
metrics in the challenged groups, before we gained access and measurements 
were taken. What was the relationship between the infected animals and controls 
in the months before we were able to obtain data from these animals?  Could it be 
that we may have been able to observe an earlier and greater deviation from 
normality apparent in the neurological malfunction in diseased animals incubating 
TSE diseases?   
Further support for this idea of increased disturbance in neurophysiological 
function appearing before clinical signs is given by work investigating spiroplasma 
(small wall-less bacteria) and the association to spongiform encephalopathies in 
ruminants (Bastian, Sanders et al.2007).  Sheep infected with spiroplasma did not 
show clinical signs during 16.5 months of observations following the inoculation 
but subsequent histological investigation revealed spongiform change in the 
brainstem of these animals.  It was reported here that those observations 
correlated well with the histology from subclinical scrapie infected sheep at half 
way through their incubation period.  It would therefore be likely that a disturbed 
neurological function in relation to these brainstem areas would have been evident 
due to the vacuolation in the neural tissue.     
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The utility of using HRV analysis to indicate disease pathogenesis is given by 
figure 4.11.  Here CVI indicates significant differences, not only between control 
and experimental animals, but also between control and field cases in addition to a 
significant difference between experimental and field animals.  The field animals 
were cases that were clearly symptomatic and had been sent for euthanasia; one 
animal that had to be immediately euthanized after measurements were taken due 
to the severity of the symptoms.  Consequently, these field animals may have 
been at a more advanced stage of disease pathogenesis than the experimental 
animals that did not show clinical signs.  The difference in the group data in figure 
4.11 is likely to reflect this differing stage of disease pathogenesis.
   
If individual animal’s longitudinal results are investigated within the experimental 
groups, an illustration of the disease pathogenesis per individual animal may be 
gleaned.  Figure 4.13 shows a combined metric of CSI/CVI that demonstrates the 
change in CVI and CSI values over time for 2 animals.  The combination of CSI 
and CVI may give a representation of the function and balance between the two 
arms of the autonomic nervous system, since it is postulated that CVI represents 
the change in activity in the parasympathetic nervous branch and that CSI 
represents changes in the sympathetic nervous system (Allen.2002;Allen, 
Chambers et al.2007;Toichi, Sugiura et al.1997).  In this respect it may be similar 
to the standard spectral estimate of LF/HF ratio used to assess changing 
autonomic function in many investigation in relation to HRV (Balocchi, Cantini et 
al. 2006;Chen, Chen et al. 2006;Choi, Hong et al. 
2006;Electrophysiology.1996;Hanss, Bein et al. 2006;Malliani, Lombardi, & Pagani 
1994;Malliani, Pagani et al. 1991;Pagani, Lombardi et al. 1986;Sollers, III, 
Buchanan et al. 2007).   
Figure 4.13 shows spine PrPD positive animals (tag 257 and tag 313) that were 
orally challenged with 1g of infected brainstem homogenate.  From these 
longitudinal measures a pattern in the change in CSI/CVI may be seen.  These 
two animals were spine positive from the 1g challenged group, and demonstrate a 
deviation in this value when compared to controls (illustrated in figure 4.13 by the 
upper and lower quartile ranges in the top panel, A).  The peak seen in epoch 3 of 
this figure is due to reduced values of CSI/CVI in the first, second and final 
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quarters of the year of investigation.  This may be due to either a reduction in 
sympathetic activity, an increase in vagal activity or a combination of both as is 
suggested from figure 4.9, spine group 2.  Figure 4.13 illustrates the see-saw 
nature in the activity of the ANS during TSE disease incubation and gives support 
for the idea of changing neural response during disease pathogenesis.    For one 
of the animals, tag 257, recordings were taken over a longer time scale and this 
profile then shows a distinct change in the smooth mediated peak seen in the 
previous 12 months.  Extreme deviations in the values of HRV are seen here and 
this again emphasises the fact that there are phases in neural performance of the 
ANS as the disease progresses.  It is possible these phases may be useful in 
assessing an individual’s signature change in HRV, suggestive of a particular 
stage in TSE pathogenesis. 
By comparison with the 2 animals shown in figure 4.13, figure 4.14 also shows 3 
animals from the spine positive but 100g animal group.  It is as if the first data 
taken from these animals (marked by * February 2001) corresponded to the 
“peaks” of the traces for tags 313 and 257 (marked by *September 2001).  The 
100g animals demonstrate the decrease in CSI/CVI and then enter into a second 
phase where extremes are seen.   
The time difference between the 1g and 100g animals, if this is the case, would 
suggest that the 100g animals were approximately 7 months ahead of the 1g 
group of animals in the disease incubation.  HRV was previously reported to be 
able to indicate a dose response relationship in animals orally challenged with 1g 
or 100g of brainstem homogenate (Pomfrett, Glover et al.2004).  In addition, these 
findings of a dose response difference in individual animal’s ANS function, 
supports the findings of Arnold.   In this work, PrPD was invariably found in the 
brainstem, the earliest signs were reported to be at 30 and 44 months following 
oral challenge for the 100g and 1g dosed animals respectively, with a low 
probability of finding PrPD in any tissues examined at more than 12 months before 
clinical onset.  From their statistical model, it is suggested that the 100g group lead 
the 1g group by 7.9 months since PrPD may be detected before clinical onset, by 
IHC in 50% of animals tested, at 9.6 months PI for the 100g animals and 1.7 
months for the 1g animals (Arnold, Ryan et al.2007).     
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The empirical neurophysiological data presented here helps support the model 
proposed by Arnold. However, significant perturbation in HRV measures may also 
be observed over 12 months before clinical onset of the disease. 
Another factor to consider is that animals from either the 1g or the 100g groups 
may contain individuals of mixed provenance and may be at differing stages of 
disease pathogenesis.  This is indicated by some of the 100g group not having 
PrPD identified in the spine and some that did. Similar diversity is seen in the 1g 
group.  This suggests that analysing the animals based upon the dose of oral 
challenge received may weaken the findings that could relate to individual animals.   
From this investigation of changing HRV metrics during TSE incubation, it was 
found that significant differences between groups of cattle were apparent over a 
12 month period of investigation, corresponding to 29-41 months following 
purposeful oral challenge.  In addition to this, differences were found within these 
groups with specific metrics of HRV demonstrating a see-saw change with respect 
to time during disease incubation.  These changes in HRV measures were able to 
distinguish infected from control animals and also identify the 100g dosed animals 
from the 1g dosed animals.  Finally these same metrics of HRV were able to 
predict those infected animals that were spine positive for PrPD from those animals 
that were spine negative at the time of autopsy based upon analysis of HRV 
measures taken months before.  This type of analysis may help to give insight into 
the disease pathogenesis of TSEs and provide an early screen for such diseases. 
When individual animals were investigated by repeated longitudinal measures of 
HRV it was seen that there was variation in HRV within the groups: not all animals 
displaying the same deviation in HRV measures at the same point in time.  This 
may be due to individual differences in each animal’s physiology and an 
interaction between the strain and specific host. There may have been more than 
one strain in the inoculum and each animal may have subtle differences in how the 
infectious agent infects its body.  It is also likely that the disease pathogenesis was 
different in individuals within the group, echoed by the histological findings of 
Arnold and Masujin (Arnold, Ryan et al.2007;Masujin, Matthews et al.2007). 
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The variation within individuals from the same group may also be explained if the 
intrinsic cardiac ganglia are considered with respect to HRV. It is suggested that at 
least 2 intracardiac ganglia interact to mediate the parasympathetic action 
controlling the heart in many mammalian species including humans, sheep and 
cows (Davies, Francis, & King 1952;Gray, Johnson et al. 2004;Johnson, Gray et 
al. 2004).  Interactions of the parasympathetic and sympathetic nervous systems 
are also thought to occur in these intrinsic cardiac ganglia (Randall, Brown et 
al.1998a;Smith.1999;Zhong, Bai et al. 2007).  The intrinsic cardiac ganglia are not 
simple relay stations for the descending efferent vagal communication but may act 
in an integrative and synergistic capacity to facilitate the control of the heart on a 
beat to beat basis and lead to modulation of the HF and LF frequency bands in 
HRV analysis (Zhong, Bai et al.2007).  These intrinsic ganglia are reported to vary 
with age and species (Pauza, Pauziene et al. 2002) and may vary significantly 
between individuals of a species (Pauza personal communication September 
2007).  Consequently the degree of HRV deviation from control values may be 
different, with respect to time, for individuals within a group based on their 
individual neurophysiology.   
Collinge speculates that different cellular populations of PrPD within a host may 
offer different environments in which infectivity may be expressed.  It is suggested 
in this work that the time delay reported between lymphoid accumulation of PrPD
and development of neural disease may be due to the appearance and interaction 
of a neuroinvasive strain of the infectious agent (Collinge & Clarke.2007).  It may 
also be postulated therefore, that this compartmentalization may also be 
extrapolated to different parts of the nervous system and indeed different 
aggregations of cell bodies within the nervous system.  This may give support for 
the observed stepped and changing responses of neurophysiological function 
observed in this investigation, obtained by monitoring the changing function in 
specific brainstem regions that correspond to those areas responsible for the 
control of HRV. 
However, Collinge uses PrPD to illustrate this compartmentalization of prion 
disease pathogenesis and not his postulated toxic counterpart, PrPL (PrPL either 
being an intermediate or a side product of the conversion of PrPc to PrPD).  PrPL
was suggested to account for the decoupling of the level of PrPD and the extent of 
disease pathology (Collinge & Clarke.2007).  This underlines the fact that PrPD 
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may only be a surrogate marker for the disease and not the infectious agent.  It 
may be that PrPL is the entity that makes the “foot prints in the snow”, the foot 
prints being the PrPD molecules, that many investigators have been studying and 
basing their opinions of infection on.  Hence the identification of PrPD molecules 
may reflect where the infectious agent has been and may not be the best marker 
for infectivity. 
PrPL may build to toxic levels before a specific type of PrPD is identified.  PrPL may 
cause neurological malfunction before PrPD is detected and may thus explain why 
an observed malfunction in parts of the ANS responsible for controlling the heart 
on a beat to beat basis, may be seen before PrPD is detected.  This idea may also 
account for the animals classed as BSE negative, despite being orally challenged 
with infectious material.  From HRV analyses, some of these cattle were identified 
as significantly different from control animals (groups 3 in the analysed groups 
here, see figure 4.9, first quarter).   
Arnold reports that PrPD is unlikely to be detected in sub-clinical cattle at more 
than 12 months before clinical signs were evident. (Arnold, Ryan et al.2007).  
From figure 4.11, HRV analysis was able to distinguish subclinical animals from 
clinical field cases as well as being able to discriminate both these groups from 
control cattle.  Consequently this technique may be tracking the change in neural 
dysfunction caused by PrPL, the progression of which is distinct from PrPD.  The 
effect of PrPL in the branches of the autonomic nervous system may not be a 
single irreversible perturbation in function.  Rather, there may be a changing and 
integrated effect on neurological function in both branches of the ANS, as the 
disease progresses causing a see-saw change in the balance of the two branches 
of the ANS.    
Of particular importance in the changing neural function during TSE pathogenesis 
may be the pathology of dendritic spines.  These appear as a variety of shapes 
including small (0.001-1 µm3) mushroom or doorknob shaped protrusions and form 
the postsynaptic part of many excitatory neurons.  Abnormalities in spine shapes 
and distributions are commonly detected in many brain dysfunctions (Nimchinsky, 
Sabatini, & Svoboda 2002) and have been described in scrapie models (Jeffrey, 
Halliday et al.2000) and in humans with CJD (Landis, Williams, & Masters 1981).  
It is also thought that the initial damage to the dendrites, caused by TSE 
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incubation,  is at the synaptic spine and is preceded by dendritic varicosities at 
these sites (Fuhrmann, Mitteregger et al. 2007).  Such damage may well be a 
mechanism affecting processing of information in the vagal complex of the medulla 
and hence HRV measures.  Loss of synapses and spines may lead to eventual 
neuronal apoptosis due to extensive reduced excitatory input to pyramidal neurons 
throughout the dendritic trees (Jeffrey, Halliday et al.2000). 
Other important observations of changing neural function during TSE incubation 
include studies on long term potentiation (LTP) of synaptic transmission.  LTP may 
be described as the persistent change in a postsynaptic potential following a high 
frequency stimulation of a synapse, a change that may last from 30 minutes to 
days or weeks and may include modification to postsynaptic receptors and 
dendritic spines (Malenka & Bear 2004).  Neurons that demonstrate LTP thus 
have an enhanced response to stimuli compared to those neurons not 
demonstrating LTP.   
This enhancement is achieved by improving the cell's postsynaptic sensitivity to 
signals arriving from the presynaptic cell membrane.   The postsynaptic sensitivity 
is achieved by increasing the activity of existing receptors and by increasing the 
number of receptors on the postsynaptic cell surface (Malenka & Bear.2004).   
It has been reported that certain neurons lose their ability to maintain LTP during 
TSE pathogenesis (a postsynaptic effect).  This was observed at 40% of the total 
incubation period (100 days PI) of a TSE disease when presynaptic functions 
showed no change, assessed by observations in response to paired pulse 
facilitation and post tetanic potentiation both of which are associated with 
presynaptic calcium concentrations (Johnston, Fraser et al. 1998)  These authors  
provided evidence that the attenuation of LTP is likely to be a result of either a loss 
of presynaptic efferents or to be a postsynaptic functional decrement related to 
loss of dendritic spines.  Furthermore, they reported that a change in LTP is 
observed before any detectable significant spine loss, again emphasising the 
earliest signs of TSE infection would be echoed in a change in neurophysiological 
function. 
Much of the work researching LTP was focused on brain slices of the 
hippocampus.  However it has been suggested that LTP is a general function of 
synapses and it has been observed in both autonomic ganglia (Brown & McAfee 
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1982) and in the nucleus tractus solitarii of mammals (Brooks & Glaum 1995).  
Both of these regions are involved in the control of heart rate variability. 
It has also been established that LTP may be induced from the postsynaptic 
synapse by tetanic stimulation of a single pathway to that synapse.  Alternatively, 
when weak stimulation (insufficient to generate a postsynaptic depolarization on its 
own) is applied to many pathways to a synapse, each weak stimulation may act 
cooperatively to induce LTP.  In this latter case weak stimuli may converge on an 
area of postsynaptic membrane and the collective weak stimulations may 
depolarize the postsynaptic membrane enough to induce LTP (Golding, Staff, & 
Spruston 2002;Lee 1983).  This highlights the fact of not only spatial summation of 
inputs, that is potentials from different multiple presynaptic cells adding to evoke 
an action potential, but also the  arrival of these weak stimulations  with respect to 
time, temporal summation, may influence LTP .  Consequently, synaptic 
malfunction resultant from TSE infection could well result in a reduction of LTP due 
to errors in both spatial and temporal summation of inputs. 
This line of reasoning taken together with the interconnection of the brainstem 
nuclei with the extrinsic and intrinsic cardiac ganglia give sites where a change in 
HRV may be elicited during TSE disease incubation due to synaptic functional 
change.   With reference to figure 1.6 and Chapter 1, Intrinsic and Extrinsic 
Cardiac Ganglia, and the work of Brooks on the NTS in rats (Brooks & 
Glaum.1995) it could be the case that an inhibitory interneuron in the NTS, or an 
intrinsic cardiac ganglia for that matter,  may be stimulated by the coordinated 
timing of different inputs to drive the interneuron.  In the diseased state, the timing 
of these inputs may be disrupted and the inhibitory interneuron would not be 
driven and hence the inhibition may be lost,  leading to an increase in activity in 
the ANS controlling the heart on a beat to beat basis and thus lead to a 
perturbation in HRV. 
A further example of how this change in synaptic function can alter the 
neurophysiological timing of neuronal signals is given by the work of Collinge from 
his work with PrP null mice (mice lacking prion protein).  It was reported that a pair 
of intracellular action potentials were recorded as the result of a train of stimuli on 
slices of brain tissue (Collinge, Whittington et al.1994).  Similarly, Barrow recorded 
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these action potential doublets following a series of stimulations in brain slices 
from scrapie infected hamsters.  
Collinge (1994) Prion protein is necessary for normal 
synaptic function
PrP null animal, showing pair 
of action potentials
Barrow (1999) Intrinsic physiological properties 
of principal cells….in hamsters infected with 
scrapie
Scrapie infected animal, showing 







Figure 4. 15 Action potential doublets.
Based on the work of Collinge 1994 and Barrow 1999.  To show action potential doublets in scrapie 
infected hamsters and mice lacking PrP. 
Reprinted by permission from Macmillan Publishers Ltd: Collinge, J., Whittington, M. A., Sidle, K. 
C., Smith, C. J., Palmer, M. S., Clarke, A. R., & Jefferys, J. G. 1994, "Prion protein is necessary for 
normal synaptic function", Nature, vol. 370, no. 6487, pp. 295-297. 
Reprinted and adapted from Barrow, P. A., Holmgren, C. D., Tapper, A. J., & Jefferys, J. G. 1999, 
"Intrinsic physiological and morphological properties of principal cells of the hippocampus and 
neocortex in hamsters infected with scrapie", Neurobiol.Dis., vol. 6, no. 5, pp.  406-423.with 
permission from Elsevier. 
These findings considered together, suggest that the presence of PrPD is 
functionally equivalent to having no PrPc.  The action potential doublets may then 
have an effect on the temporal and spatial summation at integrating axon hillocks.  
Consequently, abnormal synaptic function would result in the diseased state and 
this may lead to a change in the coordinated output of the ANS to the heart that 
may be observed as a disruption in normal HRV parameters. 
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The reduced amplitudes of medium and late afterhyperpolarizations observed in 
scrapie-infected hamster were suggested to be involved in the production of these 
double action potentials.  It is also reported that these changes in 
afterhyperpolarization appeared before the onset of overt neurological symptoms 
and histopathological change (Barrow, Holmgren et al.1999). 
These lines of evidence coupled with the work of Kretzschmar, Carleton and 
Encalada (Carleton, Tremblay et al.2001;Encalada, Moya et al. 2008;Kretzschmar, 
Tings et al.2000) who presents evidence for a functional role for PrPc in 
modulating synaptic transmission suggests that abnormal PrP will disrupt the 
normal synaptic flow of neural information used to regulate target organs, such as 
the heart, before clinical signs of the disease. 
In studies of scrapie in mice, it was observed that dendritic dysfunction and 
synaptic loss preceded neuronal cell death (Jamieson, Jeffrey et al. 2001;Jeffrey, 
Halliday et al.2000). Significant decrease in the number of synapses in brain 
regions in these experiments were observed before clinical signs were expressed 
(34% of incubation period) and even before a decrease in spine numbers (50% 
incubation period). 
It has also been reported that electrophysiological changes may occur in neurons 
in some animal models of the disease before PrP aggregates are seen and 
neuronal pathological change may be independent of neuronal PrP expression 
(Jeffrey, Goodsir et al. 1997;Jeffrey, Goodsir et al.2004).  It is also stated that 
synaptic change and dysfunction is an early step in pathogenesis of prion 
diseases and may be correlated to behavioural changes that constitute clinical 
signs of TSE diseases (Cunningham, Deacon et al. 2003). 
Consequently there is evidence to indicate that a change in neurological function 
may be observed before clinical signs of the disease or before PrPD aggregates 
are detectable. This gives support to the observed aberrant function of the 
brainstem nuclei and other neural tissue involved in the control of the heart on a 
beat to beat basis. 
The results presented here would also suggest that the agent responsible for BSE 
in these cattle, that may or may not be PrPD, causes a disturbance in brainstem 
function in the regulation of the heart in infected animals before clinical signs and 
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importantly in animals that have not been confirmed as BSE positive by IHC 
although purposely orally fed with either 100g or 1g of infectious material. 
The work by Masujin was undertaken to increase the understanding of BSE 
disease pathogenesis in cattle.  The authors stated that, contrary to previous 
belief, there is a build-up of PrPD in the peripheral nervous system and adrenals 
that coincides with, or follows, the appearance of PrPD in the CNS and the build-up 
of PrPD in the PNS is “the rule rather than the exception” in the clinical stages of 
the disease.  
In scrapie, neuronal malfunction and cell death have been described to occur 
before prion protein accumulation (Jamieson, Jeffrey et al.2001), synapse loss 
associated with abnormal PrP is reported to precede neuronal degeneration  
(Jeffrey, Halliday et al.2000) and neuronal lesions have been observed in 
neurones that are independent of PrP expression (Jeffrey, Goodsir et al.2004).  
The utility of using HRV analysis to identify preclinical scrapie infected animals 
(Glover, Pollard et al.2007) and BSE in cattle (Pomfrett, Glover et al.2004) has 
been indicated.   
A difference between sheep and cattle incubating TSE disease (figure 4.4) may be 
due to a different signature in HRV as a result of different disease pathogenesis of 
scrapie and BSE or that these groups of animals were at a different stage in the 
HRV perturbation caused by incubating TSEs.  In addition, CVI and CSI for sheep 
were not significantly different on the one occasion that measurements were taken 
(figure 4.3).  Studies on the pathogenesis of scrapie and BSE in sheep have 
revealed very similar patterns of disease progression with respect to time and 
neural tissues that are infected.  (van Keulen, Vromans et al. 2007;van Keulen, 
Bossers et al.2008;van Keulen, Schreuder et al.2000).  The main difference in the 
pathogenesis of scrapie in sheep and BSE in cattle being the reduced involvement 
of the lymphoreticular tissues in cattle ( BSE is limited to the GALT, gut associated 
lymphoid tissue) although neural routes of infection via the parasympathetic 
efferent fibres are reported to be similar (van Keulen, Bossers et al.2008).  There 
still remains the possibility that the difference between sheep and cows incubating 
TSEs identified here is due to the stage of incubation individual animals were at 
when tested.  Hence there is a likelihood that a change in neural function in central 
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nervous system areas, such as the brainstem, may appear before PrPD deposits 
are detected. 
The disassociation between the presence of PrPD and infection may be due to 
some of the caveats to the testing methods used for PrPD described in this and 
previous chapters.  The current tests being developed are more sensitive in the 
detection of PrPD in many tissues and indeed the work of Masujin has found 
numerous new sites of the peripheral nervous system to contain PrPD.  It may be 
anticipated with future tests that PrPD is detected in many more areas of the 
infected animals and thus help confirm the BSE status as positive and help identify 
the route of entry for the infectious agent. 
There is evidence that this technique of monitoring HRV from incubating animals 
may be able to not only identify infected from control animals but also to indicate a 
high dose group from a low dose group as frequency domain analysis suggested 
in previous studies (Pomfrett, Glover et al.2004).  It is suggested that the 1g 
animals are at an earlier stage of disease incubation than the 100g animals based 
upon a model of the disease pathogenesis (Arnold, Ryan et al.2007).  Therefore 
the difference in HRV measures, with respect to time, for these groups observed 
here may give information in relation to a particular stage of disease pathogenesis 
following oral inoculation of infectious agent.  It is stated that the initial tissue to be 
detected as positive for PrPD was the medulla-obex section (Arnold, Ryan et 
al.2007), which is the area where the nuclei that control the heart on a beat to beat 
basis are located.  Consequently malfunction in these areas caused by either 
neuronal loss or synaptic change will manifest as a perturbation in HRV.  
Repeated measures of HRV may prove a useful diagnostic tool for the screening 
for TSE diseases and help understand the pathogenesis of the infectious agent. 
HRV may be considered to be the result of a series of nested feedback loops 
coordinated efferent activity involving both sympathetic and parasympathetic 
branches of the ANS (see figure 1.6).  The involvement of the NTS, NA and DMNX 
in relation to baroreflex sensitivity have been discussed in Chapter 1 (pages 62-
66).  These areas are also involved in the short term and long term regulation of 
blood pressure.  While inference of changes on heart rate are implied by changes 
of HRV measures it is also possible that prion infection in the diagnostic areas of 
the brainstem may change sympathetic activity in addition to vagal activity with 
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consequential changes in blood pressure and baroreflex sensitivity.   These 
changes in baroreflex mediation of blood pressure are also associated with RSA 
(Berger, Saul, & Cohen 1989;Saul, Berger et al. 1989b;Taylor, Myers et 
al.2001;Taylor & Eckberg 1996) . This illustrates the intimate relationship between 
parasympathetic and sympathetic branches of the ANS and suggests that prion 
infection in areas of the brain responsible for their coordination may result in 
abnormal control of these functions. 
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Chapter 5 Development of Methods used to Investigate 
heart rate variability linked to respiration 
Introduction 
Heart rate variability (HRV) is described as a beat to beat change in consecutive 
cardiac cycles often measured by the change in RR interval. Measures of HRV 
may be used to assess the neural activity between the brain, heart and lungs.  It 
has been shown that respiratory sinus arrhythmia (RSA) is correlated with 
changing activity in specific areas of the brainstem (Pomfrett & Alkire 1999).  
These depressions in brainstem activity, indicated by the highlighted areas in 
figure 5.2 below, implicate the right nucleus tractus solitarii (NTS) of the medulla 
oblongata.  The NTS is the primary site for the integration of the cardiorespiratory 
reflex and its output transmitted, via other brainstem nuclei and the vagus nerve, 
to ganglia at and near the heart.  Hence, perturbation in the activity in this area 
would manifest as a change in the association of heart rate and breathing on a 
beat to beat basis and therefore would change measures of RSA. 
Breathing is an autonomic rhythmic and centrally regulated mechanical process 
and its main purpose is to supply oxygen to all the cells of the body and so is 
intimately linked to the cardiovascular system.   
In humans the medullary respiratory centre consists of at least two neural groups. 
One, whose activity relates to inspiration and another that relates to expiration.  A 
central rhythmic generator is situated in the medulla maintaining alternate activity 
of these inspiratory and expiratory neurons.  This rhythmic activity is present in 
cats after destruction of afferent pathways caused by brainstem sectioning 
(Comroe 1954;Tang 1953) see figure 5.1.   
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 Lateral Brainstem      Dorsal Brainstem Respiration pattern 
Figure 5. 1  Interaction of vagus nerve and different areas of the brainstem.
To show the interaction of the vagus and different brainstem areas on breathing patterns.  Sections 
below the medulla result in no respiratory effort.  Severe apneustic respiration is seen following 
brainstem section at level 2 and lesion of the vagus. (SC = superior colliculus, IC= inferior 
colliculus, CP=cerebellar peduncles) Reproduced by permission from Comroe, J. H., Jr. 1954, 
"Respiration", Annu.Rev Physiol, vol. 16, pp. 135-154. 
Other neural sites for the maintenance for this generation of respiratory rhythm are 
suggested to be the pons (pneumotaxic centre) and some neurons anterior to the 
medulla (apneustic centre) which cause prolonged inspiration as a result of absent 
rhythmic drive from the pneumotaxic centre and reflex vagal inhibition from stretch 
receptors in the lung.  Individual cell recordings have suggested that the rhythm 
generator is located in a group of neurons in the NTS.  This central rhythm 
generator also activates neurons in the rostral nucleus retroambigualis (NRA) 
(Randall 1978).  In turn the NRA projects directly to the NA and acts as a pool of 
premotor interneurons each producing motor actions in response to changes in 
eupneic breathing (normal “resting” breathing). Different combinations of these 
premotor neurons resulting in the final effect (Subramanian & Holstege 2009).   
165
The effects of vagal stimulation on respiratory neurons of the NTS have also been 
studied and it was found that vagal stimulation inhibited inspiratory neurons of the 
NTS (Subramanian, Chow, & Balnave 2007).  These lines of evidence point to a 
link of vagal activity and coordinated neural output from the NTS to achieve 
respiration.  The importance of the vagus and areas of the brainstem in 
coordinating respiration have been further emphasised in studies of vagotomy and 
lesions in different areas of the brainstem (Figure 5.1).   
Vagal reflexes in the modulation of breathing are evoked from the activation of 
several different types of receptors, including stretch receptors located in the lung 
and chemoreceptors located in the aortic wall.  Vagal fibres from the lung, entering 
into the NTS as cranial vagal fibres, serve to augment the excitability of the 
respiratory centre in conjunction with the main effect from afferent cardiac fibres 
(Liljestrand 1958).  The effects of the vagus in relation to respiration have been 
shown to have a moderating effect in the pattern of respiration and limit apneustic 
breathing (as indicated in figure 5.1) thus helping to regulate the respiratory 
pattern (Tang.1953).   
Evidence from the Hering-Breuer reflex summarizes the relationship of vagal 
coordination of respiration.  Activation of pulmonary stretch afferents inhibit the 
central inspiratory drive and activate expiration, facilitated by the vagus nerve.  
Inhibitory information from the lung afferents is also relayed to cardiac vagal motor 
neurons in the NA and DMNX.  Motor fibres from these centres relay neural 
information to the heart, controlling its activation on a beat to beat basis.  
Increasing pulmonary stretch receptor activity results in inhibition of cardiac vagal 
motor neurons (release of the vagal brake on heart rate) thus increasing heart rate 
as respiration changes phase.  This is the fundamental process involved in RSA. 
The medulla oblongata is a diagnostic area for many prion diseases 
(Ironside.2000;Wells, Hancock et al.1989), demonstrating accumulation of disease 
associated prion protein. The presence of prion in brain tissue has been 
associated with a change in neurological function  (Chiesa, Piccardo et al. 
2008;Collinge, Whittington et al.1994;Jeffrey, Halliday et al.2000;Kretzschmar, 
Tings et al.2000).  The change in neurological function in individual neurons, or 
pools of neurons, associated with the control of the heart on a beat to beat basis 
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would alter HRV and also disrupt the normal coordination between breathing and 
the control of the heart beat on a beat by beat basis. 
  
Figure 5. 2  Decreasing RSA with increasing depth of anaesthesia. 
From Pomfrett and Alkire illustrating decreasing RSA with increasing depth of anaesthesia and 
associated areas of brainstem affected.  Image obtained using 18 Fluorodeoxyglucose (18 FDG) 
uptake and subsequent Positron Emission Tomography (PET) (Pomfrett & Alkire 1999). 
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The proposed integration of the parasympathetic and sympathetic branches of the 
autonomic nervous system, along with the integrative centres of the NTS, NA and 
DMNX are illustrated in the diagram below (Figure 5.3, modified from chapter 1).  
The oblongs represent specific areas of the brain and neural structures relating to 
the control of the heart on a beat to beat basis. The intimate functional relationship 
of specific groups of brainstem nuclei (NTS, NA, DMNX) are illustrated.  In addition 
the potential “gating” effect of the sympathetic and efferent neural signals from the 
NTS can be seen to act in the areas of the intrinsic cardiac ganglia (RAGP and 
PAGP).  The gating effect may result in the flow of neural information being 
allowed or denied to pass onwards depending upon the state of the gate, which in 
turn may be set by other neural inputs. 
The potential for a change in function in these areas as a result of prion infection 
can be seen to have influence on feed-back and feed-forward neural relationships, 
resulting in changing heart rate variability due to deviant neural impulses arriving 
at the SA node on the heart.  This, coupled with the function of the NTS to 
coordinate inspiration and expiration with the heart on a beat to beat basis, gives 
further sites for a potential alteration of the synchronised neural flow resulting in 
the optimized control of the heart on a beat to beat basis. 
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Figure 5. 3 Schematic of Neural connections from CNS to SA node via ganglionated complexes.
Used with permission, from Armour, J. A., Collier, K., Kember, G., & Ardell, J. L. 1998, "Differential 
selectivity of cardiac neurons in separate intrathoracic autonomic ganglia", Am J Physiol, vol. 274, 
no. 4 Pt 2, p. R939-R949. Figure 7.  Comprising elements from Armour and Randall (Armour, 
Collier et al.1998;Randall, Brown et al.1998a;Randall, Brown et al.2003). 
The “triumvirate” of brainstem nuclei (NTS, NA and DMNX) and their relationship to intrinsic ganglionated complexes (RAGP 
and PAGP) and subsequent action on the SA node is illustrated here.  Parasympathetic efferent communication is indicated 
in red, sympathetic activity is indicated in blue. Black lines indicate efferent communication of the ANS with higher brain 
centres. Synergistic activity of the two branches of the ANS is indicated at the RAGP at the open circle.  Comprising 
elements from Armour, Randall and Berger et al (Armour, Collier et al.1998;Berger & Averill 1983;Randall, Brown et 
al.1998a;Randall, Brown et al.2003). 
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To investigate the perturbation in neurological function as a result from prion 
infection, focus was put on the link between cardiac and respiratory events.  To 
analyse this relationship independently of power spectral or simple time domain 
measures, circular statistics were used to relate each R-wave to a breath epoch.  
Each derived R-wave’s interval, from the start of the preceding breath event, was 
plotted on a circle whose circumference represented the duration of the breath.  
The association between the breath and the first, second, third etc., R-waves in 
each breath was then explored to examine the relationship of the neurological 
control of the cardiorespiratory reflex.   
The link between respiratory events and heart beats has also been explored 
during anaesthesia by Galletly (Galletly & Larsen 1997;Galletly & Larsen 2001).  
Although the application of circular statistics to investigate the relationship of each 
R-wave to the subsequent breath event was not made, patterns in 
cardioventilatory coupling (CVC) were observed in anaesthetised humans.
It was difficult to obtain reliable breath event markers from vCJD patients due to 
ataxia, dysphagia and myoclonus being impairments caused by the disease 
(Todd, Morrow et al. 2005).   Similarly, in animals incubating prion diseases, 
transducers to record breath events, either thoracic belts or nasal thermistors were 
not tolerated and were difficult to operate reliably.   
To more accurately assess the relationship between RR interval changes and 
respiratory events, some sort of breath estimate would be needed.  This contrasts 
with the respiratory frequency zones used in power spectral analysis typically 0.15 
to 0.5 Hz in humans.  This represents a broad band of respiratory events and may 
smear any relationship between HRV and individual breathing events.  By looking 
at each breath and the subsequent change in RR intervals, more information 
about the control of RSA may be observed. 
Consequently attempts to estimate a breath were computed from the raw high 
resolution ECG trace.  An average event time for respiration was calculated by 
combining information from the HF filtered tachogram of the RR time series (see 
earlier chapter 2), the change in the magnitude of ECG (the development and 
reliability of this technique are described in (Cysarz, Zerm et al.2008;Moody, Mark 
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et al.1985;Moody, Mark et al. 1986;Noh, Park et al.2007) and a cubic spline 
derived conversion of the RR time series. 
Method
Following a favourable ethical opinion from the relevant ethical committee (granted 
by the North West MREC, reference MREC 01/8/92), 300 seconds of ECG data 
were digitised at a sampling frequency of 1 kHz using a commercially available 
monitor with a high resolution analogue to digital convertor (Fathom, Depth of 
anaesthesia monitor Amtec Ltd and TS1, modified version of Variacardio TF4 by 
Advanced Medical Diagnostics Group.   
 A simple three connection bipolar ECG recording, giving a similar trace to a lead II 
configuration, was used since no interpretation of various ECG complexes would 
be required and it provided a quick, stable and accurate trace from which to detect 
the R-wave (the largest deviation in the ECG montage).  Electrode position was 
adjusted to obtain the greatest difference between R-wave and baseline.  No 
filtering was applied to the raw ECG since the accurate recording of the R-wave 
times was of paramount importance. 
Once collected, the data were archived and analysed via a hard drive on a 
conventional PC, exceeding the specified standards for the software to operate 
and using standard software (Spike2 v6.02, CED; Oriana2, Kovach Computing 
Services).  Using this software and hardware, automated QRS wave detection was 
applied.  Artefacts and missed beats correction were performed in Spike2 and 
were checked by eye by comparing the raw ECG with the output from the 
automated R-wave detection program.  Any corrections for missed or extra R-
wave events were made using purpose written scripts in Spike2.  An event series 
of ECG R-wave timings were obtained in order to determine variability in the R-R 
intervals and an instantaneous tachogram constructed from this event series, 
again using Spike 2 Software V 6.02 from Cambridge Electronic Design (CED) (As 
described previously in chapter 2).  
In addition, I designed and implemented a computer program, again in Spike2 
script language, that estimated breath events during the 300 second recording 
window by averaging estimates gained from: analysis of the breathing frequency 
171
(HF) filtered tachogram (Channel 3 in figure 5.4); analysis of changing magnitude 
of the recorded ECG due to the movement of the thorax (Channel 4 in figure 5.4); 
an assessment of breath events derived from the cubic spline interpolated time 
series of the R to R intervals (Channel 5 in figure 5.4) (Noh, Park et 
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The first stage in the development of the program employed to estimate the breath 
events was to investigate the variation in the slow frequency changes of the ECG.  
This consisted of using the extrapolated event series of ECG R-wave timings from 
which an instantaneous tachogram was constructed using Spike 2 Software V 
6.02 from Cambridge Electronic Design.   The tachogram was constructed by 
replacing each R-wave event marker by a cosine wave fragment of unit area (see 
figure 2.3 chapter 2). This was done to investigate the frequency changes in the 
sequence of R-wave events and hence the periodicity of the ECG.  This 
tachogram was then filtered to exclude frequencies outside the 0.15 to 0.5 Hz 
range.  This is the range for HRV that represents the power associated with 
breathing following FFT analysis of the tachogram.  Thus, this filtered version of 
the tachogram would represent the frequency changes in the RR time series 
associated with breathing.  This is shown in figure 5.4 as channel 3. 
Secondly, breath events were estimated from the variation in the amplitude of the 
ECG corresponding to changing thoracic impedance as the chest wall and 
recording electrodes moves away from and closer to the heart in time with 
breathing (Channel 4 in figure 5.4).  From the high resolution ECG waveform 
channel, any DC component of the signal was removed using Spike 2 and the 
script language to process data following collection.   This was achieved by using 
a script command which replaced the value of the original waveform at a time, say 
t, with a value representing the original value minus the average value calculated 
from the waveform data from time t-0.1s to t+0.1s. This process reduced the 
channel offset to zero without altering the channel scale and so allowing the 
difference in amplitude of the R-wave peaks to be identified and compared to the 



























































































































































































































































A further method of estimating the breathing rate from the ECG trace is to use a 
cubic spline smoothing transformation of the RR time series (Noh, Park et 
al.2007;Schafer & Kratky.2008) produced here following automated identification 
of R-waves from the ECG and checking by eye for artefacts.  The cubic spline was 
again performed using a Spike2 script function which mathematically interpolates 
data resulting in a smoothing of the time series.  This is shown as channel 5 in 
figure 5.4. 
Following the construction of the three traces derived to estimate breathing events, 
the turning points in the waveforms were calculated in the analysis program and 
compared to breathing events measured by a Magtrak turbine (Ferraris Medical 
Ltd) used in conjunction with a face mask and filter (Intersurgical Mask 1515 and 
Intersurgical filter 1944: Intersurgical, Berkshire).  The Magtrak transducer 
measures a breath event by emitting a series of electrical pulses in response to a 
vane rotating as a consequence of the passage of gas flow across a slotted 
cylinder, in a similar fashion to a Wrights respirometer.  These breath events are 
then interpreted from the series of electrical pulses shown in figure 5.5.  The start 
of each series of electrical pulses corresponding to each breath is taken as the 


































































































































































































































Figure 5.6 shows the three derived estimates displayed on channel M1.  At some 
measured breath events there may not have been an event estimated by all three 
of the methods.  For example in figure 5.6 there were only 2 estimates available 
from the three methods for the measured breath event at time 150 seconds.  This 
shows that not all three methods were equally affective at determining the breath 
event on all occasions.  The three estimated events were then averaged to form 
one event which approximated to the breathing event recorded from the Magtrak 
(Shown in figure 5.6 as channel M2).   
The average breath estimate channel still contained values that were not 
physiological and to help make the estimates more applicable to the real world 
values, smoothing of these averaged events was performed in 2 stages.  Events 
from the average breaths (channel M2) were copied to a new channel if they were 
physiologically valid, e.g. occurring within 3 seconds of each other and thus 
representing a breathing rate of more than 20 breaths per minute (channel 
SmoothAVG in the program listing in appendix 1.5). 
The second stage consisted of taking the average breaths from channel 
SmoothAVG , putting the event times into an array to which a Finite Infinite 
Response (FIR) filter with 5 coefficients was applied thus producing a second 
filtered channel (FiltAVG in the program listing in appendix 1.5).  The FIR filters 
defined in the Spike2 script language, use future as well as past data to generate 
each output point.  It is suited to this application since information in relation to the 
previous and next breathing events are considered in this smoothing algorithm 
(the frequency response of this filter is shown in appendix 1.6).  The physiological 
processes determining each breath are also linked in a cyclical fashion with each 
breath being affected by the previous breath and constrained by physiological 
feedback and feed forward neurological loops.  With 5 coefficients, this meant that 
2 events before the data point and two events after the data point were used to 
find the average of this series of 5 breathing events.  The next breath event in the 
array would then be subject to this procedure, being the centre data point in the 
smoothing algorithm. 
There is a problem at the start and end of the array where some coefficients have 
no associated data element.  The solution to this problem is to take these missing 
points as copies of the first and last points as implemented in the script command 
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(ArrFilt, Spike2 Script Language version 6).  The result of applying this function to 
the array is to produce a five point smoothing of data, replacing each point by the 
mean of itself and the two points before it and the two points after it. 
Whilst it is understood such ECG derived respiration (EDR) events will have errors 
associated with them, it was considered that breaths estimated in this fashion may 
provide utility in the investigation in the link between respiration and the change of 
the heart beat on the sub second time scale.  Since the proposed method of 
analysis would rely on breath by breath investigations, one or two erroneous 
breath events may not affect the trend derived from 5 minutes of data containing 
around 40-50 breaths. Although the estimated and recorded breath events showed 
good agreement by eye, a measure of how well the constructed algorithm 
estimated the event compared to the recorded event would be required to validate 
the method used to estimate breath events. 
As stated by Bland and Altman, new methods of measurement need to be 
validated against current methods of measurement.  A true measure of a particular 
physiological quantity may not exist.  The best measured approximation to its true 
value can be used, but this may also be subject to errors.  Consequently it is 
suggested that the degree of agreement between the new and traditional 
measurements are assessed and it is stated that it is inappropriate to use 
correlation coefficients (Bland & Altman 1986).   
In considering the problem of assessing how good the agreement of measured 
versus estimated breath events is, it was considered appropriate to use the 
technique described in the above quoted paper by Bland and Altman.  This 
method finds the bias, estimated by calculating the mean difference between two 
measures ( d ) and the standard deviation of the differences (s) to summarise the 
agreement between the two methods of measurement.   A graphical 
representation displaying average value of the breath event (abscissa) against the 
difference in estimated times (ordinate) helps summarize these differences.   
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The estimated breath events were then used with the corresponding R-wave 
events in a commercial package (Oriana2) and in a bespoke Spike 2 script to 
calculate indices of circular statistics (Batschelet 1981) such as mean vector 
length, circular variance, concentration and mean vector angle.  Investigations into 
the link between respiration event and the time to the first, second, third... R-wave 
after each breath were also performed to investigate respiratory cardiac coupling.  
In this way estimates of RSA and the changing association of beat to beat heart 
rate and breathing could be assessed to test the hypothesis in a direct fashion.  
The R-wave times from each breath are extracted and the first, second, third etc. 
R-wave times are plotted on a circle whose circumference of 360 degrees 






































































































































































































































































































































Representing circular statistical data. 
From the circular statistical analysis, two types of diagram were produced by 
importing the R-wave times, translated to an angle where 360 degrees 
represented the duration of that particular breath, into Oriana (Kovack Computing), 
a software package used to perform circular statistical analysis.  These two types 
of circular plot represented: 
 1. The distribution of the R-waves within each breath figures 5.8, 5.9 and 5.10 
(visualised as a series of "over-head transparencies" overlaid on top of each other 
with each layer representing the distribution of the first 6 R-waves within each 
breath.  For illustrative purposes, six breaths are used in this example). 
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Figure 5. 8  Example of R wave dispersion within breaths I.
R-wave dispersion for breath at time - 13.6564



















































Figure 5. 9  Example of R wave dispersion within breaths II.




















































Figure 5. 10 Overlay of constituent breaths of figures 5.8 and 5.9. 
R-waves derived from 6 breaths overlaid to illustrate how the derived resultant vectors constitute 
the “Cartwheel plot” of figure 5.11.  The amplitude of the rings represent the number of vectors in 




















2. A summary plot (Cartwheel plot) where the “spokes” of the wheel represented 
the resultant mean vectors of the summation of the individual beats associated 
with the first, second third etc., heart beat with in each breath.  The black arrowed 
line represents the resultant mean vector angle and length for all the data in the 
file. 
Figure 5. 11 Summary “Cartwheel plot” . 
made from the resultant vectors derived from R-waves of figure 5.10.  The coloured lines represent 













From these cartwheel plots a resultant mean angle and vector length could be 
calculated to provide a summary of the clustering of the R-waves to each breath 
within the 300 second sampling epoch.  Typically around 50 breaths for each 
sample were analysed.   
In addition resultant mean vector angles and lengths could be calculated for 
individual R-waves within the breath epoch based from the type 1 angular plots 
shown in figures 5.8, 5.9 and 5.10. 
  
The mean vector length gave an approximation to the clustering of R-waves to the 
breath.  A high value of MVL indicated that R-waves were more clustered to the 
breath event and hence the breath had a greater influence on the R-wave 
distribution than a data set with a lower value of MVL. 
The value of concentration (k) represents the extent the von Mises distribution (a 
circular equivalent to its linear counterpart of the normal distribution) deviates from 
a perfect circle representing a uniform distribution (see figure 5.12).  If k = 0 then 
the distribution is uniform and as k increases the distribution is concentrated more 
about the mean (Batschelet.1981).   
Circular variance and circular standard deviation are comparable to their linear 
equivalents although variance (V) is calculated from the length of the mean vector 
(r) by using the formula V = 1 – r; and the standard deviation (S) is calculated as  
))ln(2( rS −=  (Oriana V2 User manual(Batschelet.1981).  
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Figure 5. 12  Circular distributions compared to linear counterparts.
Uniform and von Mises probability distribution and their linear counterparts 
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where ø is angle as shown above,  is the 
mean angle assumed to be zero in this 
example, k is the parameter of concentration 
and I0 is a modified Bessel function of order 
0.  If k = 0 then the function represents a 
Uniform distribution.  As k increases, the 
more the distribution is concentrated around 
the mean direction. 
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Circular statistics are used in many publication in areas such as sciences 
(Aradottir, Robertson, & Moore 1997;Bowers, Morton, & Mould 2000;Gao, Chia et 
al. 2006) psychology and criminology (Brunsdon & Corcoran 2006) and political 
and social research (Gill & Hangartner 2010).  The basis for these circular 
statistical measures is the calculation of  the mean vector length and mean vector 
angle which are calculated by vector addition.  The first step is to transform the R-
wave times forming each vector (representing the occurrence of the R-wave after 
the breath event) to unit vectors where the x coordinate of the vector corresponds 
to the cosine of the angle  and the y coordinate corresponds to the sine of the 
angle.   
        
The vectors ri are then vector averaged for all the R-waves by  
  .      
This gives  , the mean resultant vector.  This mean resultant vector is 
transformed using the four quadrant inverse tangent rule to give µ, the mean 
vector angle.  (This, along with the calculation of mean vector length is performed 
in the program listing as shown in appendix 1.5).  The length of the resultant mean 
vector is derived by using Pythagoras' theorem as: 
Consequently, both the mean vector angle and mean vector length are derived 
from the angular position of the constituent vectors, hence depend critically on the 
angle (representative of the time of the R-wave after the breath event). 
Concentration is related to the length of the mean vector and measures the spread 
of angular distributions.  The summary r statistic can be subject to significance 
testing using the Rayleigh test which indicates the presence of a preferred 
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direction in the grouped data and this is also based on the mean vector angle, µ 
and concentration parameter k. 
The Rayleigh test calculates the probability of the null hypothesis that the data are 
distributed in a uniform manner. The Z value is calculated simply as Z = nr2, where 
n is the number of observations and r is the length of the mean vector. A longer 
mean vector (and the resulting larger value of Z) means greater concentration of 
the data around the mean, and thus less likelihood of the data being uniformly 
distributed. A probability less than a chosen significance level (usually 0.05) 
indicates that the data are not distributed uniformly and that they show evidence of 
a preferred direction. 
The Mardia-Watson-Wheeler test also referred to as the Uniform Scores Test, is a 
non-parametric multisample test for determining whether two or more distributions 
are identical.  If the distributions of the samples are identical then the uniform 
scores for the samples should be evenly interspersed around the circle, and their 
resultant vector lengths, r, should be short and similar.  Any significant difference 
between the vector lengths will lead to a large W test statistic and rejection of the 
null hypothesis of identical distributions. 
From the publications listed above, there is a trend in how circular statistical data 
is presented.  Data is presented to summarize  properties of angular data such as 
central tendency and spread of the data.  Since many of the parameters of circular 
distribution are derived from the mean vector angle, the 95% confidence intervals 
are often quoted and or plotted on graphs of the mean vector angles but the 
concentration values are plotted as unitless discrete points (see (Bowers, Morton 
et al.2000;Haskey 1988).  However, Batschelet illustrates how confidence intervals 
for the parameter of concentration may be obtained from charts using the 
calculated mean vector length of the sample (pages 89-92 (Batschelet.1981)). 
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Use of an ECG simulator to test the program 
In order to further validate the algorithm used here to estimate breath events and 
calculate circular statistics related to the dispersion of the R-wave intervals within 
each breath cycle, an electronic simulation of an ECG was analysed.  This came 
from a HeartSim 2000 (Laerdal-EKG-L-SIM2000 )  and provided a “standard” ECG 
trace without any arrhythmias programmed.  This gave a simulated ECG with little 
or no variability in the appearance of the R-waves.  The breaths for this file were 
estimated by running the data through the purpose written script but the thresholds 
for picking off the breath estimates were lowered to allow estimations to be made.  
The periodicity of these derived breath estimates were similar to those obtained 
from human subjects. 
Figure 5.13 below illustrates the ECG from the Heartsim and illustrates how the 
breath estimates for this file were obtained.  The Heartsim data is distinct from an 
electronically generated rhythmic series of pulses such as that generated from a 
signal generator, since it contains a small change in the amplitude of the ECG 
along with very small changes in the R-R intervals of the waveform.  This allowed 
an estimation of breathing events from these two facts, as shown in the figure. 
This is the same file used  to assess the power spectral estimates in appendix 1.2 
and consequently the reduced amplitudes of the tachograms required the 
thresholds for picking off the breath estimates to be lowered to allow estimations of 
breath events to be made. 
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Figure 5. 13 Illustration of how breath estimates were deducted from Heartsim file. 
A: data from a control to compare the breath estimation process. 
B: data from the Heartsim showing breath estimates derived from changing amplitude of ECG trace 
(channel 15) and modified by information from channel 14 which represents a breathing frequency 
filtered tachogram.   Note the reduced amplitudes of channels 8 and 14 in B, compared to those in 
A. 
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The purpose written computer program firstly estimated the breath events as 
described above and then extracted the first R-wave from each breath and 
calculated the resultant mean vector from all the first R-waves for all the breaths in 
the data file.  This process was then repeated for the nth R-wave in each breath 
cycle where n ranges from 1 to 6.  These plots indicate the dispersion of the nth R-
wave for all breaths as shown in figure 5.14.  The resultant mean vector (shown in 
the circular histogram plots below as an arrowed black line) for all the first, second, 
third etc., R-waves in each breath cycle is shown.   
Figure 5. 14 Distribution of R-waves for overlaid breaths
Circular histogram plots showing the dispersion of the nth R-wave (n from 1 to 6) within each 
breath cycle for all breaths in a 300 second recording from a control subject.  The rings represent 














































































































The resultant mean vectors from these circular histogram plots were then plotted 
on a second “cartwheel” histogram (an example is shown in figure 5.11), 
representing the associations between each R-wave in the breath cycle, averaged 
for the whole data sampling period, containing approximately 50 breaths for each 
subject. 
Results 
Shown below is the data used to evaluate the agreement between measured and 
estimated breathing events (figure 5.15). 
When the derived breath estimating algorithm was used to estimate breath events 
and compared to measured breath events, it was found that the estimated breaths 
displayed a mean difference of -0.51727 with 95% confidence interval of -0.61937 
seconds to -0.41517 seconds by comparison with 905 measured breath events 
from 15 human subjects (see appendix 1.4).  The typical association of estimated 
and measured breaths is shown in figure 5.16.  The breath estimates were 
calculated using the algorithm on the same files that contained measured breath 
events and the Bland-Altman test for agreement between measurements (Bland & 






































































































































Figure 5. 16 Relationship of measured to estimated breathing event  
Graph illustrating typical relationship of the estimated breath event against the measured breath 
































































Typical summary plots are shown in figure 5.17.  These give estimates of circular 
dispersion for the first, second, third etc. R-wave in each breath. The length of the 
mean vector, shown as an arrowed line in the figure, will range from 0 to 1 with a 
larger value of r suggesting that the observations are clustered more around a 
mean value than a lower r value.   
Figure 5. 17 Cartwheel plots.
“Cartwheel” summary plot illustrating the difference in dispersion of the R-waves within each breath 
for a vCJD patient and the control data used to construct figure 5.11 
The summary variables shown in table 5-1 below were calculated by importing the 
data from the bespoke Spike2 script into the Oriana software package.  
Table 5- 1 Circular statistics illustrating the differences between controls and repeated measures from 
a vCJD patient.
(based on analysis of summary plots shown in figure 5.11 for 3 measures from one vCJD patient 















Mean Vector (µ) 132.892° 128.439° 107.35° 134.894° 158.79° 207.286° 177.258°
Length of Mean Vector (r) 0.31 0.38 0.54 0.31 0.16 0.10 0.17 
Median 132.553° 107.378° 124.789° 134.796° 155.925° 144.853° 136.833°
Concentration 0.14 0.40 1.01 0.20 0.00 0.00 0.00 
Circular Variance 0.69 0.63 0.46 0.69 0.84 0.90 0.83 
Circular Standard Deviation 87.635° 80.219° 63.947° 88.102° 109.01° 122.133° 108.631°
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From table 5-1 it can be seen, as expected, the HeartSim data when analysed in 
the same fashion as the human data, demonstrated little variation in the 
distribution of R-waves.  What is surprising is that in the latter two data files from 
the vCJD patient, these values of variance were lower than the values from the 
simulator, perhaps demonstrating the degree of decrement in autonomic function 
in the patient.  The file from the simulator was based upon a human ECG which 
was electronically manipulated by the manufacturers to provide a base ECG on to 
which various arrhythmias could be programmed to use for training purposes. 
When the circular statistics for each R-wave within the breath epoch are 
investigated, the concentration values for the vCJD patient are higher than the 
values from the controls and the HeartSim for the first to fourth R-wave in each 
breath (see figure 5.18).  The concentration values for the vCJD patient then drop 
below the values obtained from the HeartSim.  This illustrates that the values from 
the vCJD patient display a greater range in the concentration of R-waves within 
each breath cycle compared to either the controls or data from the HeartSim.  The 
graph also illustrates the greater divergence in concentration values for the vCJD 
patient compared to controls and HeartSim for the first 3 R-waves of each breath.  
This suggests the first 3 R-waves of each breath are more grouped for the vCJD 
patient than controls and implies the R-waves demonstrate less variability than 









































































































































































































































































































































































































































































































Figure 5.19 illustrates the difference in MVL for R-waves within breaths for patients 
and controls along with the heartsim machine.   The Rayleigh test cave significant 
values for the sample points (see page 187).  Table 5-2 shows the results of a 
Mardia-Watson-Wheeler test (page 187) for significant differences in these values. 
Table 5- 2 Results of a Mardia-Watson-Wheeler test between R-wave distributions
The table shows *  indicating significant differences (p<0.05) following Bonferroni correction 
between the MVL of patients and controls and controls and patient compared to Heartsim data (A 
"0" in the table represents a value less than 1.0E-12). 
 Patient v Control Control V Heartsim  Patient v Heartsim 
R-wave position W statistic p value W statistic p value W statistic p value 
R1 9.033 0.001      * 53.434 2.49E-12  * 60.886 0          * 
R2 36.012 1.15E-08 * 23.362 8.45E-06  * 6.563 0.038 
R3 73.828 0             * 39.156 3.14E-09  * 7.281 0.027 
R4 89.816 0             * 48.609 2.78E-11  * 8.029 0.018 
R5 93.057 0             * 51.61 6.12E-12  * 9.388 0.009     * 
R6 57.011 0             * 41.456 9.98E-10 * 13.942 9.4E-04  *
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Limitations to this study 
Whilst the technique used in this chapter to assess HRV does not benefit from 
decades of refinement and review as does power spectral and time domain 
estimates of HRV, the significant differences found using this method of assessing 
the breath by breath variation in HRV demonstrates the proof of principle.   
The rationale for using breath by breath assessment of HRV was involved in trying 
to address some of the problems inherent in power spectral estimates.  Changes 
in power spectral estimates of HRV are reported to be more applicable to the 
underlying physiology (Berger, Saul et al.1989).  Vagal and sympathetic efferent 
activity is modulated by respiration and RSA may be considered to involve both 
branches of the ANS following investigations using transfer function analysis, 
positional change and selective autonomic blockade (Berger, Saul et al.1989;Saul, 
Berger et al.1989b;Taylor, Myers et al.2001). 
Berger (Berger, Saul et al.1989) reports the work of Sayers (Sayers 1973) and 
Akselrod (Akselrod, Gordon et al. 1981) who divided the spectral estimates of 
HRV into bands. HRV regulation occurring at around the 0.1Hz band represents 
arterial baroreceptor modulation and frequencies above 0.15 Hz represent RSA.  
Their work also confirmed the role of vagal modulation in the control of RSA and 
indicated the importance of the sympathetic and angiotensin systems in the lower 
frequency oscillations of HRV. 
It is reported that healthy individuals do not breathe at one set frequency or depth 
and some breaths may occur below 9 breaths per minute (0.15 Hz) or above 20 
breaths per minute (0.33 Hz) (Grossman & Wientjes 1986).  These breathing 
cycles would be outside the typical frequency window of RSA used in spectral 
estimation of HRV and confound conventional estimates.  In attempt to limit these 
issues paced or controlled breathing has been postulated.  However, this also has 
limitations in extracting information about the underlying physiology involved in the 
regulations of HRV, with the mental effort involved in the voluntary control of 
breathing reported to alter the interpretation of the autonomic control of HRV 
linked to respiration (Berntson, Bigger, Jr. et al.1997). 
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By using the variable duration of a breath cycle, represented by the circumference 
of the circle the R-waves are placed on , to investigate changes in HRV may help 
address some of these issues by focusing on all aspects of the ANS activity with 
respect to the respiratory cycle.  This will include parasympathetic and 
sympathetic activity occurring in synchrony with respiration to give estimates of 
HRV constrained by the periodicity of each breath cycle.  By overlaying  the 
variability of each R-wave within each breath cycle (visualised as a series of OHP 
(overhead projector) transparent sheets, each having the R-wave variability per 
breath on it) a picture of the R-wave variability per breath averaged over a set time 
can be established.  The circumference of the circle for each breath is variable and 
represents the duration of the breath cycle. 
The estimates of breathing cycles used here are not ideal.  It would be better to 
measure the start of each breathing cycle using a transducer of some type to 
better monitor this physiological trigger used to sub-divide the spectrum of HRV.  
To some degree the wide limits of agreement found in the estimation process used 
here (see appendix 1.4) may be influenced by the non-regular breathing frequency 
and different depths of breathing described above.  Further refinement to the 
method used to estimate breathing events is required or the use of transducers to 
measure the breathing events directly could be used.  As described previously this 
is difficult in the diseased human and animal populations. 
Further consideration to the measured inspiration event compared to the neural 
initiation of the event may also be needed.  From the empirical evidence presented 
here it was found the mean difference between the measured versus the 
estimated breath event was the estimated breath occurred 0.52 seconds before 
the measured breath event with a 95% confidence interval of 0.62-0.42s before 
the measured breath.  This delay between neural activity in the ANS and the start 
of inspiration is also highlighted in the work of Saul (Saul, Berger et al.1989b).  By 
taking into account this deviation in the start of inspiration it is likely that a different 
subset of HRV is being assessed compared to assessments made with the 
unadjusted inspiration marker (see figure in Appendix 1.9 and sections of the 
discussion).  
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 When we look at the R-R variability within each breath, it can be seen that the 
time between successive R-waves is sub second.  This would imply a frequency 
band in spectral estimates of HRV >1Hz.  Power spectral estimations do not 
normally investigate this high a frequency band.  The technique developed here 
would focus on this R-R variability within a breath.  Consequently it is likely 
different results would be obtained when power spectral estimates of HRV are 
compared to HRV measures derived from circular statistical analysis of R-R 
variability within each breath.  Circular statistics is not widely used but using the 
physiological relevant epoch of breath duration on which to base the division of 
HRV may have utility and be more discriminating when comparing the diseased 
human with controls. 
Figure 5.20 (below), illustrates the differences in assessments using power 
spectral analysis and the concentration of R-waves within breath epochs.  The 
second set of histograms indicates that using circular statistics to obtain estimates 
of the associations of the R-waves within each breath cycle may be better able to 
demonstrate the sequential change in HRV, shown here as an increasing 
concentration or a decreasing variability.  The same trend of reduced arrhythmia 
(lower power in the respiratory band of the FFT) is shown in the upper set of 
histograms.  However, when using concentration to investigate the changing 
autonomic control of the heart, there is a greater range shown for the vCJD 
patients compared to controls.  This association is reversed if power spectral 
analysis is used (shown as the range in the boxplots of figure 5.21).  This may be 
related to the fact that with power spectral analysis there is no distinct breathing 
event, a wide range of breathing frequencies (0.15-0.5 Hz) are used.  With the 
circular statistical method the changing beat to beat variability is calculated for 
each breath and so may give a better representation of the sub second R-R 
variability linked to respiration.   
  
The "zero" concentration values for the controls in figure 5.20 represent the 
degree that the distribution of R-waves deviates from a circle.  Conversely the 
higher values for concentration for the patients represent the R-waves follow a von 
































































































Figure 5. 20  Difference in metrics used to assess HRV.
Histograms indicating differences in metrics used to assess HRV. 
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Figure 5. 21  Difference in range of measures obtained from different methods of calculating HRV. 
Boxplots illustrating the ranges of measures using two metrics of HRV.
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Discussion 
The markers shown in figure 5.16 are estimates of breath events that differ from 
the measured breath events.  However, with further thought about the problem, I 
was trying to assess the neurological control of breathing and its relationship to the 
neurological control of heart rate.  By using a transducer such as the Magtrak and 
a face mask as used here, there is an offset with respect to time, in the breath 
event by the time taken for the neural conduction of breathing initiation and the 
time taken for the muscles involved in the inspiration to contract and finally the 
diaphragm to move and cause a change in airflow.  This sequence will take a 
finite, but small time.  Hence, a difference in the estimated breath event derived 
from neural information and that derived from mechanical external transducers 
would be expected. 
In studies of the sequence of respiratory muscle activation it is suggested that in 
awake humans there is a delay between the onset of muscle activation and 
inspiratory event.  From experiments this delay was found to be around 90ms 
(Strohl, Hensley et al. 1980).  In addition to this delay, further offsets from neural 
initiation of inspiration and the time taken for the inspiratory effort to be measured 
is indicated by the sequence of activation in other muscle groups associated with 
normal breathing in humans.  Upper airway muscles are stimulated preceding the 
activation of the diaphragm muscles.  It is also reported that these upper airway 
muscles take around 400ms to reach their peak activity which is well before peak 
activity of the diaphragm muscles (Patrick, Strohl et al. 1982).  Taken together 
these lines of evidence suggest a delay of around 500ms or half a second from 
neural initiation of a breath to the inspiration event occurring.  To further support 
the idea of a delay between vagal firing and lung inflation, work by Kollai illustrates 
that vagal firing occurred between activity in the phrenic nerve with the vagal 
volley ending approximately 300 ms before the start of phrenic nerve activity 
(Berne, Levy et al. 1998;Kollai & Koizumi 1979). 
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Investigations on cardiac coupling during anaesthesia have revealed a peak 
incidence for the R-wave preceding the breath event (RI-1) and this was found to 
be 0.5 seconds.  The position of this R-wave was found to be the least variable 
compared to the six R-waves assessed following the breath event (Galletly & 
Larsen.1997).  The authors state that they measured the start of ventilatory timing 
by a valve in the breathing circuit (absorption system) hence measured the time to 
airflow change and not the start of neural initiation of the breath.  The arrangement 
and activation of this valve was also stated as causing a small delay in the 
measured event, although in later publications using the same technique, these 
authors state the delay is unlikely to affect the conclusions of their study. 
However, it may be that the RI-1 R-wave was not the preceding R-wave of the 
breath but the first R-wave of the current breath cycle. (The neural initiation of the 
breath actually occurring some 0.5s before).   With these observations in mind the 
results of Galletly et al support the results of this study, namely the first R-wave 
within each breath was the least variable.  If the breath estimates derived here 
were offset by 0.5 second the R-waves were found to show less association (see 
Appendix 1.9).   
Appendix 1.9 illustrates the difference in a measure from a vCJD patient compared 
to that measure with breath events altered by 0.5 seconds.  The mean vector 
lengths obtained by using the estimated breath event versus the estimated event 
time plus 0.5 seconds are shown.  In all cases, the mean vector length for all R-
wave positions was less when the breath estimate was adjusted.  Significant 
differences (p<0.05) between the 3rd, 4th and 5th R-waves are reported from a 
Mardia-Watson-Wheeler test.  This suggests that the R-waves were less clustered 
around a mean value when the estimate was adjusted and therefore less related 
to the breath event. 
Hence the association of this R-wave to the breath event is critical especially when 
the quoted times for R-wave occurrence in relation to this breath event are in the 
hundreds of milliseconds (ms) and the consequences in having an error in the 
order of 500ms may alter the conclusions.  The delay in neural inspiratory 
activation and the measured airflow change may be important. 
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RSA is considered to be the beat to beat change in the heart rate modulated by 
afferent information from lung inflation mediated, often on a sub-second time 
scale, by changing activities of the vagus nerve.  Cardioventilatory coupling (CVC) 
is considered to be distinct from RSA and is considered to be the modulation of 
inspiratory timing by afferent haemodynamic information taking place over many 
seconds.  The result of CVC is said to be a temporal synchronisation of heart 
beats and ventilation.   
Whether the observed physiologically-optimized association seen here is the result 
of each breath being triggered by the heart beat in the preceding breath cycle, as 
suggested by Galletly is debatable.   The time course for the synchronisation of 
RR intervals to breathing is often on the sub-second time scale and the proposed 
method for the control of the CVC is postulated to be from changing afferent 
arterial receptors reflecting haemodynamic change being feedback and integrated 
by higher brain centres and consequently delivered to the heart independently of 
the vagus nerve is not compatible with this time scale (arguments supported by 
Eckberg (Eckberg 2009).   CVC therefore,  may be considered as a separate 
phenomenon with a periodicity of 3-5 seconds mediated by the sympathetic 
branch of the ANS on the SA node (Saul, Berger et al. 1989a) and the size of its 
effect may depend on the breathing rate (Eckberg 2003).  However the 
observations by Galletly et al do suggest a strong concentration of certain R-
waves within each breath cycle similarly to the results presented here.   
With reference to the diagram formulated from ideas by Armour and others (1983-
2003, figure 1.6), the beat to beat associations to ventilatory frequency are likely to 
be the result of complex, integrated and variable neural communication from both 
the parasympathetic and sympathetic branches of the ANS as suggested in the 
work of Taylor (Taylor, Myers et al.2001).   
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In addition, afferent information from pulmonary stretch receptors have 
monosynaptic relays to various areas of the NTS (Berger & Averill.1983).  This 
arrangement and integration of neural information allows the sub-second 
responses that may alter the duration of R-wave intervals in response to changing 
lung inflation. 
The cardiac ganglionated complexes may well be sites which gate the efferent 
outflow that physiologically optimizes the beat to beat variability and respiratory 
event to maximise blood passing by the alveoli air sacs to optimise gaseous 
exchange.  This rapid sub-second change in beat to beat variability being under 
the control of the parasympathetic branch of the ANS and specifically being 
mediated by the vagus nerve.  Consequently, breathing events are inextricably 
linked to the quick change in beat to beat variability of the heart controlled, 
principally by the vagus nerve acting on the SA node.  Again, the distribution of the 
heart beats within each breath epoch being governed by the effect of the neural 
outflow from the intrinsic cardiac ganglia, targeted on the SA node of the heart.  It 
is the presence of these nested neural control loops that may be the site for 
disruption in beat to beat variability caused by the presence of pathological prion. 
This association of R-wave occurrence to breathing events suggests there is a 
progressive decrease in the variability of the R-waves within each breath in 
incubating vCJD patients compared to controls.  It is suggested that these 
observations may be due to perturbation in the function of prion infected neurons 
in the medulla of the infected patient.  Recently, it has been shown that 
components of the auditory evoked potential are disrupted in cattle incubating BSE 
and it is concluded that brainstem nuclei responsible for the evoked potential are 
affected by the presence of disease associated prion (Arai et al. 2009).  Similarly, 
the abnormally folded prion associated with the disease in humans, located in the 
brainstem nuclei responsible for the control of the heart on a beat to beat basis, 
may cause mis-timing in the coordinated control cascade of impulses from the 
brain to the heart.  This would result in perturbation in the physiologically-
optimized heart beat and breath coordination.  The results from incubating human 
subjects shown here suggest there is reduced variation in the dispersion of R-
waves within each breath cycle compared to controls.  This loss of variation 
reflects the lack of coordinated control in optimizing the heart beat with each 
breath.  This fact is emphasised when the degree of variance is compared to the 
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“Heartsim” analysed data which represents an artificial heart rate electronically 
manipulated that has little HRV and consequently little variation in the beat to beat 
measures within the breath epochs (table 5-1). 
In conclusion, this method of analysis may give further insight into the disruption in 
function of the neurological control of the heart.  More conventional metrics of 
HRV, such as high frequency (HF) power investigations, also demonstrate this 
progressive decrement in function associated with disease progression for this 
subject. This trend is echoed in the values for mean vector length and circular 
variance calculated here.  This provides support for the methods used here and 
basing the analysis on the direct relationship between breath and R-wave 
distribution may help identify which brainstem nuclei, at which time point in the 
disease pathogenesis, become infected if recordings could be made early in the 
disease progression.  Putative results from cattle incubating BSE (Pomfrett et al. 
2004) and sheep incubating scrapie (Glover et al. 2007) suggest that measures of 
HRV are able to identify the diseases in preclinical animals.  Consequently this 
and other HRV analysis may provide a useful screen for transmissible spongiform 
encephalopathy (TSE) in animals and humans. 
Applications for this non-invasive repeated measures method of assessing the 
development of prion pathogenesis may have utility in giving objective assessment 
for any putative treatments for prion disease and help manage similar illness.  
Although the numbers of measures analysed here are limited due to the rarity of 
vCJD, testing the method on historic data from cows incubating BSE will give 
support for such analysis.  Other applications for this assessment of the 
decoupling of R-wave with breath event may have utility in assessing the depth of 
anaesthesia or sedation in “routine” procedures in the hospital environment. 
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Chapter 6 Applications of heart rate variability linked 
to respiration  
Introduction 
Victims of variant Creutzfeldt Jakob disease (vCJD) are few in number.  An initial 
study to investigate heart rate variability (HRV) perturbations in patients was a pilot 
study for which the recruitment of subjects was expected to be difficult.  The 
recruitment was limited by the number of people alive with the disease at the time 
of the study (less than 200 in total worldwide had been diagnosed with vCJD at the 
time of data collection) and their, or their relatives, choice to take part in this 
research. 
I reanalysed historical data for this chapter using a purpose-written program to 
interrogate the relationship between heart rate variability and breath events.  This 
analysis was not foreseen at the time of the design of the initial study.  
Consequently, a power calculation based on the data structure used here 
(specifically breath by breath measures of HRV) was not previously performed.   
Heart rate variability is related to heart rate but the relationship may be 
significantly correlated on occasions (Madanmohan, Prakash, & Bhavanani 2005) 
or changes in the beat to beat variation of the heart beat may precede changes in 
the heart rate (Hon & Lee 1963).  Since the assessment of HRV using  the breath 
by breath methods developed in chapter 5 is novel, further validation of the 
expected results would be gained from assessing the relationship between heart 
rate and the specific metric of HRV that assesses the beat to beat variation of R-
waves within each breath cycle.  This would emphasise that the heart rate is 
distinct from the beat to beat variation of R-waves within each breath cycle 
developed in chapter 5 and the derived HRV is not merely an artefact of changing 
heart rates. 
Following on from the concept that the distribution of the R-waves within each 
breath cycle could give a measure of HRV, the prospect of the change in 
distribution being to do with the average heart rate was considered.  It is known 
that when the heart rate increases there can also be an associated increase in 
breathing rate, thus the length of the breath cycle may be reduced at the same 
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time the interval between R-waves is also reduced.  This may result in a similar 
distribution of R-waves for a fast beating heart with increased breathing frequency 
as a slower beating heart and a slower breathing rate, within certain physiological 
limits.    
This association may thus account for changes in heart rate in the analysis of 
changes in HRV in relation to breathing since the interpretation of HRV is based 
on a breath by breath cycle.  An analogy between the speed of a car (the heart 
rate) and the revolutions of the engine (HRV) helps illustrate the link between 
heart rate and HRV.  The relationship between the engine speed and engine 
revolutions, although linked, may change depending on the gear selected between 
engine and transmission.  It is possible for the engine to produce considerably 
more revolutions for a given speed depending on the gearing.  Similarly, HRV may 
have different magnitudes for a given heart rate.  
Research has also demonstrated a change in breath by breath measures of HRV 
during anaesthesia (Pomfrett, Barrie, & Healy 1993).  The areas of the brainstem 
involved in controlling HRV are those areas that anaesthetic agents act on.  The 
nucleus tractus solitarii (NTS) and nucleus ambiguous (NA) are areas of the 
brainstem involved in the regulation of the heart on a beat to beat basis.  It has 
been suggested that anaesthetic agents may perturb inhibitory glycine and 
GABAergic synapses in the NTS and NA (Pomfrett 1999) and GABAergic 
receptors have been shown to mediate vagal inhibition in the NTS of rats (Wang, 
Jordan, & Ramage 2010).   
Thus, there are putative sites where anaesthesia alters the coordinated neural 
output of these brainstem nuclei and consequently affect the regulation of the 
heart on a beat to beat basis consequently altering metrics of HRV.  Furthermore, 
the functional link between the NTS and limbic system may also be affected by the 
action of anaesthesia on the endogenous peptides located in the hypothalamus 
which have been reported to affect the control of cardiac rhythm mediated by the 
vagus nerve (Pokrovsky & Osadchiy 1995).    
Regulatory peptides have also been suggested to produce an effect on 
parasympathetic intrinsic cardiac ganglia located on the heart (Pokrovskii, 
Osadchii, & Kurzanov 1992) and may serve to condition the local neural 
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environment to the flow of descending neural information.  Prions and 
neuropeptides both being proteins, have a potential to change their conformation.  
This change in shape of the protein has consequences on its function.  The region 
of influence for mis-shaped prions may also be at these intrinsic cardiac ganglia, in 
addition to the central influences in the NA and NTS. 
The link between anaesthesia and brainstem nuclei has further been highlighted 
by images from positron emission tomography (PET) of the human brain during 
anaesthesia.  These images demonstrate an association between the right NTS 
and concentration of anaesthetic agent (Pomfrett & Alkire.1999) and consequently 
suggest the anatomical location for the change in  functional synapses causing a 
change in beat to beat regulation of the heart, resultant from anaesthesia. 
PrPc has been demonstrated as a requirement for the proper function of 
hippocampal neurons due to its relationship to GABA mediated neurotransmission 
(Rangel, Madroal et al. 2009).  Early research into prion and synaptic function 
suggested that GABA(A) mediated synaptic function was impaired in PrP null mice 
(Collinge, Whittington et al.1994).  
It has been suggested that the presence of PrPD may interact directly with GABA 
mediated neural transmission in scrapie infected hamsters (Lu, Sturman, & Bolton 
1995).  It is likely that the GABA system in other brain regions would be affected 
by the presence of disease associated prion.  
GABA receptors in the NTS that mediate vagal inhibition, shown to be affected by 
anaesthesia (Wang, Jordan et al.2010), could also be the sites of disruption in the 
homeostatic neural coordination of the heart seen in prion disease (Glover, Pollard 
et al.2007;Pomfrett, Glover et al.2004;Woolfson, Glover et al. 2003).  Thus the 
presence of prion has the potential to affect GABA mediated synapses similarly to 
the action of anaesthetic agents.  The extent and signature of the effects may be 
different.  However, both have the potential to disturb the normal function of such 
synapses that could result in a perturbation in the neural output with a consequent 
change in the action on the target organs.  Specifically, the GABA-mediated 
synaptic coordination of neurons of the NTS, affected by anaesthesia, could also 
be the sites of change in the control of the heart on a beat to beat basis observed 
as a result of prion infection. 
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A recent publication has demonstrated that an observed cardiac dysfunction in the 
early stages of Parkinson’s disease is due to the parasympathetic branch of the 
ANS and not the sympathetic branch (Buob, Winter et al.2010).  This echoes the 
ideas expressed here in that early dysfunction in cardiac regulation, due to change 
in parasympathetic activity, may be a clue to burgeoning gross neurological 
disease.  Other research has also described a change in parasympathetic 
functions that appears concurrent with sympathetic denervation (Shibata, Morita et 
al.2009).  This difference in the findings of Buob and Shibata may be due to 
Parkinson’s disease patients being studied at different stages of the disease 
progression.  The difference in balance between the two branches of the 
autonomic nervous system showing different relationships at different times of the 
diseases course.  This would echo the observations and suggestions made in this 
thesis of changing autonomic balance in prion diseases.  Suggestions about prion 
and Parkinson’s disease have also been mooted.  It was stated that the 
accumulation of the aggregated mutant proteins responsible for the disease (one 
of which is -synuclein) are first seen in the dorsal motor nucleus of the lower 
brainstem and frequently detected in plexi of the autonomic nervous system 
associated with the gastrointestinal tract in preclinical cases of Parkinson’s 
disease (Olanow & Prusiner.2009).  Consequently, parallels between cardiac 
dysfunction in vCJD and Parkinson's disease can be drawn and early changes to 
the control of the heart on a beat to beat basis may be a common but subtle 
observation in the progression of both of these neurological diseases. 
The aims of this chapter are to validate the algorithm developed in chapter 5.  By 
inspection of the results comparing changes in HRV between vCJD patients and 
healthy controls, R-wave variability between successive R-waves in a breath are 
compared for differences.  The effect of heart rate on this measure of HRV is 
investigated and the algorithm is applied to patients undergoing anaesthesia to 
see if the changes in HRV are as reported in the literature. 
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METHODS: Considerations involved in the application of HRV linked to 
respiration 
Methods 1: Assessment of ability to distinguish R-wave distributions within 
a breath 
Using the data from chapter 5, derived from R-waves within each breath epoch, 
and looking at the change in the angular direction of the resultant vector from 
circular statistical analysis, it was noted that the 5th R-wave in the breath cycle was 
at the point in the breath cycle that demonstrated a turning point in the pattern of 
mean vector length (figure 5.19).   
The mean angular vector for each of the R-waves equates to the time the R-wave 
occurs from the start of the breath event.  The circle, in the circular statistical 
analysis, represents the duration of the breath cycle.  An average breath cycle 
from these data suggests this to be around six seconds (50 breaths in a 300 
second sampling window equates to an average breath duration of 300/50=6 
seconds).  Consequently, using the data from the summary circular statistics 
performed on data from chapter 5 (shown in table 6-2) we can calculate that for 
the 5th R-wave having a mean vector angle of 246 degrees for control data and a 
mean vector angle of 183 degrees for patients,  the 5th R-wave in controls occurs 
at around 4.10 seconds after the breath and for patients this value is 3.06 
seconds. (given by equations 1 and 2 below) 
For controls time of 246/360 x 6000 ms = 4100 ms    Equation 1 
For patients time of 183/360 x 6000 ms = 3055 ms  Equation 2 
The next stage of the investigation would be to use a greater number of breath 
epochs to see if the distinction still held up.  Since the number of vCJD patients 
involved in the initial study was small (n=4), all of the data was included and a 
similar number of data files from controls was also analysed in the same manner.    
216
Around 900 breath epochs from 17 vCJD measures from 4 patients and 900 
breath epochs from 19 measures from 19 controls were analysed to see if the 
association in the distribution of R-waves within the breath epoch still 
demonstrated the differences previously seen.  The 300 second samples of ECG, 
from both controls and vCJD patients, contained around 50 breath cycles in each 
300 second sample. Consequently 17 samples each of 300 seconds gave 850 
breath cycles to analyse (17 x 50 =850).  Similarly around 950 breath cycles from 
control subjects were used (19 x 50 =950). 
The controls for this investigation were screened for abnormal blood pressure and 
BMI and did not take any medication thought to affect heart rate variability.  These 
assessments were overviewed by a small team of health care professional which 
was a mix of clinical scientists, nurses and consultant anaesthetists.  The mean 
heart rate for the controls was 67.9  beats per minute and that of vCJD patients 
was 84.2 beats per minute. 
Methods 2: Investigating the effects of heart rate on distribution of R-waves 
within each breath 
A question still remained as to extent the distribution of the R-wave events was 
linked to heart rate.  The average R-wave events in each breath for controls and 
patients were calculated (see table 6-1) and found to be 6.5 and 7.8 for controls 
and patients respectively.  Thus, increased heart rate resulted in around one extra 
R-wave event in each breath cycle for the patient data compared to control data. 
217
Table 6- 1 Number of R-waves and breaths for control and patient data. 
  
 Control (17 
measures) 
 Patient (19 
measures) 
R-wave count 326.9  381.4 
Breath count 50.3  48.9 
R-waves per 
breath 
6.5  7.8 
Thus there are approximately 7 and 8 R-waves within each breath cycle for 
controls and patients respectively. This average was derived from around 900 
breath cycles from 17 patient and 19 control files of 300 seconds of ECG. 
Further differences between the control and patient data become apparent if the 
measured distributions of R-waves for each group are compared to a model 
distribution for each group derived from the average number of beats per breath 
cycle.  Separate models of R-wave distributions were constructed for patient and 
control data.  The duration of the breath represented the circumference of the 
circle for the model.  The standard positions of 7 and 8 R-waves for patients and 
controls was calculated by allowing for a typical offset of 20 degrees, to represent 
the average delay of the first R-wave following the breath and then dividing the 
remaining angular space of the circumference (360-20 degrees) into equal 
segments (for controls this was 340/7=48.5 degrees and for patients 340/8=42.5 
degrees). The rest of the circle, corresponding to the remaining breath epoch, then 
had a R-wave placed at these standard angular intervals as listed in the table 
below (table 6-9).   
To investigate the extent the distribution of R-waves within each breath cycle was 
associated to the heart rate (HR), the mean vector length (MVL) and mean vector 
angle (MVA) were inspected.  A scatter plot of MVL and MVA for controls and 
patients was plotted to illustrate the relationship between these indices of HRV 
and HR.  A one sample Kolmogorov-Smirnov test, to test for normality, was 
performed on the values of MVL and MVA using SPSS v 16, followed by the 
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calculation of the correlation coefficients. These correlation coefficients were then 
compared using  the " Fishers Z transformation " method as detailed in Gardner 
(Gardner & Altman 1989).  This transformation results in the calculation of the 95% 
confidence intervals for the correlation coefficients.  A statistical test between the 
correlation coefficients was also performed (Preacher 2002). 
Example of the method of Z transformation of the correlation coefficient to obtain 
95% confidence intervals. 




z1 = 0.5081 -   and   z2= 0.5081 + 
z1 =  0.0327   and  z2=  0.9835 
The values of z1 and z2 need to be transformed back to the original scale to give 
the confidence interval for the correlation coefficient.  This is given by: 
   to   
0.0327             to   0.7546 
So the correlation coefficient for r is given by 
r = 0.638 with a 95% confidence interval of 0.0327 to 0.7546. 
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Methods 3: Using the effect of anaesthesia on HRV during each breath cycle 
and comparing  to prion disease 
To investigate the theory that a change in the control of the heart on a beat to beat 
basis may be observed in anaesthesia as well as prion diseases, the same 
analysis techniques used previously in this chapter were performed on data from 
patients undergoing anaesthesia.  Data was analysed by comparing the 
distribution of R-waves within each breath cycle before and during anaesthesia. 
Around 400 breaths from 10 patients were analysed using the same technique of 
applying the purpose written script to 300 seconds of ECG data previously 
described in chapter 4.  This historic data was obtained as part of another study 
carried out in 2000 to 2002 to investigate Delta Sleep Inducing Peptide (DSIP) 
(Pomfrett, Dolling et al. 2009) and data was obtained following written informed 
consent and approval of the protocol by the Central Manchester local ethics 
committee.  The data chosen for the analysis performed in this chapter was from 
control subjects of the DSIP trial to exclude any effects from the administered 
pharmacology that was part of the investigation.  All files were from female ASA 1 
or ASA 2  patients undergoing minor elective surgery and received routine 
anaesthesia for surgery.  The ASA (American Society of Anesthesiologists) scale 
is a classification system used to assess individual's physical fitness  before 
surgery.  It has six categories ranging from ASA 1 to ASA 6, with ASA 1 
representing normal healthy patients with no organic, physiologic, or psychiatric 
disturbance. Healthy with good exercise tolerance.   ASA 2 patients are classed as 
having mild systemic disease but no functional limitations and have well-controlled 
disease of one body system for example, controlled hypertension or diabetes 
without systemic effects. 
Similarly, data for patients undergoing procedural sedation for endoscopic 
investigations was obtained as part of a previous study.  Sedation was achieved 
by administration of midazolam.  Data was recorded for a baseline measure before 
the procedure for at least five minutes, during the procedure and for at least five 
minutes following the procedure in recovery.  Data was collected in accordance 




Results 1: Assessment of ability to distinguish each R-wave within a breath 
Summary statistics for 5th R-
wave Control Patient
Number of Observations 141 144
Mean Vector (µ) 246.013° 183.283°
Length of Mean Vector (r) 0.69 0.838
Median 240.921° 185.13°
Concentration 1.945 3.427
Circular Variance 0.31 0.162
Circular Standard Deviation 49.375° 34.014°
Standard Error of Mean 4.165° 2.817°
95% Confidence Interval (-/+) 
for µ 237.847° 177.761°
 254.179° 188.805°
99% Confidence Interval (-/+) 
for µ 235.281° 176.026°
 256.744° 190.54°
Table 6- 2 Summary statistics for the 5th R-wave in around 140 breaths from Controls and  vCJD 
patients. 
This is from the same data tabulated in table 5-1.  It represents data from 3 controls compared 
against 3 measures from one vCJD patient over time.
Some statisticians suggest it may be more useful to quote the confidence intervals 
(CI) for the mean after data has been collected rather than calculate the power of 
the study (Swinscow & Campbell 2002).    In addition any results of a power 
calculation would be confounded by the difficulty in recruitment of vCJD patients 
and the number of these patients alive at any one time.  Consequently the sample 
size would be dictated by the availability of vCJD subjects.  By considering the 
confidence intervals (CI), we may say that, with a 99% chance of being correct, 
that the CI range includes the population mean.  For this data the values of the 
mean vector angle for the 5th R-wave and ranges are given by: 
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Control mean is 246.013 with 99% CI of the mean is 235.281° to 256.744° 
Patient mean is 183.283 with 99% CI of the mean is 176.026° to 190.54° 
  
By observation of the values in table 6-2, derived from around 140 constituent R-
waves, it may be seen that the 5th R-wave for controls shows less concentration 
and shows greater circular variance than the data from vCJD patients.  It may also 
be seen that the mean vector angle for the 5th R-wave differs by around 60 
degrees. 
Table 6-3 shows the differences between the mean vector angles for the first 6 R-
waves within a breath (obtained from analysis of the data in chapter 5, tabulated in 
table 5-1, analysed in the same manner as the analysis for the 5th R-wave).  
These values are based upon the mean values from all the data.  The mean vector 
angle equates to the mean position of the R-wave in an average breath cycle. 
Table 6- 3 Mean vector angles and associated time estimates of R-wave events within a breath cycle. 
R-wave 
position 


















0.446 1.366 2.286 3.197 4.100 4.711
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By inspection of the values in table 6-3, we can see that each R-wave is separated 
by at least 0.5 second from R-waves on either side of it.  Hence a difference of 30 
degrees in the mean vector angle equates to a time difference of 0.5s (30/360 x 
breath epoch, 6s). Thus using 30 degree displacement in the mean vector angle of 
the 5th R-wave suggests that it should not be confused with adjacent R-waves. 
Table 6-4 illustrates a difference in the position of the 5th R-wave within each 
breath cycle exists between more vCJD patient data compared to controls (using 
around 900 breaths from controls and patients). 
Table 6- 4 Statistics from all the 5th R-waves  to compare with table 5-1. 
  
Variable Angles Angles 
Subgroup Control patient 
Number of Observations (breath epochs) 890 870 
Mean Vector (µ) 236.773° 197.342°
Length of Mean Vector (r) 0.720 0.766 
Median 234.468° 195.368°
Concentration 2.141 2.499 
Circular Variance 0.280 0.234 
Circular Standard Deviation 46.393° 41.872° 
Standard Error of Mean 1.547° 1.404° 
95% Confidence Interval (-/+) for µ 233.740° 194.589°
239.805° 200.095°
99% Confidence Interval (-/+) for µ 232.788° 193.724°
240.757° 200.96° 
Kuiper's Test (von Mises, V) 1.807 1.425 
Kuiper's Test (p) < 0.05 > 0.15 
This table shows greater clustering of R-waves for patient data for the 5th R-wave. 
The 5th R-wave from control data demonstrates a greater variance and less 
concentration around its mean position.  The trend for these data is the same as 










































A Kuiper's test for a von Mises distribution compares the measured data to a 
theoretical distribution equating to a normal linear distribution (von Mises 
distribution for circular statistics is the equivalent of a normal distribution in linear 
statistics).  The large value of V and significant p value for the control data 
suggests that the null hypothesis is rejected.  Hence, the test distribution does not 
fit a von Mises distribution.  Conversely this statistic also suggests the R-waves for 
patients do fit a von Mises distribution.    There is a statistically different 
distribution in the 5th R-wave within a breath between controls and vCJD patients.  
This is illustrated in figure 6.1. 
Figure 6. 1 Distributions of constituent R-waves for controls and patients. 
Scale denotes number of R-waves.  Arrowed lines denote mean vector angle and 
length. The number of R-waves within each bin is represented by the amplitude of 
each ring. 
Figure 6.1 illustrates the distribution of around 900 R-waves that contribute to the 
mean vector length and angle data in table 6-2.  Note the difference in shape of 
the circular distributions for controls and patients (not a von Mises distribution and 
a von Mises distribution for controls and patients respectively. von Mises 
distributions are depicted in figure 5.12). 
When all of the R-wave positions are compared in a similar fashion, the results are 
summarized in table 6-5 and 6-6 and graphically displayed in figure 6.2.  Figure 
6.3 represents the summary distributions of these R-waves along with the 
summary statistics for the cart wheel plots of figure 6.3, shown in table 6-7.  The 
change in circular variance between successive R-waves for control and vCJD 
patient data is shown in figure 6.4. 
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Controls       
Mean HR 67.875       
R-wave position 1 2 3 4 5 6 
Number of Observations 899 899 899 899 890 779 
Mean Vector (µ) 26.273° 80.075° 133.350° 185.664° 236.773° 278.328°
Length of Mean Vector (r) 0.961 0.931 0.876 0.801 0.720 0.733 
Median 25.605° 78.85° 131.675° 183.814° 234.468° 278.412°
Concentration 12.631 7.562 4.341 2.869 2.143 2.226 
Circular Variance 0.040 0.069 0.124 0.199 0.282 0.267 
Circular Standard 
Deviation 16.462° 21.609° 29.458° 38.213° 46.393° 4 5.198° 
Standard Error of Mean 0.549° 0.723° 0.980° 1.261° 1.547° 1.607° 
95% Confidence Interval 
(-/+) for µ 25.197° 78.663° 131.429° 183.192° 233.740° 275.177°
 27.349° 81.486° 135.271° 188.135° 239.805° 281.479°
99% Confidence Interval 
(-/+) for µ 24.859° 78.219° 130.826° 182.415° 232.788° 274.187°
 27.687° 81.932° 135.874° 188.912° 240.757° 282.469°
Kuiper's Test (von Mises, 
V) 3.404 1.704 1.528 1.767 1.807 1.895 
Kuiper's Test (p) < 0.01 
0.10 > p 
> 0.05 > 0.15 < 0.05 < 0.05 < 0.025 
Table 6- 5 Circular statistics for 6 R-waves from control data 
vCJD Patients       
Mean HR 84.206       
R-wave position 1 2 3 4 5 6 
Number of Observations 873 873 873 873 870 861 
Mean Vector (µ) 21.261° 65.499° 109.551° 153.516° 197.342° 240.661°
Length of Mean Vector (r) 0.971 0.946 0.900 0.836 0.766 0.694 
Median 19.802° 62.878° 107.847° 151.889° 195.368° 238.977°
Concentration 17.671 9.601 5.279 3.389 2.499 1.971 
Circular Variance 0.029 0.054 0.100 0.164 0.234 0.306 
Circular Standard 
Deviation 13.832° 19.018° 26.336° 34.262° 41.872° 4 8.956° 
Standard Error of Mean 0.468° 0.643° 0.89° 1.152° 1 .404° 1.669° 
95% Confidence Interval 
(-/+) for µ 20.342° 64.238° 107.807° 151.258° 194.589° 237.389°
 22.178° 66.76° 111.296° 155.774° 200.095° 243.934°
99% Confidence Interval 
(-/+) for µ 20.054° 63.842° 107.259° 150.548° 193.724° 236.361°
 22.466° 67.156° 111.844° 156.483° 200.96° 244.962°
Kuiper's Test (von Mises, 
V) 3.769 2.752 2.025 1.505 1.425 1.338 
Kuiper's Test (p) < 0.01 < 0.01 < 0.01 > 0.15 > 0.15 > 0.15 
   

































































































































Figure 6. 2  Circular representations of the constituent R-waves contributing to 
the summary data presented in table 6-7. 
R-wave No. 1 
R-wave No. 2 




















































































































Figure 6.2 continued. 
R-wave No. 4 
R-wave No. 5 






















































































































































































































































































































































































      
Table 6- 7 Summary statistics for  Cartwheel plots of figure 6.3. 
Figure 6. 4  Plot of Circular Variance against R-wave position for control and vCJD 
patient data. 
Variable Control Patient 
Number of Observations 6 6 
Mean Vector (µ) 167.226° 131.682°
Length of Mean Vector (r) 0.174 0.333 
Median 185.66° 131.535°
Concentration 0 0.233 
Circular Variance 0.826 0.667 
Circular Standard 
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Circular variance is given by 1-r, where r is the mean vector length.  Table 6-8 
gives the results of the Mardia-Watson-Wheeler tests for differences in the 
distributions of the R-waves for controls and patients for the data in figure 6.4.  
Significant differences between patient and control data were found for all R-wave 
positions (based on around 900 R waves at each R wave position).   A zero 
indicates a p value less than 1.0E-12. 
This distinction in R wave distributions between controls and vCJD patients is 
supported by the discrete 99% CI of the mean vector in tables 6-5 and 6-6. 
R-Wave Position W statistic P value 
R1 31.601 1.37E-07 
R2 111.657 0 
R3 179.123 0 
R4 182.409 0 
R5 179.767 0 
R6 137.153 0 
Table 6- 8 To show significant differences between control and patient data 
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Results 2: Investigating the effects of heart rate on distribution of R-waves 
within each breath 
The investigation of the effects of heart rate on this measure of HRV described in 
the methods section resulted in the following models of R-wave distributions for 
controls and patients. 
Table 6- 9  Values for model R-wave distributions for patients and controls. 
The circular representation of the model R-wave distributions are shown in figure 
6.5 and compared to the measured R-wave distribution within each breath in figure 
6.6.  It may be seen that the model distribution is a better fit to the measured 
distribution from patient data than control data.  The model data is derived from a 
simple mathematical progression for the R-waves.  From table 6-10 and figure 6.6 
the variation in the R-wave incidence within each breath is less and closer to the 
model distribution for patient data than for control data.  This suggested the simple 
invariant model represented the patient’s data better than the control data. 
R-Wave Position 





R1 20 20 
R2 68.5 62.5 
R3 117 105 
R4 165.5 147.5 
R5 214 190 












































































































































































































































































































































































































































































































Circular Statistics for Model data   
Variable control patients 
Number of Observations 6 6 
Data Grouped? No No 
Mean Vector (µ) 141.25° 126.25° 
Length of Mean Vector (r) 0.23 0.365 
Median 141.25° 126.25° 
Concentration 0 0.358 
Circular Variance 0.77 0.635 
Circular Standard Deviation 98.254° 81.366° 
Standard Error of Mean ***** 64.707° 
95% Confidence Interval (-/+) for µ ***** 359.399° 
***** 253.101° 
99% Confidence Interval (-/+) for µ ***** 319.553° 
***** 292.947° 
Circular Statistics for Measured data   
Variable Control Patient 
Number of Observations 6 6 
Data Grouped? No No 
Mean Vector (µ) 167.226° 131.682° 
Length of Mean Vector (r) 0.174 0.333 
Median 185.66° 131.535° 
Concentration 0 0.233 
Circular Variance 0.826 0.667 
Circular Standard Deviation 107.225° 84.999° 
Standard Error of Mean ***** 83.938° 
95% Confidence Interval (-/+) for µ ***** 327.13° 
***** 296.235° 
99% Confidence Interval (-/+) for µ ***** 275.441° 
***** 347.924° 
***** indicates that a result could not be calculated  
    
Table 6- 10 Control and patient summary circular statistics for measured and model values. 
From data in figure 6.6 
The differences in the R-wave positions for the model and measured distributions 
are shown in figure 6.8.  The differences are shown as boxplots in figure 6.7.   The 
control data displays a greater median value for the differences and a larger range 
in the differences than for the patient data set.  Conversely, the patient data 
displays a smaller median difference between measured and model incidence and 
a smaller range of differences.  This helps to illustrate the simple mathematical 
model fits the measured values for the R-wave distributions for patients. 
The relationship between the mean vector length (MVL) and mean vector angle 
(MVA) and heart rate are shown in figure 6.9.  (MVL and MVA variables 
(dependent) against heart rate (independent))  Correlation coefficients were 
calculated in SPSS  and are tabulated in table 6-12.  Tables 6-13 and 6-14 show 
the relationship between these correlation coefficients. 
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Figure 6. 7 Differences between measured R-wave position and model R-wave 
position. 
Boxplot to show differences between measured R-wave position and model R-wave position for 
controls and patients. Note there is less deviation from the model R-wave positions in patients 
compared to controls.   
The spacings between the different parts of the box in the boxplot help indicate the degree of 
dispersion and skewness in the data.  The box is defined by the first and third quartile and the 











































































































































































































































Difference between model and measured R-wave angular position 
(degs)
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Table 6- 11 Table of statistics for the distributions of the differences in R-wave position for measured 
and model values. 
Descriptive Statistics
N Range Minimum Maximum Mean 
Std. 
Deviation Variance Skewness Kurtosis 
Statistic Statistic Statistic Statistic Statistic
Std. 







6 18.01 6.28 24.29 16.5308 2.69117 6.59199 43.454 -.648 .845 -.436 1.741
Patient 
Difference 
6 7.23 .98 8.21 4.7008 1.11688 2.73577 7.484 -.097 .845 -1.315 1.741
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Table 6- 12 Table of  correlation coefficients for MVL and MVA variables 
 (dependent) against heart rate (independent)  
Controls
Correlations
HR MVL MVA 
HR 
Pearson Correlation 1.000 .948** -.838**
Sig. (2-tailed) .000 .000
N 19 19 19
MVL 
Pearson Correlation .948** 1.000 -.812**
Sig. (2-tailed) .000 .000
N 19 19 19
MVA 
Pearson Correlation -.838** -.812** 1.000
Sig. (2-tailed) .000 .000
N 19 19 19
**. Correlation is significant at the 0.01 level (2-tailed). 
Patients 
Correlations
HR MVL MVA 
HR Pearson Correlation 1.000 .638** -.643**
Sig. (2-tailed) .006 .005
N 17 17 17
MVL Pearson Correlation .638** 1.000 -.993**
Sig. (2-tailed) .006 .000
N 17 17 17
MVA Pearson Correlation -.643** -.993** 1.000
Sig. (2-tailed) .005 .000
N 17 17 17
**. Correlation is significant at the 0.01 level (2-tailed) 
N represents the number of data files analysed for controls and vCJD patients. 
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Table 6- 13 Table of  95 % confidence  intervals for correlation coefficients for MVL and MVA 
variables (dependent) against heart rate (independent) 





Lower interval Upper interval 
Control HR vs 
MVL 
0.948 0.877 0.979 
Control HR vs 
MVA 
0.838 0.644 0.931 
Control MVL vs 
MVA 
0.812 0.594 0.919 
Patient HR vs MVL 0.638 0.033 0.755 
Patient HR vs 
MVA 
0.643 0.280 0.845 
Patient MVL vs 
MVA 
0.993 0.982 0.997 
Table 6- 14 Table of  differences between correlation coefficients 









Z Statistic P value 
HR vs MVL 0.638 0.948 -2.888 0.003 
HR vs MVA 0.643 0.838 -1.233 0.218 
MVL vs MVA 0.993 0.812 -4.626 0.000 
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Results 3: Investigating the effect of anaesthesia and sedation on the beat to 
beat variation of the heart during each breath cycle and comparisons to 
prion disease 
In a similar fashion to previous analysis of HRV variables performed in this 
chapter, R-wave distributions within each breath were compared before and during 
anaesthesia and these associations compared to R-wave distributions from 
patients with vCJD. 
Figure 6.10  illustrates the difference in MVL for 6 R-waves within a breath cycle 
for Controls, anaesthetised patients and vCJD patients.   
From table 6-15, the Mardia-Watson-Wheeler test on the distributions of the R-
waves within a breath suggests there are significant differences identified in the 
first 6 R-waves of a breath between people before and during anaesthesia.  The 
mean vector length (MVL) of the anaesthetised patients is less than their MVL 
before (controls) for all R-wave positions.   
This reduction in MVL during anaesthesia has previously been reported (Blues & 
Pomfrett.1998;Pomfrett.1995;Pomfrett, Sneyd et al.1994) although the relationship 
between successive R-waves within the breath to the start of the breath was not 
investigated.  This agreement in the trend in HRV during anaesthesia helps 
validate the developed and applied algorithm. 
Tables 6-6 and 6-7 indicate the distribution of R-waves are significantly different 
when vCJD patients are compared to people before anaesthesia( table 6-6).  Only 
the first R-wave position in a breath does not show a significant difference.  vCJD 
patients also have a significantly different distribution in all the R-waves within a 
breath  compared to people undergoing anaesthesia, table 6-7. (A zero in the 






















































































































































































































































































































































































Table 6- 15 Table of differences in R-wave distributions within a breath before and during anaesthesia
R-wave position W statistic p value 
R1 12.472 0.002       * 
R2 46.824 6.80E-11  * 
R3 63.883 0              * 
R4 67.299 0              * 
R5 85.862 0              * 
R6 116.634 0              * 
Table 6- 16 Table of differences in R-wave distributions within a breath before anaesthesia and vCJD 
patient 
R-wave position W statistic p value 
R1 2.079 0.354         
R2 12.132 0.002      * 
R3 24.785 4.15E-6   * 
R4 41.176 1.14E-09 * 
R5 63.858 0              * 
R6 79.297 0              * 
Table 6- 17 Table of differences in R-wave distributions within a breath during anaesthesia and vCJD 
patient 
R-wave position W statistic p value 
R1 14.062 8.84E-04 * 
R2 55.979 0             * 
R3 79.956 0             * 
R4 87.321 0             * 
R5 86.914 0             * 
R6 70.880 0             * 
* in the tables indicates a significant difference following Bonferroni correction
Data from patients undergoing anaesthesia and sedation were compared to control 
subjects and people with vCJD.  This comparison relied upon assessing HRV within 
each breath cycle.  Figure 6.11 illustrates the variability in successive R-waves within 
each breath.  Between 100 and 800 breaths were used to gain estimates for the 
variability in the R-waves. 
243
Similar analysis from people undergoing sedation are able to suggest the 
effectiveness of sedation during a procedure.  Figures 6.12 and 6.13 represent this.   
Significant differences (following Bonferroni correction) are indicated in the tables 
(tables 6-18 to 6-21) by *.  Data for figure 6.13 representing inadequate sedation was 
from a patient reported to be non-compliant to the procedure and the procedure was 



































































































































































































































































































































































































































































































































































































































































































































































0 1 2 3 4 5 6 7
Before Sedation HR 84
During sedation HR 122
After sedation HR 91
Figure 6. 12  Example of good sedation. 
                     R-Wave position in breath cycle 
Figure 6. 13  Example of possible inadequate sedation 












0 1 2 3 4 5 6 7
Before sedation HR 84
During sedation HR 104






























Table 6- 18 Table of differences in R-wave distributions within a breath for patient in figure 6.13 
before and after sedation 
R-wave position W statistic p value 
R1 1.646 0.439 
R2 1.397 0.497 
R3 4.095 0.129 
R4 4.262 0.119 
R5 5.255 0.072 
R6 5.228 0.073 
Table 6- 19 Table of differences in R-wave distributions within a breath for patient in figure 6.13 
before and during sedation. 
R-wave position W statistic p value 
R1 11.261 0.004       * 
R2 35.375 2.08E-08  * 
R3 60.836 0              * 
R4 69.239 0              * 
R5 71.449 0              * 
R6 72.083 0              * 
Table 6- 20 Table of differences in R-wave distributions within a breath for patient in figure 6.14 
before and after sedation 
R-wave position W statistic p value 
R1 0.883 0.643 
R2 0.002 0.999 
R3 1.584 0.453 
R4 3.684 0.158 
R5 5.584 0.045 
R6 7.013 0.030 
Table 6- 21 Table of differences in R-wave distributions within a breath for patient in figure 6.14 
before and during sedation 
R-wave position W statistic p value 
R1 3.29 0.193 
R2 0.930 0.628 
R3 1.330 0.514 
R4 1.223 0.543 
R5 4.004 0.135 
R6 5.906 0.052 
* in the table indicates a significant difference following Bonferroni correction 
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Limitations 
In relation to the comparisons of vCJD data with data from other groups used in 
this study, the vCJD patient data contained repeated measures from only 4 
individuals.  These 4 vCJD patients were at different times in the stage of disease 
incubation.  The time of death from the last data measured, ranged from 2 weeks 
to eight years.  There is evidence from previous chapters that there may be a 
decrement in HRV measures with respect to time, for vCJD patients incubating the 
disease.  Evidence from cattle suggests a perturbation in measures of HRV may 
be apparent in pre-clinical animals incubating BSE.  For these reasons the 
repeated measures for all the vCJD patients were included in the analysis so as 
not to use extremes of data.  HRV has better intravariability than intervariability 
(Jira, Zavodna et al.2010;Kobayashi 2007) but this information comes from studies 
of healthy individuals.  Given the evidence of changing HRV in animals and 
humans incubating TSE diseases this relationship may not hold true for diseased 
subjects.  Further studies in clinical populations are required (Sandercock, 
Bromley et al.2005). 
The control data for part of this analysis came from 10 individuals undergoing 
minor elective surgery with no gross changes from normal values of blood 
pressure nor BMI.  These individuals were then the same subjects that were 
anaesthetised.  The control data and data from anaesthetised subjects 
consequently had the same confounding physiological co-variates (such as blood 
pressure and BMI.  Blood pressure would have been monitored and controlled 
during anaesthesia to be maintained at the normal value for that individual).  The 
vCJD patients were not monitored constantly for changes in blood pressure but 
were screened before and after data collection for changes in their blood pressure.  
No gross changes were noted.  Patients undergoing anaesthesia were ventilated 
using a respiratory pump.  It is noted that this may have influence on the 
calculation of HRV per breath since the "natural" breathing rate is obscured (see 
discussion in relation to the work of Blues and Pomfrett 1998). 
Although significant differences between the groups was found the numbers of 
individuals in the various groups was small.  For vCJD patients this was a function 
of the small number of patients diagnosed with the disease and difficulty recruiting 
subjects.  Future work in this area could include investigations of sCJD patients 
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and comparisons to the data collected and analysed for this study.  In addition 
other physiological co-variates could be more tightly controlled in this future study. 
Discussion 
From figure 6.6 which overlays the measured and model distributions of R-waves 
within each breath, the measured distribution (shown in blue) from vCJD patients 
fit the model R-wave events (shown in red) better than the controls.  This is 
indicated by the relatively small departure between the red and blue lines for the 
patient distribution of R-waves and by the similar length and direction of the 
resultant mean vectors for both model and measured distributions, shown as 
arrows in the diagrams.  In addition to the observations stated, analysis of the 
distribution of the 800-900 R-waves that make up each R-wave estimate for each 
R-wave position, demonstrates that the circular variance is greater for controls 
than for patient’s R-waves for the first 5 R-wave events in each breath (see tables 
6-5 and 6-6).   
The 6th R-wave for the controls differs in that there is a significantly different  
increase in MVL to a value higher than that of the vCJD patients 6th R-wave as 
shown in figure 6.9 and table 6-16.  This “kick” in the graph of the MVL from 
control R-waves may be the result of greater neural control at this point in the 
breath cycle, increasing the link between the breath cycle and R-wave event, 
hence increasing the clustering of R-waves around a mean value, which is not 
seen in the patient data.   
The degree that the measured R-wave distribution matches the model one is 
illustrated by the percentage change seen in the Mean Vector Length (MVL) and 
Mean Vector Angle (MVA) of the summary cartwheel plots.   
From table 6-10; 
Control MVL change of 0.056 in 0.230 = 24% change 
Patient MVL change of 0.032 in 0.365 =   9% change 
Control MVA change of 26 deg from 141 deg = 18% change 
Patient MVA change of   5 deg from 126 deg =   4%  change 
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Thus there is a greater change in both MVL and MVA between the measured and 
model distribution for controls than there is for the patient data sets.  In this way, 
the patient’s distribution of R-waves within the breath demonstrates little variation 
from the model containing a prescribed pattern of R-waves.  This is reminiscent of 
the observations from chapter 4 when longitudinal vCJD data was compared to 
data from a heart simulator.  In this instance the variation in metrics of HRV were 
comparable to the simulator, again demonstrating a mechanistic pattern to the 
heart beat in relation to each breath, without the normal speeding and slowing of 
heart rate within the breath cycle thus demonstrating changed respiratory sinus 
arrhythmia compared to controls. 
By examination of the differences between the measured and estimated R-wave 
events, distinctions between controls and patients can be seen.  The box plot in 
figure 6.7 shows the range of differences is larger in the control group and also the 
median difference is greater for controls.  The associated values of skewness and 
kurtosis are given in table 6-11 along with the variances for the two groups.  The 
differences for the patients show a distribution that has greater kurtosis with less 
variance.  This suggests the measured and calculated positions of the R-waves 
are similar for patient data, with smaller deviations from the model values. 
From the plot of the differences in R-wave positions shown in figure 6.8, it can be 
seen that the control values show a greater and increased rate of change for the 
differences between the measured and model R-wave values compared to similar 
patient data.  Consequently the first few R-waves within the breath cycle display a 
smaller variation from the simple model values with the latter R-waves showing a 
greater variation from the model values.  Although this trend is seen in the vCJD 
patient data, the extent of the deviation from the model values are greatly reduced.  
It may be that in the control data sets, the increased variation from the simplistic 
model data observed is the result of complex integrated neurological control using 
feedback and feed forward communication to alter the heart beat to the breathing 
event, as seen in respiratory sinus arrhythmia.  This variation within the breath is 
greatly reduced in vCJD patients possibly due to an alteration in the synchrony of 
neurological control resultant from prion infection and altered synaptic function in 
areas of the brainstem specifically involved in the regulation of the heart on a beat 
to beat basis.
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Different types of coupling are described by Archie (Archie, Jr. 1981).  They are 
mathematical, functional, algebraic and physiological coupling.  The author 
highlights problems with one component containing all or parts of the other 
component of interest.  Heart rate was measured as beats per minute and MVL 
and MVA were calculated via a separate route using beat positions per breath.  
This method of deriving the components of interest helped minimise algebraic 
coupling and provides support for functional and physiological coupling between 
HR and HRV per breath derived here. 
When correlation analysis of HR and metrics of HRV analysis of circular statistical 
analysis based on a breath by breath basis obtained from summary cartwheel 
plots derived from around 900 breaths were investigated, it was found that there 
were significant correlations, however, this is not proof of causation.  In chapter 2 
when HRV in scrapie incubating sheep were investigated, certain metrics of HRV 
were shown to be independent of HR (figures 2.12, 2.13). 
There is a significant difference between the relationship of HR and MVL and MVL 
and MVA between controls and vCJD patients as shown in table 6-14.  
Consequently the results shown suggest that there is less physiological coupling 
between heart rate and R-wave distribution within each breath in patients 
compared to controls.  This may be due to aberrant function in the neurological 
homeostasis controlling the most efficient heart beat timings to breathing 
frequency, caused by perturbation in function by the presence of disease 
associated prion. 
There was a trend for metrics of HRV to be more strongly associated to heart rate 
for control data than patient data (as seen in the scatter plots of figure 6.9).  
Statistics (MVL and MVA) from the summary cartwheel plots of the whole 300 
second data epoch were compared to the average heart rate over this period for 
controls and patients.  These associations are summarized in tables 6-12, 6-13 
and 6-14.   
Correlations may be described as weak (r=0.40-0.59) moderate (r=0.6-0.79) and 
strong (0.80-1) (Swinscow & Campbell.2002). 
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In controls, there was a strong correlation between HR and MVL (0.948) and MVA 
(0.838).  These significant correlations suggest that approximately 90% (r 
squared=0.948 x0.948) of the variability of MVL is explained by HR and similarly 
about 70% (r squared= -0.838 x -0.838) of the variability in MVA is explained by 
HR.  These values contrast with data from vCJD patients where 41% of MVL and 
MVA (0.638 x 0.638 and -0.643 x -0.643 respectively) are associated with HR.   
These associations suggest a different pattern in the distribution of R-waves within 
the breath cycle for controls and patients.  There is less association in the R-wave 
position and variation per breath cycle and HR in patients than in controls 
(significant differences between the correlation coefficients are given in table 6-
14).  Around 60% of the change in MVL and MVA with respect to each breath is 
not associated with HR.  This may suggest less physiological control in the 
relationship to heart beat and breathing in patients compared to controls.  This 
could be the result of aberrant neural coordination of the heart beat within the 
breath cycle seen in vCJD patients as a result of prion infected synapses mis-
firing.  The normal increase in heart rate when individuals breath in and associated 
slowing of heart beat when exhaling (RSA) is absent in the patient group.   
Figure 6.10 illustrates the significant differences in the distribution of R-waves 
between controls, the same controls undergoing anaesthesia and vCJD patients.  
Of interest is the inflection seen between the 5th and 6th R-waves, in the control 
data and data for those individuals undergoing anaesthesia .   The kick represents 
an increase in the MVL, indicating a greater clustering of R-waves around each 
mean position for the 5th and 6th R-waves for controls and these people 
undergoing anaesthesia.  This suggests some entrainment towards a secondary 
regulatory mechanism which could well be the re-application of the vagal brake 
previously having been released to facilitate the increase of heart rate occurring in 
step with respiration events, associated with RSA.  This switch is not seen in vCJD 
patient data possibly indicating abnormal neurological function. 
 By observation of the graph of MVL, figure 6.10, for people undergoing 
anaesthesia it may be seen for all R-waves the values of MVL are lower during 
anaesthesia than before anaesthesia.  This means the R-waves are less 
associated to the respiration event during anaesthesia than before it.   
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For vCJD patients the converse is true, the MVL is higher for all R-wave positions 
suggesting there are reduced influences on the variation of the appearance of R-
waves in patients.  The variability in their occurrence is more related to the 
respiratory event.  This could be due to abnormal neural control mitigated by prion 
infection in specific brainstem and peripheral areas. 
The suggestion of aberrant neurological control, affecting HRV, as seen in vCJD 
patients, is echoed in studies of HRV following heart transplant surgery.  It was 
reported that following such surgery, where the normal neural control of the heart 
was abolished, there still remained a small degree of RSA associated with 
myogenic properties of the heart and wall compression (Bernardi, Keller et al. 
1989).  The vCJD patients may be in an interim state with malfunctioning and 
reduced neurological complexity controlling the heart on a beat to beat basis, 
where the main effect on the beat variance within each breath is the myogenic 
properties of the heart and wall compression along with a change in pleural cavity 
pressure as the lungs inflate and deflate. 
Some of the sites of action of the anaesthetic agent are located in the brainstem, 
NTS and NA, and specifically affect the GABA receptor system.  Disease 
associated prion is thought to alter GABA(A) mediation of neural transmission.  It is 
possible that the lack of variability in R-wave position seen in vCJD patients is the 
result of induced aberrant function of GABA(A) mediated synaptic communication 
and synchronisation of the heart beat to breath event. 
This physiological observation may be of use in identifying subclinical carriers 
(human or animal) of prion disease since these particular areas of the brainstem 
are the first to be affected by prion invasion (van Keulen, Schreuder et al.2000) 
and the vagus may be a conduit for the initial infection of the central nervous 
system (Pomfrett, Glover et al.2007). 
Figure 6.12 shows that during sedation the MVL increases suggesting the R-
waves are more clustered to the breath event.  This trend is restored to values of 
MVL seen before sedation took place.  In the lower panel of figure 6.13, a similar 
series of analysed data are presented to illustrate ineffectual sedation.  This 
patient was a chronic alcoholic and the procedure had to be abandoned due to 
noncompliance of the patient.  These two graphs may therefore illustrate the 
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required swing in MVL to achieve sedative levels that allow the progression of the 
procedure compared to inappropriate sedative levels suggested in figure 6.13. 
Sedation and anaesthesia demonstrate a perturbation in the distribution of R-
waves within each breath compared to controls (see figure 6.11).  During 
anaesthesia R-waves are less associated to the start of the breath indicated by the 
reduction in MVL for all R-waves.  In sedation the R-waves show a greater 
coupling to respiration, shown by an increase in MVL for all R-waves.  vCJD 
patients also demonstrate this increased coupling to respiration when compared to 
controls. 
The nucleus tractus solitarii (NTS) of the medulla receives afferent sensory 
information from stretch receptors in the lungs, which then drives respiratory-linked 
vagal inhibition of the heart via efferent fibres originating in the nucleus ambiguus 
(NA) of the medulla. The GABA system mediates neural communication in the 
NTS.  It has also been shown that GABA signalling in the nucleus tractus solitarius 
sets the level of activity in dorsal motor nucleus of the vagus (Herman, Cruz et al. 
2009).  This work involving efferents to the gut in the DMNX is suggestive of 
similar GABA mediated communications to the NA from the NTS involved in the 
coordination of breathing and heart beat and GABAergic receptors have been 
shown to mediate vagal inhibition in the NTS of rats (Wang, Jordan et al.2010).   
In Chapter 1, the link between prion and the proper function of neurons has been 
suggested, due to its relationship to GABA mediated neurotransmission (Rangel, 
Madroal et al.2009).  GABA mediated synaptic function is altered by the presence 
of prion (Collinge, Whittington et al.1994;Lu, Sturman et al.1995).  It is likely that 
the GABA system in other brain regions would be affected by the presence of 
disease associated prion.  
Consequently, GABA receptors in the NTS that mediate vagal inhibition, shown to 
be affected by anaesthesia (Wang, Jordan et al.2010), could also be the sites of 
disruption in the homeostatic neural coordination of the heart seen in prion disease 
(Glover, Pollard et al.2007;Pomfrett, Glover et al.2004;Woolfson, Glover et 
al.2003).  Thus the presence of prion has the potential to affect GABA mediated 
synapses as does the action of anaesthetic and sedative agents. 
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A change in the synaptic function in this region due to atypical GABA activity may 
manifest as abnormal vagal communication to the heart and so the normal 
increase in heart beat at the start of respiration followed by the slowing of the heart 
beat is not seen.  For each breath this would mean less variability for the R-waves 
within the breath. 
So why is there a difference between the HRV during anaesthesia and sedation?  
Why is the trend in HRV change observed in vCJD patients similar to sedated 
patients?  The recordings from anaesthetised patients were ventilated and this 
may have presented an artificial “set point” for the respiratory linked HRV 
compared to free breathing individuals.  This conflict in ventilated respiratory 
frequency and “natural” respiratory frequency has been seen in infants undergoing 
surgery.  From spectral analysis of the HRV, two peaks in the HF band were seen 
indicating the ventilation of the pump and the “natural” ventilatory frequency.  Thus 
it appeared as if the natural rhythm was fighting the applied ventilation frequency 
of the pump.  (Pomfrett, personal communication relating to the work of (Blues & 
Pomfrett.1998)  Finally, anaesthetic agents may act on different populations of 
neurons than do sedative agents. 
Anaesthetic agents can inhibit excitatory receptors or potentiate inhibitory 
receptors.  The anaesthetic state comprises many components including 
immobilization, amnesia and unconsciousness.  Specific components of 
anaesthesia can be produced by specific actions at different sites in the CNS.  It is 
reported that inhalation anaesthetics produce immobilization by action on the 
spinal cord (Antognini & Schwartz 1993;Rampil 1994).  However, sites for amnesia 
and unconsciousness must clearly be different from the spinal cord since any 
affects here would not result in central effects such as unconsciousness.  Neural 
sites in the CNS would be the targets for the action of amnesia and 
unconsciousness effects.  Inhalation anaesthetic can produce hyperpolarisation of 
neurons (Nicoll & Madison 1982) such motorneurons may play a part in the 
pacemaker and pattern generation of neural communication.  Synaptic 
communication in these sets of neurons will be affected since hyperpolarisation 
will reduce the probability that an action potential will be generated as a result of 
neurotransmitter release.   
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GABA receptors are proteins located on membranes which can be divided into two 
major groups.   GABA(A) receptors are made from five subunits forming a ligand 
gated ion channel (Inotropic receptor).  Sixteen subunits have been identified 
which are classed into seven subunit families as follows:- six , three , three ,
and single , , , and  subunits.  A pentamer of these subunits makes up the 
ionic channel through which chloride ions can pass and so alters the membrane 
potentials, inhibiting the firing of new action potentials.  Consequently these 
receptors are involved in neural inhibition.  GABA(B)  receptors are G protein-
coupled receptors (metabotropic receptors) and are in two groups dependent on 
receptor subtypes (GABA(B1)  and GABA(B2) ).  They stimulate the opening of K
+ 
channels, hyperpolarizing the neuron which in turn prevents neurotransmitter 
release.  Consequently these are also inhibitory receptors. 
Among the many postulated targets for anaesthetic agents are chloride channels 
that are gated by inhibitory GABA(A) receptors (Krasowski & Harrison 1999).  The 
action of anaesthetics on the GABA(A) receptor are mediated by binding of the 
anaesthetic to specific sites on the GABA(A) protein based from evidence that 
mutations in the GABA receptor can eliminate the effects of the anaesthetic 
(Krasowski & Harrison.1999;Mihic, Ye et al. 1997).   Reduced responses to 
noxious stimuli from the administration of propofol or etomidate are reported to be 
related to the 3 subunit on the GABA(A) receptor (Jurd, Arras et al. 2003) and the 
sedative effects of these anaesthetics are related to 2 subunit on the same 
receptor type (Reynolds, Rosahl et al. 2003).  This illustrates that different effects 
of anaesthetics and sedatives are the result of different actions of the GABA(A)
receptor subtypes.   
In addition to these GABA receptors, anaesthetics act on other ligand-gated 
receptors and affect the release of neurotransmitters.  Several anaesthetic agents 
potentiate the action of glycine on the glycine-gated chloride channels in the 
inhibitory neural pathways in the spinal cord and brainstem (GoodMan & Gilmore 
2010).  The protein complex syntaxin and the syntaxin-binding proteins SNAP-25 
and synaptobrevin are required for the effects of some anaesthetics to be shown.   
This protein complex is involved in synaptic neurotransmitter release (van, Saifee 
et al. 1999) and may be implicated in the amnesic effect of anaesthesia causing 
presynaptic inhibition in neurons of the hippocampus (GoodMan & Gilmore.2010). 
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The sedative used in the procedure reported here was midazolam, a 
benzodiazepine often used in colonoscopies.  The sites of action of this drug, 
compared to anaesthetics, are less widespread and the level of neural depression 
is less than for anaesthetics.  Awareness usually persists even when high doses 
are administered and sufficient relaxation for surgery can’t be achieved, thus 
making the drug unsuitable to replace anaesthesia.  These facts illustrate the 
difference between sedation and anaesthesia.   
The effects of midazolam are mainly exerted by action on the GABA(A) system in 
contrast to the varied targets of anaesthetics. Research into receptors have shown 
that the congregation of a  subunit with  and  subunits is required to make 
GABAA receptors sensitive to benzodiazepine (Burt 2003).  Midazolam modulates 
GABA binding and GABA alters the binding of midazolam (GoodMan & 
Gilmore.2010).  At the doses used in colonoscopy procedures it is reported that 
midazolam may slightly depress alveolar ventilation as a result of decreased drive 
related to oxygen mediated chemoreceptors (hpoxic) and not the respiratory drive 
associated with carbon dioxide chemoreceptors (hypercapnic).  Minor 
cardiovascular effects are reported where midazolam may increase heart rate 
slightly and decrease blood pressure. 
It is suggested that both anaesthesia and sedation exert their effects via GABA(A)
receptor systems. Different subunits of the GABA(A) receptor system are proposed 
to be responsible for the sedative and anaesthetic effects for some anaesthetic 
agents.  Sedative effects are the result of action on the  GABA(A) -2 subunit and 
the loss of consciousness involves the GABA(A) -3 subunit (Jurd, Arras et 
al.2003;Nelson, Guo et al. 2002;Reynolds, Rosahl et al.2003).  It is thus possible 
that anaesthesia and sedation as studied here exert their effects via different 
population of GABA(A) receptors.  The GABA receptor system has also been 
implicated in prion diseases such as vCJD.  Prion infection has reported to 
demonstrate a different  distribution in GABA receptors in the brain (Lu, Sturman 
et al.1995).  The lack of function of normal cellular prion causes a decrease in 
GABA(A)-mediated inhibitory postsynaptic currents (Collinge, Whittington et 
al.1994). 
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The precise action and effects of prion on the GABA system have still to be 
elucidated.  However, the GABA system is suitably complex to demonstrate 
heterogeneity in its functional association with anaesthetics, sedatives and 
possibly prions.  The effects induced by sedation show a similar decrease in the 
variability of R-waves per breath as the effect of prion infection in vCJD patients 
demonstrates.  Anaesthesia causes the R-waves within the breath to be more 
variable with respect to the breath event.  Consequently the difference seen during 
anaesthesia may be a result of an increased number, type and method of neuronal 
change compared to the changes observed in sedation and prion incubation. 
Neural transmissions involving the GABA system are not confined solely to the 
CNS.  Intrinsic cardiac neurons have been shown to utilize nicotinic, muscarinic 
and beta-adrenergic receptors to regulate the heart (Huang, Smith et al.1993b).  It 
has also been shown that in hearts without neural communication to the brain, 
GABA alters neuronal and cardio-regulatory effects following hexamethonium 
application (a ganglionic blocker, acting as a nicotinic receptor antagonist).  This 
suggests that synapse other than nicotinic ones were involved in GABA induced 
responses in these intrinsic cardiac ganglia.  Consequently, amino acids such as 
GABA can change the neuronal activity in intrinsic cardiac ganglia with a resultant 
change in cardiac regulation (Huang, Smith, & Armour 1993a) illustrating a 
possible peripheral effect of GABA and hence a peripheral target for the effects of 
prion during disease incubation. 
In conclusion, the application of the developed technique of assessing HRV per 
breath shows significant differences between controls and patients with vCJD.  
The methods used in this chapter are able to identify variations between individual 
R-wave distributions for control and vCJD patients.  Heart rate has been shown to 
have differing effects on the calculated measures of HRV for controls and vCJD 
patients.  Patients HRV measures have a significantly different association to heart 
rate than do controls. 
By investigating anaesthesia and sedation and comparing these results with 
people incubating TSE disease, the association of GABA-mediated neuronal 
control and the presences of disease associated prion may present an opportunity 
to investigate the neurological functional change seen in prion infection.  
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Pharmacological intervention using a battery of agonists and antagonists may 
present different responses in animals or people with prion infection compared to 
control subjects.  HRV monitoring may provide objective evidence for an abnormal 
response to the particular pharmacological intervention and help discern the 
presence or, degree of, prion infection.  Repeated measures over time may also 
help to investigate, from a neuronal functional perspective, the pathogenesis of the 
disease.  
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Chapter 7 Summary, Limitations and Further work  
Review of chapters and findings 
Review of Chapter 1 
Chapter 1 provides a review of the literature to provide information to describe the 
infectious particle and a review of the theories for TSE infection.  Functions of 
prion are discussed and focus is placed upon a functional change in synaptic 
communication during disease incubation.  This leads to discussion about the 
neuroanatomical reasons why the presence of prion in the disease classifying 
regions of the brain may alter heart rate variability.  The relationship of the NA, 
DMNX and NTS are discussed in relation to the control of the heart on a beat to 
beat basis.  In addition intrinsic and intrathoracic cardiac ganglia are discussed in 
relation to potential sites for integrating the parasympathetic and sympathetic 
branches of the ANS. 
From the information in chapter 1, one putative route for the neural transport, via 
the vagus nerve, of disease associated prion from the gut to these brain centres 
could be:- 
From innervations of the stomach (Powley & Phillips 2002)  and the afferent 
sensory pathways via the nodose ganglia to the NTS (Browning & Mendelowitz 
2003) with a degree of plasticity in the neuronal circuits associated with the vagus 
nerve and the interconnections between the NTS and DMNX being possible.  
These interconnections having GABAergic mediated inputs (Travagli, Hermann et 
al. 2003).  Other infectious pathways are possible and need not be mutually 
exclusive.  For example the DMNX has shown to be positive for PrPD before the 
nodose ganglia reflected infectivity suggesting an efferent retrograde mode of 
infection from gut to DMNX (van Keulen, Schreuder et al.2000)  
260
Review of Chapter 2 
Electrophysiological studies on the effects of aberrant prion on neural function 
have illustrated that the lack of natural prion, analogous to the presence of non-
functioning disease associated prion, causes impaired GABA(A) mediated synaptic 
inhibition and it is postulated that this dysfunction in neural communication may 
lead to synaptic and neuronal loss seen in prion diseases (Collinge, Whittington et 
al.1994).  Similar work with scrapie-infected hamsters has shown aberrant 
postsynaptic function of neurons (Barrow, Holmgren et al.1999).  A functional role 
for prion in modulating synaptic transmission has been suggested (Carleton, 
Tremblay et al.2001).  Consequently these lines of evidence help to construct the 
hypothesis that disease associated prion in the diagnostic brainstem regions of the 
medulla will disrupt the normal synaptic flow of neural information used to regulate 
target organs such as the heart causing a perturbation in the beat to beat control 
which manifests as a change in HRV. 
Chapter 2 summarizes the common methods used to collect data for subsequent 
analysis of HRV in other chapters.   The construction of adapted ECG electrodes 
is described to facilitate good quality recordings from sheep and cattle along with 
the description of the gel used to locate these electrodes on the animal.  The data 
capturing devices are described and the common software used to analyse the 
data are listed.  Some of the technical caveats to collecting and analysing heart 
rate variability data are discussed and measures taken to minimize the effects of 
these in the results are described.  To test the data capture and analysis routines 
a heartbeat simulator was used which had particularly low variability encoded in to 
the rhythm.  This machine's original function was to provide a "real" ECG rhythm 
onto which specific clinical arrhythmias could be programmed.  This was used to 
simulate cardiac dysfunction of a manikin used for cardiac resuscitation training.  
The results of the simulator are included in appendix 1.2. 
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Review of Chapter 3 
Evidence from chapter 3 of this thesis and published research by this author 
(Glover, Pollard et al.2007)  provides examples of how HRV analysis can identify 
scrapie infected sheep from controls at the pre-clinical stage.  In addition it was 
observed that these deviations in HRV were concurrent with positive rectal biopsy 
analysis indicating prion protein in the enteric nervous system before overt clinical 
signs of the disease (the enteric nervous system often classified as part of the 
ANS (Gershon 2003)).  A particular frequency band (0.032-0.138 Hz) previously 
demonstrated to have utility by our group in HRV analysis (Pomfrett, Dolling et 
al.2009) was found to show significant differences (p<0.05) between rectal biopsy 
prion positive sheep and rectal biopsy negative sheep.   
This difference was not seen in higher frequency bands of HRV variability, 
RMSSD time domain measures of HRV nor heart rate.  This observation highlights 
the fact that different metrics of HRV may give different results and a discussion 
was started in the limitations section of this chapter concerning better methods to 
subdivide the spectrum of HRV to focus on particular physiological subsets of the 
variability.  The limitations section of this chapter also addresses the caution 
required in interpretation of these results from a small number of sheep with mixed 
genotype.  However the proof of the principle in using HRV to investigate prion 
infection is demonstrated. 
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Review of Chapter 4 
Work with cows incubating BSE has shown a relationship between the amount of 
infectious inoculum the animals were challenged with and HRV at certain time 
points after the oral challenge (Pomfrett, Glover et al.2004).   
In this thesis (chapter 4), HRV analysis of cows from the same study but using a 
different method of HRV analysis based on the work of Toichi and Allen (Allen, 
Chambers et al.2007;Toichi, Sugiura et al.1997), was performed. 
Chapter 4 illustrated a difference in HRV between sheep incubating scrapie and 
cattle incubating BSE.  This analysis was also able to separate 1 gram dosed 
cattle from 100gram dosed cattle by comparison to controls (figures 4.5, 4.7).  
Significant differences in the HRV of cattle based upon histopathological 
examination of their spine in relation to the presence of prion were shown (figures 
4.8, 4.9 and 4.10) and this method was extended to show significant  differences 
in control cattle, orally challenged cattle and "field" animals showing clinical signs 
of BSE. 
The use of HRV investigations illustrated the changing pathogenesis of the 
disease during incubation, as postulated in the work into the spread of prion 
protein in neural tissues of the animal with respect to time  (Beekes, McBride et 
al.1998;Beekes & McBride.2007;Pomfrett, Glover et al.2007;van Keulen, Bossers 
et al.2008;van Keulen, Schreuder et al.2000).  As prion protein affects more neural 
compartments as the disease progresses, a change in the neural output from 
these areas would occur.  This change in neural communication to target organs 
such as the heart would appear as a change in HRV.  Both sympathetic 
communication, mediated via the spinal cord and parasympathetic activity 
mediated via the vagus nerve are integrated at the intrinsic cardiac ganglia. A 
change in this dynamic balance due to transient perturbations in either or both of 
the branches of the ANS would change HRV.   
In this opportunistic study, the practicalities of measuring a cow's individual 
physiological co-variates were limited.  To this extent the control group had the 
same treatment as the animals in the other two groups to hopefully minimize the 
effects of changes in temperature, position when monitoring and blood pressure.  
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The experiment was designed so the only difference between these groups of 
cattle would be the amount of oral challenge they received (0 gram, 1 gram or 100 
gram).  Other limitations to this study involved the changing metrics of HRV in 
individuals during disease incubation and the departure from the normal intra and 
inter variability considerations of HRV measures observed in healthy populations 
(Jira, Zavodna et al.2010;Kobayashi.2007). 
Review of Chapter 5  
Chapter 5 presents the rationale for the development of a different technique to 
assess heart rate variability per breath.  It discusses RSA and the associated 
neuroanatomical sites responsible for the control of RSA and the particular effects 
on the respiration cycle modulated by the vagus nerve.  Prion infection in these 
neural structures is postulated to cause a resultant change in HRV measures per 
breath compared to controls.  To investigate this prospective change, circular 
statistics were employed to examine the relationship of the R-wave variability 
within breath cycles. 
Difficulty in obtaining breathing events directly from vCJD patients was described 
and a method to estimate breathing events from analysis of the ECG trace was 
developed via a purpose written computer program written by myself and include 
in the appendix (Appendix 1.5).  The program then was developed to archive the 
R-wave times occurring with each respiratory cycle (Figure 5.7 illustrates the 
translation of the linear events into their circular representation).  Breath estimates 
were compared to breaths measured from control subjects and the Bland-Altman 
method to measure the level of agreement between estimating and measuring 
breath events was used.  Data from the program was input to commercially 
available software (Oriana) to perform circular statistical analysis. 
The change in R-wave distribution per breath was compared to data from a heart 
rate simulator and controls to indicate the range and magnitude of the deviations 
from control and artificially generated data.  Changes in the R-wave distributions 
with respect to their position in the breath cycle were found between controls and 
vCJD patients.  Significant differences were found in the mean vector length (MVL) 
of R-wave distributions within a breath cycle between vCJD patients and controls, 
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controls and heart simulator data and for some R-wave positions between vCJD 
patient data and heart simulation data (Table 5-2, figure 5.19).   
Limitations to the technique were discussed including the problem associated with 
estimating the start of the respiration cycle and how this may differ between the 
neurological initiation of the event and the time taken to measure a change in 
airflow in the respiratory tract.  It is reported that a change in the vagal and 
sympathetic efferent activity occurs 0.5 seconds before the onset of inspiration 
(Saul, Berger et al.1989a).  This time difference would have substantial effects on 
the sub second relationship between R-waves within a breath cycle. 
Review of Chapter 6  
In chapter 6 the application of the technique developed in chapter 5 was 
considered.  Assessment of the ability to distinguish R-wave distributions within a 
breath between controls and vCJD patients were investigated.  Significant 
differences (p<0.05) in R-wave distributions between controls and vCJD patients 
were reported following a Mardia-Watson-Wheeler test (table 6-8), a finding 
supported by the non-overlapping confidence intervals for the mean vector angle 
listed in tables 6-5 and 6-6. 
The effect of heart rate on the distributions of R-waves within a breath was 
considered and it was reported that there was a significantly different (p<0.05) 
correlation between heart rate and mean vector length (MVL) for controls and 
vCJD patients (table 6-14). 
Based upon the fact that the areas of the brainstem involved in anaesthesia are 
the same as those used for a diagnostic test for prion diseases and are those 
areas that control the heart on a beat to beat basis, HRV measures using the 
technique developed in chapter 5 were used to investigate changes in HRV in 
patients undergoing general anaesthesia.  In addition patients undergoing 
procedural sedation were also investigated to investigate if similar HRV changes 
were seen in these two pharmacological interventions. 
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Significant differences (p<0.05) in the R-wave distributions per breath were 
reported before and during anaesthesia (table 6.15), during anaesthesia compared 
to vCJD patients distributions (table 6-17) and some R-wave positions showed 
significant differences between vCJD patients compared to controls before 
anaesthesia (table 6-16, only the first R-wave in the breath was not significantly 
different in its distribution).  Significant differences (p<0.05) were reported in the R-
wave distributions of people undergoing sedation compared to people undergoing 
anaesthesia (figure 6.11).  The utility of this method of assessing HRV was 
indicated by a significant change (p<0.05) in R-wave distributions per breath 
induced by adequate sedation which contrasted with the lack of a significant 
change during a procedure abandoned due to inadequate sedation of the patient 
(Figures 6.12 and 6.13, tables 6-18 to 6-21) 
Comparisons with changing HRV per breath in vCJD patients, healthy controls and 
patients undergoing sedation or anaesthesia have led to the postulation of a link 
between prions and the GABA system, potentially the GABA(A) beta 2 receptor. 
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Limitations 
Methods of measuring HRV 
Different methods of HRV analysis may give different assessments of the degree 
of change in autonomic function of a system since each method may represent 
different interactions between branches or pathways of the autonomic nervous 
system.   
The response of the ANS is a dynamic system tailored to individual physiological 
requirements at a particular time.  Problems in relation to what HRV analysis may 
tell us about the function of the ANS are highlighted in the opinions of Parati and 
Rienzo versus Taylor and Studinger (Parati, Mancia et al. 2006).  One of the main 
issues is of the implied absolute measures of autonomic tone and the limitations of 
an accurate method of measurement.  
 Analysis of the beat to beat variations gives an approximation to the coordinated 
activity of the ANS in the control of the heart during the period of sampling.  As 
such, results represent a “snap-shot” of the dynamic state of the autonomic 
integration within the physiological system.  In addition, all measurements are 
fundamentally relative.  For example take measuring a length of string.  One may 
use a ruler and read off a value from the scale provided.  However this is relative 
to which “yardstick” (ruler) is used.  Similarly measures of HRV will be related to 
which method of analysis is used.  Inappropriate quantification may lead to 
improper interpretation of heart rate variability and its underlying physiological 
correlates.  
Consequently, the most powerful analysis of HRV will compare any values 
obtained from individual measures with ranges of normality, derived during similar 
standardised conditions.  Further insight and utility from HRV analysis is gained if 
the diseased or non-functioning range of a particular HRV analysis methodology is 
defined.  For example the work of Ewing (Ewing, Neilson et al.1984) used diabetic 
patients compared to healthy controls and also comparisons to heart transplant 
patients having medically denervated hearts to illustrate the trend in reduced 
parasympathetic activity displayed by diabetic patients.  Similarly, the analysis of 
HRV data performed in chapter 5 of this thesis compared data from control human 
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subjects and patients with vCJD and both measures were referenced to data from 
an electronically simulated ECG displaying little or no HRV.  As well as acting as a 
point of reference in the comparisons of the results, the inclusion of data with no 
HRV helped validate the purpose written algorithm used to analyse the data.  The 
analysis of the data from the simulator gave very small measures of HRV and 
helped indicate the downward trend in longitudinal measures from a vCJD patient. 
HRV may be most sensitive in identifying a change in longitudinal studies and 
looking for a change in an individual’s range of autonomic function.  This would 
minimise the errors in an individual's HRV having a different baseline value than 
the normal population.  Having a bespoke baseline from which deviation could be 
assessed would make any deviation from the day to day variability easier to see.  
However from these studies it is likely that the degree of day to day variability is 
small in comparison to the extremes of HRV seen in the diseased state.  But 
utilizing the longitudinal study method would yield an analysis that could more 
easily and sooner identify a significant change in the metric measured.   
HRV in a diseased state: Study of heart  transplant patients to illustrate 
potential for differences. 
Interpretation of the results of HRV analysis is further complicated when HRV is 
applied to a progressive detrimental disease of the autonomic system where 
different functions of the system may be seen with respect to disease pathology.  
This decrement in function may also prescent a "see-saw" pattern in coordinated 
branches of the autonomic system with respect to time, as seen in the 
investigations of cattle incubating BSE in chapter 4 and the latter stages of the 
disease shown in figures 4.13 and 4.14.  This change in measures of HRV over 
time observed in subjects incubating TSE diseases is also indicated in appendix 
1.8.  (Significant differences (p<0.05) are seen between measurements taken 12 
months apart from this individual represented in appendix 1.8).  One possible 
reason for the change in function over time is the activation and use of different 
pathways in the autonomic system.  This potential for recovery of function is 
illustrated by the resurgence of utility in the ANS following ablation as a result of 
transplant surgery.  
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Heart transplants in dogs have provided evidence for neural re-innervation 
(Sakamoto, Schuessler et al. 2009) but re-innervation is less well accepted in 
human transplants.  However, the techniques employed to explore re-innervation 
in the human use indirect techniques such as pharmacological intervention and 
autonomic reflex responses to exercise.   It has been suggested that such 
changes in the beat to beat rate of the heart may be due to an increased and 
progressive sensitivity of the donor heart to adrenalin (Koskinen, Virolainen et 
al.1996). 
Reports of re-innervation in human heart transplant patients using power spectral 
assessments of HRV have been suggested.  Power spectral analysis of the 
transplanted heart was found to be similar to a normally innervated heart and the 
observed respiratory peak corresponding to respiratory frequency was abolished 
following the administration of atropine (Fallen, Kamath et al.1988).  More 
evidence for parasympathetic and sympathetic re-innervation has also been 
reported (Gallego-Page, Segovia et al. 2004) using HRV, histological techniques 
and imaging studies using radioactive sources (scintigraphy). 
The time after transplantation is reported to have an effect on re-innervation.  It 
has been reported that HRV increases with the length of time after the operation.  
Significant changes in sympathetically mediated HRV are seen in patients having 
had a heart transplant after 3 years from the transplant compared to patients 
having had a transplant within 3 years (Halpert, Goldberg et al. 1996;Koskinen, 
Virolainen et al.1996).  Time after transplantation has also been shown to be a 
factor in the parasympathetic re-innervation of the heart (Uberfuhr, Frey et al. 
1997).   
Further support for a sympathetic re-innervation in human heart transplants is 
seen in studies of children.  HRV changes are seen following 4 years after 
transplantation in children and demonstrate a growing sympathetic influence on 
the heart with respect to time after transplantation (Pozza, Kleinmann et al.2006).  
It is suggested that sympathetic re-innervation to the sinus node and left ventricle 
occur at different times after transplantation (Lovric, Avbelj et al. 2004). 
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Evidence for re-innervation by both branches of the ANS is also found (Tio, 
Reyners et al. 1997;Uberfuhr, Frey et al.1997) although it is reported that signs of 
parasympathetic re-innervation are more common (Tio, Reyners et al.1997).  
Evidence involving analysis of HRV in patients after transplant has suggested both 
branches of the ANS may re-innervate the heart many years after surgery.  These 
lines of evidence suggest a remodelling or resurrection of function of neural 
connections controlling the heart.  One possibility into the uncertainty of re-
innervation may be the oversight of intrinsic cardiac ganglia located on the heart.  
Different surgical techniques or variation within the technique could result in 
complete, partial or absent cardiac ganglionated complexes following 
transplantation.  This would cause different rates of recovery in the local 
independent function of the intrinsic cardiac ganglia in the control of the heart with 
respect to time after transplantation.  In this respect the intrinsic ganglia could be 
viewed as a separate “brain” in an analogous fashion as the ideas postulated in 
Gershon’s thoughts on the enteric nervous system being a “second brain” 
(Gershon.2003). 
This recovery of function may be seen as a “see saw” in the regulation of the heart 
after transplant occurs.  The "see saw" nature in HRV may be revealed as a 
predominance of parasympathetic or sympathetic variability over time, accounting 
for the diverse reports on the re-innervation of the branches of the ANS. 
To this end adaptations to the surgery involved in transplants to reduce damage to 
the cardiac ganglia has been suggested to improve the recovery of patients after 
surgery and achieve better electrical stability of the heart (Singh, Johnson et al. 
1996).  If the cardiac ganglia were kept as functional units some HRV may be 
possible from “pre-programed” activity pathways.   
Similarly changes in the activity of cardiac ganglia may be seen due to prion 
causing aberrant function in either the descending neural efferent information, 
changing afferent communication to integrative centres within the medulla, 
influences at the interneurons of the cardiac intrinsic ganglia or, most likely, a 
mixture of perturbation in the interactivity of all these sites due to prion infection 
causing neuronal mis-firing and or neuronal apoptosis (for a diagram summarizing 
the interconnections and neuronal pathways for the regulation of the heart see 
figure 1.6 chapter 1).  These areas of neuronal mal-function may be represented 
as "see saw" changes in metrics of HRV as reported in this thesis. 
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This pathway has been highlighted by research into depth of anaesthesia and 
retrograde virus studies.  The areas of the brainstem involved in regulation of heart 
on beat to beat basis are those areas where prion deposits are seen in prion 
diseases.  Prions cause disruption in neural signalling so it is likely that aberrant 
neural communication from these infected areas would result in a functional 
change at the target organ, the heart in this case. 
Respiration linked to HRV 
At rest, changes in parasympathetic nervous activity represent the major part in 
the generation of HRV(Electrophysiology.1996).  Quick cholinergic communication 
of neural impulses coupled with muscarinic receptor signalling at the SA node is 
reported to account for the modulation in the RR interval, contrasting with the 
slower noradrenergic and beta receptor signalling of the sympathetic system 
(Chapleau & Sabharwal 2010;Electrophysiology.1996;Laude, Baudrie, & Elghozi 
2008;Thireau, Zhang et al. 2008). 
Debate about the relationship of vagal tone to RSA has been discussed.  It has 
been reported that the cardiac vagal tone is disassociated from RSA when the 
respiration rate is changed (Grossman & Taylor 2007), this relationship was 
stronger if respiration rate was controlled for.  This idea is countered by 
suggestions that strong correlations of RSA and respiration are not suggestive of 
an effect of respiration on vagal tone (Denver, Reed, & Porges 2007).  It is 
suggested that RSA represents phasic control of the heart affected by the 
integration of neural events (Berntson, Cacioppo, & Grossman 2007) involving 
sympathetic and parasympathetic interactions and is not simply a measure of 
vagal activity.  This latter idea is supported by the dynamic change in HRV linked 
to each breath seen in prion disease pathogenesis.  This change in HRV shows a 
recovery of function at certain stages of the disease, emphasising the dynamic 
nature of the regulation of the heart on a beat to beat basis. 
As the control of HRV is a dynamic process,  at one time slice, RSA may be 
intimately and exclusively related to parasympathetic activity and at others may 
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become disassociated from it due to changing physiological states, such as 
hormonal and blood pressure effects feeding back to the control of the electrical 
activity of the heart. 
In this thesis I proffer the idea that intrinsic cardiac ganglia are mediators in the 
determination of the integrated coordinated effects of branches from the 
parasympathetic and sympathetic arms of the ANS.  Inclusion of this level of 
neural structure may well answer, to some degree, the conflicting observations of 
Grosman and Porges and support the thoughts of Berntson of a dynamic 
regulation of HRV. 
Further to the discussion in the relationship to RSA and parasympathetic activity, 
questions remain about the method of assessing RSA.  Time domain methods 
such as RMSSD and PNN50 are confounded by the fact that the magnitude of the 
heart rate deviations on a beat to beat basis increases at lower respiratory 
frequencies and high tidal volumes.  Similarly frequency domain methods of 
assessing RSA may have limited utility in circumstances where the depth and 
frequency of respiration change during the sampling period.  For long sampling 
intervals this is more likely.  The power spectrum in humans, as a result of the FFT 
method of assessing RSA, may be represented in 3 bands, VLF less than 0.04 Hz, 
LF0.04-0.15 Hz and HF 0.15-0.54Hz (Electrophysiology.1996).  The latter HF 
band represents fluctuations in RR interval associated with the breathing cycle.  
The specific frequency involved in any one sample and therefore any one 
assessment, vary between individuals and between species.   
Power spectral measure of HRV assessment assume a regular breathing 
frequency and depth with ANS frequency components above 0.15 Hz and below 1 
Hz.  This is not the case , so such estimates may be confounded.  Similarly paced 
breathing has been criticised for altering ANS activity from the natural free 
breathing measures due to mental volitional control of breathing affecting the 
estimates of HRV.  Volitional control of breathing would require other physiological 
processes outside of the autonomic control of respiration. 
In addition, the pattern in a breathing cycle may vary even during a relatively short 
period such as the five minute epochs used in this thesis.  Consequently the 
proposed frequency band used in FFT analysis smears the breath by breath 
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variations in the respiratory cycle and the RR variability associated with respiration 
is also compromised.  This may contribute to the contention about the link to RSA 
and vagal tone discussed by Porges and Berntson above.  Consequently, 
respiration should be monitored, if not recorded, to ensure the associated power 
falls within the specific frequency band (0.15 Hz represents one breath every 
6.666 seconds and 0.5 Hz represents one breath every 2 seconds).  If an 
individual is breathing at a rate of one breath every 8-10 seconds or if a few of the 
breaths occur at these rates, then the power represented in the FFT band will not 
wholly represent the activity of the parasympathetic and sympathetic  nervous 
system on the heart.  This would infer less of an association between RSA and 
vagal tone for example in this instance as a result of an inaccurate technique for 
assessing this dynamic system. 
Consequently the method to investigate HRV adopted and developed in chapters 
5 and its application in chapter 6 for using the RR distribution within a breath, may 
have extended utility to more specifically examine the link between vagal activity 
and its effects on the synchronicity of breathing events, in conjunction with the 
sympathetic contributions of the ANS.  Overlaying many breaths gives an estimate 
of the HRV per breath where “noise” from other cardiac neuronal activity, not 
directly linked to beat to beat variability, is "random" by comparison and so when 
averaged the most predominant associations become apparent i.e. vagal 
mediated beat to beat variability within each breath.  
Since prion infection has been shown to affect areas of the brainstem including the 
DMNX, NTS, reticular formation, NA and the vagus (as described earlier in this 
thesis), disruption in the normal neural function of these areas is probable.  By 
examination of the effects of the functional interdependency involving these areas 
of brainstem in the coordination of breathing and heart rate, the application of HRV 
studies is able to interrogate specific parts of the neurology affected by prion 
infection.  As prion infection proceeds to more neural structures, a changing and 
abnormal coordination between breathing and the beat to beat regulation of the 
heart would be seen.  Such neural pathogenesis may account for the see saw 
nature observed in data from incubating subjects. 
It is possible such investigations are able to identify changes in HRV per breath 
before clinical signs of the disease appear.  This may have benefit for putative 
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therapies and may help reduce the risk of iatrogenic infection in the human 
population from the use of prion contaminated medical instruments and products.  
Application to different genotypes and other diseases. 
Prions are reported to affect synaptic transmission (Brown 2001;Jeffrey, Halliday 
et al.2000;Kretzschmar, Tings et al.2000;Mallucci 2009;Moreno & Mallucci 2010) 
and the possibility is raised that aberrant function may arise before clinical signs of 
infection (Jeffrey, Halliday et al.2000) since the clinical signs are an outward 
manifestations of  changing neural communication and coordination, it is likely the 
investigations monitoring the changing neurology will show a change before 
clinical signs.  Prion disease is still an enigma.  A continuum of disease 
phenotypes are becoming evident and much of what we have recorded about the 
epidemiology of the diseases was based on histopathological tests that are in the 
process of being refined to now be able to identify new strains of prion disease 
and disease in different genotypes that was not previously possible.  The very 
search for the elusive prion may be a search for foot prints in the snow and we are 
looking at the imprint of the disease-causing particle and not directly at the cause 
of the disease. 
Whether this is true or not, using HRV to assess the potential for disease 
incubation is independent of the cause of the disease and initial results show that 
such analysis may be able to indicate the presence of prion disease before clinical 
signs are evident. 
Recent reports of vCJD having been identified in different genotypes of the 
population (Kaski, Mead et al. 2009) raises questions about the future expression 
of this one version of prion disease (Will 2010).  Furthermore, there is the prospect 
of a “new” new variant of CJD appearing in the future in a similar fashion as did 
nvCJD (now called vCJD) in the 1990s. 
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Further Work
In an ideal experiment designed to investigate changes in HRV during prion 
disease incubation, samples of HRV data should be obtained preferably daily and 
monitored for any deviations from control values previously assessed.  Following a 
signature change in HRV the experimental animals should be euthanized and 
histologically examined for the presence of prion in associated neural tissue.  A 
map of prion protein spread and associated change in HRV could be constructed 
from large samples and this would give functional physiological evidence for a 
proposed pathway for the disease associated prion in the diseased state.   This 
ideal experiment would also help validate the utility of monitoring HRV to assess 
the presence of prion protein and may help in the differential diagnosis of prion 
diseases versus other neurological disease.   Within this ideal experiment other 
physiological variables could also be monitored to assess the inter-relationship 
with changes in HRV.  Accurate and reliable breath estimation could also be 
included to present more accurate calculations of the respiration cycle and 
consequently better relate each R-wave to its particular breath cycle. 
This ideal study could be further developed to investigate the changes in HRV 
observed here during anaesthesia and sedation.  The use of animals may allow 
local topical administration of specific anaesthetics and sedative agents to 
particular neurological tissues and direct neurophysiological recordings could be 
made.  This would help identify the particular neural pathways involved and help 
associate changes in HRV to the underlying neurological processes. 
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Discussion and Conclusions 
The methods and techniques developed in this research, in addition to screening 
for new prion diseases in the future, may also have application in the study of 
disease such as Parkinson's and Alzheimer's disease.  Comparisons with the 
trends in changing HRV per breath in vCJD patients, healthy controls and patients 
undergoing sedation or anaesthesia have led to the postulation of a link between 
prions and the GABA system, potentially the GABA(A) beta 2 receptor.  This may 
lead to further areas of research that may address  therapeutic treatments for 
prion disease. 
vCJD is termed “invariably fatal” (Knight 2006).  However one victim survived more 
than 9 years after initial diagnosis.  When a cancer patient survives longer than 5 
years after the diagnosis, they are considered cancer-free.  If the same regulation 
was applied to vCJD, the disease would not be invariably fatal. 
The prospect of a different genotype taking longer to express clinical signs of the 
disease have also been raised.  The length of time to express the disease may 
well be longer than the individual’s life.  This should not mean that it should be 
ignored since iatrogenic infection from these carriers could still threaten individuals 
of a susceptible genotype.  A non-invasive repeatable ante mortem assessment 
may have utility in the longitudinal tracking of suspected individuals as an adjunct 
to other putative tests. 
Further applications for the monitoring HRV have been indicated by the work on 
sedation and anaesthesia.  As indicated in figures 6.13 and 6.14 the efficacy of a 
sedative may be assessed from the changing effect the drug has on HRV 
measures.  In non-standard patients, for example the chronic alcoholic in figure 
6.14, an assessment of sedative effect may suggest an increase in the amount 
given and thus provide adequate sedation of the patient as intended. 
Monitoring autonomic function using HRV has many applications.  The nature of 
the autonomic system is that it is not under voluntary control and so we do not 
readily know when it is compromised or malfunctioning.  Left untreated or 
undiscovered this malfunction can lead to further pathogenesis and health 
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problems.  Consequently monitoring autonomic function may have utility not only 
in prion diseases but in general health care applications. 
The overall aim of this thesis was to investigate if a change in HRV measures was 
detectable when animals and humans incubating TSE diseases were compared to 
controls.  In conclusion this thesis has reported evidence for significant differences 
in HRV measures between sheep with scrapie, cattle with BSE and humans with 
vCJD and species specific controls.  The use of different methods of HRV 
estimation were used to address questions about different techniques having 
different relevance to the underlying physiological processes controlling the heart 
on a beat to beat basis.  In further attempting to answer these questions a new 
technique was developed to assess changing HRV per breath.   
This technique was developed to assess the effects of all the changing ANS 
activity apparent within a breath cycle and to reduce the effects of autonomic 
events outside this physiologically relevant and variable epoch.    
Using this putative technique significant differences were found between vCJD 
patients and controls.  In addition this technique also reported significant reduction 
the clustering of R-waves related to the breath cycle during anaesthesia, which 
was also supported by other workers.  The technique was also able to distinguish 
between sedation and anaesthesia and by comparison with deviations seen in 
vCJD patients particular GABA subunit types were implicated as target sites for 
the abnormal neurological function resulting from prion infection.  The proof of 
principle of investigating HRV as an indicator for TSE infection has been shown.  
However further work and validation is necessary to develop the technique to 
more accurately describe the changes in autonomic nervous control of the heart 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix 1.1 Batch output from written software to automatically calculate RMSSD                  








0.348 0.012 0.000144 Directory F:\LASSWADE SHEEP DATA  
0.338 -0.01 1E-04 File RMSSD 
0.324 -0.014 0.000196 tag b 1200 0.018337
0.326 0.002 4E-06 tag b 1204 0.151865
0.3552 0.0292 0.00085264 tag b 1205 0.0354
0.3228 -0.0324 0.00104976 tag b 1206 0.040319
0.332 0.0092 8.464E-05 tag b 1211 a 0.054277
0.34 0.008 6.4E-05 tag b 1211 b 0.174725
0.332 -0.008 6.4E-05 tag b 1212 0.056394
0.334 0.002 4E-06 tag b 1214 0.109737
0.332 -0.002 4E-06 tag b 1215 0.054594






















mean of differences 
squared =  
0.001253838 RMSSD = 0.0354
Appendix Table 1 To show an example of manual calculation of RMSSD and agreement to the coded 
algorithm.
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Appendix 1.2 Power spectral values from sheep and simulator 
Appendix Table 2 Table to show “Heartsim200” power spectral values compared to those from sheep.  
Note all values tend towards zero. 
File Grp 
AUC 0-





tag j 132 1 0.000014372 0.000027307 0.00003066 1.06565E-07
tag j 151 1 0.000165896 0.000069661 0.000129345 1.20146E-06
tag j 443 1 0.000038715 0.000006006 0.000010134 2.45499E-07
Tag j 090cut 2 0.000169519 0.000084101 0.000132198 1.06785E-06
tag j 121 2 0.000033219 0.000027831 0.000248802 9.07089E-06
tag j 352 2 0.000055161 0.000053519 0.000085513 3.90647E-07
tag j 357 2 0.000068168 0.000033185 0.00002035 1.68579E-07
tag j 168 3 0.000138621 0.000012143 0.000019771 5.09779E-07
tag j 189 3 0.000004145 0.000002512 0.00000325 3.37719E-08
tag j 354 3 0.000015974 0.000008855 0.000013003 1.2673E-07
tag j 377 3 0.000025556 0.000006344 0.000010578 1.98889E-07
tag j 388 3 0.000098928 0.000017359 0.000027247 6.73125E-07
tag j 423 3 0.000015226 0.000012297 0.000012367 2.3024E-07
tag j 370 4 0.000033093 0.000013301 0.000228224 1.42306E-05
tag b 1200 5 0.000055147 0.00005421 0.000065392 2.98618E-07
tag b 1204 5 0.000101672 0.000030259 0.000083812 2.30361E-06
tag b 1205 5 0.000031105 0.000055326 0.000365892 2.17247E-05
tag b 1206 5 0.000100862 0.000100556 0.000146455 1.50155E-06
tag b 1211 b 5 0.000091867 0.0000446 0.000060521 3.60068E-06
tag b 1212 5 0.000585721 0.000030446 0.00005841 4.98098E-07
tag b 1214 5 0.000177237 0.000025296 0.000093102 1.15668E-06
tag b 1215 5 0.000038134 0.000025189 0.000074162 2.42854E-06
tag b 1225 5 0.000037459 0.000008333 0.000018523 1.33434E-07
tag 141 a 6 0.000067291 0.0000336 0.000042535 5.39674E-07
tag 88 a 6 0.000026606 0.000008553 0.000012363 8.992E-08
tag 96 a 6 0.00014511 0.000017236 0.000053155 6.55319E-07
heartsim200d
i 0 0.000000005 0.000000025 1.12686E-10
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Appendix 1.3 Differences in windowing functions in power estimates 
To illustrate the difference in power estimation for HLF (top) and HHF (lower) using different 































Data point in group 
Data point in group 
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Appendix 1.4 Bland Altman method of measuring agreement between measured 
and estimated breaths 
  
From 904 comparisons between measured and estimated breaths the mean 
difference ( d ) was found to be -0.51727 with a standard deviation of  1.56574.   
The differences were normally distributed as shown above  
The standard error of d   is given by 
n
s 2
  , 
where n is the sample size,  
For the Breath estimate data s = 1.56574.  
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The standard error of d is thus 0.0521 ,  given  by  d =   
904
)56574.1( 2
   
There are 903 (n-1) degrees of freedom and t = 1.960 from tables of the t 
distribution with n -1 degrees of freedom. 
The 95% confidence interval for the mean is given by the observed value minus t 
standard errors to the observed value plus t standard errors, 
Hence; 
-0.51727 - (1.960 * 0.0521)  to  -0.51727 + (1.960 * 0.0521)  giving 
-0.51727-0.1021  to  -0.51727+0.1021   
-0.61937 seconds               to   -0.41517 seconds 
Therefore, the mean difference is - 0.51723 with 95% confidence interval of 
- 0.61937 seconds to - 0.41517 seconds 
The limits of agreement (from Bland and Altman (Bland & Altman.1986)) are given 
by  
d   - 2s = -0.51723 - 1.96(1.56574) = -3.64875
d  + 2s = -0.51723 + 1.96(1.56574) = 2.614206 
where s is standard deviation of differences.  s= 1.56574. 
These are illustrated in figure 4.6 of chapter 4 
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Appendix  1.5 Program listing, used to calculate circular statistics 
'Automated script written by D.G.Glover to estimate breath events 
from ECG trace using three parameters, finding the average and 
smoothing estimates to make estimates physiologically relevant. 
Then the script uses derived breath estimates and puts the time of 
these events into an array along with the times of the R-waves 
within the breath epoch (Breath to Breath time).  It then 
calculates mean vector length and angle for certain groups of 
breaths 








'This creates a memory channel representing the change in 
amplitude of the ECG channel  
'due to the change in impedance as the thorax moves towards and 
way from the signal  


















Process(0.0, 482, 0, 1, 402); 
ChanSelect(401,0);  
ChanDelete(401,0);  'make second item non zero, say 1, if you 
want confirm delete  
ChanSelect(402,1);   
ChanSave(402,15);  'Save to unused channel  
ChanDelete(402,0);   
Chanshow(15);   
'---------------------------------------------------------- 
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'This creates an EDR (ECG Derived Respiration) channel, BrCubSpli 
on chan 16  
'that is a cubic spline interpretation of chan 3 the R-wave event 
chan as per Yeon-Sik Noh 
ChanShow(VirtualChan(0, "")); 'Created new virtual channel 0 
VirtualChan(701, "IFc(3,0)", 0, 0.01, 0); 'Edit virtual channel 
making cupic spline  







MeasureToChan(0,"BrCubSpli",3,5,701,5,"0.01",0,1); '4 peak, 5 
trough 
Process(0.0, 512, 0, 1, 401); 
ChanSelect(401,1); 












MeasureToChan(0,"Channel 1",3,5,14,5,"0.001",0,1); '4 peak, 5 
trough 
Process(0.0, 482, 0, 1, 401); 
ChanSelect(14,0); 
ChanSelect(401,1); 




'this bit tidies the cursors up to equate to section that the FFT 









Cursor(2,(cursor(1)+300)); 'Fetch the cursor 
'To look at RR intervals within each breath epoch and look at how 
they vary.  
'could look at sd and if rr int varies by say 5ms or 10ms like 













name$:=FileName$(0); '0-5 options depending on which parts of the 
name you want.  
PrintLog("\n"); 
Printlog(" the file is ",name$); 
Data%:=FrontView(); 
Chan%:=MemChan(2); ' create memory event (2) channel ALL 
ChanShow(Chan%); 
ChanTitle$(Chan%,"All"); ' create mem chan called all with events 




Mem%:=MemChan(2); ' create memory event (2) channel AVG 
ChanShow(mem%); 
ChanTitle$(Mem%,"Avg"); 
CursorActive(0,14, chan%, 4.01, "", "", 1); 'Data points given by 
14, from chan%, ALL 
MeasureX(102,1,"Cursor(0)","0",0); ' measure 102 means Time, 1 is 
chan number for  
measurement 
MeasureY(100,1,"Cursor(0)","0",0); ' measure 100 means Value, 1 is 
chan number for  
measurement, both have no effect until measuretochan used 
trig%:=MeasureToChan(0,"Channel 1",3,14,Chan%,4.012,1,0,1); 
Process(0.0, View(data%).MaxTime(), 0, 1, Trig%); 
repeat 
Time:=NextTime(Trig%,Time); 

















' smoothing the AVG channel 
var filtAVG%; 
var SmoothAvg%; 
filtAVG%:=MemChan(2); ' create memory event (2) channel filtAVG 
ChanTitle$(filtAVG%,"FiltAVG"); ' create mem 
ChanShow(filtAVG%); 
CursorActive(0,14, mem%, 2.01, "", "", 1); 'Data points given by 




measuretochan 0 means  
add new channel 
Process(0.0, View(data%).MaxTime(), 0, 1, SmoothAvg%); 
' need to get cursors to scan each event in FiltAvg, put time in 








ChanData(mem%, ArrSmooth[],0, MaxTime()); ' trying to write event 






ArrFilt(ArrSmooth[], coeff[]); ' five point smoothing of whole 
array 
for i%:= 0 to 98 do 
If ArrSmooth[i%+1]-ArrSmooth[i%]>3 then; ' only put breath 
events back on the  






'This bit to amalgamate the Filtered AVG (FiltAVG) channel and the 
Smooth Channel  
(SmoothAVG%) 
BigDaddy%:=MemChan(2); ' create memory event (2) channel BreathEST 
ChanShow(BigDaddy%); 
ChanTitle$(BigDaddy%,"SmoothFiltAvg"); ' create mem chan called 
BigDaddy% with events  
from 404 405 chan no 406 
MemImport(BigDaddy%,404,0,maxtime()); 
MemImport(BigDaddy%,405,0,maxtime()); 
CursorActive(0,14, BigDaddy%, 4.01, "", "", 1); 'Data points given 
by 14, from chan%, ALL 
MeasureX(102,1,"Cursor(0)","0",0); ' measure 102 means Time, 1 is 
chan number for  
measurement 
MeasureY(100,1,"Cursor(0)","0",0); ' measure 100 means Value, 1 is 
chan number for  
measurement, both have no effect until measuretochan used 
trig2%:=MeasureToChan(0,"Channel 1",3,14,BigDaddy%,4.012,1,0,1); 
Process(0.0, View(data%).MaxTime(), 0, 1, Trig2%); 


























' this bit tidys the cursors up to equate to section that the FFT 











Cursor(2,(cursor(1)+300)); 'Fetch the cursor
'--------------------------------- to do the PSTH from which times 












var BreathTime [500]; 















































v17%:=SetPsth(3,80,0.1,0,408,2,3,0,10); ' trigger channel changed 
from 402 to 404,  
now to 408 equates to AVG to Filt AVG to BreathEst ************* 
WindowVisible(0); 
Process(View(-1).Cursor(1), View(-1).Cursor(2), 1, 1, 0, 408, 1.5, 
0); ' trigger channel  






'To get output of PSTH and calculate RSA like Hand calc of RSA 
excel spread sheet 







PrintLog("Tag","\t","File","\t","Breath Epoch","\t","Mean Vector 
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L","\t","Mean Vector Angle", 
"\t","R-waveCount"); 
for i%:=0 to (SweepCount%-1) do 'reading values into arrays: i% is 
breath epoch, a% is  
R-wave within breath epoch 
For a%:=0 to 10 do 'to look for first 11 (0-10) R-waves in each 
breath cycle '  
        Problem with "10", if less than then 10 get repeats and over 
run!!!!!!!!!!!!!!!!!!! 
'Read all into array then later filter array for Duplicates, only 
using this filtered array for the calc of SD 
chandata%:=RasterGet(801,sweep%,ST,sweeptimes[]); 
BreathTime[i%]:=ST-BinToX(0); ' this is the breath time, 
corresponding to this  






' results in 2 arrays, one holding time of breath epoch and 
the other holding the time of the R-wave in that epoch 
'---------------------------------------------------------- 




sorting Breath time array 
limiting the sort function to the points of  
interest else fills the first lots of array with zeros 
'since it is in ascending order. Alternative was to declare 
function (see 10a) so you can have dynamic array sizes depending 
on SweepCount%. This is better!  
j%:=0; 
for i%:=0 to (SweepCount%-1) do ' Sorting R-wave array out and 
filtering for duplicate values caused by reading overrun above 
'j%:=0; 
For a%:=0 to 10 do 
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'j%:=j%+1; 
if R-waveTime[i%][a%]>0 then 









'getting Breathepoch and converting R-wave events into angles, 
where breath epoch i%+1 - 
Breath epoch i% = 360 degrees  
For i%:=0 to (SweepCount%-1) do ' 
For a%:=0 to j% do 
if R-waveSorted[a%]>BreathTime[i%] and R-
waveSorted[a%]<BreathTime[i%+1] and 
R-waveSorted[a%]<>R-waveSorted[a%+1]then ' need to change if since 
a i swapped 
breathepoch:= BreathTime[i%+1]-BreathTime[i%]; ' calculating 
breath  
epoch and R-wave event as angle 
R-waveangle[i%][R-wavecount%]:=(R-waveSorted[a%]-
BreathTime[i%])/(breathepoch/360); 
'assign to R-wavecount% not j% since we want the breath and R-wave 
tied not the jth iteration 
couplingangle[i%][R-wavecount%]:=R-waveangle[i%][R-wavecount%]; ' 
put this value into a place that does not get zeroed!**use of R-
wavecount% not a% since latter related  
to j% an iterative marker** 
cosrangle[i%][a%]:=cos (R-waveangle[i%][R-
wavecount%]*(4.0*ATan(1.0)/180)); 
'in radians therefore *(4.0*ATan(1.0)/180)is equal to pi/180 
sinrangle[i%][a%]:=sin (R-waveangle[i%][R-
wavecount%]*(4.0*ATan(1.0)/180)); 
'a i switched since arrays are rows by cols, arrsum gives means 
for cols, ie want i to  
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be the columns 
R-wavecount%:=R-wavecount%+1; ' put flag here so it  




'simply add up each cosrangle and sinrangle and divide by R-
wavecount 
next 
if R-wavecount%>0 then 
Xmean:=(costotal/R-wavecount%); 
Ymean:=(sintotal/R-wavecount%); 




meanangle:= atan (Ymean/Xmean); ' radians????? not degrees then  
convert back? 
meanangle:= meanangle*(180/(4.0*ATan(1.0))); 
if Xmean<0 then 
meanangle:=meanangle+180; 
endif 
if meanangle<0 then 
meanangle:=meanangle+360; ' correction for all sinners take cocco,  
positive angle direction anticlock quadrants 
endif 
datafile$:=Right$(name$,12); 















'Now to get the circle stats analysis of the a%th R-wave in each 
breath epoch. To  
investigate the pattern in intervals. Suspect the 5th and 6th R-
wave may show less 
'association to the breath marker than the 0,1,2 etc of each 
breath cycle. 
Printlog ("\n"); 
Printlog ("R-wave No.","\t"," MVL","\t"," MVA","\t","R-wave 
No.","\t","breaths"); 
For a%:=0 to 10 do 
For i%:=0 to (SweepCount%-1) do 
if couplingangle[i%][a%] <> 0 then 
Printlog("breath event at ", "\t",BreathTime[i%], 
"\t","R-wave angle is","\t", 
couplingangle[i%][a%],"\t",R-waveangle[i%][a%],"\t","and a 
is","\t",a%,"\t","and i is","\t",i% 
); 
            cosranglec[i%][a%]:=cos 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); ' do  
            these need to be in radians? Think so 
*(4.0*ATan(1.0)/180)is equal to pi/180 
            sinranglec[i%][a%]:=sin 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); 'a i  
            switched since arrays are rows by cols, arrsum gives 







if breathno%>0 then 
Xmeanc:=(costotalc/breathno%); 
Ymeanc:=(sintotalc/breathno%); 
'NB if working out phi, (mean angle) then if xbar 
is less than 0 then  
                 180+arctan (ybar/xbar) 
rvectorc:= Sqrt((Xmeanc*Xmeanc)+(Ymeanc*Ymeanc)); 




if Xmeanc<0 then 
meananglec:=meananglec+180; 
endif 
if meananglec<0 then 
meananglec:=meananglec+360; ' correction for all sinners take 
cocco, positive angle direction anticlockwise quadrants 
      endif 
      if a% = 0 then 
      Rzero:=rvectorc; 
      endif 
      if a% = 5 then 
      Rfifth:=rvectorc; 
      endif 
if a% = 3 then                                    
Rthird:=rvectorc; 
endif 
















Printlog (" 0:2ratio of first to third R-wave is","\t",Rratio02); 
' add one for zero, ie a=0 is first 
Printlog (" 3:5ratio of 4th to 6th R-wave is","\t",Rratio35); 
'---------------------------------------------------------- 
' to get meanvector for 10 or so breaths---think about using ST as 
no.breath epochs  
and using this divided by 4,3,6 etc? use z  
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' first set of  
breaths.................................................... 
For i%:=0 to (SweepCount%) do 
While i% >= 0 and i% < (z%) do 'try replacing for next i with  
i%:= i%+1; 
if i% < SweepCount% then 
'printlog (breathno%, "\t", SweepCount%, "\t",a%,"\t",i%); 
For a%:=0 to 10 do ' 10 R-waves 
if couplingangle[i%][a%] <> 0 then 
'Printlog("breath event at ", "\t",BreathTime[i%], "\t","R-wave 
angle  
is","\t",couplingangle[i%][a%],"\t",R-waveangle[i%][a%],"\t","and 
a is","\t",a%,"\t","and  
breath is","\t",i%);  
cosranglec[i%][a%]:=cos 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); ' do 
these need to be in radians? Think so *(4.0*ATan(1.0)/180)is equal 
to pi/180 
sinranglec[i%][a%]:=sin 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); 'a i 
  
switched since arrays are rows by cols, arrsum gives means for 












if breathno%>0 then 
Xmeanc:=(costotalc/R-wavecount%); 
Ymeanc:=(sintotalc/R-wavecount%); 
'NB if working out phi, (mean angle) then if xbar is less than 0 
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then 180+arctan (ybar/xbar) 
rvectorc:= Sqrt((Xmeanc*Xmeanc)+(Ymeanc*Ymeanc)); 
meananglec:= atan (Ymeanc/Xmeanc); ' radians????? not degrees then 
convert back? 
meananglec:= meananglec*(180/(4.0*ATan(1.0))); 
if Xmeanc<0 then 
meananglec:=meananglec+180; 
endif 
if meananglec<0 then 
meananglec:=meananglec+360; ' correction for all sinners take 
cocco,  
positive angle direction anticlock quadrants 
endif 
printlog ("\n"); 
Printlog("number of breaths used ","\t", breathno%,"\t","Length of 
mean vector is ", 










' second set of  
breaths...........................................................
.................... 
For i%:=0 to (SweepCount%) do 
While i% >= z% and i%<(2*z%) do 'try replacing for next i with  
while**************************************** 
'For i%:=0 to (SweepCount%) do ' first 10 breaths 
' need a check in here to see if i% is greater than sweep count or 
do until loop 
i%:= i%+1; 
if i% < SweepCount% then 
'printlog (breathno%, "\t", SweepCount%, "\t",a%,"\t",i%); 
For a%:=0 to 10 do ' 10 R-waves 
'endif 
if couplingangle[i%][a%] <> 0 then 
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'Printlog("breath event at ", "\t",BreathTime[i%], 
"\t","R-wave angle  
is","\t",couplingangle[i%][a%],"\t",R-waveangle[i%][a%],"\t","and 
a is","\t",a%,"\t","and  
breath is","\t",i%); 
cosranglec[i%][a%]:=cos 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); ' do  
these need to be in radians? Think so *(4.0*ATan(1.0)/180)is equal 
to pi/180 
sinranglec[i%][a%]:=sin 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); 'a i  
switched since arrays are rows by cols, arrsum gives means for 











if breathno%>0 then 
Xmeanc:=(costotalc/R-wavecount%); 
Ymeanc:=(sintotalc/R-wavecount%); 
'NB if working out phi, (mean angle) then if xbar 
is less than 0 then  
180+arctan (ybar/xbar) 
rvectorc:= Sqrt((Xmeanc*Xmeanc)+(Ymeanc*Ymeanc)); 
meananglec:= atan (Ymeanc/Xmeanc); ' radians????? not degrees then  
convert back? 
meananglec:= meananglec*(180/(4.0*ATan(1.0))); 
if Xmeanc<0 then 
meananglec:=meananglec+180; 
endif 
if meananglec<0 then 
meananglec:=meananglec+360; ' correction for all sinners take 
cocco,  




Printlog("number of breaths used ","\t", breathno%,"\t","Length of 
mean vector is ", 










'third set of  
breaths..........................................................  
For i%:=0 to (SweepCount%) do 
While i% >= 2*z% and i%<(3*z%) do 'try replacing for next i with  
while**************************************** 
'For i%:=0 to (SweepCount%) do ' first 10 breaths 
' need a check in here to see if i% is greater than sweep count or 
do until loop 
i%:= i%+1; 
if i% < SweepCount% then 
'printlog (breathno%, "\t", SweepCount%, "\t",a%,"\t",i%); 
For a%:=0 to 10 do ' 10 R-waves 
'endif 
if couplingangle[i%][a%] <> 0 then 
'Printlog("breath event at ", "\t",BreathTime[i%], 
"\t","R-wave angle  
is","\t",couplingangle[i%][a%],"\t",R-waveangle[i%][a%],"\t","and 
a is","\t",a%,"\t","and  
breath is","\t",i%); 
cosranglec[i%][a%]:=cos 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); ' do  
these need to be in radians? Think so *(4.0*ATan(1.0)/180)is equal 
to pi/180 
sinranglec[i%][a%]:=sin 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); 'a i  
switched since arrays are rows by cols, arrsum gives means for 













if breathno%>0 then 
Xmeanc:=(costotalc/R-wavecount%); 
Ymeanc:=(sintotalc/R-wavecount%); 
'NB if working out phi, (mean angle) then if xbar is less than 0 
then 180+arctan (ybar/xbar) 
rvectorc:= Sqrt((Xmeanc*Xmeanc)+(Ymeanc*Ymeanc)); 
meananglec:= atan (Ymeanc/Xmeanc); ' radians????? not degrees then  
convert back? 
meananglec:= meananglec*(180/(4.0*ATan(1.0))); 
if Xmeanc<0 then 
meananglec:=meananglec+180; 
endif 
if meananglec<0 then 
meananglec:=meananglec+360; ' correction for all sinners take 
cocco,  
positive angle direction anticlock quadrants 
endif 
printlog ("\n"); 
Printlog("number of breaths used ","\t", 
breathno%,"\t","Length of mean vector is ", 












' fourth set of breaths 
For i%:=0 to (SweepCount%) do 
While i% >= 3*z% and i%<(4*z%) do 'try replacing for next i with  
while**************************************** 
'For i%:=0 to (SweepCount%) do ' first 10 breaths 
' need a check in here to see if i% is greater than sweep count or 
do until loop 
i%:= i%+1; 
if i% < SweepCount% then 
'printlog (breathno%, "\t", SweepCount%, "\t",a%,"\t",i%); 
For a%:=0 to 10 do ' 10 R-waves 
'endif 
if couplingangle[i%][a%] <> 0 then 
'Printlog("breath event at ", "\t",BreathTime[i%], 
"\t","R-wave angle  
is","\t",couplingangle[i%][a%],"\t",R-waveangle[i%][a%],"\t","and 
a is","\t",a%,"\t","and  
breath is","\t",i%); 
cosranglec[i%][a%]:=cos 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); ' do  
these need to be in radians? Think so *(4.0*ATan(1.0)/180)is equal 
to pi/180 
sinranglec[i%][a%]:=sin 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); 'a i  
switched since arrays are rows by cols, arrsum gives means for 
















'NB if working out phi, (mean angle) then if xbar 
is less than 0 then  
180+arctan (ybar/xbar) 
rvectorc:= Sqrt((Xmeanc*Xmeanc)+(Ymeanc*Ymeanc)); 
meananglec:= atan (Ymeanc/Xmeanc); ' radians????? not degrees then  
convert back? 
meananglec:= meananglec*(180/(4.0*ATan(1.0))); 
if Xmeanc<0 then 
meananglec:=meananglec+180; 
endif 
if meananglec<0 then 
meananglec:=meananglec+360; ' correction for all sinners take 
cocco,  
positive angle direction anticlock quadrants 
endif 
printlog ("\n"); 
Printlog("number of breaths used ","\t", 
breathno%,"\t","Length of mean vector is ", 










' fifth set of breaths 
For i%:=0 to (SweepCount%) do 
While i% >= 4*z% and i%<(5*z%) do 'try replacing for next i with  
while**************************************** 
'For i%:=0 to (SweepCount%) do ' first 10 breaths 
' need a check in here to see if i% is greater than sweep count or 
do until loop 
i%:= i%+1; 
if i% < SweepCount% then 
'printlog (breathno%, "\t", SweepCount%, "\t",a%,"\t",i%); 
For a%:=0 to 10 do ' 10 R-waves 
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'endif 
if couplingangle[i%][a%] <> 0 then 
'Printlog("breath event at ", "\t",BreathTime[i%], 
"\t","R-wave angle  
is","\t",couplingangle[i%][a%],"\t",R-waveangle[i%][a%],"\t","and 
a is","\t",a%,"\t","and  
breath is","\t",i%); 
cosranglec[i%][a%]:=cos 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); ' do  
these need to be in radians? Think so *(4.0*ATan(1.0)/180)is equal 
to pi/180 
sinranglec[i%][a%]:=sin 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); 'a i  
switched since arrays are rows by cols, arrsum gives means for 












if breathno%>0 then 
Xmeanc:=(costotalc/R-wavecount%); 
Ymeanc:=(sintotalc/R-wavecount%); 
'NB if working out phi, (mean angle) then if xbar 
is less than 0 then  
180+arctan (ybar/xbar) 
rvectorc:= Sqrt((Xmeanc*Xmeanc)+(Ymeanc*Ymeanc)); 
meananglec:= atan (Ymeanc/Xmeanc); ' radians????? not degrees then  
convert back? 
meananglec:= meananglec*(180/(4.0*ATan(1.0))); 
if Xmeanc<0 then 
meananglec:=meananglec+180; 
endif 
if meananglec<0 then 
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meananglec:=meananglec+360; ' correction for all sinners take 
cocco,  
positive angle direction anticlock quadrants 
endif 
printlog ("\n"); 
Printlog("number of breaths used ","\t", 
breathno%,"\t","Length of mean vector is ", 











' sixth set of breaths
For i%:=0 to (SweepCount%) do 
While i% >= 5*z% and i%<(6*z%) do 'try replacing for next i with  
while**************************************** 
'For i%:=0 to (SweepCount%) do ' first 10 breaths 
' need a check in here to see if i% is greater than sweep count or 
do until loop 
i%:= i%+1; 
if i% < SweepCount% then 
'printlog (breathno%, "\t", SweepCount%, "\t",a%,"\t",i%); 
For a%:=0 to 10 do ' 10 R-waves 
'endif 
if couplingangle[i%][a%] <> 0 then 
'Printlog("breath event at ", "\t",BreathTime[i%], 
"\t","R-wave angle  
is","\t",couplingangle[i%][a%],"\t",R-waveangle[i%][a%],"\t","and 
a is","\t",a%,"\t","and  
breath is","\t",i%); 
cosranglec[i%][a%]:=cos 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); ' do  
these need to be in radians? Think so *(4.0*ATan(1.0)/180)is equal 
to pi/180 
sinranglec[i%][a%]:=sin 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); 'a i  
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switched since arrays are rows by cols, arrsum gives means for 












if breathno%>0 then 
Xmeanc:=(costotalc/R-wavecount%); 
Ymeanc:=(sintotalc/R-wavecount%); 
'NB if working out phi, (mean angle) then if xbar 
is less than 0 then  
180+arctan (ybar/xbar) 
rvectorc:= Sqrt((Xmeanc*Xmeanc)+(Ymeanc*Ymeanc)); 
meananglec:= atan (Ymeanc/Xmeanc); ' radians????? not degrees then  
convert back? 
meananglec:= meananglec*(180/(4.0*ATan(1.0))); 
if Xmeanc<0 then 
meananglec:=meananglec+180; 
endif 
if meananglec<0 then 
meananglec:=meananglec+360; ' correction for all sinners take 
cocco,  
positive angle direction anticlock quadrants 
endif 
printlog ("\n"); 
Printlog("number of breaths used ","\t", 
breathno%,"\t","Length of mean vector is ", 












'seventh set of breaths 
For i%:=0 to (SweepCount%) do 
While i% >= 6*z% and i%<(7*z%) do 'try replacing for next i with  
while**************************************** 
'For i%:=0 to (SweepCount%) do ' first 10 breaths 
' need a check in here to see if i% is greater than sweep count or 
do until loop 
i%:= i%+1; 
if i% < SweepCount% then 
'printlog (breathno%, "\t", SweepCount%, "\t",a%,"\t",i%); 
For a%:=0 to 10 do ' 10 R-waves 
'endif 
if couplingangle[i%][a%] <> 0 then 
'Printlog("breath event at ", "\t",BreathTime[i%], 
"\t","R-wave angle  
is","\t",couplingangle[i%][a%],"\t",R-waveangle[i%][a%],"\t","and 
a is","\t",a%,"\t","and  
breath is","\t",i%); 
cosranglec[i%][a%]:=cos 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); ' do  
these need to be in radians? Think so *(4.0*ATan(1.0)/180)is equal 
to pi/180 
sinranglec[i%][a%]:=sin 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); 'a i  
switched since arrays are rows by cols, arrsum gives means for 













if breathno%>0 then 
Xmeanc:=(costotalc/R-wavecount%); 
Ymeanc:=(sintotalc/R-wavecount%); 
'NB if working out phi, (mean angle) then if xbar 
is less than 0 then  
180+arctan (ybar/xbar) 
rvectorc:= Sqrt((Xmeanc*Xmeanc)+(Ymeanc*Ymeanc)); 
meananglec:= atan (Ymeanc/Xmeanc); ' radians????? not degrees then  
convert back? 
meananglec:= meananglec*(180/(4.0*ATan(1.0))); 
if Xmeanc<0 then 
meananglec:=meananglec+180; 
endif 
if meananglec<0 then 
meananglec:=meananglec+360; ' correction for all sinners take 
cocco,  
positive angle direction anticlock quadrants 
endif 
printlog ("\n"); 
Printlog("number of breaths used ","\t", 
breathno%,"\t","Length of mean vector is ", 











'eigth set of breaths
For i%:=0 to (SweepCount%) do 
While i% >= 7*z% and i%<(8*z%) do 'try replacing for next i with  
while**************************************** 
'For i%:=0 to (SweepCount%) do ' first 10 breaths 
' need a check in here to see if i% is greater than sweep count or 
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do until loop 
i%:= i%+1; 
if i% < SweepCount% then 
'printlog (breathno%, "\t", SweepCount%, "\t",a%,"\t",i%); 
For a%:=0 to 10 do ' 10 R-waves 
'endif 
if couplingangle[i%][a%] <> 0 then 
'Printlog("breath event at ", "\t",BreathTime[i%], 
"\t","R-wave angle  
is","\t",couplingangle[i%][a%],"\t",R-waveangle[i%][a%],"\t","and 
a is","\t",a%,"\t","and  
breath is","\t",i%); 
cosranglec[i%][a%]:=cos 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); ' do  
these need to be in radians? Think so *(4.0*ATan(1.0)/180)is equal 
to pi/180 
sinranglec[i%][a%]:=sin 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); 'a i  
switched since arrays are rows by cols, arrsum gives means for 












if breathno%>0 then 
Xmeanc:=(costotalc/R-wavecount%); 
Ymeanc:=(sintotalc/R-wavecount%); 
'NB if working out phi, (mean angle) then if xbar 
is less than 0 then  
180+arctan (ybar/xbar) 
rvectorc:= Sqrt((Xmeanc*Xmeanc)+(Ymeanc*Ymeanc)); 




if Xmeanc<0 then 
meananglec:=meananglec+180; 
endif 
if meananglec<0 then 
meananglec:=meananglec+360; ' correction for all sinners take 
cocco,  
positive angle direction anticlock quadrants 
endif 
printlog ("\n"); 
Printlog("number of breaths used ","\t", 
breathno%,"\t","Length of mean vector is ", 











'ninth set of breaths 
For i%:=0 to (SweepCount%) do 
While i% >= 8*z% and i%<(9*z%) do 'try replacing for next i with  
while**************************************** 
'For i%:=0 to (SweepCount%) do ' first 10 breaths 
' need a check in here to see if i% is greater than sweep count or 
do until loop 
i%:= i%+1; 
if i% < SweepCount% then 
'printlog (breathno%, "\t", SweepCount%, "\t",a%,"\t",i%); 
For a%:=0 to 10 do ' 10 R-waves 
'endif 
if couplingangle[i%][a%] <> 0 then 
'Printlog("breath event at ", "\t",BreathTime[i%], 
"\t","R-wave angle  
is","\t",couplingangle[i%][a%],"\t",R-waveangle[i%][a%],"\t","and 




(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); ' do  
these need to be in radians? Think so *(4.0*ATan(1.0)/180)is equal 
to pi/180 
sinranglec[i%][a%]:=sin 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); 'a i  
switched since arrays are rows by cols, arrsum gives means for 












if breathno%>0 then 
Xmeanc:=(costotalc/R-wavecount%); 
Ymeanc:=(sintotalc/R-wavecount%); 




meananglec:= atan (Ymeanc/Xmeanc); ' radians????? not degrees then  
convert back? 
meananglec:= meananglec*(180/(4.0*ATan(1.0))); 
if Xmeanc<0 then 
meananglec:=meananglec+180; 
endif 
if meananglec<0 then 
meananglec:=meananglec+360; ' correction for all sinners take 
cocco,  
positive angle direction anticlock quadrants 
endif 
printlog ("\n"); 
Printlog("number of breaths used ","\t", 
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breathno%,"\t","Length of mean vector is ", 











'tenth set of breaths 
For i%:=0 to (SweepCount%) do 
While i% >= 9*z% and i%<(10*z%) do 'try replacing for next i with  
while**************************************** 
'For i%:=0 to (SweepCount%) do ' first 10 breaths 
' need a check in here to see if i% is greater than sweep count or 
do until loop 
i%:= i%+1; 
if i% < SweepCount% then 
'printlog (breathno%, "\t", SweepCount%, "\t",a%,"\t",i%); 
For a%:=0 to 10 do ' 10 R-waves 
'endif 
if couplingangle[i%][a%] <> 0 then 
'Printlog("breath event at ", "\t",BreathTime[i%], 
"\t","R-wave angle  
is","\t",couplingangle[i%][a%],"\t",R-waveangle[i%][a%],"\t","and 
a is","\t",a%,"\t","and  
breath is","\t",i%); 
cosranglec[i%][a%]:=cos 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); ' do  
these need to be in radians? Think so *(4.0*ATan(1.0)/180)is equal 
to pi/180 
sinranglec[i%][a%]:=sin 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); 'a i  
switched since arrays are rows by cols, arrsum gives means for 













if breathno%>0 then 
Xmeanc:=(costotalc/R-wavecount%); 
Ymeanc:=(sintotalc/R-wavecount%); 
'NB if working out phi, (mean angle) then if xbar 
is less than 0 then  
180+arctan (ybar/xbar) 
rvectorc:= Sqrt((Xmeanc*Xmeanc)+(Ymeanc*Ymeanc)); 
meananglec:= atan (Ymeanc/Xmeanc); ' radians????? not degrees then  
convert back? 
meananglec:= meananglec*(180/(4.0*ATan(1.0))); 
if Xmeanc<0 then 
meananglec:=meananglec+180; 
endif 
if meananglec<0 then 
meananglec:=meananglec+360; ' correction for all sinners take 
cocco,  
positive angle direction anticlock quadrants 
endif 
printlog ("\n"); 
Printlog("number of breaths used ","\t", 
breathno%,"\t","Length of mean vector is ", 













'Finally do the r vector length for all breaths in file 
For i%:=0 to (SweepCount%) do ' for all breaths 
For a%:=0 to 10 do ' 10 R-waves 
if couplingangle[i%][a%] <> 0 then 
'Printlog("breath event at ", "\t",BreathTime[i%], "\t","R-
wave angle  
is","\t",couplingangle[i%][a%],"\t",R-waveangle[i%][a%],"\t","and 
a is","\t",a%,"\t","and  
breath is","\t",i%); 
cosranglec[i%][a%]:=cos 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); '  
these need to be in radians, so *(4.0*ATan(1.0)/180)is equal to 
pi/180 
sinranglec[i%][a%]:=sin 
(couplingangle[i%][a%]*(4.0*ATan(1.0)/180)); 'a i switched since 









if breathno%>0 then 
Xmeanc:=(costotalc/R-wavecount%); 
Ymeanc:=(sintotalc/R-wavecount%); 
'NB if working out phi, (mean angle) then if xbar is less than 0 
then 180+arctan (ybar/xbar) 
rvectorc:= Sqrt((Xmeanc*Xmeanc)+(Ymeanc*Ymeanc)); 
meananglec:= atan (Ymeanc/Xmeanc); ' radians????? not degrees then  
convert back 
meananglec:= meananglec*(180/(4.0*ATan(1.0))); 
if Xmeanc<0 then 
meananglec:=meananglec+180; 
endif 
if meananglec<0 then 
meananglec:=meananglec+360; ' correction for all sinners take 




Printlog("For all breaths in file","\t","\t","Length of 
mean vector is ", "\t", 
rvectorc, "\t","mean vector angle all 
breaths","\t",meananglec,"\t","and R-wavecount","\t", 
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Appendix 1.6 Frequency response of 5 point filter of Methods section of chapter 5  
Code used 
to visualise the frequency response of the 5 point FIR filter used: 
'$FiltResp|Five point smoothing filter response 
const nr% := 201; 
const sampleRate := 1;    ' sample rate ,in Hz 
var c[5], r[nr%], rv%; 
ArrConst(c, 0.2); 
FIRResponse(r, c, 0);       'calc in dB (use 1 for linear) 
rv% := SetResult(nr%, 0.5*sampleRate/(nr%-1), 0, "Five point smooth; response", "Hz", "db", 
"Frequency", "Response"); 
ArrConst([], r); 
YRange(1, -50, 0);          ' show from 0 to -50 dB
'XAxisAttrib(1);             ' log x axis 
DrawMode(1, 2);             ' draw as lines 
WindowVisible(1); 
This filter was applied to an array holding the breath event times and not a waveform. 
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Appendix 1.7.  Typical output from the program of appendix 1.5 
the file is F:\HRV PhD\Chapter 4 Breath to breath HRV\Chapter 4 Breath files\Human\IPEM2005 Data\8sepha.smr  
48          
4          
          
Tag File   Breath Epoch Mean Vector L Mean Vector Angle R-waveCount  
 a\8sepha 12.1301 0.0284924 75.3434 6   
 a\8sepha 17.9314 0.040115 29.437 7     
 a\8sepha 23.6141 0.046812 269.244 7   
 a\8sepha 29.7239 0.0221929 4.87478 7   
 a\8sepha 35.9993 0.165211 185.922 6   
 a\8sepha 42.1202 0.0760197 300.025 7   
 a\8sepha 48.1829 0.0900342 213.06 6     
 a\8sepha 54.631 0.0617061 313.936 9   
 a\8sepha 62.9264 0.0286147 178.665 7   
 a\8sepha 69.5369 0.0576897 202.806 9   
 a\8sepha 77.7709 0.0520453 292.591 8   
 a\8sepha 84.2949 0.0421581 175.196 8   
 a\8sepha 91.5581 0.0293583 5.47823 10   
 a\8sepha 99.7776 0.0356867 359.521 9   
 a\8sepha 106.746 0.0185659 194.539 8   
 a\8sepha 113.343 0.0633714 172.28 8     
 a\8sepha 120.28 0.0426859 235.124 7   
 a\8sepha 125.879 0.0397911 165.013 7   
 a\8sepha 131.841 0.0464012 17.1697 6   
 a\8sepha 136.734 0.0865041 163.685 6   
 a\8sepha 142.17 0.0578009 321.279 8   
 a\8sepha 148.017 0.0686742 18.0934 7   
 a\8sepha 153.713 0.0105351 218.542 7   
 a\8sepha 160.388 0.0370761 221.241 8   
 a\8sepha 167.841 0.0326369 76.5668 6   
 a\8sepha 173.508 0.0504545 186.996 7   
 a\8sepha 180.533 0.0543148 191.06 6     
 a\8sepha 186.337 0.0971209 10.3465 6   
 a\8sepha 191.562 0.105765 195.106 6   
 a\8sepha 197.806 0.0457473 7.64085 7   
 a\8sepha 204.194 0.0452931 303.313 7   
 a\8sepha 210.721 0.0232243 178.374 6   
 a\8sepha 216.619 0.111569 154.533 5   
 a\8sepha 221.692 0.0260952 275.928 7   
 a\8sepha 228.021 0.0196621 132.577 6   
 a\8sepha 233.392 0.0317281 313.656 8   
 a\8sepha 240.78 0.0271502 295.223 7   
 a\8sepha 247.22 0.0640824 1.66014 7   
 a\8sepha 253.491 0.067634 185.146 6   
 a\8sepha 259.459 0.0688713 350.858 8   
 a\8sepha 266.241 0.00288451 263.071 8   
 a\8sepha 273.203 0.0513336 204.502 7   
 a\8sepha 280.226 0.0159257 174.383 7   
 a\8sepha 286.724 0.0952894 147.078 5   
 a\8sepha 291.918 0.354072 114.345 9   
 a\8sepha 303.55 0.0368578 207.285 7   
          
  breath event at  12.1301 R-wave angle is 13.0247 13.0247 R-Wave position is 0 Breath number is 0  
breath event at  17.9314 R-wave angle is 4.66132 4.66132 R-Wave position is 0 Breath number is 1  
breath event at  23.6141 R-wave angle is 39.0594 39.0594 R-Wave position is 0 Breath number is 2  
breath event at  29.7239 R-wave angle is 39.9347 39.9347 R-Wave position is 0 Breath number is 3  
breath event at  35.9993 R-wave angle is 53.622 53.622 R-Wave position is 0 Breath number is 4  
breath event at  42.1202 R-wave angle is 14.9518 14.9518 R-Wave position is 0 Breath number is 5  
breath event at  48.1829 R-wave angle is 25.6875 25.6875 R-Wave position is 0 Breath number is 6  
breath event at  54.631 R-wave angle is 0.563303 0.563303 R-Wave position is 0 Breath number is 7  
breath event at  62.9264 R-wave angle is 29.7138 29.7138 R-Wave position is 0 Breath number is 8  
breath event at  69.5369 R-wave angle is 25.2324 25.2324 R-Wave position is 0 Breath number is 9  
breath event at  77.7709 R-wave angle is 10.2161 10.2161 R-Wave position is 0 Breath number is 10  
breath event at  84.2949 R-wave angle is 27.7604 27.7604 R-Wave position is 0 Breath number is 11  
breath event at  91.5581 R-wave angle is 7.13513 7.13513 R-Wave position is 0 Breath number is 12  
breath event at  99.7776 R-wave angle is 19.0303 19.0303 R-Wave position is 0 Breath number is 13  
breath event at  106.746 R-wave angle is 40.2833 40.2833 R-Wave position is 0 Breath number is 14  
breath event at  113.343 R-wave angle is 31.8713 31.8713 R-Wave position is 0 Breath number is 15  
breath event at  120.28 R-wave angle is 13.5382 13.5382 R-Wave position is 0 Breath number is 16  
breath event at  125.879 R-wave angle is 12.7245 12.7245 R-Wave position is 0 Breath number is 17  
breath event at  131.841 R-wave angle is 13.5411 13.5411 R-Wave position is 0 Breath number is 18  
breath event at  136.734 R-wave angle is 37.8285 37.8285 R-Wave position is 0 Breath number is 19  
breath event at  142.17 R-wave angle is 20.7606 20.7606 R-Wave position is 0 Breath number is 20  
breath event at  148.017 R-wave angle is 37.4658 37.4658 R-Wave position is 0 Breath number is 21  
breath event at  153.713 R-wave angle is 43.9944 43.9944 R-Wave position is 0 Breath number is 22  
breath event at  160.388 R-wave angle is 34.3572 34.3572 R-Wave position is 0 Breath number is 23  
breath event at  167.841 R-wave angle is 36.4986 36.4986 R-Wave position is 0 Breath number is 24  
breath event at  173.508 R-wave angle is 35.7589 35.7589 R-Wave position is 0 Breath number is 25  
breath event at  180.533 R-wave angle is 22.1709 22.1709 R-Wave position is 0 Breath number is 26  
breath event at  186.337 R-wave angle is 22.1181 22.1181 R-Wave position is 0 Breath number is 27  
breath event at  191.562 R-wave angle is 49.506 49.506 R-Wave position is 0 Breath number is 28  
breath event at  197.806 R-wave angle is 17.3752 17.3752 R-Wave position is 0 Breath number is 29  
breath event at  204.194 R-wave angle is 34.9856 34.9856 R-Wave position is 0 Breath number is 30  
breath event at  210.721 R-wave angle is 39.4709 39.4709 R-Wave position is 0 Breath number is 31  
breath event at  216.619 R-wave angle is 37.8061 37.8061 R-Wave position is 0 Breath number is 32  
breath event at  221.692 R-wave angle is 0.0290101 0.0290101 R-Wave position is 0 Breath number is 34 
breath event at  228.021 R-wave angle is 8.42505 8.42505 R-Wave position is 0 Breath number is 35  
breath event at  233.392 R-wave angle is 6.57817 6.57817 R-Wave position is 0 Breath number is 36  
breath event at  240.78 R-wave angle is 15.2287 15.2287 R-Wave position is 0 Breath number is 37  
breath event at  247.22 R-wave angle is 17.8915 17.8915 R-Wave position is 0 Breath number is 38  
breath event at  253.491 R-wave angle is 37.1003 37.1003 R-Wave position is 0 Breath number is 39  
breath event at  259.459 R-wave angle is 17.1525 17.1525 R-Wave position is 0 Breath number is 40  
breath event at  266.241 R-wave angle is 38.6871 38.6871 R-Wave position is 0 Breath number is 41  
breath event at  273.203 R-wave angle is 43.0483 43.0483 R-Wave position is 0 Breath number is 42  
breath event at  280.226 R-wave angle is 27.2805 27.2805 R-Wave position is 0 Breath number is 43  
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breath event at  286.724 R-wave angle is 32.9154 32.9154 R-Wave position is 0 Breath number is 44  
breath event at  291.918 R-wave angle is 1.9949 1.9949 R-Wave position is 0 Breath number is 45  
breath event at  303.55 R-wave angle is 27.0432 27.0432 R-Wave position is 0 Breath number is 46  
0 0.97155 25.3597 1 46      
breath event at  12.1301 R-wave angle is 64.5303 64.5303 R-Wave position is 1 Breath number is 0  
breath event at  17.9314 R-wave angle is 61.2966 61.2966 R-Wave position is 1 Breath number is 1  
breath event at  23.6141 R-wave angle is 96.3316 96.3316 R-Wave position is 1 Breath number is 2  
breath event at  29.7239 R-wave angle is 94.7198 94.7198 R-Wave position is 1 Breath number is 3  
breath event at  35.9993 R-wave angle is 107.261 107.261 R-Wave position is 1 Breath number is 4  
breath event at  42.1202 R-wave angle is 75.1626 75.1626 R-Wave position is 1 Breath number is 5  
breath event at  48.1829 R-wave angle is 92.3488 92.3488 R-Wave position is 1 Breath number is 6  
breath event at  54.631 R-wave angle is 44.1346 44.1346 R-Wave position is 1 Breath number is 7  
breath event at  62.9264 R-wave angle is 83.9548 83.9548 R-Wave position is 1 Breath number is 8  
breath event at  69.5369 R-wave angle is 66.5053 66.5053 R-Wave position is 1 Breath number is 9  
breath event at  77.7709 R-wave angle is 65.1206 65.1206 R-Wave position is 1 Breath number is 10  
breath event at  84.2949 R-wave angle is 69.3456 69.3456 R-Wave position is 1 Breath number is 11  
breath event at  91.5581 R-wave angle is 45.0204 45.0204 R-Wave position is 1 Breath number is 12  
breath event at  99.7776 R-wave angle is 61.6527 61.6527 R-Wave position is 1 Breath number is 13  
breath event at  106.746 R-wave angle is 84.0487 84.0487 R-Wave position is 1 Breath number is 14  
breath event at  113.343 R-wave angle is 74.3699 74.3699 R-Wave position is 1 Breath number is 15  
breath event at  120.28 R-wave angle is 66.3921 66.3921 R-Wave position is 1 Breath number is 16  
breath event at  125.879 R-wave angle is 65.5619 65.5619 R-Wave position is 1 Breath number is 17  
breath event at  131.841 R-wave angle is 77.7739 77.7739 R-Wave position is 1 Breath number is 18  
breath event at  136.734 R-wave angle is 95.9742 95.9742 R-Wave position is 1 Breath number is 19  
breath event at  142.17 R-wave angle is 72.4759 72.4759 R-Wave position is 1 Breath number is 20  
breath event at  148.017 R-wave angle is 85.6245 85.6245 R-Wave position is 1 Breath number is 21  
breath event at  153.713 R-wave angle is 90.0039 90.0039 R-Wave position is 1 Breath number is 22  
breath event at  160.388 R-wave angle is 76.8588 76.8588 R-Wave position is 1 Breath number is 23  
breath event at  167.841 R-wave angle is 96.85 96.85 R-Wave position is 1 Breath number is 24  
breath event at  173.508 R-wave angle is 82.9611 82.9611 R-Wave position is 1 Breath number is 25  
breath event at  180.533 R-wave angle is 85.1849 85.1849 R-Wave position is 1 Breath number is 26  
breath event at  186.337 R-wave angle is 89.9776 89.9776 R-Wave position is 1 Breath number is 27  
breath event at  191.562 R-wave angle is 104.228 104.228 R-Wave position is 1 Breath number is 28  
breath event at  197.806 R-wave angle is 74.126 74.126 R-Wave position is 1 Breath number is 29  
breath event at  204.194 R-wave angle is 88.2048 88.2048 R-Wave position is 1 Breath number is 30  
breath event at  210.721 R-wave angle is 100.449 100.449 R-Wave position is 1 Breath number is 31  
breath event at  216.619 R-wave angle is 99.3286 99.3286 R-Wave position is 1 Breath number is 32  
breath event at  221.692 R-wave angle is 50.8821 50.8821 R-Wave position is 1 Breath number is 34  
breath event at  228.021 R-wave angle is 71.6347 71.6347 R-Wave position is 1 Breath number is 35  
breath event at  233.392 R-wave angle is 49.9973 49.9973 R-Wave position is 1 Breath number is 36  
breath event at  240.78 R-wave angle is 65.9242 65.9242 R-Wave position is 1 Breath number is 37  
breath event at  247.22 R-wave angle is 68.3555 68.3555 R-Wave position is 1 Breath number is 38  
breath event at  253.491 R-wave angle is 97.3627 97.3627 R-Wave position is 1 Breath number is 39  
breath event at  259.459 R-wave angle is 65.0328 65.0328 R-Wave position is 1 Breath number is 40  
breath event at  266.241 R-wave angle is 82.8436 82.8436 R-Wave position is 1 Breath number is 41  
breath event at  273.203 R-wave angle is 88.5721 88.5721 R-Wave position is 1 Breath number is 42  
breath event at  280.226 R-wave angle is 76.1955 76.1955 R-Wave position is 1 Breath number is 43  
breath event at  286.724 R-wave angle is 97.5901 97.5901 R-Wave position is 1 Breath number is 44  
breath event at  291.918 R-wave angle is 29.3219 29.3219 R-Wave position is 1 Breath number is 45  
breath event at  303.55 R-wave angle is 75.37 75.37 R-Wave position is 1 Breath number is 46  
1 0.956232 77.4528 1 46      
breath event at  12.1301 R-wave angle is 123.172 123.172 R-Wave position is 2 Breath number is 0  
breath event at  17.9314 R-wave angle is 114.638 114.638 R-Wave position is 2 Breath number is 1  
breath event at  23.6141 R-wave angle is 151.306 151.306 R-Wave position is 2 Breath number is 2  
breath event at  29.7239 R-wave angle is 148.759 148.759 R-Wave position is 2 Breath number is 3  
breath event at  35.9993 R-wave angle is 160.077 160.077 R-Wave position is 2 Breath number is 4  
breath event at  42.1202 R-wave angle is 133.473 133.473 R-Wave position is 2 Breath number is 5  
breath event at  48.1829 R-wave angle is 151.529 151.529 R-Wave position is 2 Breath number is 6  
breath event at  54.631 R-wave angle is 88.6607 88.6607 R-Wave position is 2 Breath number is 7  
breath event at  62.9264 R-wave angle is 135.309 135.309 R-Wave position is 2 Breath number is 8  
breath event at  69.5369 R-wave angle is 104.805 104.805 R-Wave position is 2 Breath number is 9  
breath event at  77.7709 R-wave angle is 116.99 116.99 R-Wave position is 2 Breath number is 10  
breath event at  84.2949 R-wave angle is 110.435 110.435 R-Wave position is 2 Breath number is 11  
breath event at  91.5581 R-wave angle is 80.6719 80.6719 R-Wave position is 2 Breath number is 12  
breath event at  99.7776 R-wave angle is 103.81 103.81 R-Wave position is 2 Breath number is 13  
breath event at  106.746 R-wave angle is 127.105 127.105 R-Wave position is 2 Breath number is 14  
breath event at  113.343 R-wave angle is 115.415 115.415 R-Wave position is 2 Breath number is 15  
breath event at  120.28 R-wave angle is 122.268 122.268 R-Wave position is 2 Breath number is 16  
breath event at  125.879 R-wave angle is 116.105 116.105 R-Wave position is 2 Breath number is 17  
breath event at  131.841 R-wave angle is 138.401 138.401 R-Wave position is 2 Breath number is 18  
breath event at  136.734 R-wave angle is 149.153 149.153 R-Wave position is 2 Breath number is 19  
breath event at  142.17 R-wave angle is 123.883 123.883 R-Wave position is 2 Breath number is 20  
breath event at  148.017 R-wave angle is 139.724 139.724 R-Wave position is 2 Breath number is 21  
breath event at  153.713 R-wave angle is 149.93 149.93 R-Wave position is 2 Breath number is 22  
breath event at  160.388 R-wave angle is 122.307 122.307 R-Wave position is 2 Breath number is 23  
breath event at  167.841 R-wave angle is 154.089 154.089 R-Wave position is 2 Breath number is 24  
breath event at  173.508 R-wave angle is 132.06 132.06 R-Wave position is 2 Breath number is 25  
breath event at  180.533 R-wave angle is 144.416 144.416 R-Wave position is 2 Breath number is 26  
breath event at  186.337 R-wave angle is 154.806 154.806 R-Wave position is 2 Breath number is 27  
breath event at  191.562 R-wave angle is 161.025 161.025 R-Wave position is 2 Breath number is 28  
breath event at  197.806 R-wave angle is 127.89 127.89 R-Wave position is 2 Breath number is 29  
breath event at  204.194 R-wave angle is 143.961 143.961 R-Wave position is 2 Breath number is 30  
breath event at  210.721 R-wave angle is 159.168 159.168 R-Wave position is 2 Breath number is 31  
breath event at  216.619 R-wave angle is 161.915 161.915 R-Wave position is 2 Breath number is 32  
breath event at  221.692 R-wave angle is 107.367 107.367 R-Wave position is 2 Breath number is 34  
breath event at  228.021 R-wave angle is 128.61 128.61 R-Wave position is 2 Breath number is 35  
breath event at  233.392 R-wave angle is 98.728 98.728 R-Wave position is 2 Breath number is 36  
breath event at  240.78 R-wave angle is 119.861 119.861 R-Wave position is 2 Breath number is 37  
breath event at  247.22 R-wave angle is 119.968 119.968 R-Wave position is 2 Breath number is 38  
breath event at  253.491 R-wave angle is 154.911 154.911 R-Wave position is 2 Breath number is 39  
breath event at  259.459 R-wave angle is 116.045 116.045 R-Wave position is 2 Breath number is 40  
breath event at  266.241 R-wave angle is 131.292 131.292 R-Wave position is 2 Breath number is 41  
breath event at  273.203 R-wave angle is 140.197 140.197 R-Wave position is 2 Breath number is 42  
breath event at  280.226 R-wave angle is 126.329 126.329 R-Wave position is 2 Breath number is 43  
breath event at  286.724 R-wave angle is 159.839 159.839 R-Wave position is 2 Breath number is 44  
breath event at  291.918 R-wave angle is 57.732 57.732 R-Wave position is 2 Breath number is 45  
breath event at  303.55 R-wave angle is 126.63 126.63 R-Wave position is 2 Breath number is 46  
2 0.926806 129.886 1 46      
breath event at  12.1301 R-wave angle is 184.979 184.979 R-Wave position is 3 Breath number is 0  
breath event at  17.9314 R-wave angle is 165.761 165.761 R-Wave position is 3 Breath number is 1  
breath event at  23.6141 R-wave angle is 202.745 202.745 R-Wave position is 3 Breath number is 2  
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breath event at  29.7239 R-wave angle is 199.988 199.988 R-Wave position is 3 Breath number is 3  
breath event at  35.9993 R-wave angle is 210.069 210.069 R-Wave position is 3 Breath number is 4  
breath event at  42.1202 R-wave angle is 189.29 189.29 R-Wave position is 3 Breath number is 5  
breath event at  48.1829 R-wave angle is 206.857 206.857 R-Wave position is 3 Breath number is 6  
breath event at  54.631 R-wave angle is 133.751 133.751 R-Wave position is 3 Breath number is 7  
breath event at  62.9264 R-wave angle is 183.451 183.451 R-Wave position is 3 Breath number is 8  
breath event at  69.5369 R-wave angle is 142.711 142.711 R-Wave position is 3 Breath number is 9  
breath event at  77.7709 R-wave angle is 164.335 164.335 R-Wave position is 3 Breath number is 10  
breath event at  84.2949 R-wave angle is 153.408 153.408 R-Wave position is 3 Breath number is 11  
breath event at  91.5581 R-wave angle is 115.885 115.885 R-Wave position is 3 Breath number is 12  
breath event at  99.7776 R-wave angle is 145.864 145.864 R-Wave position is 3 Breath number is 13  
breath event at  106.746 R-wave angle is 171.361 171.361 R-Wave position is 3 Breath number is 14  
breath event at  113.343 R-wave angle is 156.513 156.513 R-Wave position is 3 Breath number is 15  
breath event at  120.28 R-wave angle is 174.093 174.093 R-Wave position is 3 Breath number is 16  
breath event at  125.879 R-wave angle is 164.232 164.232 R-Wave position is 3 Breath number is 17  
breath event at  131.841 R-wave angle is 199.765 199.765 R-Wave position is 3 Breath number is 18  
breath event at  136.734 R-wave angle is 202.067 202.067 R-Wave position is 3 Breath number is 19  
breath event at  142.17 R-wave angle is 172.52 172.52 R-Wave position is 3 Breath number is 20  
breath event at  148.017 R-wave angle is 197.236 197.236 R-Wave position is 3 Breath number is 21  
breath event at  153.713 R-wave angle is 195.885 195.885 R-Wave position is 3 Breath number is 22  
breath event at  160.388 R-wave angle is 168.72 168.72 R-Wave position is 3 Breath number is 23  
breath event at  167.841 R-wave angle is 213.741 213.741 R-Wave position is 3 Breath number is 24  
breath event at  173.508 R-wave angle is 182.696 182.696 R-Wave position is 3 Breath number is 25  
breath event at  180.533 R-wave angle is 199.739 199.739 R-Wave position is 3 Breath number is 26  
breath event at  186.337 R-wave angle is 220.943 220.943 R-Wave position is 3 Breath number is 27  
breath event at  191.562 R-wave angle is 215.977 215.977 R-Wave position is 3 Breath number is 28  
breath event at  197.806 R-wave angle is 179.569 179.569 R-Wave position is 3 Breath number is 29  
breath event at  204.194 R-wave angle is 198.559 198.559 R-Wave position is 3 Breath number is 30  
breath event at  210.721 R-wave angle is 215.812 215.812 R-Wave position is 3 Breath number is 31  
breath event at  216.619 R-wave angle is 230.96 230.96 R-Wave position is 3 Breath number is 32  
breath event at  221.692 R-wave angle is 160.836 160.836 R-Wave position is 3 Breath number is 34  
breath event at  228.021 R-wave angle is 186.123 186.123 R-Wave position is 3 Breath number is 35  
breath event at  233.392 R-wave angle is 147.946 147.946 R-Wave position is 3 Breath number is 36  
breath event at  240.78 R-wave angle is 175.475 175.475 R-Wave position is 3 Breath number is 37  
breath event at  247.22 R-wave angle is 177.206 177.206 R-Wave position is 3 Breath number is 38  
breath event at  253.491 R-wave angle is 208.296 208.296 R-Wave position is 3 Breath number is 39  
breath event at  259.459 R-wave angle is 167.535 167.535 R-Wave position is 3 Breath number is 40  
breath event at  266.241 R-wave angle is 176.999 176.999 R-Wave position is 3 Breath number is 41  
breath event at  273.203 R-wave angle is 192.334 192.334 R-Wave position is 3 Breath number is 42  
breath event at  280.226 R-wave angle is 178.291 178.291 R-Wave position is 3 Breath number is 43  
breath event at  286.724 R-wave angle is 228.603 228.603 R-Wave position is 3 Breath number is 44  
breath event at  291.918 R-wave angle is 87.1324 87.1324 R-Wave position is 3 Breath number is 45  
breath event at  303.55 R-wave angle is 180.505 180.505 R-Wave position is 3 Breath number is 46  
3 0.886365 181.964 1 46      
breath event at  12.1301 R-wave angle is 245.545 245.545 R-Wave position is 4 Breath number is 0  
breath event at  17.9314 R-wave angle is 216.252 216.252 R-Wave position is 4 Breath number is 1  
breath event at  23.6141 R-wave angle is 251.297 251.297 R-Wave position is 4 Breath number is 2  
breath event at  29.7239 R-wave angle is 252.134 252.134 R-Wave position is 4 Breath number is 3  
breath event at  35.9993 R-wave angle is 260.003 260.003 R-Wave position is 4 Breath number is 4  
breath event at  42.1202 R-wave angle is 240.534 240.534 R-Wave position is 4 Breath number is 5  
breath event at  48.1829 R-wave angle is 259.56 259.56 R-Wave position is 4 Breath number is 6  
breath event at  54.631 R-wave angle is 177.409 177.409 R-Wave position is 4 Breath number is 7  
breath event at  62.9264 R-wave angle is 231.266 231.266 R-Wave position is 4 Breath number is 8  
breath event at  69.5369 R-wave angle is 182.454 182.454 R-Wave position is 4 Breath number is 9  
breath event at  77.7709 R-wave angle is 208.038 208.038 R-Wave position is 4 Breath number is 10  
breath event at  84.2949 R-wave angle is 199.355 199.355 R-Wave position is 4 Breath number is 11  
breath event at  91.5581 R-wave angle is 151.975 151.975 R-Wave position is 4 Breath number is 12  
breath event at  99.7776 R-wave angle is 187.608 187.608 R-Wave position is 4 Breath number is 13  
breath event at  106.746 R-wave angle is 217.146 217.146 R-Wave position is 4 Breath number is 14  
breath event at  113.343 R-wave angle is 199.115 199.115 R-Wave position is 4 Breath number is 15  
breath event at  120.28 R-wave angle is 222.189 222.189 R-Wave position is 4 Breath number is 16  
breath event at  125.879 R-wave angle is 212.42 212.42 R-Wave position is 4 Breath number is 17  
breath event at  131.841 R-wave angle is 263.335 263.335 R-Wave position is 4 Breath number is 18  
breath event at  136.734 R-wave angle is 259.285 259.285 R-Wave position is 4 Breath number is 19  
breath event at  142.17 R-wave angle is 218.51 218.51 R-Wave position is 4 Breath number is 20  
breath event at  148.017 R-wave angle is 253.611 253.611 R-Wave position is 4 Breath number is 21  
breath event at  153.713 R-wave angle is 245.616 245.616 R-Wave position is 4 Breath number is 22  
breath event at  160.388 R-wave angle is 213.154 213.154 R-Wave position is 4 Breath number is 23  
breath event at  167.841 R-wave angle is 277.714 277.714 R-Wave position is 4 Breath number is 24  
breath event at  173.508 R-wave angle is 231.999 231.999 R-Wave position is 4 Breath number is 25  
breath event at  180.533 R-wave angle is 254.256 254.256 R-Wave position is 4 Breath number is 26  
breath event at  186.337 R-wave angle is 288.114 288.114 R-Wave position is 4 Breath number is 27  
breath event at  191.562 R-wave angle is 267.989 267.989 R-Wave position is 4 Breath number is 28  
breath event at  197.806 R-wave angle is 233.163 233.163 R-Wave position is 4 Breath number is 29  
breath event at  204.194 R-wave angle is 250.123 250.123 R-Wave position is 4 Breath number is 30  
breath event at  210.721 R-wave angle is 275.448 275.448 R-Wave position is 4 Breath number is 31  
breath event at  216.619 R-wave angle is 296.669 296.669 R-Wave position is 4 Breath number is 32  
breath event at  221.692 R-wave angle is 210.722 210.722 R-Wave position is 4 Breath number is 34  
breath event at  228.021 R-wave angle is 246.115 246.115 R-Wave position is 4 Breath number is 35  
breath event at  233.392 R-wave angle is 193.412 193.412 R-Wave position is 4 Breath number is 36  
breath event at  240.78 R-wave angle is 226.115 226.115 R-Wave position is 4 Breath number is 37  
breath event at  247.22 R-wave angle is 234.387 234.387 R-Wave position is 4 Breath number is 38  
breath event at  253.491 R-wave angle is 264.396 264.396 R-Wave position is 4 Breath number is 39  
breath event at  259.459 R-wave angle is 213.557 213.557 R-Wave position is 4 Breath number is 40  
breath event at  266.241 R-wave angle is 220.225 220.225 R-Wave position is 4 Breath number is 41  
breath event at  273.203 R-wave angle is 239.498 239.498 R-Wave position is 4 Breath number is 42  
breath event at  280.226 R-wave angle is 229.754 229.754 R-Wave position is 4 Breath number is 43  
breath event at  286.724 R-wave angle is 299.516 299.516 R-Wave position is 4 Breath number is 44  
breath event at  291.918 R-wave angle is 115.604 115.604 R-Wave position is 4 Breath number is 45  
breath event at  303.55 R-wave angle is 228.085 228.085 R-Wave position is 4 Breath number is 46  
4 0.83099 233.377 1 46      
breath event at  12.1301 R-wave angle is 306.607 306.607 R-Wave position is 5 Breath number is 0  
breath event at  17.9314 R-wave angle is 272.127 272.127 R-Wave position is 5 Breath number is 1  
breath event at  23.6141 R-wave angle is 298.257 298.257 R-Wave position is 5 Breath number is 2  
breath event at  29.7239 R-wave angle is 304.911 304.911 R-Wave position is 5 Breath number is 3  
breath event at  35.9993 R-wave angle is 314.172 314.172 R-Wave position is 5 Breath number is 4  
breath event at  42.1202 R-wave angle is 287.86 287.86 R-Wave position is 5 Breath number is 5  
breath event at  48.1829 R-wave angle is 309.752 309.752 R-Wave position is 5 Breath number is 6  
breath event at  54.631 R-wave angle is 218.203 218.203 R-Wave position is 5 Breath number is 7  
breath event at  62.9264 R-wave angle is 283.546 283.546 R-Wave position is 5 Breath number is 8  
breath event at  69.5369 R-wave angle is 220.754 220.754 R-Wave position is 5 Breath number is 9  
340
breath event at  77.7709 R-wave angle is 251.409 251.409 R-Wave position is 5 Breath number is 10  
breath event at  84.2949 R-wave angle is 242.774 242.774 R-Wave position is 5 Breath number is 11  
breath event at  91.5581 R-wave angle is 191.262 191.262 R-Wave position is 5 Breath number is 12  
breath event at  99.7776 R-wave angle is 228.423 228.423 R-Wave position is 5 Breath number is 13  
breath event at  106.746 R-wave angle is 260.911 260.911 R-Wave position is 5 Breath number is 14  
breath event at  113.343 R-wave angle is 243.43 243.43 R-Wave position is 5 Breath number is 15  
breath event at  120.28 R-wave angle is 269.192 269.192 R-Wave position is 5 Breath number is 16  
breath event at  125.879 R-wave angle is 262.781 262.781 R-Wave position is 5 Breath number is 17  
breath event at  131.841 R-wave angle is 332.498 332.498 R-Wave position is 5 Breath number is 18  
breath event at  136.734 R-wave angle is 321.934 321.934 R-Wave position is 5 Breath number is 19  
breath event at  142.17 R-wave angle is 262.468 262.468 R-Wave position is 5 Breath number is 20  
breath event at  148.017 R-wave angle is 306.004 306.004 R-Wave position is 5 Breath number is 21  
breath event at  153.713 R-wave angle is 298.638 298.638 R-Wave position is 5 Breath number is 22  
breath event at  160.388 R-wave angle is 254.206 254.206 R-Wave position is 5 Breath number is 23  
breath event at  167.841 R-wave angle is 343.274 343.274 R-Wave position is 5 Breath number is 24  
breath event at  173.508 R-wave angle is 279.099 279.099 R-Wave position is 5 Breath number is 25  
breath event at  180.533 R-wave angle is 314.107 314.107 R-Wave position is 5 Breath number is 26  
breath event at  186.337 R-wave angle is 354.733 354.733 R-Wave position is 5 Breath number is 27  
breath event at  191.562 R-wave angle is 320.692 320.692 R-Wave position is 5 Breath number is 28  
breath event at  197.806 R-wave angle is 289.971 289.971 R-Wave position is 5 Breath number is 29  
breath event at  204.194 R-wave angle is 297.386 297.386 R-Wave position is 5 Breath number is 30  
breath event at  210.721 R-wave angle is 337.036 337.036 R-Wave position is 5 Breath number is 31  
breath event at  221.692 R-wave angle is 259.869 259.869 R-Wave position is 5 Breath number is 34  
breath event at  228.021 R-wave angle is 309.727 309.727 R-Wave position is 5 Breath number is 35  
breath event at  233.392 R-wave angle is 237.123 237.123 R-Wave position is 5 Breath number is 36  
breath event at  240.78 R-wave angle is 274.519 274.519 R-Wave position is 5 Breath number is 37  
breath event at  247.22 R-wave angle is 286.114 286.114 R-Wave position is 5 Breath number is 38  
breath event at  253.491 R-wave angle is 324.116 324.116 R-Wave position is 5 Breath number is 39  
breath event at  259.459 R-wave angle is 259.155 259.155 R-Wave position is 5 Breath number is 40  
breath event at  266.241 R-wave angle is 262.934 262.934 R-Wave position is 5 Breath number is 41  
breath event at  273.203 R-wave angle is 285.586 285.586 R-Wave position is 5 Breath number is 42  
breath event at  280.226 R-wave angle is 277.672 277.672 R-Wave position is 5 Breath number is 43  
breath event at  291.918 R-wave angle is 142.56 142.56 R-Wave position is 5 Breath number is 45  
breath event at  303.55 R-wave angle is 275.024 275.024 R-Wave position is 5 Breath number is 46  
5 0.78759 281.587 1 44      
breath event at  17.9314 R-wave angle is 337.378 337.378 R-Wave position is 6 Breath number is 1  
breath event at  23.6141 R-wave angle is 347.457 347.457 R-Wave position is 6 Breath number is 2  
breath event at  29.7239 R-wave angle is 358.262 358.262 R-Wave position is 6 Breath number is 3  
breath event at  42.1202 R-wave angle is 334.71 334.71 R-Wave position is 6 Breath number is 5  
breath event at  54.631 R-wave angle is 256.784 256.784 R-Wave position is 6 Breath number is 7  
breath event at  62.9264 R-wave angle is 337.896 337.896 R-Wave position is 6 Breath number is 8  
breath event at  69.5369 R-wave angle is 257.611 257.611 R-Wave position is 6 Breath number is 9  
breath event at  77.7709 R-wave angle is 294.892 294.892 R-Wave position is 6 Breath number is 10  
breath event at  84.2949 R-wave angle is 284.359 284.359 R-Wave position is 6 Breath number is 11  
breath event at  91.5581 R-wave angle is 229.147 229.147 R-Wave position is 6 Breath number is 12  
breath event at  99.7776 R-wave angle is 268.72 268.72 R-Wave position is 6 Breath number is 13  
breath event at  106.746 R-wave angle is 303.913 303.913 R-Wave position is 6 Breath number is 14  
breath event at  113.343 R-wave angle is 286.084 286.084 R-Wave position is 6 Breath number is 15  
breath event at  120.28 R-wave angle is 317.737 317.737 R-Wave position is 6 Breath number is 16  
breath event at  125.879 R-wave angle is 315.559 315.559 R-Wave position is 6 Breath number is 17  
breath event at  142.17 R-wave angle is 306.672 306.672 R-Wave position is 6 Breath number is 20  
breath event at  148.017 R-wave angle is 357.828 357.828 R-Wave position is 6 Breath number is 21  
breath event at  153.713 R-wave angle is 349.664 349.664 R-Wave position is 6 Breath number is 22  
breath event at  160.388 R-wave angle is 294.438 294.438 R-Wave position is 6 Breath number is 23  
breath event at  173.508 R-wave angle is 327.326 327.326 R-Wave position is 6 Breath number is 25  
breath event at  197.806 R-wave angle is 344.073 344.073 R-Wave position is 6 Breath number is 29  
breath event at  204.194 R-wave angle is 343.767 343.767 R-Wave position is 6 Breath number is 30  
breath event at  221.692 R-wave angle is 311.803 311.803 R-Wave position is 6 Breath number is 34  
breath event at  233.392 R-wave angle is 282.004 282.004 R-Wave position is 6 Breath number is 36  
breath event at  240.78 R-wave angle is 324.823 324.823 R-Wave position is 6 Breath number is 37  
breath event at  247.22 R-wave angle is 338.588 338.588 R-Wave position is 6 Breath number is 38  
breath event at  259.459 R-wave angle is 307.301 307.301 R-Wave position is 6 Breath number is 40  
breath event at  266.241 R-wave angle is 309.624 309.624 R-Wave position is 6 Breath number is 41  
breath event at  273.203 R-wave angle is 334.34 334.34 R-Wave position is 6 Breath number is 42  
breath event at  280.226 R-wave angle is 330.022 330.022 R-Wave position is 6 Breath number is 43  
breath event at  291.918 R-wave angle is 170.537 170.537 R-Wave position is 6 Breath number is 45  
breath event at  303.55 R-wave angle is 323.565 323.565 R-Wave position is 6 Breath number is 46  
6 0.808519 313.402 1 32      
breath event at  54.631 R-wave angle is 294.974 294.974 R-Wave position is 7 Breath number is 7  
breath event at  69.5369 R-wave angle is 292.85 292.85 R-Wave position is 7 Breath number is 9  
breath event at  77.7709 R-wave angle is 342.236 342.236 R-Wave position is 7 Breath number is 10  
breath event at  84.2949 R-wave angle is 325.35 325.35 R-Wave position is 7 Breath number is 11  
breath event at  91.5581 R-wave angle is 265.543 265.543 R-Wave position is 7 Breath number is 12  
breath event at  99.7776 R-wave angle is 310.516 310.516 R-Wave position is 7 Breath number is 13  
breath event at  106.746 R-wave angle is 348.169 348.169 R-Wave position is 7 Breath number is 14  
breath event at  113.343 R-wave angle is 327.182 327.182 R-Wave position is 7 Breath number is 15  
breath event at  142.17 R-wave angle is 351.862 351.862 R-Wave position is 7 Breath number is 20  
breath event at  160.388 R-wave angle is 339.209 339.209 R-Wave position is 7 Breath number is 23  
breath event at  233.392 R-wave angle is 327.763 327.763 R-Wave position is 7 Breath number is 36  
breath event at  259.459 R-wave angle is 355.818 355.818 R-Wave position is 7 Breath number is 40  
breath event at  266.241 R-wave angle is 357.968 357.968 R-Wave position is 7 Breath number is 41  
breath event at  291.918 R-wave angle is 200.897 200.897 R-Wave position is 7 Breath number is 45  
7 0.790612 322.743 1 14      
breath event at  54.631 R-wave angle is 337.981 337.981 R-Wave position is 8 Breath number is 7  
breath event at  69.5369 R-wave angle is 328.439 328.439 R-Wave position is 8 Breath number is 9  
breath event at  91.5581 R-wave angle is 302.114 302.114 R-Wave position is 8 Breath number is 12  
breath event at  99.7776 R-wave angle is 354.223 354.223 R-Wave position is 8 Breath number is 13  
breath event at  291.918 R-wave angle is 231.535 231.535 R-Wave position is 8 Breath number is 45  
8 0.751353 315.59 1 5      
breath event at  91.5581 R-wave angle is 338.642 338.642 R-Wave position is 9 Breath number is 12  
9 1 338.642 1 1      
          
 0:2ratio of first to third R-wave is 1.04828         
 3:5ratio of 4th to 6th R-wave is 1.12541         
          
number of breaths used  4 Length of mean vector is  0.0241996 mean vector angle is 205.251 and R-wavecount 27 
          
number of breaths used  4 Length of mean vector is  0.0396785 mean vector angle is 269.931 and R-wavecount 29 
          
number of breaths used  4 Length of mean vector is  0.0183318 mean vector angle is 235.598 and R-wavecount 35 
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number of breaths used  4 Length of mean vector is  0.0169137 mean vector angle is 203.637 and R-wavecount 32 
          
number of breaths used  4 Length of mean vector is  0.00521598 mean vector angle is 175.616 and R-wavecount 27 
          
number of breaths used  4 Length of mean vector is  0.00866175 mean vector angle is 23.9051 and R-wavecount 28 
          
number of breaths used  4 Length of mean vector is  0.0291604 mean vector angle is 193.183 and R-wavecount 25 
          
number of breaths used  4 Length of mean vector is  0.00611701 mean vector angle is 171.938 and R-wavecount 25 
          
number of breaths used  4 Length of mean vector is  0.0143331 mean vector angle is 292.311 and R-wavecount 21 
          
number of breaths used  4 Length of mean vector is  0.0259469 mean vector angle is 337.085 and R-wavecount 28 
          
For all breaths in file Length of mean vector is  0.0116486 mean vector angle all breaths 175.84 and R-wavecount
 326and breath count is 49 
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Appendix 1.8  Illustration of the changes in HRV over time in a vCJD 
patient. 
Chapters 5 and 6 of this thesis demonstrated that people incubating vCJD displayed 
a change in HRV per breath compared to controls and indicated a variable but 
increasing MVL over time suggesting less variability in the R-waves within each 
breath compared to controls, as time progressed .  This see-saw nature compares 
with the trend in different metrics of HRV seen in pre-clinical cattle (figures 4.13, 
4.14).   
Changing MVL of vCJD patient over time.  
The value of MVL for the heart simulator was 0.454.  There was a significant difference (p<0.05)  
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Appendix 1.10  Figure to accompany figure 4.4
      
The y axis scale has been transposed in SPSS v 16 using the “power” exponent transform scale using 
the default 0.5 exponent.  This represents the square root of the data and is performed to better show 
the ranges of measures for the left hand panel of figure 4.
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Appendix 1.11  95% Confidence Intervals (CI) for the constituent mean vectors for the MVL 
data points of figures 5.9, 6.10 and 6.11. 
95% Confidence intervals relating to data of Figure 5.19 
Variable control control control control control control 
R-Wave position 0 1 2 3 4 5 
Mean Vector (µ) (degs) 26.744 81.944 137.164 191.807 246.013 282.692 
Length of Mean Vector (r) 0.959 0.932 0.876 0.798 0.69 0.726 
95% CI (-) for µ (degs) 24.011 78.399 132.316 185.516 237.847 274.328 
95% CI (+) for µ (degs) 29.477 85.489 142.013 198.097 254.179 291.057 
Variable Patient Patient Patient Patient Patient Patient 
R-Wave position 0 1 2 3 4 5 
Mean Vector (µ) (degs) 21.12 61.663 102.196 142.774 183.283 223.233 
Length of Mean Vector (r) 0.978 0.964 0.934 0.892 0.838 0.788 
95% CI (-) for µ (degs) 19.159 59.125 98.75 138.304 177.761 216.82 
95% CI (+) for µ (degs) 23.082 64.202 105.643 147.243 188.805 229.646 
Variable Simulator Simulator Simulator Simulator Simulator Simulator 
R-Wave position 0 1 2 3 4 5 
Mean Vector (µ) (degs) 17.958 57.443 96.399 134.796 172.724 211.43 
Length of Mean Vector (r) 0.97 0.946 0.914 0.88 0.846 0.857 
95% CI (-) for µ (degs) 16.902 51.615 88.985 125.935 162.639 201.614 
95% CI (+) for µ (degs) 21.081 63.271 103.814 143.656 182.809 221.246 
95% Confidence intervals relating to data of Figure 6.11 and 6.10 
Variable Before Before Before Before Before Before 
R-wave position 0 1 2 3 4 5 
Mean Vector (µ) (degs) 20.464 58.355 97.324 137.447 170.511 199.973 
Length of Mean Vector (r) 0.969 0.91 0.859 0.775 0.702 0.758 
95% CI (-) for µ (degs) 18.501 54.977 93.041 131.939 163.905 193.87 
95% CI (+) for µ (degs) 22.427 61.733 101.608 142.955 177.116 206.077 
Variable During During During During During During 
R-wave position 0 1 2 3 4 5 
Mean Vector (µ) (degs) 25.674 77.591 129.649 181.87 233.624 278.249 
Length of Mean Vector (r) 0.964 0.929 0.859 0.764 0.673 0.626 
95% CI (-) for µ (degs) 23.556 74.596 125.367 176.2 226.57 270.035 
95% CI (+) for µ (degs) 27.793 80.585 133.931 187.54 240.677 286.463
Variable Sedation Sedation Sedation Sedation Sedation Sedation 
R-wave position 0 1 2 3 4 5
Mean Vector (µ) (degs) 19.614 56.745 93.818 130.612 168.046 204.909 
Length of Mean Vector (r) 0.985 0.976 0.958 0.931 0.898 0.859 
95% CI (-) for µ (degs) 16.845 53.244 89.237 124.662 160.775 196.277
95% CI (+) for µ (degs) 22.384 60.246 98.399 136.562 175.317 213.541 
Variable vCJD vCJD vCJD vCJD vCJD vCJD
R-wave position 0 1 2 3 4 5 
Mean Vector (µ) (degs) 21.26 65.499 109.557 153.516 197.342 240.661 
Length of Mean Vector (r) 0.971 0.946 0.9 0.836 0.766 0.694
95% CI (-) for µ (degs) 20.342 64.238 107.811 151.258 194.589 237.389 
95% CI (+) for µ (degs) 22.178 66.76 111.304 155.774 200.095 243.934 
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Appendix 1.12  Tables of significance testing for figure 6.11 
* in the tables indicates a significant difference following Bonferroni correction 
Sedation versus Anaesthesia 
R-wave position W statistic p value 
R1 15.139 5.16E-4        * 
R2 38.802 3.75E-8        * 
R3 58.047         0           * 
R4 62.734          0          * 
R5 64.414          0          * 
R6 58.782          0          * 
Sedation versus vCJD patient 
R-wave position W statistic p value 
R1 6.896 0.002        
R2 4.652 0.098 
R3 13.262          0.001        * 
R4 18.623       9.04E-5       * 
R5 22.867       1.08E-5       * 
R6 24.998       3.73E-6       * 
Sedation versus Patients Before Anaesthesia 
R-wave position W statistic p value 
R1 7.096 0.029        
R2 8.106 0.017 
R3 15.010               5.50E-4       * 
R4 13.450              0.001          * 
R5 11.430              0.003          * 
R6 2.086  0.352            
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Appendix 1.13  Published work related to this thesis
      
All enclosed PDF versions of the listed papers relating to the subject of this thesis 
have been reproduced with permission from the publishers of the relevant journals. 


Description of enclosed reprint material  
Glover, D. G., Pollard, B. J., Gonzalez, L., Siso, S., Kennedy, D., & Jeffrey, M. 2007, "A 
non-invasive screen for infectivity in transmissible spongiform encephalopathies", 
Gut, vol. 56, no. 9, pp. 1329-1331. 
This publication suggests that changes in heart rate variability in sheep incubating scrapie 
may be an early feature of this disease. 
Pomfrett, C. J., Glover, D. G., Bollen, B. G., & Pollard, B. J. 2004, "Perturbation of heart 
rate variability in cattle fed BSE-infected material", Vet.Rec., vol. 154, no. 22, pp. 687-
691. 
A similar perturbation in heart rate variability in cows with BSE is observed to that observed in 
scrapie infected sheep.  This may suggest that changes in HRV may be a common and early 
feature of transmissible spongiform encephalopathies. 
  
Woolfson, L. A. M., Glover, D. G., Pollard, B. J., & Pomfrett, C. J. "Symptomatic vCJD 
alters heart rate variability", in  Proceedings of the Physiological Society, Trinity 
College, Dublin: Communications J Physiol 551P, C47.
  
Further study of changes in heart rate variability in human subjects incubating vCJD also 
illustrate a difference when compared to healthy control subjects. 
Pomfrett, C. J., Glover, D. G., & Pollard, B. J. 2007, "The vagus nerve as a conduit for 
neuroinvasion, a diagnostic tool, and a therapeutic pathway for transmissible 
spongiform encephalopathies, including variant Creutzfeld Jacob disease", Med 
Hypotheses, vol. 68, no. 6, pp. 1252-1257. 
This paper postulates that the vagus nerve may provide a route of infection for prion diseases 
and underlines the involvement of a potential change in the function of the vagus nerve in 
prion diseases. 
Pomfrett, C. J., Dolling, S., Anders, N. R., Glover, D. G., Bryan, A., & Pollard, B. J. 2009, 
"Delta sleep-inducing peptide alters bispectral index, the electroencephalogram and 
heart rate variability when used as an adjunct to isoflurane anaesthesia", Eur J 
Anaesthesiol., vol. 26, no. 2, pp. 128-134. 
This publication illustrates the diverse use of heart rate variability analysis and its use in 
investigating efficacy of novel interventions in routine anaeasthesia 
Rockliff, H., Gilbert, P., McEwan, K., Lightman, S., & Glover, D. 2008, "A pilot 
exploration of heart rate variability and salivary cortisol responses to compassion-
focused imagery", Clinical Neuropsychiatry, vol. 5, no. 3, pp. 132-139. 
Heart rate variability studies may also be effective in assessing psychopathology and 
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patient groups with respect to their ratio of hGRa
to hGRbmRNA levels. Unfortunately, among the
12 patients evaluated prospectively, only one
turned out to be steroid dependent and one
steroid resistant in a two year follow up, allowing
no statistical analysis. However, these two
prospectively evaluated patients with impaired
steroid response did not differ in their hGRb
mRNA expression from the steroid responders.
Our findings do not exclude the possibility
that hGR protein levels may differ in the
respective groups as a result of post-transcrip-
tional regulation. However, quantification of
hGR protein levels is difficult and does not
provide evidence for the amount of ‘‘free’’
receptor with the ability to bind steroids.
Nevertheless, our data indicate that the ratio
of PBMC hGRa to hGRb mRNA expression is
not correlated with effective glucocorticoid
treatment in IBD. Therefore, we conclude—in
contrast to Honda and coworkers—that hGRb
expression has no predictive value for the
efficacy of steroid treatment.
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A non-invasive screen for
infectivity in transmissible
spongiform encephalopathies
The risk of transmissible spongiform encepha-
lopathy (TSE) infection from endoscopic pro-
cedures has been discussed recently in this
journal.1 2 Subclinical carriers of variant
Creutzfeldt–Jakob disease (vCJD), the num-
bers of whom are unknown, may present a risk
of iatrogenic infection to susceptible patients
participating in endoscopy. We report a pilot
study, undertaken here on sheep, describing a
non-invasive assessment of autonomic func-
tion based on heart rate variability (HRV)
which may provide a useful screening method
for subclinical carriers of certain TSE diseases.
Detection of disease associated prion protein
(PrPd) in the brain stem is used in confirma-
tory postmortem tests for bovine spongiform
encephalopathy (BSE) and sheep scrapie; this
protein is also present in humans with vCJD.3–5
In scrapie, the timing of PrPd accumulation in
the dorsal motor nucleus of the vagus nerve
(DMNX) indicates that this is a likely site of
initial neuroinvasion.4 Non-myelinated vagal
fibres from the DMNX and faster myelinated
vagal fibres from the nucleus ambiguus are
involved in the control of HRV, which is the
millisecond beat to beat change that is distinct
from the heart rate. Cardiac vagal tone may be
considered to be the sum of low frequency (LF)
variation in HRV influenced by vagal efferents
from the DMNX, plus high frequency (HF)
variations, influenced by the respiratory fre-
quency, resulting from the efferent output
from the nucleus ambiguus.6 The DMNX
contains parasympathetic neurones whose
axons communicate directly with the gut,
heart, and other viscera and can be implicated
in the transport and initial site of infection and
subsequent infection in the nucleus tractus
solitarius and the nucleus ambiguus.4 Thus
analysis of HRV may provide an index of vagal
Conflict of interest: None declared.
Figure 1 Typical high frequency (HF) and low frequency (LF) filtered tachygrams on which a fast Fourier transformation is done to give estimates of heart
rate variability (HRV) in different frequency bands. The reduced HRV is indicated by the flatter lines in the infected sheep.
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dysfunction caused by the presence of PrPd in
brain stem regions before clinical signs become
noticeable.
PrPd has been detected in vCJD rectal
samples and implications for potential iatro-
genic infection to humans of susceptible
genotypes have been drawn.1 2 Large scale
studies of sheep scrapie show that PrPd
aggregates are consistently present in the
recto-anal-mucosa-associated lymphoid tissue
(RAMALT) of preclinically and clinically
infected sheep.7 8 This pilot study investigated
the possibility that HRV might also recognise
TSE infection in clinically normal sheep,
positive for PrPd in RAMALT biopsies.
We recorded HRV data from 25 sheep. Six
were clinically normal but PrPd positive in
RAMALT biopsies, and 19 were clinically
normal and PrPd negative in RAMALT biopsies.
Among the latter, three were unchallenged
controls, 11 were naturally exposed to scrapie
infection and of resistant PrP genotypes, one
was naturally exposed to scrapie and of
susceptible genotype, and four were orally
dosed and of susceptible genotypes.
Experimentally infected sheep had been dosed
with 5 g of a 10% homogenate of a pool from
scrapie affected sheep brains.
ECG samples (300 s) were collected and
digitised using a commercially available moni-
tor (VariaCardio). ECG R wave timings were
obtained to determine variability in the R–R
intervals, and an instantaneous tachygram was
constructed (fig 1) from which power spectra
were calculated.
Power spectral analysis in the 0.032 to 0.138
Hz band (LF), but not the 0.15 to 0.5 Hz band
(HF) showed significant differences (LF,
p,0.005) between RAMALT biopsy negative
and biopsy positive sheep (fig 2). As all positive
sheep were asymptomatic, HRV assessment
may be a useful preclinical test for TSE
infection. This HRV index on its own, used
once, may not distinguish between individual
rectal biopsy positive animals and controls, as
ranges overlapped. However, the negative and
positive biopsy groups contained animals of
different provenance—the negative biopsy
group contained sheep of resistant genotypes,
unexposed sheep, and sheep of uncertain
infection status; the positive group contained
infected sheep at approximately 40–90% of the
incubation period. Owing to the small number
of sheep investigated here, further large scale
studies are needed to refine the methods and
aid the interpretation of the results; however,
being a live non-invasive screen for TSE
infection it has the advantage that repeated
measures over time may be taken to strengthen
confidence in the interpretation.
We have previously demonstrated a similar
reduction in HRV in BSE infected cattle9 and in
humans incubating vCJD10 compared with con-
trols. We herewith show that changes in HRV
may be a common and early feature of TSE
infections. Improved preclinical testing for TSEs
using specific signature changes in HRV with
respect to time could help minimise the risk of
iatrogenic infection from endoscopy and other
invasive procedures, and also provide an objec-
tive measure of the pathogenesis of the disease.
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Transient elastography in patients
with non-alcoholic fatty liver
disease (NAFLD)
Non-alcoholic fatty liver disease (NAFLD) is
one of the most common causes of chronic
liver injury in many countries around the
world.1 NAFLD covers a wide spectrum, ran-
ging from simple steatosis—which is generally
non-progressive—to non-alcoholic steatohepa-
titis (NASH). There are no established non-
invasive methods of evaluation for patients
with NASH, and until recently liver biopsy was
the only method for evaluating liver fibrosis.
Transient elastography is a new technique that
allows rapid, non-invasive measurement of
mean tissue stiffness, which has been shown
to be useful for accurate estimation of hepatic
fibrosis in patients with chronic hepatitis C.2
We carried out a study to determine the
value of liver stiffness measurement with the
new medical device called the Fibroscan
(EchoSens, Paris, France), based on ultrasound
transient elastography, in patients with
NAFLD. We carried out liver stiffness measure-
ments in 67 NAFLD patients (mean (SD) age,
50.4 (3.3) years) in whom the diagnosis had
Figure 2 Box plots (median, upper and lower
quartiles, and range) showing heart rate
variability (HRV) measures, demonstrating a
significant difference (**p,0.005) between
biopsy positive and biopsy negative animals
(Mann–Whitney test following a Kolmogorov–
Smirnov test with Lilliefors significance correction
to test for a normal distribution). There is no
significant difference in the heart rates of the
animals or in the high frequency range of HRV.
Within the negative biopsy group, there was no
difference in either low frequency or high
frequency between the orally challenged and
non-infected animals.
Table 1 Summary of the genotypes
















ARR/ARR and ARQ/ARR are resistant
genotypes.
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Symptomatic vCJD alters heart rate variability
L.A.M. Woolfson*, D.G. Glover†, B.J. Pollard*† and Chris J.D. Pomfrett*
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Ante-mortem diagnosis of variant Creutzfeld Jacob disease (vCJD) is based on 
the subjective assessment of clinical signs, sometimes combined with invasive 
biopsy for the presence of infectious prion protein (PrPsc) in the tonsils. Post
mortem diagnosis of transmissible spongiform encephalopathies in animals 
routinely depends on the microscopic immunohistochemical identification of 
PrPsc in the medulla oblongata of the brainstem (Wells et al. 1989), and in 
particular the nucleus tractus solitarii (NTS) and the dorsal vagal nucleus (DVN), 
the vagus nerve being a suspected route of infection in some species (Beekes et
al. 1998). It has already been suggested that symptomatic bovine spongiform 
encephalopathy is associated with disturbance in heart rate variability (HRV) 
(Pomfrett & Austin, 1997), possibly occurring as a result of functional changes in 
NTS and DVN in the presence of PrPsc, and we sought to determine whether 
this is also the case in humans exhibiting symptoms of vCJD.
Data were collected in accordance with a protocol approved by the North West Multi 
Centre Research Ethics Committee, including written, informed consent. Three-
hundred-second samples of electrocardiogram (ECG) were collected at repeated 
intervals during a 3-month period from two subjects exhibiting definite clinical signs of 
vCJD, and who had also been confirmed as carrying PrPsc by tonsil biopsy. Control 
data were collected from seven healthy volunteers of comparable age not taking 
medication and with no relevant medical history. The ECG was digitised using a 
portable monitor (Fathom, Amtec Medical) at 1 kHz frequency and 12 bit resolution. 
Data were transferred to a PC, translated and analysed using standard software 
(CED Spike2 v4.02). The ECG waveform was reviewed by eye and artefacts rejected. 
Tachygrams of instantaneous ECG R-wave frequency were obtained in order to 
determine power spectra. Interval histograms of the R-R wave intervals were also 
plotted (see Fig.1). Non-parametric statistics were applied (SPSS v10.1).
We observed that symptomatic vCJD disturbed HRV. There was a significant 
difference in the variances of ECG R wave intervals between controls and vCJD 
suspects (Kruskal-Wallis H test, P < 0.001). Frequency histograms obtained from 
controls described normal distributions (Kolmogorov-Smirnov test, P < 0.05) whereas 
some frequency histograms of vCJD suspects demonstrated high levels of kurtosis, 
with significantly greater numbers of ECG R wave intervals in a narrow band between 
0.9 and 0.98 s (Kruskal-Wallis test, P < 0.05). There was no significant difference 
between the mean heart rates of the two groups. Power spectral analysis revealed a 
significant increase in low frequency HRV (0-0.05 Hz) between the vCJD suspects 
and controls (Mann-Whitney U test, P < 0.05).
Further work is needed with a much larger sample size. However, this study allows us 
to suggest that measurement of HRV has potential as a non-invasive aid to the 
diagnosis of vCJD.
This study was funded by the Department of Health.
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The vagus nerve as a conduit for neuroinvasion, a
diagnostic tool, and a therapeutic pathway for
transmissible spongiform encephalopathies,
including variant Creutzfeld Jacob disease
Chris J.D. Pomfrett *, David G. Glover, Brian J. Pollard
Division of Cardiovascular and Endocrine Sciences, The University of Manchester,
Department of Anaesthesia, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK
Received 17 October 2006; accepted 19 October 2006
Summary It is hypothesised that the vagus nerve (cranial nerve X) is an important conduit for infective neuroinvasion
during the incubation of certain transmissible spongiform encephalopathies (TSEs) including scrapie in sheep, variant
Creutzfeld Jacob disease in humans, chronic wasting disease in deer, and bovine spongiform encephalopathy in cattle.
Presence of infection in the brainstem will disrupt normal function of this important region responsible for autonomic
control of visceral function via the vagus nerve. It is proposed that physiological study of disrupted vagal function using
techniques such as heart rate variability will indicate early, and ongoing, functional signs of infection even before
levels of abnormal prion protein reach the thresholds currently used in tests for the presence of TSEs. It is further
suggested that repeated measures of vagal function during treatment with experimental therapies will give a non-
invasive, repeated measures index of drug efficacy. In addition, pharmaceutical interventions directed via the vagus
nerve will bypass the blood brain barrier and take an anatomical route appropriate to the treatment of TSEs.
c 2006 Elsevier Ltd. All rights reserved.
Introduction
Transmissible spongiform encephalopathies (TSEs)
are contagious diseases of the nervous system asso-
ciated with the accumulation of abnormal prion
proteins. PrPd will be used in this article as a label
for disease-associated abnormal prion. Other re-
ports freely interchange other labels, e.g. PrPSc,
denoting the pathological isoform, and PrPres,
which indicates abnormal prion partially-resistant
to digestion by the enzyme proteinase-K, an essen-
tial step in many biochemical tests for prion dis-
ease. Normal prion proteins (PrPc) appear to have
a role in neuronal copper transport [1,2] and are
necessary for the propagation of TSEs. PrPc is al-
tered into PrPd, which accumulates and is associ-
ated with pathological damage to neurones; the
presence of PrPd is both a symptom of and a bio-
chemical marker for, TSEs. TSEs include bovine
0306-9877/$ - see front matter c 2006 Elsevier Ltd. All rights reserved.
doi:10.1016/j.mehy.2006.10.047
* Corresponding author. Tel.: +44 161 276 8582; fax: +44 161
273 5685.
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spongiform encephalopathy (widely known as mad
cow disease or BSE), scrapie (sheep), chronic wast-
ing disease (CWD in deer and other Cervidae), and
variant Creutzfeld Jacob disease (vCJD in man).
vCJD is of particular healthcare relevance, since
cross infection has been demonstrated between
vCJD infected humans receiving blood from asymp-
tomatic vCJD donors, and between BSE-infected
sheep by blood transfusion [3–5]. Post-mortem
testing of prion disease in animals, for the purposes
of disease surveillance and public food screening,
is performed by biochemical detection of the pres-
ence of PrPd in an obex section through the brain-
stem. The dorsal vagal motor nucleus (DMNX, after
dorsal motor nucleus of cranial nerve X, the vagus)
is located within the medulla oblongata of the
brainstem, and has a high concentration of PrPd
in all animals orally challenged with TSE-infected
brainstem, and symptomatic field cases of BSE.
Concentration of PrPd around neurones of DMNX
has also been noted in humans with vCJD [6].
Ante-mortem live testing is performed on human
subjects, and depends on the detection of PrPd in
biopsy samples of appendix, tonsil or brain tissue.
No routine blood test has been implemented to
date. Anatomical surrogate markers have also been
reported in the brains of victims of vCJD, including
the presence of changes in the pulvinar region of
the thalamus observed by magnetic resonance
imaging, and florid amyloid plaques observed
post-mortem [6].
Hypotheses
The vagus nerve as an infectious conduit
It is proposed that the vagus nerve (cranial nerve X)
is an important pathway for the neuroinvasion of
infectious agent after oral challenge in all mam-
mals susceptible to transmissible spongiform
encephalopathies (TSEs), and not just scrapie
(sheep and rodents) and chronic wasting disease
(deer) where this has already been suggested [7–9].
The vagus will act as both a centripetal conduit,
conveying infection from the gut to the central
nervous system, and as a centrifugal pathway,
spreading infection to viscera from the brainstem.
This hypothesis is independent of prion protein only
hypotheses for infection [10], and would be equally
valid if some other infectious co-factor were dis-
covered in addition to the PrPd which is a widely
accepted marker for TSEs. The proposed vagal
route is not the sole pathway of neuroinvasion,
and will operate in parallel with other routes of
entry for TSE-associated pathogens entering the
central nervous system e.g. other cranial nerves,
the sympathetic nervous system, spinal cord etc.
It should be considered that the vagus nerve has
unique anatomy facilitating a fast track for neuro-
invasion of the brainstem that bypasses the blood
brain barrier. Early neuroinvasion via the vagus
nerve may prime the brainstem to the presence
of the disease, and hence predispose the mammal
to succumb on challenge via the other, slower,
routes delivering their pathogenic agents to the
central nervous system later in the course of incu-
bation. The short length of vagal nerves in young
mammals e.g. beef calves, and small mammals
e.g. rodents, may be a factor in the shorter incuba-
tion times observed in younger and smaller mam-
mals, which would support this hypothesis. The
medulla oblongata is widely accepted as a diagnos-
tic region of choice for a number of TSEs [10], and
the entry of the vagus at the medulla oblongata
may explain the high concentration of abnormal
prion in the brainstem at diagnostic, and fre-
quently overtly symptomatic, stages of TSEs.
Experimental lesion of the vagus nerve, either by
physically cutting the nerve or by pharmacological
intervention, will test this hypothesis.
Vagus nerve activity as a diagnostic tool
Monitoring vagally-mediated physiological activity
(e.g. heart rate variability) gives an indirect index
of brainstem function at the sites of neuroinvasion
of infectious agents and replication of PrPd, and so
may be used as both a diagnostic screen, and as a
repeated measures index of disease progression.
Such a tool would be especially useful as an indi-
rect indication of neurophysiological recovery dur-
ing trials of putative therapies for TSEs. Repeated
measures of heart rate variability after inoculation
will test this hypothesis.
The vagus as a therapeutic pathway from the
gut and lungs to the brainstem
It is suggested that the vagus nerve is a potential
therapeutic route for the administration of drugs
for the treatment of TSEs, permitting such drugs
to enter identified regions of the brainstem with
the highest concentrations of prion infection whilst
bypassing the blood-brain barrier. Inoculation of a
labelled virus known to use the gut to vagus nerve
axis as a conduit (e.g. pseudorabies virus) in ani-
mals already incubating a TSE, and measuring any
co-localisation of label with abnormal prion pro-
tein, will test the potential for this hypothesis.
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Discussion
There is ongoing debate regarding whether PrPd is
the sole infectious component of TSEs. Infection
appears to have occurred with passage of brain tis-
sue containing undetectable levels of PrPd in a
mouse model of the disease, suggesting that an
additional component is necessary in order to
cause infection [11]. In addition, infection of sheep
with scrapie occurs even when digestion in the gut
denatures all measurable PrP [12]. Whatever the
eventual outcome of this debate, accumulation of
PrPd is a symptom of TSEs, as is progressive neuro-
physiological impairment. Other symptoms are
behavioural and reflect advancing functional dis-
ruption of neuronal activity; behavioural symptoms
include hallucination and ataxia in humans, and
loss of motor control in cattle. Why does DMNX
have such a high concentration of PrPd after oral
challenge? The vagal conduit hypothesis would sug-
gest that transport of PrPd is via the vagus nerve
from infected regions of the gut directly to DMNX.
Vagal neurones with cell bodies located in DMNX
innervate the gut (and other organs such as the
heart) via their axons within the vagus nerves.
The function of these vagal motor fibres is to facil-
itate autonomic function such as gut motility, gas-
tric secretion, and the control of heart rate. Such
function is affected by pharmacological interven-
tion at the synapse, as seen during surgical planes
of anaesthesia, where functional imaging on human
volunteers has confirmed that vagal brainstem
functional control of heart rate variability is im-
paired in an anaesthetic dose- dependant relation-
ship [13]. The synapses between these motor cell
bodies, local interneurones within DMNX, and inter-
neurones connecting DMNX to adjacent structures
in the brainstem, such as the nucleus tractus soli-
tarii, would be the first sites for replication and
passage of infectious prion within the central ner-
vous system. It is interesting that DMNX, as part
of the brainstem, is a specified risk material in
BSE and absolutely prohibited from entry into the
human food chain, and yet axons within the vagus,
that can be considered tubes of cytoplasm (arising
from the cell bodies that comprise DMNX) located
in the vagus nerve, are not specified risk material
and will be eaten as mechanically recovered mate-
rial from the carcass’ of cattle, and from vagal ax-
onal material released when the cattle are
decapitated. The vagus of only one BSE-infected
cow has been tested to date and that was shown
to be positive for PrPd [14].
Studies on the sub-cellular pathology of neuro-
nes from the DMNX during infection of sheep with
scrapie have revealed characteristic structures
e.g. coated pits and vesicles along with frequently
herniated myelin sheaths around axons [15,16].
The coated pits and vesicles suggested increased
levels of uptake of PrPd from extracellular com-
partments. Disruption of myelin would hamper sal-
tatory conduction, an important method by which
myelinated neurones propagate action potentials
rapidly along the axon. Both of these observations
describe processes that could affect the ability of
neurones to function efficiently, and would be ex-
pected to adversely affect the control of vagally
modulated reflexes, e.g. heart rate variability
(HRV, millisecond changes in heart rate varying
breath by breath) at early stages of neuroinvasion.
The neuroanatomy of synaptic connections be-
tween neurones has been studied in mice infected
with scrapie [17]. The authors observed that there
was a significant loss of synapses during incubation
of scrapie, at stages well before subsequent neuro-
nal death. It was suggested that progressive loss of
synapses, and the consequent reduction in quanti-
ties of neurotransmitter received at post synaptic
sites, could serve to facilitate subsequent neuronal
death.
The vagal route of neuroinvasion has been dem-
onstrated very clearly in deer suffering from CWD
[8], a disease endemic in the natural deer and elk
populations of North America. The vagus nerve
has stained positive for the presence of PrPd in
one study of deer exhibiting symptoms of CWD
[8]. In that study, a single anatomical section was
prepared through the vagus nerve (near the brain-
stem) and through the medulla oblongata that
clearly demonstrated the contiguous nature of
the staining, with some (but notably not all) indi-
vidual axons within the vagus nerve staining posi-
tive for PrPd, as well as DMNX. A potential
problem with such work is that the vagus is a long
and extensively branched nerve, and studies need
to be conducted on all branches of the vagus, and
not just an unidentified sample from a sensory
branch that connects to regions of the body that
may not express PrPc, such as the lungs. Should
an infectious co-factor other than prion be involved
with the initiation of PrPd replication, e.g. as some
form of catalyst, the vagus would be a possible
route for its passage into the CNS, even if PrPd
takes a different and parallel route. If that was
the case, PrPd would not be measurable in the va-
gus, and yet the vagus could still be a potential
source of infection if eaten.
The vagal route may be of therapeutic use as a
fast track to the brainstem, by-passing the blood
brain barrier and facilitating axonal transport of
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vesicles (both natural and theoretically synthetic).
Certain viruses are known to use the vagus nerves
as a conduit for neuroinvasion (e.g. influenza A
and pseudorabies). Perhaps this could be exploited
by modifying such an existing, vagally-vectored,
virus to act as a carrier for targeted anti-TSE ther-
apeutics? Since such therapy will be following the
same route as the original infection, this should
facilitate treatment.
It has been demonstrated that heart rate vari-
ability (HRV), comprising perturbation in the milli-
second timing of sequential heart beats, is
modulated by vagal brainstem function. In cattle,
after oral challenge with TSE infected material,
the medulla oblongata of the brainstem reaches a
stage whereby PrPd is detectable using post-mor-
tem tests. This presumably occurs in vivo some
time before classical behavioural symptoms of dis-
ease e.g. staggering, since the medulla oblongata
is not involved in dysfunction of voluntary motor
control that would cause staggering. It has been
demonstrated in vitro that TSE infection upsets
electrical properties of living neuronal synapses in
cell culture [18,19]; after hyperpolarisation was
enhanced, making neurones more excitable, which
would disrupt timings within neuronal networks
in vivo. The brainstem includes such neural net-
works, the physiological role of which includes
modulation of HRV. The most readily identified
component of HRV is respiratory sinus arrhythmia
(RSA), a parasympathetic, vagally-modulated re-
flex. Although also present in mature adults, RSA
is most readily observed in the heart beat timing
of children and young adults, where the electrocar-
diogram (ECG) P–P wave variability can exceed



















































Figure 1 Repeated measurements of heart rate variability (HRV) in a patient exhibiting the symptoms of variant
Creutzfeld Jacob disease (vCJD). Representative mean values of HRV (±1 standard error) are also shown for fifty
healthy controls. The study was approved by the UK North West Multicentre Research Ethics Committee (study 01/8/
92). The methodology was similar to that already used in cattle with BSE [20]. The measurements were:
electrocardiogram R–R wave intervals presented as a histogram of numbers of intervals within 50 ms bins (upper
trace); the power spectral derivatives low frequency area under the curve (LF; 0.032–0.138 Hz) and high frequency
area under the curve (HF; 0.15–0.5 Hz). Wider ECG R–R wave histograms indicate greater heart rate variability
whereas narrower histograms indicate less variability. The lowest level of HRV (narrowest histogram) was seen in March
2003. HF HRV is solely mediated by activity in the vagus nerve, LF HRV and ECG R–R interval histograms contain
components of vagal (parasympathetic autonomic nervous system), as well as a sympathetic autonomic nervous system
origin. The patient started receiving a putative therapeutic (pentosan polysulphate) by intraventricular cerebral
infusion after the first measurement of HRV was made. All values were below those observed for controls, suggesting
that vagal control of HRV has been impaired. The patient is still alive (October 2006), some five years after the onset of
symptoms.
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a high vagal tone. RSA results in the speeding up of
heart rate during inspiration whilst lying down, as a
result of a cyclic reduction in vagal tone. The pres-
ence of PrPd in those centres of the brainstem
responsible for controlling cardiac timing, upset-
ting neuronal timing as it does in vitro, would be
expected to alter such HRV, including RSA, in vivo.
Significant perturbation of HRV in cattle incu-
bating BSE after experimental oral challenge has
been reported [20]. In that study, cattle had been
fed 100 g, 1 g or no homogenised brainstem from
symptomatic, BSE-infected cattle. Repeated mea-
sures data obtained from those cattle indicated
that, while pre-symptomatic, there were signifi-
cant differences in HRV between the high, low
and control groups, indicating that the presence
of infection disrupted brainstem function in a
dose-dependant manner before other clinical signs
were apparent. The changes in HRV were observed
as a sustained increase in low frequency HRV com-
pared with controls (indicative of increased activ-
ity at DMNX) and ‘‘spikes’’ in high frequency HRV.
This suggested an alteration in vagal balance during
the incubation of TSEs.
A more pronounced disruption in the HRV of pa-
tients exhibiting classical clinical signs of vCJD has
been demonstrated [21]. Human subjects are
examined at a much later state than cattle; ani-
mals in obvious signs of distress are euthanized,
and are not allowed to live to the same stage as hu-
man patients receiving extensive palliative care.
The human clinical profile of HRV is, therefore, fur-
ther advanced than that observed in animals. In
four human subjects with vCJD, severe reductions
in HRV were observed. One subject is the longest
survivor with vCJD (5 years post symptoms) and
has been in receipt of experimental intraventricu-
lar infusion of pentosan polysulphate. The HRV of
this patient was monitored repeatedly during the
course of treatment (Fig. 1). Unfortunately, this
is the only case in whom repeated physiological
measures have been made during therapy, and then
only from 2003 to 2004. One other subject showed
progressive reduction in HRV up to death.
The vagus nerves are short in immature mam-
mals, and lengthen during maturation. Young cat-
tle and humans seem more susceptible to TSEs,
with shorter incubation times. Could it be that
the shorter vagus nerves result in more rapid neur-
oinvasion by the infectious agent? Young mammals
have a greater resting level of HRV than adults, due
in part to a higher level of activity in the vagus
nerve. Does this higher activity equate to higher
levels of PrPc transferred between neurones as a
result of copper transport. Might this result in an
age-related effect on the passage of TSE- associ-
ated infectious agent?
The vagus nerve is an essential component of the
normal inflammatory reflex [22]. TSEs are charac-
terised by the lack of a classical immune reflex.
However, spread of PrPd has been shown to be in-
creased in animals with an inflammatory reflex to
other diseases [23]. Should this immune reflex to
other pathogens be accompanied by increased va-
gal activity, this could facilitate vagal transport
of the infectious agent for TSEs, and so indirectly
affect neuroinvasion.
Conclusions
Current biochemical tests for PrPd were validated
by the European Union for use as tools for disease
surveillance. As such, the priority was for high sen-
sitivity in symptomatic animals, with high specific-
ity i.e. no false positives. These tests were not
validated for use on pre-symptomatic animals incu-
bating BSE, and yet they are now being used, in
conjunction with the removal of specified risk
material known to be infectious, to protect the
public from infection by BSE-infected, asymptom-
atic, animals, not just in the EU but world-wide.
There is still a need for ante-mortem tests for
infectivity, both for asymptomatic food animals
and for human blood donors. HRV may form a com-
ponent of such a live test.
There are potentially important consequences
that arise should the vagus be a route for neuroin-
vasion in animals entering the human food chain.
Vagus nerves, by their Latin name, wander, and
are not the easiest of tissues to dissect in the lab-
oratory. Consider the difficulty of removing vagus
nerve from the carcass of slaughtered cattle on a
production line. Vagus nerves are not classified as
specified risk material and would not be removed
from the carcass; we may be eating fragments of
vagus nerves within processed meat products. It
has been demonstrated, in one bovine with classi-
cal symptoms of BSE, that the vagus was indeed po-
sitive for PrPd [14]. It is, therefore, possible that
the human food chain is still being exposed to
infectious material from asymptomatic cattle, at
the early signs of infection, via the vagus nerve.
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Delta sleep-inducing peptide alters bispectral index, the
electroencephalogram and heart rate variability when used
as an adjunct to isoflurane anaesthesia
Chris J.D. Pomfretta, Stuart Dollingb, Nicola R.K. Andersc, David G. Gloverc,
Angella Bryanc and Brian J. Pollardd
Background and objective Delta sleep-inducing peptide
(DSIP) is an endogenous peptide that crosses the blood–
brain barrier, named after its association with natural sleep
and enhanced electroencephalogram (EEG) delta rhythm.
The objective of this study was to determine whether DSIP
could be used as an adjunct to volatile anaesthesia in
humans, our hypothesis being that DSIP is a natural
hypnotic that would increase anaesthetic depth. The aims
were to assess depth of anaesthesia using bispectral index
(BIS), the EEG and heart rate variability (HRV), and to
determine whether DSIP altered the symmetry of EEG
between the left and right cerebral hemispheres.
Methods Twenty-four female ASA I or II patients gave
written, informed consent to a protocol approved by our
local research ethics committee. Twelve were randomly
assigned as controls to receive saline. The other 12 were
randomly allocated to receive one of three intravenous
bolus doses of DSIP (Clinalfa) at 25, 50 or 100nmol kgS1.
The first administration of DSIP was while awake and
the second after induction of anaesthesia with propofol
and maintenance with isoflurane. BIS and EEG parameters
were measured continuously using a bilateral electrode
montage.
Results DSIP significantly increased heart rate,
decreased HRV and, paradoxically, significantly reduced
delta rhythm along with reducing burst suppression and
increasing BIS at 25nmol kgS1 during isoflurane
anaesthesia. DSIP also significantly altered bilateral
symmetry of EEG.
Conclusion DSIP probably reduced parasympathetic tone
and decreased (lightened) the depth of anaesthesia
measured using BIS. Eur J Anaesthesiol 26:128–134
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Introduction
Delta sleep-inducing peptide (DSIP) is an endogenous
sleep-associated hormone, first characterized in 1977 [1–
3], that enhances delta wave activity in the electro-
encephalogram (EEG). DSIP is present in blood, crosses
the blood–brain barrier, and has been used therapeuti-
cally in the treatment of insomnia [4,5].
Direct administration of DSIP to the brainstem of
anaesthetized cats was reported to modulate heart rate
variability (HRV) [6]. This was likely to be a direct
effect on the dorsal vagal nucleus, nucleus ambiguus
and/or the nucleus tractus solitarius, which together
constitute the vagal complex of the medulla oblongata
and are responsible for the control of HRV. It is known
from a functional imaging study (positron emission
tomography) that volatile anaesthesia affects glucose
metabolism in this vagal complex of the brainstem in
humans in an asymmetric (right side of the brainstem),
dose-dependent manner [7] when vagal tone was
assessed using HRV.
Bispectral index (BIS) is a proprietary, weighted compo-
site of processed EEG derivatives presented as a number
from 0 to 100 [8], widely used to indicate the depth of
anaesthesia. Certain multichannel BIS monitors enable
the recording of bilateral EEG derivatives, in addition
to BIS.
Based on the literature, we considered that DSIP was a
putative natural hypnotic. The principal objective of our
studies was to determine whether DSIP has a therapeutic
role as an adjunct to hypnotic anaesthesia. Our hypothesis
was that DSIP would increase the overall depth of
anaesthesia as measured using BIS and HRV. We are
not aware of any prior literature by other groups reporting
the effects on EEG or HRV of co-administration of DSIP
with a volatile anaesthetic in humans.
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Methods
The design of this study was a randomized, controlled
pilot to characterize the effect of DSIP on bilateral
components of the EEG andHRV in patients undergoing
routine elective surgery. No power calculations were
possible, as DSIP has been given in conjunction with
anaesthesia in neither animals nor humans. Twenty-four
ASA I or II, right-handed female patients scheduled for
minor elective surgery gave written, informed consent to
a protocol approved by the Central Manchester local
research ethics committee, which entailed contact and
distribution of information sheets at least 24 h before
surgery. Patients were tested and had to be negative to
a screen for drugs.
Clinical anaesthesia was standardized to propofol induc-
tion and isoflurane maintenance. Two anaesthetists
attended. One anaesthetist made up the independently
randomized test pack of DSIP (Clinalfa) provided by our
hospital pharmacy, and administered the agent. The
other anaesthetist administered a routine propofol induc-
tion/isoflurane maintenance surgical anaesthetic and was
blinded to whether the agent was active or placebo.
The experimental procedure is shown in Fig. 1. Doses
were chosen on the basis of prior therapeutic adminis-
tration of DSIP reported in the literature for the
treatment of insomnia [5]. One of three doses
of DSIP (25 nmol kgÿ1¼ 21.2mg kgÿ1; 50 nmol kgÿ1¼
42.4mg kgÿ1 or 100 nmol kgÿ1¼ 84.8mg kgÿ1) was ran-
domly administered intravenously to each patient in
the active group using the contralateral arm to that used
for injection of anaesthetic agents. The same dose of
DSIP was administered once while awake and once
during isoflurane anaesthesia. The control group received
an equivalent volume of saline. In order to screen for
adverse events, the first administration of DSIP after a
10min baseline was in the form of a tolerance test, and
was conducted while the patient was lying awake in the
reception area of the operating rooms and monitored with
standard ECG and noninvasive blood pressure equip-
ment. A delay of at least 30min allowed for washout of
DSIP after the awake tolerance test, and before induction
of anaesthesia.
In addition to standard monitoring (SpO2, noninvasive
blood pressure, and ECG), a series of independent
monitors were attached to the patient for continuous,
automated high-resolution logging to a PC. These com-
prised EEG (Aspect Medical Systems A-1000 with BIS
v3.3, bilateral two-channel referential montage 10/20
locations Fp1–F7, Fp2–F8 with ZipPrep electrodes
and matched impedances, updating every 15 s); ECG
at 1 kHz (CED 1401 with Digitimer Neurolog amplifier);
and end-tidal and inspired gas concentrations (Datex
Ultima-1). Bilateral EEG electrode-derived data
included the following parameters (as described by the
manual for the A-1000 monitor): unfiltered BIS; absolute
delta power (0.5–3.75Hz measured in decibel with
respect to 0.001mV2); relative delta power (% of delta
power within the total power); total power (0.5–30.0Hz
measured in decibel with respect to 0.001mV2); electro-
myogram (EMG) band (70–110Hz measured in decibel
with respect to 0.001mV2); burst suppression (percentage
of epochs in the past 63 s in which the EEG signal is
suppressed, i.e. free of any waveform [8]); signal quality
index (percentage of artefact-free epochs in the last
minute that could be used for BIS calculations); spectral
edge frequency (SEF; the frequency derived from spec-
tral analysis of the EEG waveform below which 95% of
the power is present); median frequency [the frequency
derived from spectral analysis of the EEG waveform that
is at the median (50%) of the power distribution]. Ten-
minute epochs of EEG, HRV and gas data were ident-
ified after administration of DSIP or saline. Data were
analysed off-line using standard software (CED Spike2
version 4.0 and Microsoft Excel). Tachygrams of instan-
taneous ECG frequency were calculated from R–R wave
intervals resampled at 4Hz. A 1024-point fast Fourier
transform-based power spectral analysis was performed
on these tachygrams in order to determine low-frequency
(LF; 0.032–0.138Hz; sympathetic and parasympathetic
activity) and high-frequency (0.15–0.5Hz; predomi-
nately vagal parasympathetic activity) HRV from 5min
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Fig. 1
Baseline DSIP (10 min)
30 minutes
washout
Transfer to OR DSIP (10 min)
Awake Anaesthetized
Baseline Saline (10 min)
30 minutes
washout
Transfer to OR Saline (10 min)





Diagram of the experimental procedure showing two parallel and randomly selected groups of 12 patients receiving either intravenous (I/V) saline
(control) or intravenous delta sleep-inducing peptide in one of three doses (25, 50 or 100nmol kgÿ1) before and during isoflurane anaesthesia.
Boxes denote data collection epochs. DSIP, delta sleep-inducing peptide.
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epochs of ECG, as previously described [9]. Data were
statistically analysed using standard software (SPSS ver-
sion 15). All EEG data were marked as ‘missing’ when
the signal quality index was less that 95.
Normality of data was rejected using the Kolmogorov–
Smirnov test, and the Mann–Whitney U nonparametric
test was subsequently used to compare the randomized
active (DSIP) versus control (saline) groups. The effect of
DSIP in the awake patients was assessed by calculating in
each patient the difference between BIS before and after
DSIP administration. Coincident measurements of
paired, processed bilateral unsmoothed raw EEG (Aspect
A-1000) collected in the same patients every 15 s were
studied using a Wilcoxon signed ranked test. Statistical
significance was assigned with P less than 0.001 for EEG
data and P less than 0.05 for HRV data.
Results
Awake
DSIP was well tolerated in participants while awake;
there were no adverse reactions. There was no significant
change in heart rate (HR) or HRV when DSIP was
administered to patients while awake (data not shown).
The Wilcoxon signed rank test showed that asymmetry
in left and right paired BIS values was significant
with 25 nmol kgÿ1 and 100 nmol kgÿ1DSIP (Fig. 2). This
asymmetry was confirmed when changes in BIS relative
to pre-DSIP baseline were calculated (Fig. 3) in the same
patients. The relative BIS changes observed while
awake were significantly different between 50 and
100 nmol kgÿ1 DSIP (Fig. 3).
Anaesthetized
There was no significant difference in the level of end-
tidal isoflurane administered between each of the ex-
perimental or control groups (data not shown). When
anaesthetized, administration of 25 nmol kgÿ1 DSIP
resulted in a significant increase in mean HR (from
73.6 to 92.4 beatsminÿ1; P< 0.05), whereas HRV signifi-
cantly decreased; the low-frequency area under the
curve (LFAUC) fell significantly from 1.4 10ÿ6 to
2.6 10ÿ7Hz2 (P< 0.05) and the high-frequency
area under the curve (HFAUC) fell significantly from
3.010ÿ8 to 4.7 10ÿ9Hz2 (P< 0.05). No significant
changes were observed in HR or HRV at the other DSIP
doses (50 nmol kgÿ1 DSIP: mean HR 62.8 beatsminÿ1,
LFAUC 7.2 10ÿ7Hz2, HFAUC 5.71 10ÿ9Hz2;
100 nmol kgÿ1 DSIP: mean HR 65.4 beatsminÿ1,
LFAUC 1.3 10ÿ6Hz2, HFAUC 2.2 10ÿ8Hz2).
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Fig. 2
Graph showing absolute levels of bispectral index while awake. This
and subsequent graphs show median (bold line), quartiles (boxes) and
ranges including extreme and outlier values (whiskers). Unshaded bars
indicate activity from the left side of the head and shaded bars the
activity from the right side. Closed circles in this and subsequent
figures denote significant difference between paired sides of EEG data



































Graph showing relative changes in bispectral index after administration
of delta sleep-inducing peptide in 12 awake participants, calculated
by subtracting each 15 second BIS value from the corresponding
paired value in the baseline, pre-delta sleep-inducing peptide epoch
obtained from the same patient and then performing paired
statistics between pre-delta sleep-inducing peptide and post-delta
sleep-inducing peptide values. The open circle denotes a significant
difference between 50 and 100nmol kgÿ1 delta sleep-inducing peptide
groups (P<0.001).
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Figure 4 shows the significant increase in bilateral BIS
observed with 25 nmol kgÿ1DSIP. Most notable was that
no BIS values below 30 were recorded when 25 nmol kgÿ1
DSIP was administered, suggesting that a component of
processed EEG within the BIS algorithm, and essential
for coding deep anaesthesia, had been attenuated. No
BIS level above 65 was observed when 100 nmol kgÿ1
DSIP was administered, at which level the significant
asymmetry in BIS values observed at lower levels of
DSIP was lost.
Figure 5 shows that total power of the EEG was signifi-
cantly reduced with 25 and 100 nmol kgÿ1 DSIP com-
pared with saline controls during isoflurane anaesthesia.
Significant asymmetry in total power was observed at 0,
25 and 50 nmol kgÿ1 DSIP.
Figure 6 demonstrates that a significant reduction in the
right relative delta rhythm was observed with 25 and
100 nmol kgÿ1 DSIP administered during isoflurane
anaesthesia. Significant asymmetry in relative delta
rhythm observed in the control groups was not seen on
administration of DSIP.
Figure 7 demonstrates that the low levels of burst sup-
pression (<2%) encountered during isoflurane anaesthe-
sia were significantly reduced on the left side of the
head with 25 nmol kgÿ1 DSIP, and eliminated with
50 nmol kgÿ1 DSIP. At 100 nmol kgÿ1 DSIP, bilateral
levels of burst suppression significantly increased com-
pared with saline controls.
Figure 8 demonstrates that significant asymmetry in the
EMG frequency band (70–110Hz) was present during
anaesthesia. The magnitude of EMG asymmetry was
most pronounced in non-DSIP controls and smallest with

















Graph showing absolute levels of bispectral index in patients
anaesthetized with isoflurane. The open circles in this and subsequent
figures denote significant differences between the delta sleep-inducing
























Graph showing the total power of the EEG (0.5–30Hz) at different





































DSIP (nmol kg  )-1
Left
Right
Graph showing the percentage of delta rhythm comprising the total
power of the EEG at different levels of delta sleep-inducing peptide
during anaesthesia with isoflurane. Open circles denote significant
differences between right relative delta power and controls with 25 and
100nmol kgÿ1 delta sleep-inducing peptide.
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100 nmol kgÿ1DSIP. Significant increases in EMGpower
were observed with 25 nmol kgÿ1 DSIP compared with
controls, with significant decreases in EMG power at 50
and 100 nmol kgÿ1 DSIP.
Figure 9 demonstrates that the unilateral level of SEF
was not significantly altered byDSIP. Significant bilateral
asymmetry of SEF was observed in anaesthetized con-
trols and with 50 and 100 nmol kgÿ1 DSIP.
Median frequency was significantly reduced compared
with controls in the left EEG montage during adminis-
tration of 25 nmol kgÿ1 DSIP (Fig. 10). Paired analysis
suggested significant asymmetry in median frequency in
controls and those treated with 50 nmol kgÿ1 DSIP. The
range of median frequency values was notably large in
control and 50 nmol kgÿ1 DSIP groups.
Discussion
DSIP did not induce hypnotic anaesthesia when admi-
nistered as the sole agent. Our hypothesis was that DSIP
could act as a hypnotic adjunct to isoflurane. Although we
did observe some significant changes in HR, HRV, BIS
and components of the EEG, these effects were rela-
tively small and so the original hypothesis was not sup-
ported. It is possible that DSIP will have more clinically
relevant synergistic actions with anaesthetic agents other
than isoflurane. After data collection was completed, and
initial analysis was performed, we were advised that a
crossover rather than randomized, controlled experimen-
tal design would have been more appropriate for looking
at the small changes in EEG we observed in this study.
Such a design would have no controls, and analysis would
be based on a comparison of EEG in each participant
before and after intervention with DSIP. Although such
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Graph showing the level of burst suppression of the EEG at different
levels of delta sleep-inducing peptide during anaesthesia with




















Graph showing the absolute level of frontalis electromyogram activity at




































Graph showing the spectral edge frequency at different levels of delta
sleep-inducing peptide during anaesthesia with isoflurane.
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retrospective analysis was possible on data collected from
awake participants in this study (Fig. 3), the drawback
with such a crossover design would have been an
additional delay in surgery of 10min while baseline
EEG data were collected before administration of DSIP,
which was impossible for most of the cases we studied
(and not in the approved experimental protocol). Ideally,
future research into DSIP should consider such a
crossover design.
DSIP (25 nmol kgÿ1) rapidly, and significantly, reduced
both LFAUC and HFAUC components of HRV in
patients already anaesthetized with isoflurane, accom-
panied by a significant increase in HR. HFAUC is
believed to bemostly parasympathetic in origin, whereas
LFAUC is reported to be a combination of sympathetic
and parasympathetic tone [9]. A reduction in parasym-
pathetic tone would be expected to increase HR,
whereas an equal reduction in parasympathetic and
sympathetic tone may not alter HR. Therefore, our
results suggest that DSIP is effecting a small reduction
in parasympathetic tone.
DSIP (25 nmol kgÿ1) caused a small, but statistically
significant, rise in BIS during anaesthesia (Fig. 4). BIS
is a complex analysis incorporating several different
signal analyses of the EEG waveform, including several
others apparently influenced by DSIP in this study, such
as delta rhythm, burst suppression, SEF and median
frequency; any combination of which may have been
influenced by DSIP. The version of BIS studied here
was 3.3, the most recent available for the A-1000 monitor.
The A-1000 was used, rather than a more recent BIS
monitor, as it had the capability to record asymmetry in
BIS values during anaesthesia, and because the A-1000 is
compatible with ZipPrep electrodes needed for a bilat-
eral electrode montage, rather than BIS sensors designed
for application to one side of the head. We noted a wide
range of median frequency values in 0 and 50 nmol kgÿ1
groups that may be indicative of artefacts present within
the median frequency data even with a signal quality
index greater than 95, which was used as our automatic
screen for artefacts.
The site(s) of action for the DSIP administered in this
study is unknown. It is known that DSIP crosses the
blood–brain barrier [1]. DSIP is reported to increase
(gamma-aminobutyric acid) GABAA-activated currents,
and to inhibit N-methyl-D-aspartic acid activated currents
[10,11] in vitro (cultured cerebellar and hippocampal
neurones). Considering the small effect on parasympa-
thetic tone that we have described and the effect of DSIP
reported when administered directly to the brainstem of
the cat [6], a putative site for such a central effect in vivo
would be the vagal complex of the medulla oblongata,
especially the dorsal vagal nucleus and nucleus ambiguus.
We were surprised by the degree of asymmetry in BIS
observed in this study, even with no DSIP. This asym-
metry in BIS was accompanied by asymmetry in the facial
EMG and was also present in multiple EEG parameters.
The magnitude of EMG asymmetry was most pro-
nounced in the absence of DSIP, but the greatest
EMG activity was observed with 25 nmol kgÿ1 DSIP.
Facial EMG originates neurally in the brainstem [12].
This supports the suggestion that DSIP has a direct effect
on this region of the brainstem. Future studies using
functional imaging (e.g. positron emission tomography)
of the brainstem during anaesthesia in volunteers treated
with DSIP may help to locate the sites of action for
this agent.
Whether DSIP has any clinical utility during anaesthesia,
rather than just insomnia, remains to be demonstra-
ted. We found some evidence that DSIP at 25 and
50 nmol kgÿ1significantly reduced burst suppression of
the EEG, i.e. periods of isoelectric EEG during deepen-
ing depths of anaesthesia. Burst suppression constitutes a
large part of the BIS algorithm when BIS is less than 40
[13], which is the region of BIS implicated in cumulative
deep hypnotic time (BIS< 45) as described by Monk
et al. [14]. Reducing the level of anaesthetic agent would
be the first course of action to reduce the amount of burst
suppression, but perhaps DSIP or an agent with a similar
profile could serve some role in moderating the level of
burst suppression in a preventive manner.





























Graph showing the median frequency at different levels of delta sleep-
inducing peptide during anaesthesia with isoflurane.
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We found that DSIP appeared to asymmetrically influ-
ence the level of EMG activity (Fig. 8). BIS changed in a
similar way (Fig. 4), especially when asymmetry was taken
into account. It has already been suggested that the EMG
affects BIS levels when ZipPrep electrodes are used with
an A-1000 monitor in a bipolar frontal montage [15] and
the A-2000 monitor using a four-electrode Quattro Sensor
[16]. It would be of interest to study bilateral responses
from the EMG, especially with respect to their influence
on BIS and other EEG-derived indices. Should EMG
demonstrate measurable asymmetry, this may provide
additional methods to extract it from the EEG signal.
Synthetic DSIP is currently prohibitively expensive for
all but research use, although a more potent derivative of
DSIP is commercially available in some countries (Del-
taran). We observed a reduction in parasympathetic HRV
that may be of interest in certain specialties, such as
cardiac anaesthesia and intensive care medicine. The
apparent lack of side-effects and rapid breakdown of
DSIP make it suitable for further study.
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A PILOT EXPLORATION OF HEART RATE VARIABILITY AND SALIVARY CORTISOL
RESPONSES TO COMPASSION-FOCUSED IMAGERY
Helen Rockliff, Paul Gilbert, Kirsten McEwan, Stafford Lightman and David Glover
Abstract
This study measured heart-rate variability and cortisol to explore whether Compassion-Focused Imagery (CFI)
could stimulate a soothing affect system. We also explored individual differences (self-reported self-criticism, attachment
style and psychopathology) to CFI. Participants were given a relaxation, compassion-focused and control imagery
task. While some individuals showed an increase in heart rate variability during CFI, others had a decrease. There was
some indication that this was related to peoples self-reports of self-criticism, and attachment style. Those with an
increase in heart rate variability also showed a significant cortisol decrease. Hence, CFI can stimulate a soothing
affect system and attenuate hypothalamic-pituitary-adrenal axis activity in some individuals but those who are more
self-critical, with an insecure attachment style may require therapeutic interventions to benefit from CFI.
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Self-criticism is a major vulnerability factor to
psychopathology (Gilbert & Procter 2006, Whelton &
Greenberg 2005, Zuroff et al. 2005). In addition, it can
undermine the success of traditional psychotherapies
such as Cognitive Behavioural therapy (Rector et al.
2000). Recent research has explored the use of
compassion-focused imagery (CFI) as part of a
therapeutic process to help people who are highly self-
critical (Gilbert 2000; Gilbert & Irons 2004, 2005;
Wheatley et al. 2007)
For thousands of years imagination has been used
to stimulate various physiological states (Frederick &
McNeal 1999, Leighton 2003). Sexual, anxious, excited
and calm feelings, along with self-confidence and
preparation for tasks, can be stimulated via the
imagination (Singer 2006). Mental imagery has also
been used as a therapeutic aid to help desensitisation to
aversive stimuli, coping with stress, and for the
promotion of positive states of mind (Arbuthnott et al.
2001, Hall et al. 2006, Holmes et al. 2007, Singer 2006).
Recent research and clinical work has focused on the
value of helping patients develop self-compassion via
various means including imagery (Gilbert 2007; Gilbert
& Irons 2004, Gilbert et al. 2006).
Compassion evolved with the attachment system,
such that signals of care, support and kindness, help to
calm and sooth distressed individuals (Bowlby 1969).
The soothing/calming that results from receiving
kindness and support from others has been linked to a
specific oxytocin-opiate affiliative type of positive
affect regulation system (Carter 1998, Depue &
Morrone-Strupinsky 2005, Wang 2005) and reduces
sensitivity in the amygdala, especially to socially
threatening stimuli (Kirsch et al. 2005). This can be
contrasted with an agentic positive affect regulation
system associated with drive and excitement (Depue
& Morrone-Strupinsky 2005). Imagery and fantasising
are believed to access these different systems  much
as other forms of imagery stimulate other affect systems
(e.g., anxious or sexual).
Porgess Polyvagal theory (2003, 2007) details
how the evolution of the myelinated vagus nerve has
supported interpersonal approach behaviours that
enable social affiliations, caring and sharing. The
myelinated vagus nerve evolved with attachment and
the ability for infants to be calmed by parental caring
behaviours (Depue & Morrone-Strupinsky 2005). This
addition to the autonomic nervous system can inhibit
sympathetically driven threat-defensive behaviours
(e.g. fight/flight) and hypothalamic-pituitary adrenal
(HPA) axis activity, and promote a calm physiological
state, conducive to interpersonal approach and social
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affiliation. In general, the safer people feel, the more
open and flexible they can be in response to their
environment (Gilbert 1993). This is reflected in the
dynamic balancing of the sympathetic and para-
sympathetic nervous systems that give rise to the
variability in heart rate (Porges 2007). Hence, feeling
safe is linked to HRV, and higher HRV is linked to a
greater ability to self-sooth when stressed (Porges 2007).
In contrast, when individuals feel unsafe, they will
tend to rely on more threat focused and stereotyped
defensive behaviours (Dickerson & Kemeny 2004,
Gilbert 1993) characterised by a less flexible balance
of the sympathetic and parasympathetic nervous
systems, with lower tone in the myelinated vagus nerve
(Porges 2007). This relative inflexibility and unbalance
of the autonomic nervous system, associated with lower
measures of HRV, has been associated with both mental
and physical ill health (Appelhans & Luecken 2006;
Thayer & Lane 2007).
This study is a pilot exploration of both the impact
of baseline HRV measures on individual experiences
of CFI, and the acute effects of CFI on HRV and cortisol.
Imagery conditions were designed to stimulate two
different types of positive affect. One type focused on
being the recipient of compassion, while the control
imagery focused on anticipation of reward (making
ones ideal sandwich). Having two types of imagery
targeted to stimulate the two different positive affects
enables exploration of the specificity effects of positi-
ve affect on HRV.
We also explored the influence of self-reported
self-criticism, self-compassion, attachment style, ease
of feeling socially safe and stress, anxiety and
depression on HRV responses to the CFI. We
hypethesised whether self-criticism was associated with
people finding CFI difficult and if this would be
reflected in HRV and cortisol measures.
Method
Participants
Participants were recruited from the University of
Derby (n =184) and completed a self-report screening
questionnaire. Inclusion criteria were: aged between 18
and 35 years; BMI between 19 and 28; non-smoker;
not-currently using medication (except contraception)
or illicit drugs; consuming under 30 units alcohol per
week; not working night shifts; no history of
cardiovascular problems; and no major mental health
problems (47 met these criteria). The final analyses
consisted of 22 participants, exclusions included: A
heart arrhythmia, being unable to sit still and concen-
trate, falling asleep, and imagining pity rather than
compassion.
Procedures
All experimental sessions commenced at 14:00 (to
allow consistent recording of cortisol levels) in the
psychology department at the University of Derby.
Participants were welcomed by the researcher and
seated in a relaxed but upright position with arm and
head supports for the duration of the study. Figure 1
outlines the procedure.
Imagery
Imagery was verbally guided by the researcher.
Each condition (relaxation/baseline, compassion and
control) lasted five and a half minutes. This was to
ensure that 300 seconds of artefact-free ECG data was
available for calculation of HRV metrics (Task Force
1996). During relaxation participants were asked to
allow the tension to drain from each of their muscles
in turn. Previous studies have used a variety of different
instructions for obtaining baseline measures, including
continuous counting, instructions to relax (Osumi et
al. 2006) and no baseline but inclusion of a control
condition (Takahashi et al. 2005).
CFI
The CFI imagery asked participants to imagine
compassion for them coming from an external source.
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helpful to create a mental picture of this compassionate
other (human or non-human). It was stressed that the
image was to help them feel they were the recipient of
compassion, and it was feeling that compassion that
the research was exploring.
Participants were verbally prompted every 60
seconds by the researcher with various statements such
as: Allow yourself to feel that you are the recipient of
great compassion; allow yourself to feel the loving-
kindness that is there for you.
Control Imagery
As noted, the positive affect system underpinning
appetitive and resource acquiring activity is different
to the soothing/contentment system (Depue & Morrone-
Strupinsky 2005). Therefore to compare different types
of positive affect inducing imagery, our control imagery
focused on preparing ones favourite sandwich.
Participants were prompted every 60 seconds with
statements like Imagine entering the shop of your
choice and taking some time to browse and look around
at the selection of food before you and Imagine
preparing your bread and beginning to build your sand-
wich. The full script is available on request.
Measures
Laboratory Measures
A three lead ECG was recorded using Ag-AgCl
disposable electrodes with Biopac PRO Lab software
version 3.6.7 and MP30 Hardware (Linton Instru-
mentation). Data was sampled at 1Khz to ensure
millisecond accuracy of the Inter-Beat Intervals (IBIs).
IBIs were determined off line using the Biopac R-wave
detection algorithm for 3 x 300 second periods
corresponding to baseline and each imagery condition.
All IBIs were manually checked by a researcher to
ensure their accuracy, and to correct missed and ectopic
beats due to the reported effects from such errors
(Berntson et al. 2005). Artefacts were corrected
according to the Task Force (1996) recommendations.
Heart Rate Variability Metrics
Using the artefact corrected ECG data, inter-beat
intervals were measured and from these heart rate was
calculated. CMetx software (Allen et al. 2007) was used
to calculate the SDNN, the standard deviation of inter-
beat intervals, a measure recommended by the Task
Force (1996). This is a global measure of HRV,
reflecting the sum of all of cyclic components
contributing to the variation of inter-beat intervals. This
was chosen as an appropriate measure for pilot work,
which would give good indication as to the likely merit
of further exploration using other measures of HRV.
To obtain measures of HRV reactivity to CFI the
raw HRV metrics corresponding to each condition
(baseline, compassion and control) were used to
calculate participants change in HRV values. These
change values were calculated by subtracting each
participants control imagery HRV value from their CFI
HRV value. (The control imagery HRV value was used
as it attempts to keep constant the possible effects of
mental effort and visualisation on HRV). Since HRV
shows less acute reactivity in individuals with low HRV
(Porges 2007), we adjusted the raw HRV change values
in proportion to the participants baseline value by
expressing HRV change values as a percentage of the
baseline HRV value. These variables, which we will
refer to as HRV change, make the magnitude of HRV
response to imagery comparable between individuals.
Cortisol
Saliva samples were collected using salivettes
(Sarstedt Ltd). The final cortisol sample was optimally
timed to allow for a delay in possible HPA axis response
to CFI (Dickerson & Kemeny 2004). All samples were
frozen before being assayed for cortisol by Obsidian
Research Ltd (Port Talbot, UK) using an Enzyme-
Linked ImmunoSorbent Assay (ELISA).
Self-Report Measures
Participants completed a demographics form, the
following self-report scales and additional questions.
Forms of Self-Criticism/Self-Reassuring Sca-
le (FSCRS) (Gilbert et al. 2004).
This 22-item scale assesses participants thoughts
and feelings about themselves during a perceived
failure. Two subscales measure forms of self-criticising,
(inadequate self and hated self) and one subscale
measures tendencies to be reassuring to the self
(reassured Self). Participants respond on a Likert scale
0  4. The scale has good reliability with Cronbachs
alphas of .90 for inadequate self, .86 for hated self, and
.86 for reassured self (Gilbert et al. 2004).
Self-Compassion Scale (SCS) (Neff 2003)
This 26-item scale assesses levels of self-
compassion. There are three factors of positive self-
compassion: self-kindness, common humanity and
mindfulness, and three factors that focused on a lack of
self-compassion: self-judgement, isolation and over-
identification. Participants indicate how often they
engage in these ways of self-relating on a Likert scale
1  5. The scale has good reliability (Cronbachs alphas
ranging from .75 to .81).
Adult Attachment Scale (Collins & Read 1990)
This 18-item scale measures three attachment
dimensions. Depend measures abilities to depend on
others, anxious measures degree of worry about
abandonment and close measures ease of getting close
to others. Respondents are asked to rate on a Likert
scale 1  5 how characteristic each statement is of them.
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The Cronbachs alphas were 0.75 for depend, 0.72 for
anxiety and 0.69 for close.
Social Safeness Scale (Gilbert et al. submitted)
This 11-item scale was developed to measure the
extent to which people experience their social world as
safe, warm and soothing, and their ability to enjoy
feelings of closeness with others. Each item is scored
on a Likert scale 0  4. This scale had a Cronbachs
alpha of .82.
Depression, Anxiety and Stress Scale (DASS-
21) (Lovibond & Lovibond 1995)
This 21-item shortened version of the DASS-42
consists of three subscales measuring depression,
anxiety and stress. Participants are asked to rate how
much each statement applied to them over the past
week, on a Likert scale 0  4. The DASS-21 subscales
have Cronbachs alphas of .94 for Depression, .87 for
Anxiety and .91 for Stress (Antony et al. 1998).
Results
Analysis was conducted using SPSS version 14.
The data were screened for normality of distribution
and for outliers.
CFI. Some people showed a reduction in HRV
(measured by SDNN) in response to compassion, while
others showed an increase. We felt these were important
differences and therefore split participants into two
groups. Group 1 contains 11 individuals who showed a
reduction in SDNN value from control to CFI (called
Group 1SDNNdowns), while Group 2 contains 11
individuals who showed an increase in SDNN value
during the CFI (called Group 2SDNNups). This equal
number arose by chance.
Means and standard deviations for each
condition and group are reported in Table 1. In addition,
the mean SDNN for each group during each condition
are depicted in Diagram 1.
The SDNN was analysed using repeated measures
ANOVAs to explore the effects of imagery condition
(relaxation, control and compassion) and group (i.e.
whether participants decreased or increased in SDNN
in response to CFI). The SDNN value calculated for
each imagery condition was used as within-subjects
variable, and group was used as a between-subjects
variable. Post hoc t-tests were performed to explore
where any significant differences lay between different
imagery tasks.
The ANOVA showed both a significant main effect
of imagery condition (F(1.15, 23.00) =4.41, p=.042)
and interaction effects with group (F(1.15, 23.00) =5.18,
p=.028). The difference in mean SDNN value between
Group 1SDNNdowns and Group 2SDNNups is apparent at
relaxation and is accentuated during the CFI. However,
the groups are very similar in SDNN during the control
imagery. The implications of this are that for some po-
sitive imagery tasks (e.g. making a sandwich), there
are no discriminatory effects on HRV. However, for
positive imagery associated with affiliative
interpersonal affects (warmth, kindness and social
connectedness) certain individuals responded with a
decrease in HRV whilst others had an increase in HRV.
The post hoc t-test revealed a significant difference
between groups during the CFI (t(20)=-2.20 p=.043).
This is visually represented in Diagram 1.
Cortisol
Cortisol values after relaxation and before CFI
(Cortisol A), and after CFI (Cortisol B) were analysed
using a repeated measures ANOVA, with group as a
between-subjects variable. There was a significant main
effect of imagery on cortisol value (F = 4.54, (df =1,
19) p = .046) but no significant interaction of group.
Post-hoc t-tests revealed a non-significant difference
between the two groups cortisol A values (Group
1SDNNdowns = 5.80ng/ml, Group 2SDNNups = 5.40ng/ml).
Both groups showed a mean cortisol value decrease
after CFI (Group 1SDNNdowns = 5.70ng/ml; Group 2SDNNups
= 4.92ng/ml). However, for Group 2SDNNups this decrease
in cortisol was significant, while for Group 1SDNNdowns
the decrease was non-significant. This greater decrease
in Group 2SDNNups resulted in a significant difference
between the group means for cortisol B (t=2.50, p=
.022) and can be seen clearly in Diagram 2. Cortisol A
correlated negatively with change in cortisol meaning
that the lower a participants initial cortisol value was,
Table 1. Means and standard deviations of SDNN across
conditions for both groups
Condition SDNN
Group1M(SD) Group2M(SD)
Baseline (Relaxation) 55.28 (17.74) 64.06 (23.35)
Compassion imagery 44.61 (17.09) 60.05 (16.44)
Control imagery 53.85 (15.25) 51.51 (18.87)
Participants reported boredom and fatigue
during the second CFI (C2) and therefore we removed
this data as it was unreliable.
Heart rate changes and HRV changes are related
but distinctly different measures. We therefore
performed an ANOVA to determine whether there were
any differences in heart rate between the three
experimental conditions, or between groups. There were
no significant differences, indicating that any changes
in HRV found were not merely a product of changes in
heart rate. Physical demands were kept constant
throughout the study to ensure that any changes in the
measures taken could be attributed to thought induced
alterations of metabolic demand.
Heart Rate Variability
The HRV data showed two opposing responses to
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the bigger their decrease in cortisol during compassion
also was. These results show that for people who had
an increase in HRV during CFI there was a significant
decrease in cortisol. While for those who had a decrease
in HRV during CFI, there was a minimal non-significant
decrease, as would be expected from diurnal rhythm
alone.
Mauchlys test indicated that the assumption of
sphericity was violated for SDNN. Therefore,
Greenhouse-Geisser estimates of sphericity were used
to correct the degrees of freedom. Calculations of effect
size (indicated by partial eta squared) revealed that
effect sizes associated with cortisol measures were
higher (i.e. ω2>.08). than for SDNN (ω2= <.08).
Self-Report Scales
Data were screened for normality of distributions,
skewness values ranged from 0.09 to 1.43 and Kurtosis
values from -0.23 to 1.42. The hated self subscale
derived from the forms of self-criticism and
reassurance scale was skewed and kurtotic. This is
not surprising to find in a non-clinical population due
to a floor effect, and we chose to remove this subscale
from further analyses. T-tests were conducted to
examine differences in self-report scores between
groups 1SDNNdowns and 2 SDNNups. A significant difference
was found between social safeness scores (t=0.03),
with Group 1SDNNdowns having a lower mean score
(38.00) than Group 2SDNNups (44.64). We also noted that
the group differences on the other self-report variables
are all in the predicted directions, however statistical
significance was not reached, possibly a limitation of
the small numbers.
Correlation Analysis
Pearsons correlation coefficients for self-report
scales, cortisol measures, baseline HRV and HRV
change data are given in Table 2.
Change in SDNN was positively correlated with
ability to depend on others (adult attachment scale),
and with the social safeness and pleasure scale (r =
.52, .014 and r = .57, p = .006 respectively). In other
words, HRV response to CFI is linked to peoples
current experiences of themselves in social
relationships. This is further indicated with the
contrasting result that anxious attachment was
negatively correlated with change in SDNN (r = -.48,
p = .025). We also found self-criticism that focuses on
feelings of self-inadequacy was negatively associated
with reduced HRV when trying to engage in CFI (r=-.54).
In addition, although not significant, the ability to be
self-reassuring (r=.36) and self-compassionate (r=.33)
were positively correlated with SDNN change.
Discussion
This study aimed to explore the impact of CFI on
two different physiological measures (HRV and
cortisol) we also explored individual differences
informed by clinical observations that some people find
CFI difficult or threatening (Gilbert 2007). Our data
indicates two key processes. First, CFI does impact on
HRV. Some people show a clear increase in HRV,
whereas others show a more threat-like response with
a reduction in HRV. We also found that those individuals
who showed elevated HRV to compassionate imagery
experienced a drop in cortisol, indicative of a soothing
effect on the HPA axis. In contrast, those who showed
a reduction in HRV experienced a non-significant
cortisol change. There is research suggesting that some
individuals with secure attachments, typically engage
in soothing images and memories of feeling cared for
and these can aid emotional regulation (Baldwin 2005,
Mikulincer & Shaver 2007). Buddhism also specifically
focuses on training people in CFI (Leighton 2003).
It appears that different people have different
physiological responses to CFI. So the question is to
try to identify the sources of these differences. Why do
some people benefit from CFI and experience it as
soothing while others appear threatened? We explored
this with self-report measures. The self-report data
suggests that peoples experiences of CFI are related
to current experiences of social safeness; Group 2SDNNups
had higher mean scores of social safeness. Although
other self-report measures did not show significant
differences between the two groups, all differences
showed trends in the expected directions (e.g. Group
1SDNNdowns had higher mean scores of self-criticism, self-
coldness, anxious attachment and psychopathologies;
whilst Group 2SDNNups had higher mean scores of self-

















































Table 2. Correlations between change in HRV measures and self-report scales
Note for readers interested in the results of other HRV metrics: RMSSD change also showed a correlation with the Depend
attachment subscale (r = .44, p =.043), Toichis Cardiac Vagal Index change also showed positive correlations with the Depend
attachment subscale (r = .45, p =.034), Toichis Cardiac Sympathetic Index also showed a significant correlation with the social
safeness and pleasure scale (r = .45, p =.035)
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others and experience close relationships). This would
fit with Gilberts (1989) concepts of a safeness system
and Porges (2003, 2007) view that higher HRV is linked
to interpersonal approach and socially adaptive
behaviours.
Further evidence for this link was revealed in the
pattern of correlations. A significant positive correlation
was found between change in SDNN during CFI and
social safeness and ability to depend on others. In
contrast, anxious attachment was negatively associated
with SDNN change; in other words, anxious attachers
may find CFI more threatening. The data raises
important implications for psychotherapy (Gilbert &
Irons 2005; Gilbert & Procter 2006). The differences
in HRV response seen between participants reflect
clinical observations; that for some people (particularly
self-critics and those scoring low in social safeness),
focusing on compassion can at first be unfamiliar,
threatening and feel unsafe (Gilbert 2007; Gilbert &
Irons 2005; Gilbert et al. 2006). Self-critics often report
feeling reluctant to let go of their self-criticism for
fear of their standards slipping; that they might
become selfish or arrogant, or that it constitutes a
change to self-identity. They can also fear compassion
because they feel they do not deserve compassion or
because it is unfamiliar, triggers sadness, or it is
frightening to let others (even imagined ones) get close
(Gilbert & Procter 2006).
It is unclear which aspects of compassion are
particularly threatening because our CFI involved
experiencing acceptance, loving kindness, warmth, and
compassion. Clinically, people often experience sadness
and grief when their attachment systems are activated
(Bowlby 1969, 1980). Compassionate imagery involves
activating these systems and drawing on emotional
memories of attachment (Gilbert 2007). The finding
that self-criticism was linked to an SDNN decrease
when engaging in CFI provides further support that self-
critics may find CFI difficult at first, this could also be
related to a lack of compassionate memories on which
to draw. This difficulty, and/or negative response to
feeling compassion for the self, can be a barrier to the
development of self-compassion, and could also be a
cause of the HRV decrease seen in Group 1SDNNdowns.
This suggestion fits with data by Segerstrom and
Solberg Nes (2007) who found HRV decreases to be
associated with self-regulatory processes, such as
inhibition of emotion.
A number of authors have noted that self-criticism
is a major vulnerability factor for low mood and
psychopathologies (Whelton & Greenburg 2005). Both
criticism from others (Dickerson & Kemeny 2004) and
self-criticism is linked to HPA axis arousal and cortisol
release (Mason et al. 2001). Gilbert (2007) suggests
that chronic self-criticism continually stimulates the
threat system thus having a detrimental impact on po-
sitive affect.
We concentrated on reporting the SDNN as
recommended by the global HRV metric Task Force,
(1996). However, there are other methods for exploring
the periodic processes involved in HRV, which may
shed more light on the relationships indicated by this
study. Second, we did not measure respiration or muscle
tension, and consequently the HRV changes could be
attributable to changes in breathing rate/depth, or
muscle tension. However, physical demands were kept
constant throughout the study making this unlikely.
Yet to be explored is whether training and working
through the fears and blocks to self-compassion, will
impact on HRV and other neurophysiological processes
linked to social soothing, and if this methodology could
be adapted for evaluating psychotherapies. Given the
increasing interest in compassion as a therapeutic aid,
further research into the neurophysiological mediators
and effects of compassion, may indicate ways of
developing psychotherapeutic techniques (Gilbert &
Irons 2005).
Acknowledgments
The authors would like to thank Linton
Instrumentation (Diss, Suffolk) for their facilitative
attitude and help with using Biopac software. This work
was undertaken by the Mental Health Research Unit who
received a proportion of its funding from the Department
of Health. The views expressed in this publication are those
of the authors and not necessarily those of the Department
of Health.
References
Appelhans BM & Luecken LJ (2006). Heart rate variability as
an index of regulated emotional responding. Review of
General Psychology 10, 229-240.
Allen JJB, Chambers AS & Towers DN (2007). The many metrics
of cardiac chronotropy: A pragmatic primer and brief
comparison of metrics. Biological Psychology 74, 243-262.
Antony MM, Bieling PJ, Cox BJ, Enns MW & Swinson RE
(1998). Psychometric properties of the 42-item and 21-
item versions of the depression anxiety stress scales in
clinical groups and a community sample. Psychological
Assessment 10, 176-181.
Arbuthnott KD, Arbuthnott DW & Rossiter L (2001). Guided
imagery and memory: Implications for psychotherapies.
Journal of Counselling Psychology 48, 123-132.
Baldwin MW (Ed) (2005). Interpersonal Cognition. Guilford,
New York.
Berntson GG, Lozano DL & Chen YJ (2005). Filter properties
of root mean square successive difference (RMSSD) for
heart rate. Psychophysiology 42, 246-252.
Bowlby J (1969). Attachment and Loss: Attachment, vol. 3. Basic
Books, New York.
Bowlby J (1980). Loss: Sadness and Depression. Attachment
and Loss, Vol. 3. Hogarth Press, London.
Carter CS (1998). Neuroendocrine perspectives on social
attachment and love. Psychoneuroendorinlogy 23, 779-
818.
Collins NL & Read SJ (1990). Adult attachment, working models
and relationship quality in dating couples. Journal of
Personality and Social Psychology 58, 644-663.
Depue RA & Morrone-Strupinsky JV (2005). A neurobehavioral
model of affiliative bonding: Implications for conceptua-
lizing a human trait of affiliation. Behavioural and Brain
Sciences 28, 313-350.
Dickerson SS & Kemeny ME (2004). Acute stressors and cortisol
response: A theoretical integration and synthesis of
laboratory research. Psychological Bulletin 130, 335-39.
Frederick C & McNeal S (1999). Inner Strengths: Contemporary
Psychotherapy and Hypnosis for Ego Strengthening .
Lawrence Erlbaum Associates, Mahwah, NJ.
378
139
Heart Rate Variability and Salivary Cortisol Responses to Compassion-Focused Imagery
Clinical Neuropsychiatry (2008) 5, 3
Gilbert P (1989). Human Nature and Suffering. Lawrence
Erlbaum Associates, London.
Gilbert P (1993). Defence and safety: Their function in social
behaviour and psychopathology. British Journal of Clinical
Psychology 32, 131-153.
Gilbert P (2000). Social mentalities: Internal social conflicts
and the role of inner wamth and compassion in cognitive
therapy In Gilbert P, Baily KG (Eds). Genes on the Couch:
Explorations in Evolutionary Psychotherapy. Brunner-
Routledge, Hove, pp.118-50.
Gilbert P (2007). Psychotherapy and Counseling for Depression.
Sage, London.
Gilbert P & Irons C (2004). A pilot exploration of the use of
compassionate images in a group of self-critical people.
Memory 12, 507-516.
Gilbert P & Irons C (2005). Focused therapies and compassionate
mind training for shame and self-attacking In Gilbert P
(Ed) Compassion: Conceptualisations, Research and Use
in Psychotherapy. Routledge, London, pp. 263-325.
Gilbert P & Procter S (2006). Compassionate mind training for
people with high shame and self criticism: Pilot study of a
group therapy approach. Clinical Psychology and
Psychotherapy 13, 353-379.
Gilbert P, Clarke M, Hempel S, Miles JNV & Irons C (2004).
Criticizing and reassuring oneself: An exploration of forms
style and reasons in female students. British Journal of
Clinical Psychology 43, 31-50.
Gilbert P, Baldwin M, Irons C, Baccus J & Palmer M (2006).
Self-criticism and self-warmth: An imagery study exploring
their relation to depression. Journal of Cognitive
Psychotherapy: An International Quarterly 20, 183-200.
Gilbert P, McEwan K, Mitra R, Mills A, Bellew R, Irons C, Gale
C & Legg L (submitted). Safeness and two types of positi-
ve affect. Cognition and Emotion.
Hall E, Hall C, Stradling P & Young D (2006). Guided Imagery:
Creative Interventions in Counselling and Psychotherapy.
Sage, London.
Holmes E, Arntz A & Smucker M (2007). Imagery rescripting
in cognitive behaviour therapy: Images, treatment
techniques and outcomes. Journal of Behavior Therapy
and Experimental Psychiatry 38, 297-305.
Kirsch P, Esslinger C, Chen Q et al. (2005). Oxytocin modulates
neural circuitry for social cognition and fear in humans.
The Journal of Neuroscience 25, 11489-11493.
Lovibond SH & Lovibond PF (1995). Manual for the Depression
Anxiety Stress Scales, 2nd Ed. Sidney Psychology
Foundation.
Leighton TD (2003). Faces of Compassion: Classic Bodhisattva
Archetypes and their Modern Expression. Boston, Wisdom
Publications.
Mason JW, Wang S, Yehuda R, Riney S, Charney DS &
Southwick SM (2001). Psychogenic lowering of urinary
cortisol levels linked to increased emotional numbing and
a shame-depressive syndrome in combat-related
posttraumatic stress disorder. Psychosomatic Medicine 63,
387-401.
Mikulincer M & Shaver PR (2007). Attachment in Adulthood:
Structure, Dynamics, and Change. Guilford, New York.
Neff K (2003). Self-compassion: An alternative conceptua-
lization of a healthy attitude toward oneself. Self and
Identity 2, 85-102.
Osumi T, Shimazaki H, Imai A, Sugiura Y, Ohira H (2006).
Psychopathic traits and cardiovascular responses to
emotional stimuli. Personality and Individual Differences
42, 1391-1402.
Porges S (2003). The Polyvagal theory: phylogenetic
contributions to social behaviour. Physiology & Behavior
79, 503-513.
Porges SW (2007). The polyvagal perspective. Biological
Psychology 74, 116-143.
Rector NA, Bagby RM, Segal ZV, Joffe RT & Levitt A (2000).
Self-criticism and dependency in depressed patients treated
with cognitive therapy or pharmacotherapy. Cognitive
Therapy & Research 24, 571-584.
Segerstrom SC & Solberg Nes L (2007). Heart rate variability
reflects self- regulatory strength, effort, and fatigue.
Psychological Science 18, 275-281.
Singer JL (2006). Imagery in Psychotherapy. American
Psychological Press, Washington DC.
Takahashi T, Murata T, Hamada T, Omori M, Kosaka H, Kikuchi
M, Yoshida H & Wada H (2005). Changes in EEG and
autonomic nervous activity during meditation and their
association with personality traits. International Journal
of Psychophysiology 55, 199-207.
Task Force of the European Society of Cardiology and the North
American Society of Pacing and Electrophysiology (1996).
Heart rate variability: Standards of measurement,
physiological interpretation, and clinical use. Circulation
93, 1043-1065.
Thayer J & Lane RD (2007). The role of vagal function in the
risk for cardiovascular disease and mortality. Biological
Psychology 74, 224-242.
Wang S (2005). A conceptual framework for integrating research
related to the physiology of compassion and the wisdom
of Buddhist teachings. In Gilbert P (Ed) Compassion:
Conceptualisations, Research and Use in Psychotherapy.
London, Routledge, pp. 75-120.
Wheatley J, Brewin CR, Patel T, Hackmann A, Wells A, Fischer
P & Myers S (2007). Ill believe it when I see it: Imagery
re-scripting of intrusive sensory memories. Journal of
Behaviour Therapy and Experimental Psychiatry 39, 371-
385.
Whelton WJ & Greenberg LS (2005). Emotion in self-criticism.
Personality and Individual Differences 38, 1583-1595.
Zuroff DC, Santor D & Mongrain M (2005). Dependency, self-
criticism, and maladjustment. In Auerbach JS, Levy KN,
Schaffer CE (Eds) Relatedness, self-Definition and Mental
Representation: Essays in Honour of Sidney J. Blatt.
London, Routledge, pp.75-90.
379
